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iabetes mellitus is a major public health problem in the developed as 
well as developing countries. It is a silent killer that kills 1 person 
every 8 seconds in the world and 4 million persons a year.  The 
prevalence of diabetes for all age groups worldwide was estimated to be 2.8% 
in 2000 and 4.4% in 2030. The total number of people with diabetes is 
projected to rise from 171 million in 2000 to 366 million in 2030. Its 
prevalence is higher in men than women, but there are more women suffering 
from diabetes than men. The urban population in developing countries is 
projected to double during this period (King, 1997).The most important 
demographic change to diabetes prevalence across the world appears to be the 
increase in the proportion of people > 65 years of age (Wild et al., 2004).  
As per a study done in the year 2008 in SKIMS Soura, Srinagar, 2.5% had 
diabetes in the productive age, 25% were prediabetes i.e., 1 in every 4 persons 
had prediabetes. 
Hyperglycaemia is one of the common manifestations of diabetes. Chronic 
hyperglycaemia causes damage to the eyes, kidneys, nerves, heart and blood 
vessels (Davidson et al., 1995).  The etiology and pathophysiology leading to 
hyperglycaemia, however, show marked differences among patients with 
diabetes mellitus, warranting different preventive strategic, diagnostic 
techniques and treatment methods (Susman & Helseth, 1997). Large-vessel 
atherosclerosis is the most common cause of death in diabetics.  
The new classification system identifies four types of diabetes mellitus i.e. 
Type I, Type II, Gestational Diabetes and other specific types of diabetes 
mellitus.  
Type I Diabetes Mellitus- IDDM (Insulin Dependent Diabetes Mellitus), is 
characterized by beta cell destruction caused by an autoimmune process usually 
leading to absolute insulin deficiency. The onset is usually acute, developing 
over a period of a few days to weeks. Over 95% of persons with Type I diabetes 
mellitus develop the disease before the age of 25, with an equal incidence in 
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both and an increased prevalence in the white population (Alberti & Zimmet, 
1998). 
Type II Diabetes Mellitus- NIDDM (Non- Insulin Dependent Diabetes Mellitus) is 
characterized by insulin resistance in peripheral tissue and an insulin secretory 
defect of the beta cells. This is the most common form of diabetes mellitus and 
is highly associated with a family history of diabetes, older age, obesity and lack 
of exercise (Davidson, 1986). 
 Gestational Diabetes mellitus identifies women who develop diabetes 
mellitus during gestation. However, most women classified with gestational 
diabetes mellitus have normal glucose homeostasis during the first half of the 
pregnancy and develop a relative insulin deficiency during the last half 
of the pregnancy, leading to hyperglycaemia (Davidson, 1986). 
Specific types of diabetes mellitus are of various known etiologies. This group 
includes persons with genetic defects of beta-cell function or with defects of 
insulin action,  with diseases of the exocrine pancreas such as pancreatitis, 
dysfunction associated with other endocrinopathies (e.g. acromegaly) and 
pancreatic dysfunction caused by drugs, chemicals or infections (Davidson, 1986). 
Different model systems are available to screen the antidiabetic activity of 
a given substance. In the in- vivo models, chemicals like alloxan and 
streptozotocin are used to produce marked diabetic effects in animals 
(Szkudelski, 2001). Alloxan diabetic model resembles Type I diabetes (IDDM) 
without significant insulin resistance whereas streptozotocin  induced 
diabetic animals exhibit reduced response to insulin in hepatic and 
peripheral tissues. Further, rats treated with streptozotocin display many 
of the features seen in humans with uncontrolled diabetes mellitus 
(Chattopadhyay et al., 1997). 
An ideal oral treatment for diabetics would be a drug that not only 
controls the glycemic level but also prevents the  development of 
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atherosclerosis and other complications of diabetes. Previously, insulin was 
considered the only drug for the control of diabetes. Unfortunately, among the 
currently available drugs, the choice is very limited.  
Although presently many classes of drugs like insulin secretagogues (sulfonyl 
ureas, meglitinides, D-phenylalanine derivatives), biguanides, 
thiazolodinediones, alpha glucosidase inhibitors etc. are available, usually they 
are associated with side effects. 
In the indigenous system of medicine (Ayurvedic, Unani, etc.) large number of herbs 
and herbal formulations have been tried in the treatment of diabetes mellitus 
(Chopra, 1955; 1966). Some of them include Aconitum napeilus, Allium cepa, 
Allium sativum, Ficus bengatanesis, Momordia charantia, Ocimum sanctum, and 
Trigonella foecum graecum (Satyawati, 1984; Sharma et al., 1990). 
Portulaca oleracea (Purslane) (Family: Portulaceae), commonly known as 
Nunar in Kashmir, is a succulent, prostrate herb, with fleshy leaves and 
flowers. It is found growing abundantly all over India and is eaten as a leafy 
vegetable(Yang et al., 2007;2009). It contains more omega-3-fatty acids than 
any other leafy vegetable plant. Besides vitamins (mainly vitamin C, 
vitamin B), carotenoids and dietary minerals have been reported (Burkill et 
al., 1997). Some alkaloid pigments (Zijuan et al., 2009) large amounts of 
norepinephrine, a neurohormone that has vasopressor and hypertensive 
activities have been reported in in this plant. Other constituents include 
dopamine, coumarins, flavonoids, saponins and urea (Leung & Foster, 1996). It 
is reported to have analgesic (Islam et al., 1998), tumour inhibiting (Yoon et 
al., 1999) and wound healing activity (Rashed et al., 2003). Portulaca 
oleracea has been claimed to possess anti diabetic activity in traditional 
system of medicine but no systematic, scientific work has been done to 
prove this activity.  
Eriobotrya japonica (Family: Rosaceae) popularly known as loquat is a type of 
fruit tree, similar to an evergreen tree in appearance. Loquat fruits are 
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considered a delicacy in some Asian nations. It contains malic acid, tartaric 
acid, citric acid, tannate, carotene and vitamins, etc. Its leaves and kernel 
contains amygdalin, benzaldehyde, caffeic acid, oleanic acid, rutin, tormentic 
acid and urosolic acid (El-Hossary et al., 2000). It has been reported to 
lower blood glucose levels of normal and alloxan induced diabetic rabbits 
(Wadood et al., 1988). Hypoglycaemic activity of loquat leaf  has  shown that 
sesquiterpene glycosides and polyhydroxylated  triterpenes are responsible for 
hypoglycaemic action (Tommasi et al., 1991; Chen et al., 2008). However 
no antidiabetic work has so far been conducted in India on loquat fruit and 
seeds. 
Both Portulaca oleracea and Eriobotrya japonica are found abundantly in 
Kashmir so  the present research work entitled “Study of anti diabetic 
activity of some locally available plants in animals  and their toxici ty 
evaluation  studies” using alloxan and streptozotocin as the agents for 
inducing diabetes, was conducted in experimental animals to scientifically 
validate their antidiabetic activity.       
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2.1 DIABETES MELLITUS 
The  term  Diabetes,  coined  by  Aretaeus  of  Cappadocia,  is   derived  from  the  
Greek  word, ―diabainein‖  that   literally  means  ―passing  through,  or  siphon‖,  a 
reference  to  one  of  diabetes  major    symptoms-  excessive  urine  production. 
Diabetes is classified into diabetes mellitus and diabetes insipidus. Diabetes  
insipidus is characterized  by the  persistent  excretion  of  excessive  quantities  of  
dilute  urine  and   by  thirst because of  deficiency  of  production of  ADH, a  
hormone  secreted  by  posterior  pituitary gland.    Diabetes  mellitus is a  metabolic 
disorder  characterised  by  resistance  to  the  action  of  insulin,  insufficient  insulin  
secretion, or both. The clinical manifestation of diabetes mellitus is hyperglycaemia 
i.e., high glucose blood sugar (Davidson et al., 1995; James et al., 2006). 
It is becoming one of the most common diseases of the world (King, 1997). Today  
in India  alone  there  are  more  than 4  crore  diabetics  and  the number  is  going  to  
be  around  9  crore  by  2030 (Sarah et al., 2004). Its prevalence in India has risen 
from 1.2% to 11% over the last three decades (Pradeep, 2002). Over 7.20 lakh 
Indians die every year due to diabetes. It  is  the  most  common  cause  of  
amputation  and is   responsible  for  over  1  million  amputations  each  year. People  
with  this  disease  are  2-4  times  more  likely  to  develop  heart   diseases (Wild et 
al., 2004). 
A  study  conducted  by  Department  of  Endocrinology Sher-e-Kashmir  Institute  of  
Medical  Sciences (SKIMS),  Srinagar  has   revealed  that  8%  adult  Kashmiris  are 
suffering  from   diabetes   mellitus. Another  study  from   SKIMS  reveals  26.5% 
prevalence  of  prediabetic  state  in  Kashmiri  adults  aged  40  years  or   more 
(Zarger et al., 1999; 2000; Javid et al., 2011). 
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2.1.1 Cause 
Normal glucose metabolism and homeostasis 
In humans, blood glucose is tightly regulated by homeostatic mechanisms and 
maintained within a narrow range of 3.5-6.5 mmol/l. A balance is preserved  between  
the entry of glucose into the circulation from the liver, supplemented  by  intestinal   
absorption  after   meals,  and  glucose  uptake  by  peripheral  tissues, particularly  
skeletal  muscle. A continuous  supply  of   glucose  is essential  for the   brain  which  
uses  glucose  as its  principal   metabolic  fuel. When  intestinal  glucose  absorption   
declines  between  meals,  hepatic  glucose   output  is   increased  in response  to the  
counter-regulatory hormones glucagon  and adrenaline,  and   it   falls  during  
prolonged starvation  as  other  metabolic  fuels   derived   from   fat  become    more 
important. The liver produces glucose by gluconeogenesis and glycogen   
breakdown. The main substrates for gluconeogenesis are shown in the Fig. 1a, 1b. 
Insulin is the only anabolic hormone that has profound effects on the metabolism of 
carbohydrates, fat and protein.  
 
 
 
 
 
 
 
 
 
Fig 1 a: Major Glucoeogenic substrates and their tissues of origin. Insulin suppresses gluconegenesis and 
promotes glycogen synthesis and storage. It promotes the Peripheral uptake of glucose, particularly 
in skeletal muscle, and encourages storage (as muscle glycogen) and protein synthesis. It also 
pramotes lipogenesis and suppresses lipolysis. These processes are reversed in the absence of insulin 
(NEFAS- Non esterified fatty acids)  
                                                           (Adapted   from   Frier BM 2002) 
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Metabolic effects of Insulin are shown in the table (Table 1). 
Table 1: Metabolic effects of Insulin 
Increase (Anabolic Effects) Decrease (Anticatabolic Effects) 
Carbohydrate  metabolism                                               
Glucose  transport  (muscle, 
adipose  tissue)                            
Glucose  phosphorylation                                                         
Glycogenesis 
Glycolysis 
Pyruvate  dehydrogenase  
activity 
Pentose  phosphate  shunt 
Lipid   metabolism 
Triglyceride  synthesis                                                            
Fatty  acid  synthesis (liver)                                           
Lipoprotein   lipase  activity                               
(adipose  tissue) 
Protein  metabolism 
Amino  acid   transport                                                            
Protein  synthesis 
 
Gluconeogenesis 
Glycogenolysis 
 
 
 
 
 
Lipolysis 
Lipoprotein  lipase (muscle) 
Ketogenesis 
Fatty  acid  oxidation (liver) 
 
 
Protein  degradation 
(Adapted from Frier BM, 2002) 
Insulin is secreted from pancreatic beta cells into the portal circulation with a brisk 
increase in response to a rise in blood   glucose (after meals).  A glucose   sensor has 
been identified in the portal vein which modulates insulin secretion via neural 
mechanisms. Some characteristics   of normal   insulin   can be seen in the   Table 1. 
Insulin lowers blood glucose by suppressing hepatic glucose production and 
stimulating peripheral glucose uptake in skeletal muscle and fat, mediated by the 
glucose transporter, GLUT 4 (Frier BM, 2002). 
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Fig 1 b: Pancreatic structure and endocrine function. The normal adult pancereas contains about 1 mlllion 
islets which re scattered throughout the exocrine parenchyma. On staining with haemotoxylin and 
eosin the islet in the centre is identified by its distinct morphology and lighter staining than the 
surrounding exocrine tissue. The core of each islet consists of beta cells the produce insulin, and is 
surrounded by a cortex of endocrine cells that produce oter hormones including glucagons (alpha 
cells,) somatostatin (delta Cells) and pancereatic polypeptide (PP Cells)  
                                                                 (Adapted from FrierBM2002). 
Adipocytes and the liver synthesize triglyceride from   non-esterified   fatty acids 
(NEFAs)   and    glycerol. Insulin   stimulates   lipogenesis and   inhibits   lipolysis, 
so preventing fat catabolism (Davidson, 1986). Lipolysis, mediated by triglyceride   
lipase, is stimulated   by catecholamines   and   liberates NEFAs   which   can   be   
oxidised by many tissues. Their  partial   oxidation   in the   liver  provides   energy   
to   drive    gluconeogenesis   and   also   produces   ketone   bodies (acetoacetate,  
which   can  be   reduced  to  3- hydroxybutyrate   or  decarboxylated  to acetone)   
which   are  generated   in hepatocyte   mitochondria. Ketone  bodies   are  organic  
acids  which, when  formed  in  small  amounts, are  oxidised  and  utilised  as  
metabolic  fuel (WHO Report, 1980). However, the  rate  of   utilization  of  ketone   
bodies  by  peripheral  tissues  is  limited,  and  when  the  rate  of  production  by  the  
liver  exceeds  their   removal, hyperketonaemia  results. Ketogenesis  is  regulated  
by   the  supply  of  NEFAs  reaching  the   liver  and is  therefore  enhanced  by  
insulin  deficiency  and  release  of  the   counter-  regulatory  hormones  that  
stimulate  lipolysis. 
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2.1.2. Types 
Different types of Diabetes Mellitus include: 
 Type I  
 Type II 
 Gestational Diabetes 
 Other Types.      
2.1.2.1. Type I   
Type I  diabetes  mellitus, formerly  known  as  insulin- dependent  diabetes mellitus 
(IDDM), childhood  diabetes,  or  juvenile- onset  diabetes- is  characterized  by  loss  
of  the  insulin- producing beta cells  of the islets  of Langerhans  of  the  pancreas  
leading  to  deficiency   of  insulin.  There  is  no  known  preventative  measure    
which  can  be  taken  to  avoid  type I  diabetes.  Most  people  affected  by  type I  
diabetes  are  otherwise  healthy   when  onset  occurs. Diet  and  exercise  cannot  
reverse  or  prevent  type I  diabetes.  Sensitivity  and  responsiveness  to  insulin  are  
usually  normal,  especially  in  the  early  stages.  This  type  of  diabetes can affect  
children  or  adults,  & has  traditionally  been  termed  ―  juvenile  diabetes‖  because  
it  represents a  majority of  cases of diabetes  affecting  children (Alberti & 
Zimmet, 1998)   
The most  common  cause  of  beta cell  loss  leading  to  type I  diabetes  is  
autoimmune  destruction, accompanied  by  antibodies  directed  against  insulin  and  
islet  cell  proteins and  antibodies  to   glutamic  acid   decarboxylase.  The  principal  
treatment of type I  diabetes,  even  from  the  earliest  stages,  is  replacement  of  
insulin. Without insulin, ketosis and   diabetic    ketoacidosis can develop and coma 
or   death    will   result (Frier BM, 2002) 
The average  glucose  level  for  the  type I patient  should  be  as   close  to   normal 
(80-120 mg/dl, 4-6 mmols/l )  as possible.  Some  physicians  suggest  up  to 140-
150mg/dl (7-7.5 mmols/l)  for  those  having  trouble  with  lower  values,  such  as  
frequent  hypoglycaemic  events. Values  above  200mg/dl (10mmols/l)  are  often  
accompanied  by  discomfort  and  frequent  urination   leading  to  dehydration. 
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Values  above  300mg/dl (15mmols/l)  usually  require  immediate  treatment  and  
may  lead  to  ketoacidosis. Low  levels   of  blood  glucose,  called  hypoglycaemia,  
may  lead  to  seizures  or  episodes  of  unconsciousness (Mayfield, 1998) 
2.1.2.2 Type II 
Previously  known as  adult- onset  diabetes,  maturity- onset  diabetes, or  non-
insulin  dependent   diabetes  mellitus (NIDDM) (Stamler, 1993), it is due to a  
combination of  defective  insulin  secretion and  defective  responsiveness to  insulin 
(often  termed  insulin  resistance or  reduced  insulin  sensitivity),  almost  certainly  
involving  the  insulin  receptor in  cell  membranes (Chan  et al., 1994).   In early  
stages,  the  predominant  abnormality is  reduced  insulin  sensitivity,   characterized  
by  elevated  levels  of  insulin  in the  blood.  In the early  stages, hyperglycaemia  
can  be  reversed  by a  variety  of  measures  and  medications  that  improve  insulin  
sensitivity  or  reduce  glucose  production  by the  liver,  but  as the  disease  
progresses  the  impairment of  insulin  secretion  worsens,  and therapeutic  
replacement  of  insulin  often  becomes  necessary. Numerous  theories  have been 
put  forth  as to  the  exact  cause  and   mechanism  for  this  resistance,  but  central  
obesity  (fat concentrated around the waist in relation  to  abdominal  organs,  is 
known  to predispose for  insulin  resistance,  possibly  due to its  secretion  of  
adipokines (a group  of  hormones)  that impair  glucose  tolerance (Joshi, 2003). 
Abdominal fat is especially active hormonally. Obesity  is  found in approximately  
90%  of  developed  world  patients  diagnosed  with  type II  diabetes. Other  factors  
may  include  aging  and   family  history,  although in the  last decade it  has  
increasingly begun to  affect  children and  adolescents. In addition, hypertension, 
dyslipidemia, high  triglyceride  levels  and  low  HDL- cholesterol  levels  and  
elevated  inhibitor  plasminogen  activator -1( PAI-1)  levels  are  often  present  in  
these  individuals (Mohan  et al ., 2005). 
This  clustering  of  abnormalities  is  referred  to  as the  ―insulin  resistance  
syndrome‖ or the  ―metabolic  syndrome.‖ It is the association of insulin resistance 
with a clustering of cardiovascular risk factors including hyperinsulinemia, 
hypertension, abdominal obesity, dyslipidemia, and coagulation abnormalities (Deo 
et al., 2006). 
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Type II diabetic individuals are characterized by:  
 Impaired insulin secretion 
 Insulin resistance involving muscle, liver and the adipocyte. Insulin 
resistance is present even in lean type II diabetic individuals (Zimmer, 1982; 
Abate & Chandila, 2001). 
a) Normal Insulin Action 
In the fasting state 75% of total body glucose disposal takes place in non-insulin 
dependent tissues: the brain and splanchnic tissues (liver and gastrointestinal tissues). 
In fact, brain glucose uptake occurs at the same rate during fed and fasting periods 
and is not altered in type II diabetes. The remaining 25% of glucose metabolism 
takes place in muscle, which is dependent on insulin. In the fasting state 
approximately 85% of glucose production is derived from the liver, and the amount 
is produced by the kidney. In the fed state, carbohydrate ingestion increases the 
plasma glucose concentration and stimulates insulin release from the pancreatic β 
cells. The resultant hyperinsulinemia (1) suppresses hepatic glucose production and 
(2) stimulates glucose uptake by peripheral tissues. The majority (~80% to 85%) of 
glucose that is taken up by peripheral tissues is disposed off in muscle, with only a 
small amount (~4% to 5%) is being metabolized by adipocytes. Although fat tissue is 
responsible for only a small amount of total body glucose disposal, it plays a very 
important role in the maintenance of total body glucose homeostasis. Small 
increments in the plasma insulin concentration exert a potent antilipolytic effect, 
leading to a marked reduction in the plasma free fatty acid (FFA) level. The decline 
in plasma FFA concentration results in increased glucose uptake in muscle and 
reduces hepatic glucose production. Thus a decrease in the plasma FFA 
concentration lowers plasma glucose by both decreasing its production and 
enhancing the uptake in muscle (Frier BM, 2002). 
b) Impaired Insulin Secretion 
The pancreas in people with a normal-functioning β cells is able to adjust its 
secretion of insulin to maintain normal glucose tolerance. Thus in nondiabetic 
individuals, insulin are increased in proportion to the severity of the insulin resistance 
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and glucose tolerance remains normal. In  Type  II  diabetic   patient  impaired  
insulin  resistance  and  the   evolution of  beta cell dysfunction   has been  well 
established. 
c) Site of Insulin Resistance in Type II Diabetes 
 Liver 
In type II diabetic subjects with mild to moderate fasting hyperglycemia (140 to 200 
mg/dL, 7.8 to 11.1 mmol/L), basal hepatic glucose production is increased by ~0.5 
mg/kg per minute. Consequently, during the overnight sleeping hours the liver of an 
80-Kg diabetic individual with modest fasting hyperglycemia adds an additional 35 g 
of glucose to the systematic circulation. This increase in fasting hepatic glucose 
production is the cause of fasting hyperglycemia. Following glucose ingestion, 
insulin is secreted into the portal vein and carried to the liver, where it suppresses 
hepatic glucose output.  (Li et al., 2002). 
 Peripheral (Muscle) 
Muscle is the major site of glucose disposal in man, and approximately 80% of total 
body glucose uptake occurs in skeletal muscle. In response to a physiologic increase 
in plasma insulin concentration, muscle glucose uptake increases linearly, reaching a 
plateau value of 10 mg/kg per minute. In contrast, in lean type II diabetic subjects, 
the onset of insulin action is delayed for ~40 minutes, and the ability of insulin to 
stimulate glucose uptake is reduced by 50%. Therefore the primary site of insulin 
resistance in type II diabetic subjects resides in muscle tissue (Frier BM, 2002). 
 Peripheral (Adipocyte) 
In obese non diabetic and diabetic humans, basal plasma FFA levels are increased 
and fail to suppress normally after glucose ingestion. FFAs are stored as triglycerides 
in adipocytes and serve as an important energy source during conditions of fasting. 
Insulin is a potent inhibitor of lipolysis, and restrains the release of FFAs from the 
adipocyte by inhibiting the hormone-sensitive lipase enzyme. It is now recognized 
that chronically elevated plasma FFA concentrations can lead to insulin resistance in 
muscle and liver, and impair insulin secretion. In addition to FFAs that circulate in 
plasma in increased amounts, type II diabetic and obese nondiabetic individuals have 
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increased stores of triglycerides in muscle and liver, and the increased fat content 
correlates closely with the presence of insulin resistance in these tissues (Frier BM, 
2002). 
In obese individuals and in the majority (>80%) of type II diabetic subjects, there is 
an expanded fat cell mass and the adipocytes are resistant to the antilipolytic effects 
of insulin. Most obese and diabetic individuals are characterized by expanded 
visceral adiposity, which is especially refractory to insulin effects and results in a 
high lipolytic rate. Both type II diabetes and obesity are characterized by an elevation 
in the mean 24-hour plasma FFA concentration. Elevated plasma FFA levels, as well 
as increased triglyceride/ fatty acyl CoA content in muscle, liver lead to the 
development of muscle/hepatic insulin resistance and impaired insulin secretion. 
2.1.2.3 Gestational diabetes mellitus 
Gestational diabetes, defined as hyperglycaemia diagnosed for the first time in 
pregnancy, is a common problem. It occurs in individuals who have an inherited 
predisposition to develop diabetes and may take the form of either type I or type II 
diabetes. The hyperglycaemia may not disappear after delivery. It is associated not 
only with increased rates of perinatal mortality and neonatal morbidity but also with 
a high incidence (possibly as great as 80% at 25 years postpartum) of subsequent 
clinical diabetes (both type I and type II) in the mother. Normalisation of 
metabolism, whether by treatment with dietary measures alone or, more commonly, 
with additional treatment in the form of insulin, undoubtedly reduces the fetal risk; 
its effect on diminishing the maternal risk of subsequent diabetes is less certain 
(Frier BM, 2002). 
Gestational diabetes mellitus occurs in   about 2-5% of all pregnancies.  It  is  
temporary,  and  fully  treatable,  but  if  untreated,  may  cause  problems   with    the  
pregnancy,  including  macrosomia (high  birth  weight)  of  the  child. It requires 
careful    medical supervision during the pregnancy (Frier BM, 2002). Fetal/ 
Neonatal  risks  associated  with  GDM (Gestational diabetes mellitus) include  
congenital  anomalies  such  as  cardiac,  CNS and  skeletal  muscle malformations, 
increased fetal insulin, fetal surfactant production and cause respiratory distress 
syndrome. Hyperbilirubinemia may result from RBC destruction. In  severe  cases  
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perinatal  death  may  occur,  most  commonly  as a  result  of  poor  placental  
profusion  due  to  vascular  impairment (Mayfield, 1998). 
2.1.2.4 Other types 
There  are  several  rare   causes  of  diabetes  mellitus   that   do    not    fit  into  type 
I,  type  II,  or gestational  diabetes. These are: 
a) Genetic defects in beta cells and insulin resistance with or without 
lipodystrophy (abnormal body fat deposition). 
b) Diseases of the exocrine pancreas: Pancreatitis, Trauma/pancreatectomy, 
Neoplasia, Cystic fibrosis, Hemochromatosis. 
c) Endocrinopathies: Acromegaly, Cushing syndrome, Glucagonoma, 
Pheochromocytoma, Hyperthyroidism, Somatostatinoma, Aldosteronoma. 
d) Drug or chemical-induced: Pentamidine, Nicotinicacid, Glucocorticoids, 
Diazoxide, Beta-adrenergic agonists, Thiazides, Phenytoin, Alfa-interferon. 
e) Other genetic syndromes sometimes associated with   diabetes: Down 
syndrome, Klinefelters syndrome, Turners syndrome Wolfram syndrome, 
Friedreichs ataxia, Huntington’s choreaLawrence-Moon Beidel syndrome, 
Myotonic dystrophy, Porphyria, Prader-Willi syndrome (Mayfield, 1998). 
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2.1.3 Risk Factors 
Some of the risk factors responsible for causing diabetes mellitus are: 
Age 
Family history 
Central obesity 
Physical inactivity and sedentary living 
Insulin resistance 
Urbanisation 
Stress (Stamler, 1993) 
Age 
An early occurrence of diabetes gives much time for development of the chronic 
complications of diabetes. The incidence of diabetes increases with age. When the 
life span increases the number of people with diabetes also increases (Menon et al., 
2006) 
Family history 
The prevalence of diabetes increases with a family history of diabetes. The risk of a 
child developing diabetes with a parental history increases above 50 per cent. A high 
incidence of diabetes is seen among the first degree relatives (Abate and Chandila, 
2001) 
Central obesity 
The association of obesity with Type II diabetes is well known. Even with an 
acceptable body weight range, weight gain could increase the risk of diabetes. An 
excess of body fat specially concentrated within the abdomen has an increased risk of 
diabetes. The cut-off limit for waist circumference has been recommended to be  90 
cms for  males and 80 cms for females.Abdominal obesity is defined by waist 
circumference above these limits (Barbara and Jeffrey, 2000). 
Physical inactivity and sedentary living 
Physical inactivity is an  Independent factor for the  development of Type II                    
diabetes.The  availability   of   transport, sedentary  occupations and  giving  much  
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time to T.V programmes  has  reduced the physical activity in all groups  of 
populations. (Mohan et al., 2005) 
Insulin Resistance 
Insulin resistance has been observed to be the cause for Type II diabetes. 
Urbanization 
The developing countries like India are undergoing rapid urbanization. Urbanisation 
is associated with increasing obesity, decreasing physical activity due to changes in 
lifestyle, diet and a change from manual work to less physical occupations. 
Stress 
Physical and mental stress causes Type II diabetes in persons having strong genetic 
background (Menon et al., 2006). 
2.1.4 Pathogenesis 
2.1.4.1 Pathogenesis of Type-I Diabetes 
This form of diabetes results from an autoimmune destruction of beta cells. A severe, 
insulin-requiring form of type I diabetes usually develops in children and 
adolescents, but this autoimmune disease may manifest in adults in a milder, initially 
non-insulin-requiring form, so-called latent autoimmune diabetes in adults (LADA). 
Young type 1 patients depend on insulin for survival; hence the older terms insulin-
dependent diabetes mellitus (Clare-Salzler, 2003; Skyler, 2004) 
Three interlocking mechanisms are responsible for the islet cell destruction: (Fig 1c) 
a) Genetic  susceptibility 
b) Autoimmunity and 
c) Environmental insult 
 
a) Genetic susceptibility 
Genome-wide scans have revealed many by some counts upto 20 chromosomal 
regions that regulate susceptibility to type-I diabetes. Of these loci, the best 
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characterized is the association with chromosome 6p21, where the MHC class II 
genes (HLA-DP, -DQ, - DR) map. This locus termed IDDMI, accounts for about 
45% of genetic susceptibility to this disease. It is important to note that genes within 
this region provide both susceptibility and resistance to type-I diabetes. Within the 
MHC class II region, the strongest disease linkage is to specified alleles of the HLA-
DQA1 and HLA-DQB1 genes (Clare-Salzler, 2003). 
b) Autoimmunity 
Although the clinical onset of type I diabetes mellitus is abrupt, this disease in fact 
results from a chronic autoimmune attack against beta cells that usually exists for 
years before disease onset. The classic manifestation of the disease (hyperglycemia 
and ketosis) occurs late, after more than 90% of the beta cells have been destroyed. A 
lymphocyte-rich inflammatory infiltrate, often intense (insulitis), is frequently 
observed in the islets of patients early in the course of clinically manifest disease. 
The infiltrate consists mostly of CD8+T Lymphocytes, with variable numbers of 
CD4+ T lymphocytes and macrophages (Clare-Salzler, 2003). Islet beta cells are 
selectively destroyed, with preservation of other cell types. Cytotoxic CD8
+ 
lymphocytes appear to kill islets either through release of cytotoxic granules or by 
inducing Fas-medicated apoptosis. Autoantibodies to islet cell antigens indicate a risk 
for type 1 diabetes. They appear as early as 9 months of age and are present in 80% 
of patients with new-onset disease. Among the intercellular antigens against which 
autoantibodies react are glutamic acid decarboxylase (GAD), insulin, and several 
other cytoplasmic proteins. In addition, peripheral blood T-cell responses to these 
same target antigens are often detected. There is no evidence that the autoantibodies 
cause beta injury. They arise perhaps as a consequence of T-cell-mediated damage 
(Clare-Salzler, 2003). 
c) Environmental insult 
An environmental insult could trigger autoimmunity by damaging the beta cell. 
Epidemiologic observations suggest that viruses may be such a trigger. Seasonal 
trends in the diagnosis of new cases often correspond to the prevalence of common 
viral infections. Several viruses are associated with type- I diabetes, including 
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coxsackievirus B, mumps, measles, rubella, and infectious mononucleosis. Although 
many viruses are beta cell topic, direct virus-induced injury is rarely severe enough 
to cause diabetes mellitus (Clare-Salzler, 2003). 
 
GENETIC PREDISPOSITION 
 
             
                                                                   ENVIRONMENTAL INSULT 
 
 
 
      
AUTOIMMUNE ATTACK  
 
 
 
 
Fig 1 c: Possible pathways of beta-cell destruction leading to type I (insulin-dependent) Diabetes mellitus. 
An environmental insult, possible viral infection, is thought to provoke autoimmune attack on beta 
cells in genetically susceptible individuals. Environmental insults may involve molecular mimicry, 
in which a viral antigen evokes autoimmune attack against a cross-reactive beta-cell antigen, or 
may cause direct damage to beta cell and thus evoke an immune response against already beta-cell 
antigens. 
2.1.4.2. Pathogenesis of Type-II Diabetes. There is no evidence that autoimmune 
mechanisms are involved. The two metabolic defects that characterize type II 
diabetes are (Fig 1d): 
a) Derangement in beta-cell secretion of insulin 
b) Insulin  resistance and  obesity ( Zimmer, 1982) 
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a) Derangement in beta - cell secretion of insulin 
The defects in insulin secretion are subtle and quantitatively less severe than in type I 
diabetes. In fact, early in the course of the disease, insulin levels may actually be 
elevated to compensate for insulin resistance. However, it is highly unlikely that 
insulin resistance alone gives rise to type II diabetes. 
Early in the course of type II diabetes, insulin secretion appears to be normal and 
plasma insulin levels are not reduced. However, later in the course of the disease, a 
mild to moderate absolute deficiency of insulin is present, which is less severe than 
that of type I diabetes. On the basis of data from experimental animals with type II 
diabetes, it is thought that initially insulin resistance causes a compensatory increase 
in the beta cell mass and production of insulin. In those with genetic susceptibility to 
type II diabetes, this compensation fails. Later in the course of this disease, there is a 
20% to 50% loss of beta cells, but this is not sufficient to account for a failure in 
glucose-stimulated insulin secretion. Instead, there appears to be a defect in glucose 
recognition by the beta cells. The molecular basis of such impairment in glucose-
mediated insulin secretion is not entirely clear. Recent studies implicate a 
mitochondrial protein that uncouples biochemical respiration from oxidative 
phosphorylation (thus producing heat rather than ATP. This protein, called 
uncoupling protein 2 (UCP2), is expressed in beta cells (Clare-Salzler, 2003). 
Another mechanism of beta-cell failure in type II diabetes is related to the deposition 
of amyloid in the islets. Amylin, the major component of the amyloid deposited, is 
normally produced by pancreatic beta cells and is cosecreted with insulin in response 
to a glucose load. The hyperinsulinemia caused by insulin resistance in the early 
phases of type II diabetes caused a concomitant increase in the production of amylin, 
which then deposits as amyloid in the islets. Amylin surrounding the beta cells may 
render them somewhat refractory to receiving the glucose signal. More importantly, 
amyloid is toxic to beta cells and may thus contribute to the beta-cell loss seen in 
advanced cases of type II diabetes. 
b) Insulin resistance and obesity (Mckeigue et al., 1991) The evidence suggests 
that insulin resistance is a major factor in the development of type II diabetes 
(Mooradian et al., 2001). In both obesity and pregnancy, insulin sensitivity of target 
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tissues decreases (even in the absence of diabetes) and serum levels of insulin may be 
elevated to compensate for insulin resistance. Thus, either obesity or pregnancy may 
unmask subclinical type II diabetes by increasing the insulin resistance to a degree 
that cannot be compensated by increased production of insulin. Obesity is an 
important environmental risk factor in the pathogenesis of type II diabetes, and it is 
strongly implicated in the rising incidence of this form of diabetes in children 
(Barbara & Jeffrey, 2000; Clare-Salzler, 2003). 
GENETIC PREDISPOSITION   ENVIRONMENT  
 
 
PRIMARY BETA-CELL           PERIPHERAL TISSUE  
  DEFECT           INSULIN RESISTANCE  
 
 
 
 
 
 
 
Fig 1d: Pathogenesis of type II Diabetes mellitus. Genetic predisposition and environmental influences 
converage to cause hyperglycemia and overt diabetes. The primacy of deranged beta-cell insulin 
secretion and peripheral insulin resistance is not established, in patients with clinical disease, both 
defects can be demonostrated. 
2.1.5 Pathogenesis of Complications of Diabetes Mellitus 
Many mechanisms linking hyperglycemia to the complications of long-standing 
diabetes have been explored. Currently, two such mechanisms are considered 
important (WHO Report, 1980). 
 Nonenzymatic glycosylation is the process by which glucose chemically 
attaches to free amino groups of proteins without the aid of enzymes. The 
degree of nonezymatic glycosylation is directly related to the level of blood 
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glucose. Indeed, the measurement of glycosylated hemoglobin (HbA1c) levels 
in blood is a useful adjunct in the management of diabetes mellitus, because it 
provides an index of the average blood glucose levels over the 120-day life 
span of erythrocytes. The early glycosylation products of collagen and other 
long-lived proteins in interstitial tissues and blood vessel walls undergo a 
slow series of chemical rearrangements to form irreversible advanced 
glycosylation end products (AGEs), which accumulate over the lifetime of the 
vessel wall. AGEs have a number of chemical and biologic properties that are 
potentially pathogenic (Skyler, 2004). 
 AGE Formation on proteins such as collagen causes cross-links between 
polypeptides; this in turn may trap nonglycosylated plasma and interstitial 
proteins, trapping of circulating low-density lipoprotein (LDL), for example, 
retards its efflux from the vessel wall and promotes the deposition of 
cholesterol in the intima, thus accelerating atherogensis. AGEs may also 
affect the structure and function of capillaries, including those of the renal 
glomeruli, which develop thickened basement membranes and become leaky. 
 AGEs bind to receptors on many cell types- endothelium, monocytes, 
macrophages, lymphocytes, and mesangial cells. Binding induces a variety of 
biologic activities, including monocyte emigration, release of cytokines and 
growth factors from macrophages, increased endothelial permeability, and 
enhanced proliferation of fibroblasts and smooth muscle cells and synthesis 
of extracellular matrix. All these effects can potentially contribute to diabetic 
complications (Clare-Salzler, 2003). 
 Intracellular hyperglycemia with disturbances in polyol pathways is the 
second major mechanism proposed for complications related to 
hyperglycemia. In some tissues that do not require insulin for glucose 
transport (e.g, nerves, lens, kidney, blood vessels), hyperglycemia lead to an 
increase in intracellular glucose, which is then metabolized by aldose 
reductase to sorbitol, a polyol, and eventually to  fructose. These changes 
have several untowards effects. The accumulated sorbitol and fructose lead to 
increased intracellular osmolarity and influx of water, and, eventually, to 
osmotic cell injury. In the eye lens, osmotically imbided water causes 
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sweeling and opacity. Sorbitol accumulation also impairs ion pumps and is 
believed to promote injury of Schwann cells and pericytes of retainal 
capillaries, with resultant peripheral neuropathy and retinal microaneurysms. 
In keeping with this hypothesis, experimental inhibition of aldose reductase is 
capable of ameliorating the development of cataracts and neuropathy.  
The pathogenesis of accelerated atherosclerosis is in all likelihood multifactorial. 
About one third to one half of patients have elevated blood lipid levels, known to 
predispose to atherosclerosis, but the remainder also have an increased predisposition 
to atherosclerosis. Qualitativeve changes in the lipoproteins, brought about by 
excessive nonezymatic glycolation, may affect their turnover and tissue deposition. 
Low levels of high-density lipoproteins (HDLs) have been demonstrated in patients 
with type II diabetes (Stalenhoef et al., 1978) Because HDL is a ―protective 
molecule‖ against atherosclerosis, this could contribute to increased susceptibility to 
atherosclerosis. In addition, from 40% to 70% of patients with diabetes also have 
hypertension, which is a well-known risk factor for atherosclerosis (Clare-Salzler, 
2003). 
Morphology of Diabetes Mellitus and its Late Complications 
In most patients, however, after 10 to 15 years, morphologic changes are likely to be 
found in arteries (atherosclerosis), the basement membranes of small vessels 
(microangiopathy), kidneys (diabetic nephropathy), retina (retinopathy), nerves 
(neuropathy) and other tissues. These changes are seen in both types of diabetes 
(Yajnik, 2002). 
a) Pancreas 
Distinctive changes are more commonly associated with type I than with type II 
diabetes. Once or more of the following alterations may be present. 
 Reduction in the number and size of islets. 
 Leukocytic infiltration of the islets principally by T lymphocytes.  
 Beta-cell degranulation.  
 Amyloid replacement of islets in type II diabetes appears as deposits of pink, 
amorphous material in and around capillaries and between cells. 
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b) Vascular system 
 The aorta and large and medium-sized arteries suffer from accelerated severe 
atherosclerosis. 
 Myocardial infarction, caused by atherosclerosis of the coronary arteries, is the 
most common course of death in diabetic patients. Significantly, it is almost as 
common in diabetic women as in diabetic men. 
 Gangrene of the lower extremities, as a result of advanced vascular disease, is 
about 100 times more common in diabetic persons than in the general population.  
The larger renal arteries are also subject to severe atherosclerosis, but the most 
damaging effect of diabetes on the kidneys is exerted at the level of the glomeruli and 
the microcirculation (Clare-Salzler, 2003). 
c) Diabetic microangiopathy 
One of the most consistent morphologic features of diabetes is diffuse thickening of 
basement membranes (Alder et al., 2000). Despite the increase in the thickness of 
basement membranes, diabetic capillaries are leakier to plasma proteins than normal. 
The microangiopathy underlies the development of diabetic nephropathy and some 
forms of neuropathy (Clare-Salzler, 2003).  
d) Diabetic nephropathy 
Three important lesions are encountered: 
 Glomerular lesions,  
 Renal vascular lesions, principally arteriolosclerosis; and  
 Pyelonephrities, including necrotizing papillitis.  
The glomerular capillary basement membranes are thickened throughout their entire 
length. Diffuse glomerulosclerosis consists of a diffuse increase in mesangial matrix 
along with mesangial cell proliferation and is always associated with basement 
membrane thickening. (Clare-Salzler, 2003).  
e) Diabetic ocular complications 
The ocular involvement may take the form of retinopathy, cataract form of 
retinopathy, cataract formation, or glaucoma. The lesion in the retina takes two 
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forms: nonproliferative   retinopathy and proliferative retinopathy.Nonproliferative 
retinopathy includes intraretinal or preretinal hemorrhages, retinal exudates, 
microaneurysms, venous dilations, edema, and most importantly, thickening of the 
retinal capillaries (microangiopathy).  The proliferative retinopathy is a process of 
neovascularization and fibrosis. The lesion can lead to serious consequences, 
including blindness, especially if it involves the macula (Rema et al., 2005). 
f) Diabetic neuropathy 
The central and peripheral nervous systems are also affected by diabetes. The most 
frequent pattern of involvement is is a peripheral, symmetric neuropathy of the lower 
extremities that affects both motor and sensory function but particularly the latter. 
Other forms include autonomic neuropathy, which produces disturbances in bowel 
and bladder function and sometimes sexual impotence and diabetic mononeuropathy. 
The brain, along with the rest of the body, develops widespread microangiopathy. 
Such microcirculatory lesions may lead to generalized neuronal degeneration. These 
are in addition a predisposition to cerebrovascular infarcts and brain hemorrhages, 
perhaps related to the hypertension and atherosclerosis often seen in diabetic patients. 
Degenerative changes have also been observed in the spinal cord (Clare-Salzler, 
2003). 
g) Acute diabetic ketoacidosis 
Diabetic   ketoacidosis ( DKA)  is  an  acute, dangerous  complication  and  is  
always  a  medical  emergency.  On    presentation   at  hospital,  the  patient  in  
DKA  is  typically  dehydrated  and  breathing  both  fast  and  deeply.  Abdominal 
pain is common and may be severe. The  level  of  consciousness  is  normal   until  
late  in the  process.,when   lethargy (dulled  or  reduced  level  of  alertness  or  
consciousness)  may  progress  to   coma.  The   ketoacidosis can become severe 
enough to cause hypotension and shock.  It   is  much  more   common  in    type  I  
diabetes  than  type  II,  but  can  still  occur  in  patients  with  type  II  diabetes 
(Davidson, 1986) 
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h) Nonketotic hyperosmolar coma 
While  not  always  progressing  to  coma,  this   hyperosmolar  nonketotic  state  
(HNS)  is  another  problem   associated  with  diabetes  mellitus. It  has  many  
symptoms  in  common  with  DKA,  but  a  different  cause,   and   requires  
different  treatment. In  anyone  with  very  high  blood    glucose  levels(   usually  
considered  to be  above 300 mg/dl  or  16  mmol/l),   water will  be  osmotically  
driven   out  of  cells  into  the  blood. The  kidneys  will  also  be ―  dumping ‖ 
glucose  into  the  urine,   resulting  in   concomitant  loss  of  water,  causing  an  
increase  in  blood  osmolality. If  the  fluid  is  not  replaced( by  mouth  or  
intravenously),  the  osmotic  effect  of  high  glucose  levels  combined  with  the  
loss  of  water  will  eventually  result  in  such  a  high  serum  osmolality   
(dehydration).  The  body
,
s  cells  may  become  progressively  dehydrated  as   water  
is  drawn  out  from  them  and   excreted.  Electrolyte imbalances are also common.   
This is the diabetic coma which more commonly occurs in type II   diabetes. 
i) Amputation 
Persons  with  poorly  controlled  diabetes  often   have  a  hard  time  healing  even  
from   small  cuts  or  abrasions. In  such  an  event   the  cut,   if  left  unnoticed  or  
untreated,  can  result  in  an  infection, and  the   resulting  infections in  extreme   
cases  can   lead  to   amputation. 
j) Diabetic foot 
Often    due  to  a  combination  of  neuropathy  and    arterial  disease,  may  cause   
skin  ulcer  and  infection  and in  serious  cases,  necrosis  and  gangrene.  It  is  the  
most  common  cause  of  adult  amputation,  usually  of  toes and  or  feet. 
2.2 SIGNS AND SYMPTOMS 
The  classical  triad  of  diabetes   symptoms  is  polyuria (frequent  urination),  
polydipsia (increased thirst and consequent increased fluid intake)  and  polyphagia 
(increased appetite). These  symptoms  may  develop  quite  fast  in  type I, 
particularly  in  children (weeks  or  months), but  may  be  subtle  or  completely  
absent- as  well  as  developing  much  more  slowly- in  type  II.  In   type  I  there  
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may  also  be    weight  loss (despite  normal  or  increased  eating) and   irreducible   
fatigue. Those  symptoms  may  also  manifest  in   type  II  diabetes  in  patients   
whose   diabetes  is  poorly  controlled.  
Thirst  develop  because  of osmotic  effects- sufficiently  high  glucose (above  the 
―renal  threshold‖)  in the blood is  excreted  by  the  kidneys,  but   this  requires   
water  to  carry  it  and  causes   increased  fluid  loss,  which  must   be   replaced.  
The  lost  blood volume  will   be  replaced  from  water   held  inside body  cells,  
causing  dehydration. Prolonged  high  blood  glucose  causes  changes  in  the  shape  
of  the   lens  in  the  eye,  leading  to  vision   changes. Blurred vision is a common 
complaint   leading   to a diagnosis of type I. 
Patients  usually  with  type I  diabetes  may  also  present  with  diabetic   
ketoacidosis DKA is an   extreme  state of  dysregulation  characterized   by  the   
smell  of  acetone on  the   patients  breath, Kussmaul  breathing (a rapid,  deep  
breathing),  polyuria, nausea, vomiting and  abdominal  pain  and   any  of  many  
altered  state  of  consciousness or  arousal (e.g., Hostility and mania or, equally, 
confusion and lethargy). In severe DKA, coma (unconsciousness) may follow, 
progressing to death if untreated.  
A rarer  but  equally  severe  presentation  is  hyperosmolar  nonketotic  state,  which  
is  more  common  in  type II   diabetes, and is  mainly  the  result  of  dehydration  
due  to  the   polyuria.  Often,  the  patient  has  been  drinking  extreme  amounts  of  
sugar-  containing  drinks,  leading  to  a  vicious  circle  in  regard  to  water  loss 
(Alberti  & Zimmer, 1998). 
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2.3 DIAGNOSIS 
Diagnosis of diabetes mellitus involves biochemical estimations and 
histopathological examination of various organs (Report, 1997; Sood, 1999) 
2.3.1 Biochemical Tests 
a) Blood                  
 Blood  glucose 
 Oral glucose tolerance test (OGTT)  
 Glycated  proteins 
 Glycated haemoglobin (Trivilli et al., 1971) Glycated plasma proteins 
(Fructosamines) 
b) Urine  
 Glucose 
 Ketone  bodies   
c)  Other biochemical parameters  
 Insulin 
 C-Peptide  
 Auto-antibodies  
 Lipid  peroxidation products (MDA) (Suryawanshi et al., 2006) 
 Lipid  profile 
 Oxidative  stress  parameters (Baynes JW, 1991) 
d) Genetic test  
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a) Blood 
 Blood Glucose 
Estimation of blood glucose concentration (glycemia) is a laboratory examination 
providing basic information on patient’s saccharide metabolism. Either capillary or 
venous blood is taken, and glucose level is estimated in the whole blood, plasma or 
serum. Glycemia values in the whole blood are 10-15% lower than in plasma/serum 
(depending on hematocrit); arterial blood gives 10% higher glycemia values than 
venous blood (arterio-venous difference). In order to stop glycolysis (consumption of 
glucose by red blood cells) sodium fluoride, NaF, is added to the sample vessels (2.5 
mg per 1 ml of the whole blood) (Abou-Seif,  2004). 
The blood sugar concentration or blood glucose level is the amount of glucose 
(sugar) present in the blood of a human or animal. Normally in mammals, the body 
maintains the blood glucose level at a reference range between about 3.6 and 5.8 mM 
(mmol/L, i.e. millimoles/ liter), or 64.8and 104.4 mg/dl
.
 The human body naturally 
tightly regulates blood glucose levels as a part of metabolic homeostasis. 
Glucose is the primary source of energy for the body’s cells, and blood lipids (in the 
form of fats and oils) are primarily a compact energy store. Glucose is transported 
from the intestines or liver to body cells via the bloodstream, and is made available 
for cell absorption via the hormone insulin, produced by the body primarily in the 
pancreas.  
Blood sugar levels outside the normal range may be an indicator of a medical 
condition. A persistently high level is referred to as hyperglycemia; low levels are 
referred to as hypoglycemia.  
Examination of blood glucose concentration is fully informative only if time interval 
between taking the blood sample and last food intake is known (Mistry, 2011). 
Examination of Glycemia measured in venous plasma is shown (Table 2) 
 
 
 
 
Chapter 2  Review of Literature 
 
Ph.D Thesis                                                 31                                   University of Kashmir  
 
Examination of glycemia is performed: 
 As fasting glycemia (blood taken at least 8 hours after the last meal)- screening 
test for finding diabetics in population, for confirmation of diagnosis of DM, or 
for monitoring of therapy of DM. 
 As random glycemia (blood taken regardless of food intake)- in cases of suspect 
hypoglycemia or hyperglycemia; 
 After meal postprandial glycemia (1 hour after meal containing saccharides)- for 
monitoring of therapy of DM; 
 As glycemic profile- glycemia is estimated several times per day, typically 
between main meals, sometimes also after meals or during night. 
Table 2: Evaluation of glycemia measured In venous plasma 
Evaluation 
Fasting Glucose Concentration 
(mmol/l) 
Normal 5.6 
Impaired fasting glycemia ≥5.6 and < 7 
Diabetes mellitus ≥ 7.0 
 Oral Glucose Tolerance Test (OGTT) 
OGTT evaluates glucose clearance from the circulation after glucose loading under 
defined and controlled condition. The OGTT stimulates oral food intake. Enteric 
factors such as gastric emptying, intestinal absorption and liver function may 
influence the results of the test; therefore OGTT shows a significant range of 
variation (Mistry, 2011). 
Glycemia and OGTT fasting glycemia < 5.6 mmo1/1, and in OGTT glycemia in 120 
minutes <7.8 mmo1/1 are considered normal (Table 3). 
In contrast, fasting glycemia ≥ 7.0 mmo1/1, or glycemia ≥ 11.1 mmo1/1 in random 
sample or in 120 minutes of OGTT together with classical clinical signs (thirst, 
polyuria, and unexplained weight loss) point to diagnosis of diabetes mellitus. For 
confirmation of diagnosis of DM the examination must be repeated. 
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Table 3: Threshold values for OGTT in venous plasma 
Evaluation 
Glycemia In 120 Minutes Of 
OGTT (mmol/l) 
Normal < 7.8 
Impaired  glucose  tolerance ≥  7.8 and < 11.1 mmol/l 
Diabetes  mellitus ≥  11.1 mmol/l 
 Glycated proteins 
Glucose and other monosaccharides react spontaneously with protein to form 
glycated proteins. Such reaction take place in healthy individuals as well, and all 
soluble serum proteins as well as structural proteins can be involved. The extent of 
glycation depends on the average glucose to which the protein is exposed and the 
half life of the protein. 
This process of non-enzymatic glycation of protein molecules is referred to as the 
Maillard reaction. 
i) It is initiated when a free sugar aldehyde or ketone group condenses with a 
free amino group of proteins to form a Schiff base (aldimine).  
ii) The Schiff base then slowly (within days) rearranges to form a fairly stable 
Ketoamine called the Amadori product (frucosamine).  
iii) Finally during weeks and months and independently in the presence of 
glucose the Amadori products react with structural proteins (collagen, elastin, 
myelin of nerves etc) and produce complex series of cross-linkages and 
adducts called the Maillard products or advanced glycation end products 
(AGEs). These processes are irreversible.Non-enzymatic glycation of proteins 
is considered as one of the causes of the late complications and organ damage 
in patients with diabetes mellitus. 
Measurement of the Amadori products of protein glycation is useful in monitoring 
long-term glucose concentration and provides indirect information on the course of 
glycemia for the life time of the protein whose glycation is assessed. Routinely 
glycated hemoglobin and glycated serum proteins (fructosamine) are measured 
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(Johnson et al., 1983). Estimation of glycated hemoglobin and glycated proteins is 
used in controls of diabetic patients and for detection of permanent hyperglycemia. 
Increased values of glycated derivatives indicate that elevated blood glucose levels 
prevailed during the past few weeks and diabetes has not been well compensated. 
Evaluation of glycated proteins (S-glycated proteins): 
Normal values:    205-285 µmo1/1 
Good compensation of DM   285-32- µmo1/1 
Satisfactory compensation of DM  321-370 µmo1/1 
Poor compensation of DM   > 370 µmo1/1 
Glycated hemoglobin (HbA1C) 
It is considered as the best marker for monitoring of blood glucose in diabetic 
patients.  Concentration of glycated hemoglobin informs about glycemia during last 
6-8 weeks. It is measured by chromatographic or immunochemical methods 
(Mayfield, 1998) 
Evaluation of concentration of glycated hemoglobin (HbA1c): 
Normal values:    ≤ 4.0 % 
Compensated DM:               ≤ 5.0 % 
Need to change therapy   ≥ 6.0 % 
Glycated plasma proteins (fructosamines) 
These have shorter half-life and their levels reflect average glycemia during the last 2-
3 weeks. The major component is glycated albumin. Results of this estimation can be 
affected by hypoproteinemia. Nowadays, measurement of fructosamines is not 
routinely performed in diabetic patients (Johnson et al., 1983). 
c) Urine 
 Glucose in urine 
Glucose in the kidney is first filtered through glomerular membrane to primary urine, 
and then is reabsorbed in proximal tubules. The body aims at preserving glucose and 
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protecting it from losses-normally the tubular reabsorption system is occupied from 
1/3 of its capacity. However, if the blood glucose concentration exceeds 9-10 
mmo1/1, also referred to as the renal threshold, the capacity of tubular reabsorption is 
saturated, and glucose appears in the urine-glycosuria (glucosuria). Normally only 
very small amount of glucose- up to 0.72 mmo1/24 hours is excreted into urine. 
Detection of glucose in urine suggests presence of diabetes mellitus; therefore, every 
case of glucosuria needs further examination. 
 Ketone bodies in urine 
The term ―Ketone bodies‖ includes three chemicals: acetoacetic acid, ß-
hydroxybutyric acid and acetone. When biochemical energy is not produced from the 
conversions of glucose, metabolism shifts to the oxidation of lipids. Ketone bodiesare 
synthesized in the liver from acetyl CoA, derived from the oxidation of fatty acids. 
Some of the acetoacetate may be then reduced to ß-hydroxybutyrate, while minor 
part of it undergoes a spontaneous decarboxylation to acetone and CO2. All three 
products of excessive conversion of fatty acids are excreted in the urine. The relative 
proportion in which the three ketone bodies are present in urine is following: 60-70 
% of ß-hydroxybutyrate acid, 30-35 % of acetoacetate and about 2% of 
acetone.Estimation of urine ketones is useful for control of patients with diabetes 
mellitus Type 1.  Their presence suggest metabolic ketoacidosis and is always 
accompanied by hyperglycemia..The test for ketone bodies in urine uses a reaction of 
acetoacetate and acetone with sodium nitroprusside in alkaline medium, producing a 
purple-coloured complex.  
Na2[Fe(CN)5NO]       +   CH3CO-R + NaOH  Na2[Fe(CN)3N=CHCO-R + H2O 
Sodium nitroprusside             Ketone                                        OH    
                                                                                    Coloured Complex 
R=     -CH2COOH    acetoacetic acid 
          - CH3                       acetone  
 Principle of the nitroprusside test for ketone bodies in urine 
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C) Other Biochemical Parameters 
 Insulin 
According to the employed techniques also called immunoreactive insulin, IRI. 
Because of high ciracadian fluctuations, interference of autoantibodies and inability 
to distinguish endogenous insulin from the one given therapeutically, the 
immunoreactive insulin are usually measured the glucose tolerance tests (OGTT). Its 
values are low in Type 1 diabetics, but often increased in the syndrome of insulin 
resistance. 
 C-peptide 
It is a part of proinsulin molecule that is cleaved out prior to secretion of insulin. 
Conservation of C-peptide in serum corresponds to amount of secreted insulin. It is 
not degraded in the liver and because the exogenous insulin given in injections does 
not contain any C-peptide, its estimation is not affected by the therapy. The C-
peptide passes the glomerular membrane; therefore its concentration rises in renal 
insufficiently. 
 Autoantibodies 
The type I diabetes is often associated with positivity for antibodies against 
Langerhans islets (ICA), against insulin (IAA) and especially against one isoform of 
glutamate decarboxylase (GAD 654). 
 Lipid peroxidation 
It is measured in terms of malondialdehycle (MDA) (Kesavulu et al., 2000). 
 Lipid Profile 
Total Cholesterol, Serum triglycerides, HDL-Cholesterol, LDL and VLDL 
Cholesterol (Mooradian, 2007). 
 Oxidative-stress parameters like (Baynes, 1991;Tripathi  & Deepak, 2009)  
 Erythrocyte reduced glutathione (GSH). 
 Superoxide dismutase (SOD) 
 Glutathione peroxidase GSH-Px 
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 Glutathione reductase (GSH-Red) 
 Serum nitric oxide. 
d) Genetic test 
Scientists  have  mapped  the   most  important  genes  associated  with  the  risk  of   
developing  Type II  diabetes  mellitus. Researchers  have  identified  five  loci  or  
locations  on  peoples  genetic  maps  that  correspond  to  a   risk  of  developing   
this life  threatening  disorder.  The  study  confirmed  the  association  of  mutated  
TCF7L2  genes  with  an  increased  risk  of  developing   the  disease, as  well as  
identifying  four  other  gene  mutations  that  are  also  implications  in  increased  
risk  of  disease  development. 
The  other  most  significant  new  genes  identified  was   SLC30A8, which  encodes  
a  zinc  transporter  expressed  solely  by  the  secretory  vesicles  of  ß-cells. This  
gene  is  implicated  in  the  final  stages  of  insulin  biosynthesis. 
2.3.2 Additional Parameters (KFT, Lipid, Profile, LFT) 
a)  Serum Urea Levels 
The handling of urea by the kidneys is a vital part of human metabolism. Besides its 
role as carrier of waste nitrogen, urea also plays  a role in the countercurrent 
exchange system of the nephrons, that allows for re-absorption of water and critical 
ions from the excreted urine. Urea is reabsorbed in the inner medullary collecting 
ducts of the nephrons,   thus raising the osmolarity in the medullary interstitum 
surrounding the thin ascending limb of the loop of Henle, which in turn causes water 
to be reabsorbed. By action of the urea transporter 2, some of this reabsorbed urea 
will eventually flow back into the thin ascending limb of the tubule, through the 
collecting ducts, and into the executed urine (Marshall, 2004). 
b) Serum  Creatinine  Levels 
Creatinine is a breakdown product of creatine phosphate in muscle, and is usually 
produced at a fairly constant rate by the body (depending on muscle mass).Creatinine 
is chiefly filtered out of the blood by the kidneys (glomerular filtration and proximal 
tubular secretion). There is little-to-no tubular reabsorption of creatinine. If the 
filtering of the kidney is deficient, creatinine blood levels rise. Therefore, creatinine 
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levels in blood and urine may be used to calculate the creatinine clearance (CrCl), 
which reflects the glomerular filtration rate (GFR). The GFR is clinically important 
because it is a measurement of renal function (Marshall, 2004). 
c)  Serum  Lipid  Profile 
Cardiovascular disease (CVD) is a major cause of death in the world and is mainly 
due to atherosclerosis (hardening of the arteries). Abnormal blood lipids are risk 
factors for CVD (Chandila et al., 1988). The optimal, borderline and high levels of 
serum lipids are shown in Table 4.                                              
Table 4: Serum Lipid Profile 
Component Optimal   Borderline      High risk 
LDL Cholesterol <100 130-159  
 
160 
HDL Cholesterol   >60 35-45   
 
<35 
Triglycerides   <150 150-199  
 
>200 
Total Cholesterol  <200 200-239  
 
>240 
Cholesterol to HDL Ratio <4  5             
 
>6 
 
High-density lipoproteins (HDLs) are a separate group of lipoproteins that contain 
more protein and less cholesterol than LDL, HDL cholesterol (HDL-C) is also called 
―good cholesterol‖. HDL is produced primarily in the liver and intestine, and it 
travels in the bloodstream, picks up cholesterol, and gives the cholesterol to other 
lipoproteins for transport back to the liver (Trivedi et al., 2004). If total cholesterol is 
200 milligrams per deciliter (mg/dl) or higher, or HDL-C is less than 40 mg/ dl, the 
individual will need to have a follow- up lipoprotein profile done to determine LDL-
C and triglyceride levels (Del Pilar et al., 2005; Mooridian, 2007). 
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d)  Serum   Liver  function tests 
Liver function tests (LFTs or LFs), are group of clinical biochemistry laboratory 
blood assays designed to give information about the state of patient’s liver  (Baig  et 
al., 2001). Various liver function   tests   include: 
  Serum Albumin (Alb) 
Albumin is a protein made specifically by the liver, and can be measured cheaply and 
easily. It is the main constituent of total protein. Albumin levels are decreased in 
chronic liver disease, such as cirrohosis. It is also decreased in nephritic syndrome, 
where it is lost through the urine.  
 Serum Alanine transaminase (ALT) 
Alanine transaminase (ALT), also called serum glutamic pyruvate transaminase 
(SGPT) or alanine aminotransferase (ALAT) is an enzyme present in hepatocytes 
(liver cells) (Erbey et al., 2000; Vozarova et al., 2002). 
 Serum   Aspartate transaminase (AST)  
Aspartate tansaminase (AST) also called serum glutamic oxaloacetic transaminase 
(SGOT) or aspartate aminotransferase (ASAT) is similar to ALT in that it is another 
enzyme associated with liver parenchymal cells. It is raised in acute liver damage, 
but is also present in red blood cells and cardiac and skeletal muscle and is therefore 
not specific to the liver. The ratio of AST to ALT is sometimes useful in 
differentiating between causes of liver damage.  Elevated AST levels are not specific 
for liver damage, and AST has also been used as a cardiac marker (Marshall, 2004). 
  Serum  Alkaline phosphatase (ALP) 
Alkaline phosphatase (ALP) is an enzyme in the cells lining the biliary ducts of the 
liver. ALP levels in plasma will rise with large bile duct obstruction, intrahepatic 
cholestasis or infiltrative diseases of the liver  (Marshall, 2004). 
  Serum  Total bilirubin (TBIL) 
Bilirubin is a breakdown product of heme ( a part of hemoglobin in red blood cells). 
The liver is responsible for clearing the blood of bilirubin. It does this by the 
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following mechanism: Bilirubin is taken up into hepatocytes, conjugated (modified to 
make it water- soluble), and secreted into the bile, which is excreted into the intestine 
(Jick et al., 1999). 
         Table 5: Clinical Significance of various parameters in Diabetes mellitus 
Biochemical 
Parameter 
Clinical Significance Inference 
1. Lipid   Profile  Dyslipidemia major risk factor for 
cardiovascular disease in diabetes 
mellitus, increased plasma 
triglyceride concentration, low HDL 
cholesterol concentration, increased 
concentration of LDL and VLDL. 
(Mooridian,2009) 
Prevention of 
cardiovascular disease 
in diabetic patients.  
2. Liver function 
tests, which 
include: 
Serum aminotrans- 
ferases,  
ALT,  
AST,  
Alkaline 
phosphatases (AP), 
Bilirubin, 
Albumin. 
 
Chronic mild elevation of 
transaminases (Elizebath et 
al.,2005) are found in type II 
diabetic patients, due to insulin 
resistance.Elevated transaminases in 
insulin resistant states include 
oxidative stress from reactive lipid 
peroxidation. The insulin resistant 
state is also characterized by an 
increase in pro-inflammatory 
cytokines such as tumour necrosis 
factor ά (TNF- ά) which may also 
contribute to hepatocellular injury. 
All elevated transaminases 
contribute to direct hepatocyte 
injury. 
Prevention of liver 
injury in type-II diabetes 
due to insulin resistance.  
(Salmela et al., 1984; Lebovitz et al., 2002; Tietz, 1995; Marshall, 2004) 
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2.3.3 Histopathological Studies 
After preserving the livers in 10% formalin, the liver sections are processed which 
involves the following step. 
a) Preparation of Tissues  
b) Processing of Tissues 
c) Embedding in paraffin  
d) Preparation of sections 
e) Staining 
a) Preparation of Tissues 
Fixation- Fixation is a process of killing and hardening of tissue. The first phase of 
fixation is the rapid killing of tissue and the second phase, the hardening of tissue. 
Tissue should be placed in the fixative immediately upon removal from the body to 
preserve the relation of the tissue elements as they were in life. Blocks are cut 
enough so that the fixing fluid penetrates the tissue in a reasonably short time. Blocks 
should not be more than 0.5 cm thick and are immersed in at least twenty times their 
volume of fixative. 10% formalin is the most widely used fixative because it is 
compatable with most stains. Length of fixture depends upon the size of the blocks. 
After fixation the tissue is washed, from 3 to 24 hrs, in running water before 
dehydration, clearing and embedding:-  
  10% formalin solution  
  37-40% formaldehyde  100 ml 
  Tap water     990 ml 
  Formalin saline solution   
  37-40% formaldehyde   100 ml 
  Sodium Chloride    9.0 gm 
  Tap water     900 ml  
b) Processing of Tissues  
Every specimen is marked with an identifying number or name. This identification is 
copied with a soft lead pencil on a string tag and is kept with the tag throughout 
processing. The surface, from which sections are to be cut, is indicated by notching 
the opposite surface or marking it with India ink. While embedding the tissue in 
 
Chapter 2  Review of Literature 
 
Ph.D Thesis                                                 41                                   University of Kashmir  
 
paraffin, the marked surface of the block is kept uppermost. Fixed tissues are 
maintained in position by a firm medium so that these uniform sections can be cut. 
Media suitable for this purpose are paraffin, colloidin, nitrocellulose and carbowax. 
Embedding in paraffin is accomplished most rapidly and gives the best results when 
thin sections of soft tissues are wanted. Since paraffin is not miscible  with water, the 
tissue must be dehydrated and then cleared in a solution that is miscible with 
paraffin. Dehydration is done either by 80%, 90%, 100% alcohol as acetone.Tissue is 
then ready for embedding. 
c) Embedding in paraffin 
Embedding can be accelerated by the use of shallow tin pans. For embedding of 
multiple blocks, pans with slightly sloping side, ranging from 1 X 2 inches and ¾ 
inch in depth are satisfactory. The pan is placed on  a masonite rack, which holds it 
about 6 inches above the desk top.The pan is warmed gently with a Bunsen burner 
and filled with paraffin which has been melted and filtered. Each piece of tissue is 
placed in position with the appropriate string tag beside it and when all are in place 
the lowest part of the paraffin is hardened by rubbing an ice cube across the bottom 
of the pan. The pan is floated on cold water, when the paraffin has collected 
sufficiently so that a heavy film forms across the top.  The paraffin, when hardened 
throughout, contracts from the sides of the pan and the mass is lifted out and cut into 
blocks of appropriate size.  
d) Preparation of sections 
A properly cared knife is used, since the results produced by histological technique 
depend greatly upon the knives used to cut the sections. A perfect edge for a 
microtome knife may be defined in simple terms as the junction of the smooth plane 
surfaces at an angle of about 14 degree. Various kinds of knives are required for 
microtomes of different types, 110 mm knife is used for cutting frozen sections, the 
120 mm and 185 mm knives for routine paraffin work.  
 Cutting section: After mounting the paraffin block on the object holder excess of 
paraffin is cleaned and clamped in the block holder on the microtome. The knife 
clamp is adjusted towards the paraffin block and sectioning is begun slowly. To 
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facilitate sectioning, wet cotton is applied on to the surface of the block after 
cutting. Bubbles are removed by putting the ribbon very gently across the long 
edge of a glass slide half below the section in the water bath. After the section is 
mounted on the slide, bubbles in the tissues are removed by gentle brushing with 
a fine camel’s hair brush. 
 Resealing blocks: After cutting the sections from the paraffin block, it is resealed 
to prevent drying of the tissue or destruction by insects and to make subsequent 
cutting easier. The block sealer provides a continuous supply of molten paraffin 
with which to seal cut specimen blocks as they are removed from the microtome.  
 Forming a Ribbon: The first section is unrolled with a fine camel’s hair brush 
and is held down tightly against the knife. The ribbon often forms and follows 
number 1, 2 & 3. Camel’s hair brush is used to remove the ribbon from knife. 
The glass slides on which tissue sections are to be mounted are marked before 
hand with the identifying case number usually with a glass marking pencil.  
Paraffin sections can be attached to slides in several ways. A small drop of Maeyer’s 
egg albumin is smeared our surface of the slide with the finger and the excess rubbed 
off with the help of the hand. A clean foam rubber   sponge is usually preferred so 
that the epithelial cells from the fingers do not adhere to the slides and produce 
artifacts when stained. 
e) Staining 
Sections picked up on albuminized slides are dried before staining as they may be 
stained singly by carrying each section through various solutions with a bent glass 
rod. Paraffin section (5 microns thick) is stained with haematoxylin and eosin 
(Drury, 1973; Bancroft et al., 1996). 
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2.4 ANIMALS USED  
a) Rats 
Male albino, wistar rats   having    weight 104-214 gms are taken.  They are   given 
standard rat cubes and   water.  80mg/kg    alloxan monohydrate is given i.v. through 
tail vein.  They are left for  7 days. Blood glucose   levels are estimated after 7 days 
using Trinders glucose oxidase method.  Blood  is collected from tail vein(  0.5  ml)   
at  0,2,4,6,8, and 24  hours. Alloxan  monohydrate 2.4% is also given in normal 
saline s.c. at a dose of 120mg/kg   b.w. Single dose -5% dissolved in normal saline 
(125mg/kg b.w) is given i.p. Animals are acclimatized for a period of   10 days to 
room temperature (28± 5 C) with a relative humidity of 50%. They are housed in 
standard   cages. When   streptozotozin   is used, it is dissolved in citrate buffer (0.1 
M, ph-4.5) - 50mg/kg   i.p injection.  Diabetes  is  confirmed  96  hours  after  STZ  
injection  or  48  hours  after  STZ administration.  Albino rats with blood glucose 
level above 200 mg/dl are taken for studies. STZ can also be dissolved in 0.9% ice- 
cold saline immediately before use. Blood samples are collected from orbital sinus   
of each rat (Kumar, 1997). 
b) Mice 
Swiss albino mice weighing  30-35  gms  of either  sex  are  taken.Standard  
conditions  of  temperature (24±2▪C)   and  relative  humidity  (30-70%)  with  12:12   
light  dark  cycle. They are fed with standard   pellet diet and water ad libitum. 
Animal handling is performed according to Good Laboratory Practice (GLP).  Single 
i.v injection of aqueous alloxan monohydrate (70 mg/kg)   i.v   is given.   After 48 
hours, animals with blood   glucose levels above 200mg/dl are taken. Animals  given   
free  access  to  tap  water  and  pellet  diet  and   maintained  at   room   temperature  
in  plastic  cages.  Blood   samples were collected by retro-orbital puncture. (Bell, 
1983). 
c) Rabbits 
Male,  adult rabbits of  local strain  weighing  1-2   kg  are  fed  on  green  vegetables,   
grains,  soaked   grams  and   tap  water  ad libitum.Temperature  is  maintained  at   
24-28 C  and   relative humidity 60-70%   is maintained.  Fasted  rabbits are deprived 
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of food for 16 hours. Rabbits are made diabetic by   10%   solution of alloxan 
monohydrate in distilled water (150mg/kg b.w) through marginal ear vein.  Diabetes 
mellitus develops after one week. After 8 days, blood glucose levels are estimated. 
Rabbits   having 200mg/dl   or above are taken    for studies (ADA, 1985) 
d) Other Animals 
Other animals used are: 
 Obese mouse: Diabetic mouse, Sand mouse [Psammomys obesus] 
 Spiny mouse [Acomys cahirinus], BB rats, KK mouse, Yellow mouse 
 Yellow KK mouse, New Zealand obese mouse 
 Tuco-tuco [clenomys talarum]- these are burrowing rodents from Argentina. 
 Chinese hamster [Cricetulus griseus] 
 NOD mouse 
 Japanese wistar rat [Goto rat] etc. 
                               (Srinivasan, 2007; WHO Report, 1985; Rees, 2005) 
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2.5 MODELS USED FOR INDUCING DIABETES 
  Various drugs and chemical agents used to induce diabetes in experimental animals 
for the evaluation of antidiabetic agents   
                                Table 6: Models used for inducing diabetes   
Diabetes Inducing Agent Mechanism 
Alloxan produces IDDM 
Induces permanent diabetes. Highly reactive molecule 
which produces free radical change to beta islet cells and 
causes cell death. In rats used in the dose of 100-120 mg/kg. 
In rabbits used in the dose of 150 mg/kg. 
Streptozotocin  produces IDDM 
      Neonatal Model for NIDDM 
Broad spectrum antibiotic causes beta islet cell damage by 
free radical generation, produce changes similar to those 
induced by alloxan. Used in dose of 60-70 mg/ kg. in rats in 
citrate buffer solution causes severe pancreatic β-cell 
destruction accompanied by decrease in pancreatic insulin 
stores. Neonatal rats treated with streptozotocin (90 mg per 
kg. b.w) in citrate buffer. 
Virus produce IDDM include 
-RNA 
-Picomovirus, 
-encephalo-myocarditis  EMC-D) 
-coxsackie B4 ( CB-4)  
(Jun, 2004) 
Destroys B- Cells of pancreas. 
 In mice, 01 ml of 1.50 dilution of D-Varviant 
encephalomyocardits (EMC) used. 
Insulin antibodies 
Prepared in guinea pigs. Bovine insulin, dissolved in 
acidified water (pH.30) at a dose of 1 mg is injected to 
guinea pigs Anti- insulin sera is collected after two weeks of 
antigenic challenge. Adult albino rats are injected with 0.25-
1.0 ml of guinea pig anti-insulin serum. 
Hormone-  
Dexamethasone induced Diabetes 
Dexamethasone- steroid causes auto- immune reaction in the 
islets and produces type I diabetes. In rats used at a dose of 
2-5 mg /kg twice a day. Repeated injection of same dose 
level is carried out for a period of 20-30 days resulting in 
IDDM. 
Genetic Models 
NOD Mouse  
(Non-obese diabetic Mouse. 
(Bio-Breeding rats [BB rats) 
Model for IDDM.Auto immune destruction of pancreatic 
beta cells. Mice bred at laboratory by sib mating over 20 
generations. After. 20 generations of sib mating, 
spontaneous development of IDDM in mice in obtained. 
Model for IDDM. Rats bred at the laboratory by sib mating 
over 20 Generations. After 20 generations of sib mating 
spontaneous development of IDDM in rats in obtained. 
Adrenaline induced acute 
hyperglycemia 
Increases hyperglycemia in albino rats, injected at a dose 
level of 0.1 mg/ kg. 
Dithizone induced Diabetes 
Organic agents  
- EDTA, 
- 8- hydroxy  quinolone       
Organic agents react with zinc in islets of Langerhans 
causing destruction of islet cells and producing diabetes. 
They produce spontaneous type II diabetes in experimental 
animal. Dithizone at a dose of 40-100 mg/ kg produces 
diabetes type II in mice, cats, rabbits and golden hamsters. 
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2.5 Models Used for inducing Diabetes 
2.5.1. Alloxan 
Alloxan (2,4,5,6-tetraoxypyrimidine; 2,4,5,6- pyrimidinetetrone)  is  an  oxygenated  
pyrimidine  derivative. It is present as alloxan hydrate in aqueous solution. Alloxan  
also known as  Mesoxalylurea  and  5-Oxobarbaturic  acid   has  molecular  formula 
C4H2N2O4 , Molar  mass    142.07g/mol  and  freely  soluble  in water. IUPAC name  
is 1,3 Diazinane-2, 4, 5, 6- tetrone. 
 
 
 
 
 
                             
 Alloxan 
It  is  a  toxic  glucose  analogue,  which  selectively  destroys  insulin  producing  
cells  in  the  pancreas (that is  beta  cells)   when  administered  to  rodents  and  
many  other   animal species. This  causes  an  insulin  dependent  diabetes  mellitus  
(Alloxan  Diabetes)   in these  animals, with  characteristics  similar   to type I  
diabetes  in humans. Alloxan  is  selectively  toxic  to  insulin  producing  pancreatic  
beta  cells  because  it  preferentially  accumulates  in  the beta  cells   through  uptake  
via  the  GLUT2 glucose  transporter. Alloxan,  in  the  presence  of  intracellular  
thiols,  generates  reactive  oxygen  species  ( ROS)  in  a  cyclic  reaction  with  its  
reduction  product,  dialuric   acid. The   beta  cell  toxic  action  of   alloxan  is   
initiated  by   free  radicals  formed  in this  redox  reaction. One  study  suggests  that  
alloxan  does  not  cause  diabetes  in  humans.  
Mechanism of Action  
Alloxan has two distinct pathological effects. It selectively inhibits glucose-induced 
insulin secretion through specific inhibition or glucokinase, the glucose sensor of the 
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beta cell, and it causes a state of insulin-dependent diabetes through its ability to 
induce ROS formation, resulting in the selective necrosis of beta cells. These two 
effects can be assigned to the specific chemical properties of alloxan, the common 
denominator being selective cellular uptake and accumulation of alloxan by the beta 
cell (Szkudelski, 2001). 
a) Beta cell selectivity of alloxan   
Alloxan is a very unstable chemical compound with a molecular shape resembling 
glucose. Both alloxan and glucose are hydrophilic and do not penetrate the lipid 
bilayer of the plasma membrane (Lenzen, 1988) The alloxan molecule is structurally 
so similar to glucose that the GLUT2 glucose transporter in the beta cell plasma 
membrane accepts this glucomimetic and transports it into the cytosol. Alloxan does 
not inhibit the function of the transporter, and can therefore selectively enter beta 
cells in an unrestricted manner (Lenzen, 1991). It is therefore not toxic to insulin-
producing cells that do not express this transporter. The half-life of alloxan is short, 
in aqueous solution it spontaneously decomposes into non-diabetogenic alloxanic 
acid within minutes (Lenzen  et al., 1992) Because of this, it must be taken up and 
accumulated quickly in the beta cell  and is therefore ineffective when blood flow to 
the pancreas is interrupted for the first few minutes after alloxan injection (Lenzen  
et al., 1996).   
b) Glucokinase inhibition  
Selective inhibition of glucose-induced insulin secretion is the major path 
physiological effect of the thiol group reactivity of alloxan. Alloxan has a central 5-
carbonyl group that reacts very avidly with thiol groups. Glucokinase (hexokinase 
IV) is the most sensitive thiol enzyme in the beta cell with a half maximal inhibitory 
concentration in the 1-10 umol/l range. At higher concentrations, alloxan can inhibit 
many functionally important enzymes as well as other proteins and cellular 
functions.Inhibition of glucokinase reduces glucose oxidation and ATP generation, 
thereby suppressing the ATP signal that triggers insulin secretion. Inhibition of 
glucokinase is achieved within I min of exposure to alloxan (Mlaisse, 1982). The 
inhibition of glucose-induced insulin secretion is preceded by a very transient (1-2 
min) stimulation of insulin secretion immediately after exposure to alloxan. This ef-
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fect can be explained by an initial reduction of ATP consumption resulting from the 
blockade of glucose phospholylation by glucokinase, which produces a transient 
increase in ATP in the beta cell and triggers a transient release of insulin.  The 
inhibition of insulin secretion after exposure to alloxan is restricted to that induced by 
glucose and its epimer, mannose, both of which induce insulin secretion through 
intimation with glucokinase. Insulin biosynthesis is also inhibited by alloxan, most 
likely through the same mechanism (Lenzen, 1988; 1991). The insulin secretory 
response to other nutrient secretagogues, such as 2-ketoisocaproic acid and leucine. 
or non-nutrient secretagogues, such as the sulfonylurea drug tolbutamide, remains 
intact initially because it is not mediated via glucokinase , but is lost after a delay of 
up to one  hr  as a consequence of the gradual deterioration of beta cell function. 
Thiols such as the tripeptide glutathione (GSH), cysteine and dithiothreitol protect 
glucokinase against alloxan inhibition because they reduce alloxan to dialuric acid, 
which is not thiol reactive.  However, only dithiols such as dithiothreitol can readily 
reverse alloxan-induced glucokinase inhibition. They achieve this by reducing func-
tionally essential cysteine residues of the glucokinase enzyme, which are oxidized 
through alloxan action (Lenzen, 1988; 1991). 
Likewise, glucose protects against alloxan-induced inhibition of glucose-induced 
insulin secretion because its binding to the sugar-binding site of glucokinase prevents 
the oxidation of the functionally essential thiol groups. The non-metabolisable seven 
carbon sugar mannoheptulose protects glucokinase through the same mechanism, but 
this alone is not sufficient to prevent alloxan-induced inhibition of insulin secretion. 
The glucose analogue 3-0-methylglucose, which is not a substrate of glucokinase, 
does however prevent inhibition. It does this through competitive blockade of alloxan 
uptake into the beta cell via the GLUT2 glucose transporter. Thus, the inhibition of 
glucose-induced insulin secretion by alloxan is the result of the exquisite thiol 
reactivity of the glucose sensor glucokinase (Lenzen, 2008). 
c)  Beta cell toxicity and diabetogenicity of alloxan  
Alloxan can generate reactive oxygen species (ROS) in a cyclic reaction with its 
reduction product dialuric acid. In the beta cells the toxic action of alloxan is initiated 
by free radicals.  Authorization of dialuric acid generates superoxide radicals and 
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hydrogen peroxide, and in the Fenton reaction, in the presence of a suitable metal 
catalyst typically iron, hydroxyl radicals. The authorization of dialuric acid involves 
the intermediate formation of the alloxan radical (Munday, 1988). 
The reduction of alloxan to dialuric acid in the cell requires the presence of a suitable 
thiol, typically the tripeptide glutathione (GSH) to generate the redox cycling partner, 
dialuric acid, and oxidized glutathione. The triketone structure of alloxan is vitally 
important for this two-step reaction with glutathione, which generates the alloxan 
radical as an intermediate product .Other thiols such as cysteine, which are present at 
lower concentrations in the cell, dithiols and ascorbic acid are also suitable reducing 
agents and may therefore contribute to alloxan reduction. Alloxan can also generate 
ROS by reacting with thiol groups on proteins such as enzymes and albumin. During 
each typical redox cycle a small amount of 'Compound 305', an alloxan-GSH 
adduct,is formed. The intracellular concentration of Compound 305 increases in a 
time-dependent manner, which gradually decreases the amount of reduced GSH 
available in the cell for redox cycling, thus producing a lower pro-oxidative ratio 
between alloxan and GSH, rather than a higher antioxidative ratio. (Winterbourn et 
al., 1989) 
The major oxidation pathway of dialuric acid, a chain reaction dependent upon 
superoxide radicals, is inhibited by superoxide dismutase (SOD). In the presence of 
SOD, an autocatalylic process involving the interaction between dialuric acid and 
alloxan becomes important, while in the presence of a transition metal, a third 
oxidation mechanism, dependent upon hydrogen peroxide, has been identified. This 
latter step is inhibited by the hydrogen peroxide inactivating enzyme catalase. The 
other hydrogen peroxide inactivating enzyme, glutathione peroxidase, can principally 
act in a similar manner. But this enzyme requires GSH, which is oxidized in the 
reaction (Lenzen, 1998; 2008) 
When kept in the oxidized form, alloxan does not generate ROS. Thus, alloxan is not 
cytotoxic in the absence of thiols such as GSH or when restricted to the extracellular 
space. Thiols in the plasma membrane, with which alloxan could interact and 
generate ROS in a redox cycle, are apparently not present or not accessible to a 
sufficient extent to allow the generation of ROS and damage the cells. The reduction 
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product dialuric acid is also not toxic when kept in the reduced from. However, in 
contrast to alloxan, dialuric acid autoxidises spontaneously in the presence of O2 thus 
generating cytotoxic ROS in the absence of thiols. As a result of subsequent redox 
cycling it can also induce diabetes and cause beta cell lesions as alloxan (Lenzen et 
al.,1992) 
 The antioxidative enzyme SOD has a cytoprotective effect against both alloxan and 
dialuric acid in the presence of GSH by virtue of its ability to scavenge superoxide 
radicals, which are generated in the 02-dependent chain reaction between dialuric 
acid and alloxan. The resultant suppression of dialuric acid autoxidation prevents the 
generation of further ROS, although increasing the concentrations of the toxins can 
reinstate the toxic action of both compounds. This is due to an autocatalytic reaction 
between the oxidized and reduced pyrimidine, which generates ROS even when the 
chain reaction is suppressed by SOD (Lenzen et al., 1996). 
 Apparently, the superoxide radical is not the species responsible for the cytotoxicity 
of alloxan and dialuric acid. Several lines of' evidence point to hydroxyl radicals as 
the principal culprit (Lenzen, 1998; 2008). 
 First, the hydrogen peroxide-inactivating enzyme catalase provides significantly 
better protection against the toxic effects of alloxan and dialuric acid on insulin 
producing cells than the superoxide radical-inactivating enzyme SOD, though 
catalase does not prevent redox cycling and therefore superoxide radical formation . 
Second, since intracellular GSH concentrations are in the same millimolar 
concentration range in insulin-producing cells as in liver cells, and since both cell 
types express the GLUT2 glucose transporter, a difference in the intracellular GSH 
concentration cannot be responsible for the much greater susceptibility in vivo of 
insulin-producing cells compared with liver cells to the toxicity of alloxan. However, 
liver cells are much better endowed with the hydrogen peroxide-inactivating enzyme 
catalase compared with insulin-producing cells. When the low intracellular levels of 
catalase are raised in insulin-producing cells through ovcrcxprcssion of the gene for 
this enzyme, these cells are protected equally well (Lenzen, 1998; 2008). 
Taken together, these data provide convincing evidence that the hydroxyl radical, 
rather than the superoxide radical, is the ultimate toxic ROS species and that its 
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formation is prevented by the destruction of hydrogen peroxide by catalase. Optimal 
protection against the cytotoxic action of alloxan and dialuric acid is provided only 
by a combination of SOD plus catalase, which completely prevents redox cycling 
between alloxan and dialuric acid, and thus the generation of all ROS species in this 
reaction pathway. Glucose also provides complete protection against all toxic effects 
of alloxan both in vivo and in vitro. This universal protection is achieved through the 
prevention of glucokinase inhibition and the preservation of the antioxidative defence 
mechanisms of the beta cell. The non-metabolically glucose analogue 3-0-
methylglucose also provides protection but does this exclusively through the 
prevention of alloxan uptake into the beta cell via the GLUT2 glucose transporter. 
Thus, it can be concluded that the pancreatic beta cell toxicity and the resultant 
diabetogenicity of alloxan are due to redox cycling and the generation of toxic ROS 
(Lenzen, 1998; 2008). 
2.5.2. Streptozotocin  
Streptozotocin (Streptozocin, STZ, Zanosar)  is a  naturally  occurring  chemical  that 
is  particularly  toxic  to the  insulin  producing  beta  cells  of the  pancreas  in 
mammals. It  is  used in medicine   for  treating  certain  cancers  of  the Islets of 
Langerhans  and  used  in medical  research  to  produce  an   animal   model  for  
Type I  diabetes. It has IUPAC name 2-deoxy-2- methyl-nitroso-amino-carbonyl-
amino-ß-D-glucopyranose  and  has mol mass of 265.221 g/mol. Its  formula is 
C8H15N3O7 (Takasu et al., 1991; Szkudelski, 2001).  
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Mechanism of Action  
Streptozotocin inhibits insulin secretion and causes a state of insulin-dependent 
diabetes mellitus. Both effects can be attributed to its specific chemical properties, 
namely its alkylating potency.  As with alloxan, its beta cell specificity is mainly the 
result of selective cellular uptake and accumulation (Eisner et al., 2000). 
a) Beta cell selectivity of streptozotocin   
Streptozotocin is a nitrosourea analogue in which the N-mcthyl-N-nitrosourea 
(MNU) moiety is linked to the carbon-2 of a hexose. The toxic action of 
streptozotocin and chemically related alkylating compounds requires their uptake 
into the cells. Nitrosoureas are usually lipophilic and tissue uptake through the 
plasma membrane is rapid; however, as a result of the hexose substitution, 
streptozotocin is less lipophilic. Streptozotocin is selectively accumulated in 
pancreatic beta cells via the low-affinity GLUT2 glucose transporter in the plasma 
membrane. Thus, insulin-producing cells that do not express this glucose transporter 
are resistant to streptozotocin . This observation also explains the greater toxicity of 
streptozotocin compared with N-methyl-N-Nitrosourea in cells that express GLUT2, 
even though both substances alkylate DNA to a similar extent. The importance of the 
GLUT2 glucose transporter in this process is also shown by the observation that 
streptozotocin damages other organs expressing this transporter, particularly kidney 
and liver (Yamamoto et al., 1981; West et al., 1996) 
b) Beta cell toxicity of streptozotocin  
It is generally assumed that the toxicity of streptozotocin is dependent upon the 
DNA alkylating activity of its methylnitrosourea moiety, especially at the 0
6
 
position of guanine. The transfer of the methyl group from streptozotocin to the 
DNA molecule causes damage, which along a defined chain of events , results 
in the fragmentation of the DNA . Protein glycosylation may be an additional 
damaging factor. In the attempt to repair DNA, poly (ADP-ribose) polymerase 
(PARP) is over stimulated. This diminishes cellular NAD, and subsequently 
ATP stores. The depletion of the cellular energy stores ultimately results in 
beta cell necrosis. Although streptozotocin also methylates proteins, DNA 
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methylation is ultimately responsible for beta cell death, but it is likely that 
protein methylation contributes to the functional defects of the beta cells after 
exposure to streptozotocin. Inhibitors of poly ADP-ribosylation suppress the 
process of DNA methylation. Thus, injection of nicotinamide and other PARP 
inhibitors in parallel with, or prior to the administration of streptozotocin is 
well known to protect beta cells against the toxic action of streptozotocin and 
to prevent the development of a diabetic state. Also, mice deficient in PARP 
arc resistant to beta cell death mediated by streptozotocin, in spite of DNA 
fragmentation. The absence of PARP prevents the depletion of the cofactor 
NAD' and the subsequcnt loss of ATP and thus cell death  (Lenzen, 1998; 2008).  
The role of alkylation in beta cell damage has also been examined by the use of 
ethylating agents, which are less toxic than their methylating counterparts, on 
account of 0
6
 ethylguanine being less toxic than O
6
-methylguanine . The fact 
that N-ethyl-N-nitrosourea and ethyl methanesulphonate are significantly less 
toxic to insulin-producing cells than MNU and methyl methanesulphonate has 
been taken as support for the notion that in insulin producing cells, as in other 
cell types, the mechanism of toxic action is due to alkylation, with methylation 
of DNA bases being more toxic than ethylation (Lenzen, 1998; 2008). 
An alternative hypothesis proposes that part of the diabetogenic effect of 
streptozotocin may relate not to its alkylating ability but to its potential to act 
as an intracellular nitric oxide (NO) donor. Both streptozotocin and MNU 
contain a nitro group and can liberate NO. In fact, streptozotocin has been 
shown to increase the activity of guanylyl cyclase and the formation of cGMP, 
which are characteristic effects of NO. However, the alkylating agent methyl 
methanesulphonate is the most toxic compound though unlike MNU, it is not a 
NO donor, indicating that NO is not an indispensable prerequisite for the toxic 
action of the family of alkylating agents that streptozotocin belongs to.  
Finally, some minor generation of ROS, including superoxide and hydroxyl 
radicals originating from hydrogen peroxide dismutation during hypoxanthine 
metabolism may accompany the effect of streptozotocin and accelerate the 
process of beta cell destruction but ROS do not play a crucial role  (Lenzen, 
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1998; 2008).  
c) Inhibition of insulin secretion by streptozotocin  
The effects of streptozotocin on glucose and insulin homeostasis reflect the 
toxin-induced abnormalities in beta cell function. Initially, insulin biosynthesis, 
glucose-induced insulin secretion and glucose metabolism (both glucose 
oxidation and oxygen consumption) are all affected On the other hand, 
streptozotocin has no immediate, direct inhibitory effect upon glucose transport 
or upon glucose phosphorylation by glucokinase. However, at later stages of 
functional beta cell impairment, deficiencies in terms of gene expression and 
protein production lead to the deterioration of both glucose transport and 
metabolism.  
Even before the negative effects of mitochondrial DNA and protein alkylation 
and glycosylation become evident, streptozotocin-induced depletion of NAD' 
may result in the inhibition of insulin biosynthesis and secretion. Later, 
inhibition of glucose-induced and amino acid induced insulin secretion as a 
result of mitochondrial enzyme dysfunction and damage to the mitochondrial 
genome become apparent. This impairment is more marked for nutrient - than 
for non-nutrient-induced insulin secretion. This interpretation has been 
confirmed through studies which have shown that pre-treatment of isolated 
pancreatic islets with the poly(ADP-ribose) polymerase (PARP) inhibitor 
nicotinamide prevents early inhibition of beta cell function during the first day 
after streptozotocin  exposure, while long-term inhibition of insulin secretion 6 
days after streptozotocin exposure was not counteracted by nicotinamide 
(Lenzen, 1998; 2008). 
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Table 7: Comparison of the chemical properties of alloxan and 
streptozotocin 
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2.6 CONVENTIONAL TOXICITY STUDIES 
(OECD Guidelines, 2002; Ghosh, 1984) 
In  order  to  assess  the   toxic  effects  after  administration of  alcoholic  extracts  of   
different   plants, toxicological  studies   are  carried  out  which are   as   follows:- 
Acute Toxicity Studies 
Short-Term Studies (Subacute or Subchronic) 
Long-Term Toxicity Studies 
2.6.1 Acute   Toxicity Studies 
These  involve  either  a  single  administration  of a   drug  under  test  or  several  
administration  within  a  24-hour  period  to  72  hour  period. 
These studies  are  conducted  to  calculate  the  median  lethal   dose  ( LD50) of  the  
drug  (Paget, 1983). 
The common procedure to conduct acute toxicity study is as follows:- 
i) Experimental design 
 Selection of species of animal. 
 Route of administration. 
 Dosage and numberof animals. 
 Environmental factors. 
 Selection  of  species  of  animal 
In  general,  rat  and   mouse  are   preferred  because  they  are   economical,  readily   
available  and  easy  to   handle. Sometimes,  a  non- rodent  species  is  desirable,  
when  LD50  values  in  rats  and  mice  are  markedly  different  or  when  the  
pattern  or  rate  of  biotransformation  in  humans   is  known  to be   significantly   
different  from   rats  and  mice. LD50  is  preferably  done  in  animals  of  both  
sexes, and  also  in  adult   and  young  animals,  because  of  their   differences  in  
susceptibility. 
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 Route  of  administration 
The  drug  should  be  administered  by  the  route  by  which  humans  would  be  
exposed.  The oral route is commonly used   by gavage. Sometimes, dermal and 
inhalation routes are also used. Parenteral routes are mainly   used in assessing the 
acute toxicity of parenterals. 
 Dosage  and  number  of  animals 
To  ascertain  LD50,  it is  necessary  to  try  to  select  a  dose  that  would  kill  about  
half  of  the  animals,  another  that  would   kill   more  than  half  and  a  third  dose  
that  would  kill  less than  half  of the  animals.In  general,  the  precision  of  LD50  
is  improved  by  increasing  the  number  of  animals  per  dose  and  by  decreasing  
the  ratio  between  successive  doses. Many  investigators  use  40-50  animals  per  
LD50  test  and  select  ratio  of  1.2  -1.5.  Another  simple  test  procedure  has  been  
described  more  recently  involving  the  use  of  only  6  to 9  animals  per  test. In  
determining  the  LD50  in  large  animals,  such  as   dogs  generally  a  much  
smaller   number  of  them  is   used. 
 Environmental  factors 
The  type  of  cage  can affect  the  reactions  of  the  animals  to  drugs. Temperature  
of  the  environment  e.g  toxicity  of  nicotine,  atropine  is  increased  in  cold  
temperature  whereas  toxicity  of  parathion (an organophosphorus   compound)   is   
reduced  by  hypothermia. A  higher  relative  humidity  may  increase  the  acute  
toxicity   resulting  in a  lower  LD50  dose. 
ii) Observations and examinations 
The observation period should be sufficiently long usually 7-14 days.  
Histopathological examinations of selected organs and tissues may also be indicated. 
Different signs observed during acute toxicity studies are shown in Table 8a. 
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Table 8a: Toxic Signs observed on different body organs in Acute Toxicity 
Study 
System                    Toxic Signs 
Autonomic 
Relaxed nictitating membrane, nasal discharge, salivation, 
diarrhea, urination Behavioural Sedation, restlessness, severe 
depression, Panting, aggressive and defensive hostility, Fear, 
confusion. 
Neuromuscular 
Decreased  and  increased  activity, tremors, Convulsions, 
pain  and  hind  limb  reflexes, Muscle  tone. 
CVS 
Increased and decreased heart rate, Vasoconstriction, 
vasodilation, hemorrhage. 
Respiratory Dyspnoea, gasping, apnea. 
Ocular 
Mydriasis, miosis, lacrimation, cyclopegia, papillary Light   
reflex. 
GIT Salivation,  diarrhoea 
Urinary 
Blood stool and urine, constipation, emesis, involuntary 
Urination and   defecation. 
Cutaneous Pilo-erection, erythema, edema, necrosis, swelling. 
 
Table 8b: Classification of drugs according to their relative toxicity 
(Ghosh, 1984) 
Category LD50 
Supertoxic 5mg/kg or less 
Extremely toxic 5-50mg/kg 
Highly toxic 50-500mg/kg 
Moderately toxic  0.5-5gm/kg 
Slightly toxic 5-15gm/kg 
Practically non-toxic  > 15gm/kg 
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2.6.2 Short Term Toxicity Studies 
Humans  are  more  often  exposed  to  chemicals  and  drugs  at  levels  much  lower  
than  those  that  are  acutely  fatal;  but  they  are  exposed  over  longer  periods  of  
time. To  assess  the  nature  of  the  toxic  effects  under  these  more  realistic    
situations,  short-term  and  long  -term  toxicity  studies  are   conducted. These   
studies  involve  repeated   administrations,  usually   on  a  daily  or  5  times   per  
week   basis,  over a  period  of  about  10%  of  the  life  span,  namely  3  months  in  
rats  and  1  or  2   years  in dogs.  However,  shorter   durations  such  as  14  and   28  
days  treatment  have  also   been  used. 
i) Experimental design 
 Species and  number 
Generally, two or more species of animals are used. Ideally, the  animals  chosen  
should  biotransform  the  chemical  in a  manner  essentially  identical  to  humans.  
The   rat and the dog are usually selected.  This  preference  is  based  on  their  
appropriate  size,  ready  availability  of  these  animals. Equal   number of   male and 
female animals should be used.  Generally,  10-30  rats  are   used  in  each  dose  
group  as  well as  in   the  control  group. As  a  rule,  this  procedure  will   provide   
data  that  is  statistically  analyzable.  Smaller  number  of  dogs ( 4-8  per  group)   
are  used   because  of  the  greater  number  of   examinations  that   can  be  made  
on   each  animal  and    because  of   their size and   the   expense  involved. 
 Route  of  administration 
Common route   is oral-gavage. Sometimes  dermal  applications,  exposure  by  
inhalation  and  parenteral  routes   also  used. 
 Dosage  and  duration 
A control group  should  be  included.  Doses  are  generally  selected  on the   basis  
of  information  obtained  in  acute  toxicity   studies.  Any  information  on  related   
chemicals  and  on  their  metabolism,  especially  the  presence  or  absence  of  
accumulation  is  also  taken  into  account. 
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Generally, 5  to   6   rats  of  either   sex  are     taken  for  7  days.  The  criteria   for   
toxic  effects  are  mortality,  body   weight  gain,  relative  liver  and  kidney   
weights  and  feed   consumption. The  results  from  7  day  tests  are  generally  
better  than  90-day  toxicity   study. In   rats, the   doses are   expressed in mg/kg 
body weight of the animals. As  the  animals   grow,  there  are  changes  in  the  
body  weight  of the  animals,  as  well  as in the  food  consumption. 
In  the  dog,  the  duration  is  often  extended  to  6  months  or  even  1  or  2   years. 
 Observation  and  examination 
 Body weight and food consumption: These should be determined weekly. 
Decreased body weight is a sensitive   index of toxic effects. Food consumption 
is also a useful indicator. 
 General observations: These include appearance, behaviour and any 
abnormality.  Dead  animals  should  be  removed  from  the  cages  for   gross  
and  possibly  microscopic  examination. 
 Laboratory  tests: Hematological examinations  usually  include  haemotocrit,  
haemoglobin, erythrocyte count, T.L.C, DLC, special tests  such  as  reticulocyte  
count,  platelet   count  and  glucose-6-PO4 dehydrogenase    may  be  indicated. 
Clinical  laboratory  tests  usually  include  fasting  blood  glucose,  serum   glutamic  
oxalo-acetic  acid  transaminase (SGOT), serum glutamic pyruvic  acid  transaminase 
(SGPT),  alkaline  phosphatase,  total  protein,  albumin,  globulin,  blood  urea   
nitrogen (BUN)  and  elements   such  as   sodium,  potassium,calcium  and chloride. 
Urinalysis  usually  include  colour,  specific  gravity,  pH protein,  glucose,  ketones,  
etc. 
 Postmortem  examination: All  animals   which  are   found  dead  should  be  
subjected  to  gross  pathological  examination.  Histologic examination should   
be   done. In addition, weights  of  the  organs  should  be  taken  as   useful  
indicators  of  toxicity.  The   organs which are usually   weighed   are   liver, 
kidneys, adrenals, heart, brain, thyroid, testes and ovaries. 
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2.6.3 Long  Term  Toxicity  Studies These involve  repeated   administrations  over  
the  entire  life  span  of  the  test  animals  or  at   least  a  major  fraction  of  it  e.g  
18  months  in  mice,  24  months  in   rats  and  7-10  years  in   dogs  and   monkeys. 
i) Experimental  design 
 Animals 
Species and number. Generally, one or more species of animals are used.  Rats and   
dogs are   generally   used. Non-human primates are also   used.  Because  of  their  
small  size,  mice  are  not  suitable   for  their  long-term  general  toxicity   studies  
although  they  are  often  used  in   carcinogenesis   studies. An equal number of 
male and   female   animals should be used.  Generally, 40-100  rats  are  placed  in  
each  dose   group  and  in the  control  group.  Much smaller number of dogs and 
non-human primates are used. 
 Route  of  administration 
Same as in short term   studies. The   duration of such studies in rats is   usually   2 
years.  Dogs and monkeys are kept for 7 years or more. 
a) Observations and examinations 
These should   include body   weight, food consumption,   general   observations,   
laboratory   tests and   post-mortem   examinations. 
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Table 8c: Clinical laboratory tests and   pathological examination conducted in 
sub-chronic toxicity studies 
Organ 
General 
Observation 
Clinical 
Laboratory  Tests   On 
Blood 
Pathology 
Examination 
LIVER Discolouration  of  
mucous  membrane, 
Edema. 
SGPT,SGOT,alkaline 
Phosphatase,cholestero, 
Total  protein, albumin 
Globulin. 
Liver 
GIT Diarrhoea,  vomiting,  
stool,  appetite 
Total  protein,albumin 
Globulin, Na,  K. 
Stomach, gallbladder, 
Salivary gland, 
pancreas 
URINARY  
SYSTEM 
Urine volume, colour. Blood  urea  nitrogen, 
total  proteins,  albumin, 
Globulin 
Kidney, urinary 
Bladder. 
HEMOPOIETIC 
SYSTEM 
Discolouration  of  
mucous  membrane, 
Lethargy,weakness 
Packed  cell  volume, 
RBC  count, TLC,DLC, 
Platelet count, 
prothrombin time. 
Spleen, thymus, bone 
marrow smear. 
NERVOUS  
SYSTEM 
Posture  
movements,responses, 
Behaviour. 
 Brain,spinal  cord, 
sciatic  nerve. 
EYE Appearance,discharge, 
Ophthalmic 
examination 
 Eye    and   optic 
Nerves. 
 
RESPIRATORY 
SYSTEM 
Rate, coughing,  nasal 
Discharge. 
Total  protein, albumin 
Globulin. 
One lung  with  a  
major   bronchus. 
ENDOCRINE 
SYSTEM 
Skin, hair body weight. Glucose, Na, k, 
Cholesterol. 
Thyroid,adrenal,panc
reas. 
REPRODUCTIVE 
SYSTEM 
Appearance  and 
Palpitation  of  external 
Reproductive  organs 
 Testes,ovaries,uterus 
Prostate, seminal 
Vesicle. 
SKELETAL 
SYSTEM 
Growth,deformation 
Lameness. 
Calcium,phosphorus. 
Alkaline  phosphatase. 
Bone 
CVS   SYSTEM Rate &  characteristics 
Of  pulse,  rhythm, 
Edema. 
GOT Heart,aorta,small  
arteries in  other  
tissues. 
SKIN Colour, appearance Total  protein, albumin 
Globulin 
Dermal  studies. 
MUSCLE Weakness, decreased 
Activity. 
GOT,creatine, 
phosphoKinase. 
Clinical  chemistry, 
Gross  lesions. 
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2.7 EVALUATION OF DIABETES MELLITUS 
      Biochemical Parameters evaluated in the present study include:          
a)  Serum Glucose Levels                          (Trinder, 1969) 
b)  Lipid Profile 
i. Serum  Total  Cholesterol Levels          (Allain et al., 1974) 
ii. Serum   Triglycerides   Levels               (Bucolo, 1973) 
iii. Serum   HDL Cholesterol    Levels                (Izzo et al., 1981) 
iv. Serum  LDL  Cholesterol  Levels               (Friedewald et al., 1972) 
c)        Kidney Function Test 
i. Serum   Urea  Levels                                      (Varley, 1980) 
ii. Serum   Creatinine  Levels                        (Zender, 1972) 
d)       Liver Function Tests 
i. Serum Bilirubin Levels           (Jendrassik et al., 1938) 
ii. SGPT Levels                        (Reitman  & Frankel, 1957) 
iii. SGOT Levels                    (Reitman & Frankel, 1957) 
iv. Serum total protein Levels      (Lowry et al., 1951) 
v. Serum albumin  Levels         (Hallbach  et al, 1991) 
vi. Serum alkaline phosphatase   Levels             (Bowers et al., 1966) 
e)        Hemoglobin value                      (Ghai, 2006) 
f)        WBC   Count                                      (Ghai, 2006) 
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2.8 TREATMENT OF DIABETES MELLITUS 
Emphasis   is on   managing   short-term as well as long-term    diabetes- related 
problems.  There  is  an  important  role  for  patient   education,  nutritional  support,  
self  glucose  monitoring,  as well as  long-term  glycaemic control. A scrupulous 
control is needed to help reduce the risk of long term complications. In  addition,  
given the associated higher  risks  of  cardiovascular  disease,  lifestyle  modifications  
must be implemented to control  blood pressure and cholesterol  by exercising  more,  
smoking  cessation, and  consuming  an  appropriate diet (Susman  et al., 1997)  
2.8.1 Management of Diabetes without Drugs  
 Exercise, Weight and Diet control play an important role in management of 
diabetes. 
a) Exercise: Regular exercise is of particular importance for diabetics. It ultimately 
helps you to keep your blood sugars within a normal range. By exercising, the cells 
in the body help to make insulin more effective because it makes the body's cells 
more sensitive to insulin. Consequently, individuals who have to inject insulin daily 
will have to inject less insulin if their bodies are using it more efficiently. Patients 
with type 1 or type II diabetes have an increased risk of coronary artery disease.  
Physical exercise is a key component of lifestyle modification that can help 
individuals prevent or control type II diabetes. Although diet is probably more 
important in the initial phases of weight loss, incorporating exercise as part of a 
weight –loss regimen helps maintain weight loss and prevent weight regain.  Mild to 
moderate activity levels have been associated with a lower risk of developing 
diabetes or pre-diabetes. 30 minutes of moderate physical activity daily may offer 
protection from diabetes.Greater levels of physical activity are associated with lower 
risks of developing diabetes in women compared with lesser levels of activity.  These 
studies indicate that exercise should be a mainstay of primary prevention of diabetes 
(Michael, 2007; Stewart, 2008). 
 b) Weight: It can be important factor in diabetics because it can make  ones body 
become resistant to insulin. Exercise helps to keep weight down because calories are 
burned when one exercises. If fewer calories are comsumed than one can burn, 
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weight  can  be lost.  A recent study demonstrated that both women and men who 
have a BMI > 35 kg/ m
2  
had a 20-fold increase in their risk of developing diabetes 
compared to people with a BMI of 18.5 -24.9 kg/m
2.
 Obese people also have a high 
incidence of hypertension and hyperlipidemia compared to nonobese people, which 
may further increase their risk of microvascular and macrovascular complications of 
diabetes. Weight loss also has been shown to decrease systolic and diastolic blood 
pressure and LDL cholesterol and lipid levels in obese diabetic patients.    
c) Diet: The diet plays a tremendous role in the management of diabetes because it is 
important to keep your blood sugar within a normal range..  The persons with 
diabetes who are  taking a fixed dosage of insulin have   to manually adjust their diet 
so that their blood sugar will be within a normal range.  Substantial dietary restriction 
to 1,100 kcal/day has been shown to decrease fasting blood glucose of obese patients 
with diabetes and even in those without diabetes in as few as 4 days (Michael, 2007;  
Kirkwood, 2007). 
i. Carbohydrates.  Carbohydrates are the body's main source of energy. Starches 
and sugars are carbohydrates and they are both broken down into glucose at 
approximately the same speed.  Foods, such as candy and jams,  can cause  
diabetes. (Beaser, 1995) Carbohydrates raise the blood sugar much more rapidly 
than fats and proteins. 
ii. Protein.  The body uses protein as the  second major  nutrient to build body 
tissue as well as repair body tissue. Proteins consist of foods such as meats, 
eggs, cheese, peanut butter, and tofu. The best sources of protein are those that 
are low in fat, such as lean meat and skinless poultry. Proteins contain enzymes. 
Some enzymes are responsible for breaking down starches into sugars. Proteins 
also slow the release of sugars into the bloodstream. (Michael, 2007) 
iii. Fat. The third major nutrient needed by the body is fat. Fats are important 
because they carry fatty acids and vitamins in the body.  It can be found in such 
things as cheese, margarine, butter, meat, milk, and vegetable oils. All fats are 
high in calories. Fats, like proteins, slow the release of sugars into the 
bloodstream.  
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Because saturated fats are the major dietary determinants of serum LDL cholesterol 
levels, people with diabetes should strive to keep saturated fat consumption to <7% 
of total daily calories and to minimize consumption of trans-fatty acids. Cholesterol 
consumption should be <200 mg/ day.Diets high in fish oil may   decrease  the risk of 
cardiovascular disease. Being a diabetic does not mean that one has to give up all of 
the foods that we enjoy, but we  have to pay particularly close attention to the meals 
that we eat. (Michael, 2007) 
2.8.2 Allopathic   Treatment of Diabetes Mellitus 
Conventional treatment of  diabetes  in   allopathic   medicinal   system  revolves  
around  the   use  of   following   drugs (Tripathi, 2010)  
a) Insulins : Rapid   acting, Short  acting,  Intermediate  acting, Long   acting 
b) Sulfonylureas   First   generation,-  Second   generation 
c) Biguanides 
d) Meglitinide/Phenylalanine  analogues 
e) Thiazolidinediones 
f) Glucosidase   Inhibitors 
g) Novel  drugs in diabetes 
a) Insulins: Secretion   of insulin  from   beta   cells  of  pancreas,  which  has  a   
overall  effects  to  favour  storage  of   fuel. Insulin  also   facilitates   glucose  
transport  across  cell  membrane   &   glycogen  synthesis   from  glucose  in   liver,  
muscle  and   fat  by  stimulating  the  enzyme   glycogen    synthetase.  It   inhibits  
gluconeogenesis   from   protein  in liver  and   lipolysis  in  adipose  tissue  and  
favours  triglyceride   synthesis (Drug  Today, 2012). 
Different  types of  insulin  preparations , insulin  analogues   are  shown in the  
Table 9a. 
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Table  9a : Types of Insulin Preparations and Insulin Analogues (Tripathi, 2010) 
Type  Appearance  Onset 
(hr) 
Peak 
(hr) 
Duration 
(hr) 
Can be mixed 
with 
Rapid acting 
Insulin Lispro 
Insulin aspart 
Insulin glulisine 
 
Clear 
Clear 
Clear  
 
0.2-
0.4 
0.2-
0.4 
0.3-
0.5 
 
1-2 
1-1.5 
1-2 
 
3-5 
3-5 
2-4 
 
Regular, NPH 
Regular, NPH 
Regular, NPH 
 
Short acting 
Regular (Soluble) 
insulin 
 
Clear  
 
0.5-1 
 
2-4 
 
6-8 
 
All 
preparations 
(except insulin 
glargine)  
Intermediate acting 
Insulin Zinc 
suspension or Lente 
Neutral protamine 
hagedorn (NPH) or 
isophane insulin 
 
Cloudy 
 
Cloudy 
 
1-2 
 
1-2 
 
8-10 
 
8-10 
 
20-24 
 
20-24 
 
Regular 
 
Regular 
Long acting  
Protamine zinc 
insulin (PZI) 
Insulin glargine 
 
Cloudy 
Clear 
 
4-6 
2-4 
 
14-
20 
 
24-36 
24 
 
Regular 
None  
i) Highly Purified Insulin  Preparations  
Pork insulin, being more homologous to human  insulin, is less immunogenic and is  
used. Gel filtration reduces proinsulin content to 50-200 ppm, but pancreatic peptides 
and insulin derivatives remain; the preparation is called ― single pork insulin.‖ It has  
significant  immunogenicity. Further purification by ion-exchange  chromatography  
removes most  contaminants and  reduces proinsulin to< 10 ppm. These preparations 
are termed ―Highly purified or Monocomponent ( MC) insulins.Immunogenicity of 
pork MC insulins is similar to that of  human insulins. Moreover, MC insulins are 
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more stable, cause less insulin resistance or injection site lipodystrophy (Tripathi, 
2010) 
Table 9b:  Highly Purified  Insulin Preparations 
Preparation Dose 
Highly purified (monocomponent) pork regular insulin 40 U/ml inj 
Highly purified (MC) pork lente insulin 40 U/ml  inj 
Highly purified (MC) pork isophane (NPH)  insulin 40 U/ml inj 
Mixture of highly purified pork regular insulin (30%) and 
isophane insulin (70%) 
40 U/ml  inj 
ii) Human insulins 
In the  1980s, the human insulin ( having the same amino acid sequence as human 
insulin)  were  produced  by  recombinant  DNA technology in Escherichia coli – 
proinsulin  recombinant bacterial (prb) and in yeast- precursor yeast recombinant 
(pyr) or  by  enzymatic modification of porcine insulin.Human  insulin is more  water 
soluble  as well as hydrophobic than  porcine or bovine insulin. It has a slightly  more 
rapid s.c absorption, earlier and  more defined  peak and slightly shorter duration of  
action (Tripathi, 2010). Different Human Insulin Preparations and Insulin Delivery  
Systems  are  listed  in the Table 9c and 9d respectively. 
Table 9c:Different  Human  Insulin Preparations 
Preparation Dose 
Human regular insulin 40 U/ml inj vial &100 U/ml pen injector cartridge 
Human lente insulin 40 U/ml, 100 U/ml 
Human  isophane  insulin 40 U/ml inj vial &100 U/ml pen injector cartridge 
Human soluble insulin (30%) 
and isophane insulin (70%) 
40 U/ml inj vial &100 U/ml pen injector cartridge 
Human soluble insulin (50%) 
and isophane insulin (50%) 
40 U/ml inj vial &100 U/ml pen injector cartridge 
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9d. Different Insulin Delivery Systems 
Insulin syringes Mouth sprays 
Insulin infusion pumps Pills 
Insulin jet injectors The patch 
Insulin pens  
Insulin inhalers  
Insulin Nanopump  
(Tabakha, 2008; Fineberg, 2006; Cernea, 2006; Barnett, 2004)                                                 
b) Sulfonylureas 
First generation    Second generation 
Tolbutamide     Glibenclamide 
Chlorpropamide     (Glyburide) 
      Glipizide 
      Gliclazide 
      Glimepiride 
c) Biguanides 
Metformin 
d) Meglitinde/ Phenyl Alanine Analogues 
Repaglinide, Nateglinide 
e) Thiazolidinediones 
Rosiglitazone, Pioglitazone 
 f) Glucosidase Inhibitors 
Acarbose, Miglitol 
g) Miscellaneous: This  is  aimed  at  lowering  hyper-triglyceridaemia  and   
oxidative stress  and  biologists  are  hunting  novel  targets   like:- 
 Protein  tyrosine  phosphatase-IB( PTP-IB)  and  glycogen  synthase  
kinase -3 ( GSK-3) 
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 Inhibitors  of  glyconeogenesis  like  pyruvate  dehydrogenase   kinase  
(PDH), lipolysis 
 Fat  oxidation  including  carnitine  palmitoyl  transferase ( CPT) I  and II  
inhibitors 
 ß-3  adrenoreceptor  agonists. 
h) Novel Drugs in Diabetes: 
i) Guargum: It is a dietary fibre (polysaccharide) from Indian cluster beans ( Guar), 
which forms a viscous get on contract with water. Administered just before or mixed 
with food, it shows gastric emptying, intestinal transit and carbohydrate absorption: 
postprandial glycaemia is suppressed but overall lowering of blood glucose is 
marginal. It also reduces serum cholesterol by about 10% (Tripathi, 2010).  
ii) Glucomannan: This powdered extract from tubers of Konjar is promoted as a 
dietary adjunct for diabetes. It swells in the stomatch by absorbing water and is 
claimed to reduce appetite, blood sugar, serum lipids and relieve constipation. 
iii) Exenatide: The glucagon-like peptide-1 (GLP-1) is an important incretin that is 
released from the gut in response to oral glucose.  Exenatide is a synthetic GLP-1 
analogue, resistant to enzyme dipeptidyl peptidase-4  DPP-4,  but with similar action, 
viz, enhancement of postprandial insulin release, suppression of glucagon release and 
appetite as well as showing of gastric emptying (Tripathi, 2010)  
 iv) Sitagliptin: This orally active inhibitor of DPP-4 prevents degradation of 
endogenous GLP-1 and other incretins, potentiating their action, resulting in 
limitation of postprandial hyperglycaemia.  
v) Pramlintide: This synthetic amylin ( a polypeptide produced by pancreatic β cells 
which reduces glucagon secretion from α cells and delays gastric emptying) analogue 
attenuates postprandial hyperglycaemia when injected s.c. just before a meal, and 
exerts a centrally mediated anorectic action (Tripathi, 2010). 
vi) Vogliobose: It inhibits the hydrolase (alpha glucosidase) enzyme for   
disaccharides that catalyzes decomposition of disaccharides into monosaccharides in 
the intestine.  Thereby, it delays the digestion and absorption of carbohydrates, 
resulting in   improvement of postprandial hyperglycaemia (Drug Today, 2012). 
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vii) Chromium  picolinate: It  is a  nutritional  supplement  that   works to   increase  
the   efficiency  of  insulin  to   optimal   levels. 
viii) Vildagliptin: a new hypoglycemic agent dipeptidyl peptidase-4 (DPP-4) 
inhibitor. It works by increasing the amount of two incretin hormones found in the 
body, called glucagon-like peptide-1 (GLP-1) and glucose dependent insulinotropic 
peptide (GIP). GLP-1 and GIP have two main actions that help to control blood 
glucose. They stimulate the pancreas to produce insulin in response to increasing 
levels of glucose in the blood. GLP-1 also reduces the production of glucagon, GLP-
1 and GIP are normally broken down by an enzyme in the body called dipeptidyl 
peptidase- 4 ( DPP-4). Vildagliptin works by binding to this enzyme and preventing 
it from breaking down the GLP-1 and GIP. This increases the levels of these 
hormones in the body and so increases their effect on controlling blood sugar. 
Another drug  in this  category is Linagliptin   which works by blocking the DPP-4 
enzyme, which releases insulin boosting hormones that help control blood sugar 
levels (Malik, 2012). 
2.8.3 Recent Advances 
a) Pancreas   transplantation  
b) Islet cell  transplantation 
c) Artificial  pancreas 
d) Stem  cell  approach 
e) Gene therapy approach 
f) Nanotechnology 
       (Robertson, 1999) 
 
a) Pancreas transplantation 
Highly recommended for patients who require a kidney transplant. 
b) Islet cell  transplantation 
Highly used approach in humans to cure type I diabetes. Islets  cells  are  injected   
into  the  patients  liver,  where  they  begin  to  produce  insulin.  The  islet  cells  
seem  to  produce  insulin  well  in that  environment.  The  patients  body  treats the  
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new  cells  just  as it  would  do to  any  other    foreign  body.  The  immune  system  
will  attack  the  cells  as  it  would  do  to  a  bacterial  infection.  Thus,  the  patient  
also  needs  to  undergo  treatment  involving  immune  suppression,  which  reduces  
immune  system  activity (Robertson, 1999). 
c) Artificial pancreas 
Artificial  pancreas  involves  implantation  of  bio-engineered  tissue  containing 
islet  cells,  which  would  secrete  the  amounts  of  insulin, amylin  and   glucagon  
needed  in  response  to  glucose (Klonolf, 2003) 
 d) Stem cell approach 
Islet  cells  are  developed  from  stem  cells  taken  from  umbilical  cord  blood of 
newborn  babies. 
e) Gene therapy approach 
Gene  therapy  can  be  used  to  manufacture  insulin  directly,  consisting  of  viral  
vectors  containing   the  insulin  sequence,  is  digested  and  delivers  its  genes  to  
the  upper  intestines. Those  intestinal  cells  will  then  behave  like  any  viral  
infected  cell  and  will  reproduce  the  insulin  protein.  The  virus  can  be  
controlled  to  infect  only  the  cells  which  respond  to  the  presence  of  glucose,  
such  that  insulin  is  produced  only  in the  presence  of  high  glucose  levels. Gene  
therapy  is  also  used  to  cure  patients  having  ß cell  destruction. It  is  also  used  
to  turn  duodenum  cells  into ß cells,  which  produce  insulin  and  amylin.Naturally 
ß cells  will  produce  insulin  in  proportional  response  to  carbohydrates  consumed 
(Welsh, 1999;Yamaoka, 2001). 
f) Nano-technology  approach To  cure  diabetes  type I  patients  many  nanobots  
are  injected  into  the  patients  blood stream.  These  nanobots  synthesize  insulin  
and  secrete it  according  to  the  level  of  glucose  they  would  sense. 
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2.8.4 Herbals as Anti-Diabetics 
Since  Allopathic  system  of  medicine  only  provides  symptomatic  relief  and  
fails  to     cure  diabetes,  alternative  medicinal   system  provides  an  avenue  for   
reduction  in   cost,  complete  cure  and  minimization  of  side  effects  associated  
with   allopathic  system.  Indian  traditional  medicinal  system   ayurveda  and  
unani    system  in  particular    claim  to   cure  the  diabetes  with  the  use  of   
natural    substances (Kirtikar  & Basu, 1933; 2000a; 2000b; 2001; 2003).  
Classification of herbal antidiabetics 
Based on the possible mechanism of action, reported plant antidiabetics may be 
classified as follows (Piyush et al., 2006; Grover et al., 2002). Some of these plants 
are shown in the table 13 
               Table 10a:  Herbals Reported To Have Antidiabetic Activity  
Type of Antidiabetic Action   Name  of the  Plants Reference 
Plants acting like insulin Momordica charantia 
Cuminum nigrum 
Panax  ginseng 
Pongamia pinnata 
Satyavati et al., 1976; 
1987; Atta-ur Rehman, 
1989; Piyush et al., 
2006; Agarwal, 2007 
Akhtar et al., 1981 
Plants increasing insulin 
secretion from beta cells of 
pancreas 
Panax ginseng, 
Azadirachta indica,  
Syzygium cumini, 
Eugenia jambolana, 
Pterocarpus marsupium,  
Euphorbia prostate,  
Fumaria parviflora, 
Bridelia ferruginous, 
Cassia tamala, 
Cassia nigrum,  
Swertia chirayita 
Piyush et al., 2006 
 
Plants acting by 
regeneration of beta cells of 
islets of Langerhans 
Morusbomoysis, 
Pterocarpus marsupium, 
Tinospora cordifolia, 
Tinospora crispa, 
Piyush et al., 2006 
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Gymnema sylvestre 
Plants inhibiting glucagon 
secretion from alpha cells in 
pancreas 
Ke-Tang-Ling Piyush et al., 2006 
Plants reducing absorption 
of glucose from 
gastrointestinal tract 
Cyamopsis tetragonoloba, 
Cuminum nigrum, 
Ocimum sanctum, 
Mangifera indica 
Piyush et al., 2006 
 
Plants inhibiting aldose 
reductase activity 
Paeonia latiflora, 
Glycyrrhiza glabra, 
Atracyloides lancea,  
Cinnamomum, 
Phellodendron amurense, 
Aralia elata 
Piyush et al., 2006 
Plants increasing glucose 
utilization 
Zingiber officinale, 
Nelumbo nucifera 
Piyush et al., 2006 
Plants reducing lactic 
dehydrogenase and gamma 
glutamyl tranpeptidase 
Lythrum salicaria Piyush et al., 2006 
Plants inhibiting glycogen 
metabolizing enzymes 
Bryonia alba Piyush et al., 2006 
Plants acting on liver 
glycogen 
Allium sativum, 
Coccinia indica 
Augusti, 1973  
Piyush et al., 2006 
Plants increasing glyoxalase 
I activity in liver 
Trigonella foenum graecum Piyush et al., 2006 
Plants increasing glucose 
uptake in lipocytes 
Swertia japonica Piyush et al., 2006 
Plants inhibiting glucose -6-
phosphate system 
Bauhinia megalandra Piyush et al., 2006 
Plants having oxygen radical 
scavenging activity 
Momordica charantia, 
Pterocarpus marsupium, 
Trigonella foenum graecum,  
Ocimum sanctum, 
Eugenia jambolana,  
Tinospora cordifolia,  
Macuna pruriens 
Piyush et al., 2006; 
Dubey et al., 1987; 
Jain et al., 1987 
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Table 10b: List of Indian Plants Reported To Possess Hypogycemic Activity In 
Various Animal Models Using Different Models For Inducing Diabetes 
S.No Name of the Plant 
Part used 
(Active Principle) 
Animal Model 
1.  Acacia melanoxylon Seeds Normal and alloxan diabetic 
Albino rats 
2.  Allium cepa Bulbs  
(Allyl Propyl disulphide) 
Bulbs (Allicin or dially1 
Disulphide oxide) Ether 
soluble & stem volatile 
fractions 
Juice   
Tops 
Alloxan diabetic rabbits 
Alloxan diabetic rabbits  
Alloxan and adrenaline diabetic rats 
3.  Allium.sativum Bulbs Alloxan diabetic rabbits 
4.  Aloe vera  Leaves Normal & alloxan diabetic rabbits 
5.  Amla racemosa Roots Rabbits 
6.  Azadirachta indica  Seeds oil Normal & hyperglycaemic rabbits 
7.  Bambusa dendrocalamus Leaves 
(Propylene glycol Soluble 
compound) 
Alloxan diabetic rabbits 
8.  Bauhinia retusa Seeds Normal & alloxan diabetic 
 albino rats 
9.  Bougainvillea spectabilis Leaves 
(Pinitol) 
Normal & alloxan diabetic mice 
Diabetic rats  
Alloxan induced mice 
10.  Cassia auriculata  Seeds Alloxan rabbits and dogs 
11.  Clerodendron phlomoides Whole palnt Adrenaline induced rabbits 
12.  Coccinia indica Roots 
Leaves  
Alloxan diabetic rabbits Alloxan rats 
Alloxan diabetic rats 
 
13.  Cuminum nigrum Seeds Normal & alloxan diabetic rabbits 
14.  Cyamopsis tetrogonolobus Fruits, seeds Alloxan diabetic rabbits 
15.  Dolichos lablab Green pods  Alloxan diabetic rats 
16.  Ficus bengalensis  Root bark  
(Phytosterolin ) 
Bark  
Bark 
(Flavonoids) 
(Glycosides) 
 Glycisidal 
fraction) 
Milk stap  
Rabbits  
Fasting rabbits  
Rabbits, mice 
Male rats 
Rabbits 
Fasting rabbits & dogs Dogs  
Rats 
 
Rats   
17.  Ficus bengelensis Bark  
(Bengalinoside)  
Bark 
Normal and alloxan rabbits 
 
 Alloxan rabbits 
18.  Ficus glomerata Bark  Normal & alloxan rabbits 
19.  Ficus glomerata Bark 
Bark 
Rabbits  
Rats  
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Bark 
(Sitosteryl glucosides)  
Rabbits  
20.  Fumaria parviflora  Whole plant  Normal rabbits  
21.  Glycine max Seeds Rats  
22.  Grewia asiatica Stem Bark Diabetic cats and rabbits  
23.  Gymnema sylvestre  Leaves  Hyperglycemic rats 
Normal & diabetic rabbits 
Alloxan diabetic rabbits 
Alloxan diabetic rats  
24.  Gymnema sylvestre  Leaves  
(Glycosamino glycan and 
protein bound 
polysaccharidcs)  
Leaves  
Whole plant  
Rats  
 
 
 
Rats  
Rabbits  
25.  Hamiltonia suaveloens  Roots Rats, dogs and monkeys 
26.  Hamiltonia suaveolens  Roots  Alloxan diabetic rats 
27.  Inula racemoma  Roots Glucose induced hyperglycaemia in 
rabbits  
28.  Launaea nudicaulis  Roots Alloxan diabetic rabbits 
 (Glycoside) 
29.  Launaea nudicaulis (glycoside) Rats  
30.  Leucaena leucocephala Seed Rats  
 
31.  Momordica charantia   Fruits 
 
Fruits 
(Bigger variety without 
seed) 
Fruits 
 
 
Seeds 
Seeds 
Diabetic rabbits  
Alloxan diabetic dogs, rabbits 
Alloxan diabetic rabbits 
 
 
Alloxan diabetic dogs  
Against anterior pituitary extract in 
glucose fed rats  
Adrenaline induced diabetic rats  
Streptozotocin induced diabetes 
mellitus in rabbits 
 
32.  Momordica charantia Fruits 
Fruits 
Fruits 
Seeds 
Fruits 
Leaves 
Fruits 
Fruits 
(Charantin) 
Fruits & seeds 
Polypeptide 
Plant Insulin 
Rabbits 
Rabbits & dogs) 
Dogs 
Rats 
Rabbits 
 
Rats 
Rabbits  
 
 
Gerbils & langur 
Monkeys 
33.  Mucuna pruriens Seeds Rats 
34.  Murraya koenigii  Leaves Alloxan diabetic dogs 
35.  Murraya koenigii Leaves Dogs 
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36.  Musa paradisiacal Flower Rabbits 
37.  Nymphaea nouchali Root Rabbits 
38.  Phyllanthus fraternus Leaves  
(Flavonoid) 
Rabbits 
Rats 
39.  Pinus roxberghii Bark & root  Rabbits 
40.  Pongamia pinnata Bark Alloxan diabetic rabbits  
41.  Pongamia pinnata Bark Rabbits 
42.  Prunus persica Leaves  Dogs and rabbits 
43.  Pterocapus marsupium  Bark  
(flavonoid) 
(-) – Epicatechin) 
(-)- Epicatechin 
Alloxan induced necrosis of beta cell 
population of  
pancreas in rats  
Alloxan diabetic rats  
44.  Pterocarpus marsupium Aqueous infusion  
Bark 
Pituitary diabetes in rats 
Alloxan induced necrosis 
45.  Pterocarpus marsupium Heart wood 
Wood 
(pterostilbine) 
Heart- wood 
Wood 
(flavonoid) 
Wood 
Rabbits 
Dogs 
 
Rabbits 
Rats 
Albino rats 
46.  Rauwolfia serpentine Total alkaloid 
(Ajmaline) 
Cats  
47.  Rivea cuneata  Heartwood & leaves  Diabetic rats  
 
48.  Securigera securidaca Seeds Cats & Rabbits 
49.  Solatia  prenoides Root bark Rabbits  
50.  Solatia macrosperma Leaves & roots Rabbits 
51.  Syzgium cumini Seed kernel 
Seeds 
Seeds, fruits   
Alloxan diabetic rats 
Alloxan diabetic rats & rabbits 
Diabetic rabbits and dogs 
52.  Syzygium cumini  Seeds 
fruits & seeds 
Seeds 
Albino rats  
Rabbits  
Rats 
53.  Tephrosea purpurea  Seeds Rabbits  
54.  Tephrosia purpurea  Extract  Alloxan induced diabetes in rabbits 
55.  Tinospora cordifolia Stem Alloxanised rat and rabbit; adrenaline 
induced diabetic rabbits  
56.  Tinospora cordifolia Stem  
Stem 
Stem 
Rats 
Rats 
Rats & rabbits  
57.  Tricosanthes diocia Seeds Albino rats 
58.  Trigonella foenum graecum Seed 
(alkaloids)  
Rabbits  
(Kirtikar  & Basu, 1933; 2000a; 2000b; 2001; Satyavati et al., 1976; 1987;   
                                                        Nandkarni, 1999) 
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Table 10c: List of Locally  Available Plants with Anti Diabetic Activity  
S. 
No. 
Plant Part Used 
Animal 
Model 
Family Local Name Reference 
1 Acorus calamus  Rhizome Rats  Acoraceae Eng:Sweet flag  
Hindi :Bach Gora 
Bach, Vai Gander 
David et al., 2011 
2 Allium species  Bulbs Rats Liliaceae Eng: Onion, Garlic, 
Hindi: Piyaz, Lasan 
Jain, 1973 
3 Aralia 
cachemirica 
Roots Rats  Araliaceae Eng: Aralia  
Hindi Khoree 
Bhat et al., 2005 
4 Artemisia  
abisinthium 
Aerial 
PartsPaPP
PPrtsp 
Rats Compositae Eng: Sweet Sage Wort 
Hindi: Tethwan 
Al Shamaony et al., 1994 
5 Astragalus  
species  
Root,Herb Rats,Mice Legumi naceae Hindi:Shatavani Chen et al., 2008 
6 Bauhinia  
variegate 
Stem  Rats  Caesalpinia                        
ceae 
Eng: Orchid  
Hindi: Kachnara 
Kumar et al., 2012 
7 Berberis  
aristata 
Root Rats  Berberidaceae Eng:Indian Berberry 
Kashmiri: Kawdach 
Semwal et al., 2009 
8 Brassica  
Juncea 
Leaf Rats Brassicaceae  Eng: Mustard  
Hindi: Sarsu 
Khan et al., 1995  
9 Catharanthus  
Roseus  
Leaves Rats  Apocynaceae Eng:Vinca,Periwinkle. 
Hindi:Sadabahar 
Benjamin et al., 1994 
10 Cichorium  
intybus 
Leaves  Rats Asteraceae Eng : chicory 
Kashmiri:Hand, Kasni 
Nayeemunnisa, 2009 
11 Coriandrum  
sativum 
Seeds  Mice  Umbelliferae Eng: Coriander 
Hindi:Dhaniya 
Chitra, 1999 
12 Cucumis  
sativus  
Fruit  Rabbit Cucurbitaceae Eng: Cucumber  
Hindi:Kheera 
Karthiyayini  et al., 2009 
13 Daucus carota Seeds, 
Roots 
Rats, Mice  Umbelliferae Eng: Carrot 
Hindi: Gajar 
Swanston et al., 1989 
14 Dioscorea  
deltoida 
Root Rats Dioscoraceae Eng: Diascorea  
Hindi: Kreench  
Iwu et al., 1990 
15 Ephedra elata Herbs Rats Mice Ephedraceae Eng: Ephedra 
Hindi: Ma Haung 
Bnouham et al., 2006 
16 Equisetum  
myriochaetum  
Aerial 
parts 
Rats Equisetaceae Eng:Mexican Giant 
Horsetail 
Andrade et al., 2000 
17 Gentiana lutea Root / leaf Rats Gentianaceae Eng: Yellow Gentian Rodriguez et al., 1998 
18 Gingko biloba Fruit Rats Gingoaceae Eng: Maiden hair tree Shankar et al., 2005 
19 Hibiscus 
rosa sinensis 
Flowers Rats,Mice Malvaceae Eng:Shoe Flower 
Hindi :Jasund, Urhul, 
Gudhal 
Venkatesh et al., 2008 
20 Juniperus Berries Rats Cupressaceae Eng: Common juniper Nilufer et al., 2012 
21 Lycium 
barbarum 
Berries Mice Solanaceae Eng: Wolfberry, Goji 
berry 
Sharma et al., 2003 
22 Marruibium  
vulgare 
Aerial 
Parts 
Rabbits, 
Rats  
Labiateae Kashmiri:Gand Soi Ramon et al., 1992 
23 Momordica 
charanetia 
Seeds / 
fruits  
Rats Cucurbi taceae Eng: Bitter gourd  
Hindi: Karela  
Sarkar et al., 1996 
24 Morus  
Alba 
Leaves Mice  
Rabbits 
Moraceae  
 
Eng: Mulberry  
Hindi: Tul 
 
Singab et al., 2005 
 
25 Myristica 
fragrans 
Seeds Rats  Myrtaceae Eng: Nutmeg  
Hindi :Jaiphal 
Somani, 2008 
26 Polygonatum Rhizomes  Rats and Liliaceae Eng:Solomons seal Kato, 1994 
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officinalis  Mice  
27  Psidium 
guajava 
 
Stem bark Rats Myrtaceae Eng:Guava 
Hindi:Amrud 
Mukhtar et al., 2006 
28 Punica  
granatum 
Flowers Rats Punicacaea Eng: Pomegranate 
Hindi: Anar 
Jafri et al., 2000 
29 Salvia   
Lavandulifolia 
leaves Rabbits  Lamiaceae Eng:Spanish Sage Zarzuelo et al., 1990 
30 Sausurrea  
Lappa 
Root Rats  Asteraceae  Eng:Costus root kuth 
Hindi :Kutha, kut 
Chaturvedi et al., 1993 
31 Smilax glabra  Rhizomes Mice  Smilacaceae Eng:Chinaroot 
Sarsaparilla 
Fukanaga et al., 1997 
32 Swertia  
chirayita 
Whole 
Plant 
Rats, Mice Gentianaceae Eng:Swertia  Chandrasekar et al., 1990 
33 Swertia 
japonica 
Whole 
Plant 
Rats, Mice Gentianaceae Eng:Swertia  Basnet et al., 1994 
34 Swertia  
petiolata 
Whole 
Plant 
Rats, Mice Gentianaceae  Eng:Swertia Goutam et al., 2004  
35 Swertia  
tetragona 
Whole 
Plant 
Rats, Mice  Gentianaceae  Eng:Swertia Goutam et al., 2004 
36 Syzygium  
cumini  
Seeds Rats Myrtaceae Eng:Clove 
Hindi: Laung 
Prince et al., 1998 
37 Tribulus 
terrestris 
Whole 
Plant  
Rats  Zygophyllaceae Eng: Small Caltrops 
Hindi :Chota Gokhru 
Tantawy, 2007  
38 Trigonella 
foenum 
graecum 
Seeds/ 
leaves 
Rats  Papilliona ceae 
(Flabaceae 
Eng: Fenugreek 
Hindi: Methi 
Madar et al., 1988 
39 Vinca minor/ 
major 
Whole 
Plant 
Rats Apocyana ceae Eng:Periwinkle 
Hindi :Sadabahar 
Chattopathyay et al., 1991  
40 Vitis  
venifera  
Seeds Rats  Vitaceae Eng:Common 
Grapevine 
Kashmiri: Kawdach 
 Xiao et al., 2008 
41 Withania 
somnifera 
Roots and 
leaf  
Rats Solanaceae  Eng:Winter Cherry 
Hindi :Ashwagandh 
Rajangam et al., 2009 
42 Zea mays Styles and 
stigmas 
collected 
from 
unripe 
corn 
Rats Gramineae Eng: Maize  
Hindi:Makkai 
Ranilla et al., 2009 
44 Zingiber 
Officinale 
Rhizomes Mice and 
rats 
Zingeberaceae Eng: Ginger 
Hindi: Adrak 
Ojewole, 2006 
                          (Rastogi &  Mehrotra, 1990, 1991, 1995, 1999) 
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                       2.9 LITERATURE REVIEW OF THE PLANTS  
        2.9.1 Pharmacognostical Characteristics of Portulaca oleracea Linn.   
 
Fig 2: Portulaca oleracea Linn. 
2.9.1.1 Plant Monograph: 
Classification: 
Kingdom           Plantae (Plants) 
Subkingdom              Tracheobionta   (Vascular plants)    
Superdivision            Spermatophyta (Seed plants) 
Division               Magnoliophyta (Flowering plants) 
Class                      Magnoliopsida (Dicotyledons) 
Subclass                Caryophyllidae 
Order                       Caryophyllales  
Family                       Portulacaceae (Purslane family) 
Genus                 Portulaca L (Purslane) 
Species                        Portulaca oleracea L. (Little hogwood) 
 
Vernacular Names: 
English                Common Purslane/Purslane 
Arabic/Persian             Hurfa, Kurfa 
Bombay                     Kurfa 
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Chinese Ma Chi Xian 
Gujarati                     Loni, Ghol 
Hindi & Bengali       Kursa, Chhota Lunia 
Punjabi                Lonak 
Tamil                   Karikkirai, Parupukkirai 
Kashmiri                 Nunar 
Flowering Period  March to August. 
Part Used  Whole plant, seeds and leaves. 
Distribution: A  cosmopolitan  weed  in  warm  temperate,  tropical  and  subtropical  
regions  of the    world.  Srinagar  along  waste  lands  and  in  cultivated  gardens  
ascending  upto  2300-2400  m (Gorske et al., 1979) 
2.9.1.2 Description:  
 The plant is an annual, succulent, erect or decumbent; prostrate herb growing up to 
40 cm height. It has a taproot with fibrous secondary roots and is able to tolerate 
poor, compacted soils and drought. The stem is cylindrical and succulent of 2-3 mm 
diameter. It has numerous glabrous branches, reddish and swollen at the nodes. It is 
felt very slippery due to presence of mucilage when crushed. The internodes are 1.5-
3.5 cm in length. Nodal appendages are less in number as compared to Portulaca 
quadrifida, minute and scarious. Leaves are alternate, succulent, cuneate oblong or 
spathulate, 0.4-2.5 cm long, truncate or retuse at the apex, thick, very short 
petiolated, stipular appendages minute or absent, taste sour without any smell, pale 
and glistening beneath. Petiole is very short and stipular about 1-1.5 mm long and 0.5 
mm thick with greenish upper surface and reddish lower. Flowers are bright yellow 
in colour and appear depending upon rainfall and may occur year-round and open 
singly at the center of the leaf cluster for only a few hours on sunny mornings. The 
blooming period occurs from mid-summer through the early fall and lasts about 1-2 
months [Fig. 3]. They are sessile in terminal heads, sepals 2 subequal, lanceloate, 
fleshy, acute and persistent; petals 5, obovate, yellow, about as long as the sepals, 
very delicate and soon falling; stamens 8-12, ovary enclosed by the calyx stigma 4 or 
5 fid capsules; style 3-5 fid; capsules/fruits are ovoid, circumcissile.Seeds are many, 
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dark brown, concentrically striate and granulate, formed in a tiny pod, which opens 
when the seeds are ready. (Kumar BSA, 2008). 
Microscopic characters: 
i) Leaf: Transverse section of leaf shows broadly concave on the adaxial side 
and convex on the abaxial side. The ground tissue consists of large, thin walled 
compact parenchyma cells. The vascular stand has a central small segment and 
two larger lateral segments; three together arranged in shallow arc, the phloem 
cells occur on the abaxial convex part of xylem strand. Stomata occur on both 
adaxial and abaxial sides of the leaf. Stomata are paracytic in nature. The 
guard cells are 30 x 40 μm inside. The epidermal cells are rectangular to 
polygonal, slightly lobed; their antidinal walls are thin and slightly wavy. The 
lamina is 600 μm thick along the midrib and 450 μm thick along the wings. 
The leaf is isobilateral and hydromorphic. The midrib region has small 
collateral vascular bundle placed in the median part of the leaf. The vascular 
bundle is 50 x 100 μm in size. Each bundle has a vertical fi le of xylem 
elements and small nest of phloem elements. A ring of dilated bundle sheath 
cells surrounds the bundle; these bundle sheath cells are called Kranz-tissue, 
which are characteristic C4 -type of photosynthesis of some selected plants. 
Crystals of calcium oxalate are fairly abundant in the mesophyll cells. The 
crystals are druses that are found in the ground cells as well as along the veins, 
mostly along the major veins. The crystals are 10-20 μm is surrounded by a 
ring of dilated. The lateral veins are thick and prominent. They form distinct 
veinislets. The islets are wide, rectangular and mostly one vein termination in 
each islet. The terminations are long and thick (Kumar BSA, 2008). 
ii) Stem: The stem is circular in with smooth and even surface. It consists of 
distinct epidermis, broad cortex and pith. Epidermis is thin with tangentially 
rectangular cells and distinct cuticle; epidermal layer is about 60 μm thick. The 
cortex is nearly 800 μm broad and consists of one or two layers of outer 
collenchyma layers and remaining portion being large, thin walled lest 
compact parenchyma cells. The bundles are collateral with radial xylem 
elements and phloem elements on the outer part. The pith is wide and consists 
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of cells similar to cortical parenchyma. The xylem elements are thick walled 
and angular and possess dense calcium oxalate crystals (Kumar BSA, 2008). 
iii) Root: The young roots show primary growth. It has diarch or triarch primary 
xylem and narrow cortex. The old root has a central core of primary xylem and 
wide secondary xylem. The periderm consists of two or three layers of 
phellem, a single layer of phelloderm and phellogen layer. The cortex consists 
of 4-6 layers of thin walled, tangentially stretched parenchyma cells. The 
vascular cylinder is wide and has 7 or 8 radial, fan shaped bands of xylem 
alternating with parenchymatous, wide bands. The xylem bands have narrow, 
thick walled elements; phloem occurs only along the xylem bands. Calcium 
oxalate crystals are fairly abundant in the xylem cells of old root (Kumar 
BSA, 2008; NIIR Board of Consultants and Engineers, 2003). 
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a1) Microscopy of the Leaf   
 
 
 
 
 
 
 
 
 
 
Abbreviations used: 
Sc- Subsidiary cells     GC- Ground Cell Ec- Epidermal Cells    Abs- Abaxial side  Ads- Adaxial side
  
VB- Median vascular bundle Cr- Crystals VT- Vein termination VI- Vein islet  
 
Fig 3a: Microscopy of the leaf of Portulaca oleracea L. 
 
 
a2) Photomicrography showing the transverse 
section of the midrib  
a3) Paradermal Section showing crystals  (a4) A portion of leaf showing the vein islets and 
termination  
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Fig 3b: Microscopy of the stem of Portulaca oleracea L 
 
 
  
 
 
 
 
 
 
 
 
Fig 3c: Microscopy of the root of Portulaca oleracea L 
 
 
 
b1) Microscopy of the stem  b2) Crystals occurring in the vessels stem  
c1) Photomicrography showing the transverse 
section of the taproot enlarged view  
c2) Secondary xylem in radial bands alternate with 
parenchymatous rays  
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2.9.1.3 Chemical Constituents 
It contains small amounts of alkaloids (nor-adrenaline, dopamine, calcium, and 
oxalate (Mohammed,1994; Xiang et al., 2005) It also contains vitamin A, B, C, E 
and carotenoids, as well as dietary minerals, such as magnesium, calcium potassium 
folate, lithium and iron (Mirajkar, 1984).  Two types of betalain alkaloid pigments, 
the reddish betacyanins (visible in the coloration of the stems) and the yellow 
betaxanthins  (Liu, 2000) (noticeable in the flowers and in the slight yellowish cast 
of the leaves) have been reported (Mitish, 1997).  It  also  contains  oxalic  acids, 
coumarins, tannins, flavonoids, cardiac glycosides, and  anthraquinone  glycosides, 
fatty  acids  and  ß carotene , lipids, sterols, triterpenes (Elkayat et al., 2008). 
Phenolic constituents include scopoletin, bergapten, isopimpinellin, lonchocarpic 
acid, robustin, genistein. Plant acids present include citric, malic, ascorbic, succinic, 
fumaric and acetic acids. The volatile oil reported are mainly linalool and 3, 7, 11, 
15- tetra methyl-2-hexadecen-1-ol (Liu, 2000). Preliminary  phytochemical  
screening  of   Portulaca  oleracea  shows  presence  of  carbohydrates (Bagepalli  et 
al., 2008) fixed oil, saponins (Kamil et  al., 1998) proteins and  amino  acids  and  
steroids (Zijuan et al., 2009)  and omega-3-fatty acids (Omara et al., 
1991;Simopoulous et al., 1992). 
Amino acids in the leaves of Portulaca species include phenylalanine, alanine, 
tyrosine and aspartate. Antioxidants including glutathione and alpha-tocopherol are 
also found in the plant. Mucilage and a gum which is used as food emulsifier is also 
found in the plant. An enzyme phosphoenolpyruvate carboxylase is also found in the 
plant (Asia et al., 2004). 
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Table 11: Reported Phytoconstituents of   Portulaca oleracea 
(Dukes, 1985)                
Chemical   Constituents Part of the plant  in which  present 
Alanine Plant  and  herb 
Alkaloids Leaf 
Caffeic  acid Plant 
Calcium  oxalate Herb 
Catechol Plant 
Beta-cyanin Herb 
Digalactosyldiacylglycerol Herb 
Docosahexaenoic  acid Herb 
Dopa Plant 
Eicosapentaenoic acid Herb 
HCN Plant 
Histidine Herb 
L-noradrenaline Plant 
Linoleic  acid Herb 
Linolenic   acid Herb 
Alpha-linolenic  acid Herb 
Lysine Herb 
Methionine Herb 
Norepinephrine Plant 
Oleic  acid Herb 
Omega-3s Plant 
Oxalates Shoot 
Oxalic  acid Plant 
Phytin –p Plant 
Saponin Plant 
Sinapic  acid Plant 
Beta-sitosterol Seed 
Tannin Plant 
Threonine Herb 
Tryptophan Herb 
Valine Herb 
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Oleraceins A                                                             Oleraceins B 
 
   
Oleraceins C                                                          Oleraceins D 
 
 
Hesperidin 
Fig 4a: Reported Phytoconstituents of Portulaca oleracea L. 
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Caffeic acid                                       Portulene 
 
 
 
Portuloside A 
 
 
Daucosterol 
Fig 4b: Reported Phytoconstituents of Portulaca oleracea L. 
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                  Quercetin                                                     Myricetin 
 
 
 
           
                     Lupeol                                           Apigenin 
 
 
 
 
Kaempferol 
Fig   4c: Reported Phytoconstituents of Portulaca oleracea L. 
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2.9.1.4 Traditional /Ayurvedic Uses: 
It can be used as a salad, cooked like soups and stems. Externally it is used to treat 
burns earache, insect stings, inflammation, skin sores, ulcers, pruritis (itching skin) 
eczema and abscesses (Banerjee et al., 1996). The plant is said to be refrigerant, 
antiscorbutic, and aperient, diuretic.  It is useful in scurvy and diseases of liver, 
spleen, kidney and bladder. It is prescribed in treatment of cardiovascular disorders, 
dysuria, haematuria, gonorrhoea, dysentery, sore nipples and ulcers of mouth. It is 
used as blood purifier. Roasted seeds are reported to be diuretic and anti-dysenteric 
(Kaul, 1977; Mitish, 1997; Leung & Foster, 1996) 
 Omega 3– fatty acids (Simopoulos et al., 1992) present are used in the production of 
compounds that effect blood pressure clotting, the immune system, lower cholesterol 
(LDL) and prevent certain cancers  and control coronary spasms (Palaniswamy et 
al., 1997). They have positive effect on brain and in such conditions as depression, 
bipolar disorder, alzhemiers disease, schizophrenia, hyperactivity and migrane. It 
also contains carboxylic acids and polysaccharides (Gao, 1996; Gao et al., 2006). It  
also   contains some  gums , fatty acids ,  beta-carotene  and  volatile  oil and 
Portuloside A (Sakai et al.,1996), a  monoterpene  glucoside  (Liu  et  al ., 1994; 
2000)  
2.9.1.5 Reported Pharmacological Activities  
i ) Anti-fertility activity  
The anti fertility effects of alcoholic extract of Portulaca oleracea seeds were 
observed on the reproductive organs of male albino mice after s.c. administrations of  
l5, 20 and 30 doses (l  dose=50 mg./ kg mouse per alternate day). The treatment 
produced mass atrophy of   spermatogenic elements. Epididymal lumina were devoid 
of spermatozoa or contained debris.  Treatment led to significant decrease in absolute 
weights of testes, epididymides, vas deferens and seminal vesicles. Administration ot 
30 doses produced a significant decrease in protein content and sialic acid of testes, 
epididymides and seminal vesicles remained  unaltered alter 30 doses while it was 
drastically reduced in testes. The administration (s.c) of alcoholic extract of 
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Portulaca oleracea seed induced an effective impairment of spermatogenesis  
(Verma  et al., 1982).  
ii ) Antihypertensive activity   
An aqueous extract of the stems and leaves of Portulaca oleracea abolished the 
twitch contraction of the directly stimulated rat hemidiaphragm preparation. An 
aqueous   extract of Portulaca oleracea leaves and stems produced a dose dependent 
relaxation of guinea pig fundus, taenia coli and rabbit jejunum and a dose dependent 
contraction of the rabbit aorta.On spontaneously beating rabbit right atria and 
electrically paced left atria, the extract produced a dose dependent negative inotropic 
and chronotropic effects. On rat blood pressure, the extract produced dose dependent 
pressor responses (Parry et al., 1988). 
iii ) Anti-inflammatory and analgesic activity 
Ethanolic extract of the aerial parts (dried leaves and stem) of Portulaca oleracea sp 
sativa) showed significant anti-inflammatory and analgesic activities after 
intraperitoneal and topical but not   after oral administration  compared with the 
synthetic drug, diclofenac  sodium as the active control (Zakaria et al., 1998)   
(Islam   et al., 1998; Chan et al., 2000; Karimi, 2008). 
iv ) Antimicrobial activity 
Aqueous and ether extracts of the herb showed activity against gram-negative 
bacteria.  A crude sample obtained by ethylacetate extract showed a specific and 
marked activity against dermatophytes of the genera trichophyton.  Whole plant of 
Portulaca oleracea extracted in ethanol was found inhibitory to Bacillus subtilis and 
those extracted in chloroform, ethanol and hexane to Rhizobium Leguninosarum. The 
species failed to prove antagonistic to E. coli. Fungitoxicity of aqueous and organic 
solvent (eg. hexane. ethanol and chloroform) extracts were tested against Aspergillus 
Niger, Rhizopus artocarpi and Fusarium sp. (Awad, 1994; Oh et al., 1998; 
Banerjee, 2002; 2003) 
 v) Antioxidant Activity Portulaca oleracea was studied for its ability to reduce 
oxidative stress induced by vitamin A deficiency in  male Wister rats.. The 
thiobarbituric acid-reactive substances (TBARS), reduced (GSH) and oxidized 
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(GSSG) glutathione and antioxidant enzyme activities were determined in the heart 
and liver.It has been  suggested that the ingestion of purslane or malanga leaves may 
have a protective effect against oxidative stress caused by vitamin A deficiency 
(Sanja et al., 2009; Arruda et al., 2004) .Three phenolic alkaloids, i.e., Oleracein A 
(OA), Oleracein B (OB) and oleracein E (OE)  isolated from Portulaca oleracea 
were studied for antioxidant activity based on scavenging activity against 1.1-
diphenyl- 2-picryl-hydrazyl (DPPH) radical and inhibitory effect on hydrogen 
peroxide-induced lipid peroxidation in rat brain homogenates. The DPPH radical 
scavenging activities of these phenolic alkaloids were lower than caffeic acid but 
higher than ascorbic acid alpha-tocopherol, being in the following order: OB > OA > 
OE. OE was most potent in preventing formation of malondialdehyde (MDA) with 
an EC50 value of 73.l3 µM, close to that of caffeic acid   (72.09 µM). It was 
demonstrated that phenolic alkaloids served as  a new class of antioxidant agents in 
this plant. Treatment  with  an  extract of Portulaca   oleracea (100 mg/kg  and  250 
mg/kg  body  weight) for three  weeks  showed  a  significant  reduction in  
thiobarbituric  acid reactive   substances  (TBARS)  and an increase  in  glutathione  
reductase (GSH-R) in both  the  liver  and   kidney  of  STZ  diabetic  rats (Zeng, 
1999; Sharma  et al., 2009). 
vi ) Anti-phenolic endocrine disruptors 
Portulaca oleracea showed the ability to effectively remove from water bisphenol A 
(BPA) which is well known as an endocrine disrupting compound (EDC) having 
estrogenic properties (Imai et al., 2007).  
vii) Anti-tumour activity 
 Ethanol/chloroform  extract  of  fresh  entire  plant, administered  intraperitoneally   
to  mice  at a  dose  of  360  mg/kg  was inactive  on  CA-775  and  LEUK-L 1210. A 
dose of 450 mg/kg was inactive on sarcoma 180 (ASC). Water extract  of  dried  
entire  plant,  administered i.p  to  mice at a  dose of  150 mg/kg  on  days  5,6  and  7  
was  active  on  CA- Ehrlich- ascites;methanol  extract  produced  weak activity  
(Kosuge  et al., 1985;Yoon  et al., 1999; Xiao et al., 2005). 
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viii)  Bronchodilatory activity  
The bronchodilatory effect of the boiled extract of Portulaca oleracea in the airway 
of asthmatic patients was examined and the results showed that the boiled extract of 
Portulaca oleracea caused significant increases in all measured pulmonary function 
tests (PFTs). (P< 0.05 to P< 0.01).. The results showed that Portulaca oleracea has a 
relatively potent but transient bronchodilatory effect on asthmatic airways (Malek et 
al., 2004; Dong et al., 2005). 
ix ) Gastric Antiallergenic activity  
Aqueous and ethanolic extracts of Portulaca oleracea were studied in mice for their 
ability to inhibit gastric lesions induced by HCI or absolute ethanol. In addition their 
effects on gastric acid secretion were measured. Both extracts showed a dose-
dependent reduction in severity of ulcers. The highest dose of extracts exerted similar 
activity to sucralfate. The oral and intraperitoneal administration of extracts reduced 
the gastric acidity in pylorus-ligated mice. These results suggested that Portulaca 
oleracea has gastro protective action and validates its use in folk medicine for 
gastrointestinal diseases (Gholamreza et al., 2004; Karimi et al., 2004). 
x ) Hypoglycaemic activity.  
Dried  entire  plant  administered intragastrically  to  rabbits  at  doses  of 0.5  and  
1.0  gm/kg  produced  no  effect  after 4,8  and  25  hours. At  doses  of 1.5  and  2.0  
gms/kg  significant  effect    was  observed  after 8  and  12  hours (Akhtar  et al., 
1985). Seeds in mixture  with  seven  other  plants, administered  orally to  male  rats 
at a  dose  of  4.0 gm/animal  gave   active  response..The  aqueous  extract  of  
Portulaca  oleracea  did   not   show  any  hypoglycaemic   activity (Rafiullah et al., 
2006). In another study (Medhabati  et al., 2011)   the  aqueous  extract  of  
Portulaca  oleracea  leaves  produced  significant  decrease  in  blood  glucose  level  
in  normal  albino  rats.  
xi ) Intestinal parasitical Activity:  
Bioactive compounds appear to be present in all these plants  Ambrosia hispida 
(Asteraceae) Aristolochia Trilobata (Aristlochiaceae), Chenopodium ambrosioides 
(Chenopodiacae) Portulaca oleracea (Portulacaceae), and Artemisia absinthium 
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(Asteraceae). The cognitive salience of these plant remedies coupled with evidence 
of biochemical properties suggest that they provide efficacious treatments for 
controlling intestinal parasite loads (Quinlan MB, 2002) 
xii ) In Urinary Problems: 
The study was based on ethnobotanical interviews conducted from 1996-2000 in 
Trinidad and Tobago with thirty male and female respondents. A non-experimental 
validation was conducted on the different plants used for urinary problems and 
diabetes mellitus. Thus  establishing that the plants used are safe or effective. to help 
direct clinical trials and to inform Caribbean physicians of the plants known 
properties to avoid counter-prescribing. Portulaca oleracea was one of the plants 
having sufficient evidence to support their traditional use for urinary problems 
(Chun  et  al., 1999; Lans, 2006)  
xiii ) Muscle  relaxant   activity: 
 It  has  been  shown  that  Portulaca  oleracea   also  has   muscle  relaxant   activity  
and calcium ions  influence the smooth  muscle relaxant  response to aqueous  extract 
of   Portulaca  oleracea  (Okwuasaba  et  al.,  1986,  1987;   Parry  et  al., 1993; 
Oluwole, 2007). 
xiv)  Neuropharmacological effect: 
Ethanolic extract of Portulaca oleracea var. sativa, on intraperitoneal administration, 
showed a significant reduction in the locomotor activity in mice, anti-nociceptive 
activity in rats using tail fick method, an increase in the onset time of 
pentylenetetrazole induced convulsions in mice and muscle relaxant activity in in 
vitro (rat hemidiaphragm) and in vivo (grip strength) experiments (Meng, 2006). The 
anti-nociceptive activity of the extract in rats was attenuated by naloxone pre-
treatment indicating the involvement of opioid receptors in its anti-nociceptive 
effects. It indicated that Portulaca oleracea var. sativa possesses varied effects on 
both the central and peripheral nervous system (Radhakrishan et al., 1998; Wang 
et al., 2007). 
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xv ) Spasmogenic activity: 
95%  ethanolic and  aqueous  extracts  of  leaves  and  stem,  at a concentration  of  
33 mg/litre  administered   i.p.  to   guinea  pigs  were  active  on the  ileum  (Feng  et 
al., 1962). 
xvi ) Uterine stimulant effect: 
Water  extract  of  leaves  was  active  on the  uterus  of  pregnant  and   non-pregnant  
rats  and   mice. Active in excessive menstrual bleeding, gynaecological diseases, 
irregular menstruation, lack of menses and painful menses. It also  acts  as a  paste  
for  vaginal  itching (Sharaf, 1969). 
xvii ) Wound healing activity:   
The preliminary wound healing activity of Portulaca oleracea was studied using Mus 
musculus JVI 1. For this purpose fresh homogenized crude aerial part of Portulaca 
oleracea were applied topically, on the excision wound surface as single and two 
doses in different amounts. Wound contraction and tensile strength measurements 
were used to evaluate the effect of the plant on wound healing. The results obtained 
indicated that Portulaca oleracea accelerates the wound healing process decreasing 
the surface area of the wound and increasing the tensile strength. The greatest 
contraction was obtained at a single dose of 50 mg and the second greatest by two 
doses of 25 mg. Measurements of tensile strength and healed area were in agreement 
(Rashed et al., 2003).                                                                                                                                          
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      2.9.2 Pharmacognostical Characteristics of Eriobotrya japonica Lindl 
 
 
 
 
 
 
               
 
 
 
Fig  5: Eriobotrya  japonica 
2.9.2.1 Plant Monograph 
Classification: 
Kingdom              Plantae- Plants 
Subkingdom     Tracheobionta- Vascular plants 
Superdivision  Spermatophyta- Seed   plants        
Division          Magnoliophyta- Flowering plants 
Class              Magnoliopsida-Dicotyledons 
Subclass       Rosidae 
Order            Rosales     
Family      Rosaceae- Rose family 
Genus      Eriobotrya Lindl 
Species     Eriobotrya japonica (Thunb) Lindl 
Vernacular Names 
English-    Green Loquat                                                     
Hindi-         Lokat 
Malay- Lokwat, Paginggong 
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Tamil-          Ilakotta, Nokkotta 
Kashmiri Loquat  
Flowering Period          April to June 
Part Used                       Fruits, seeds and leaves 
Distribution: Originally   from  regions  with a  subtropical  climate,  it  requires a  
mild  climate  with  rainfall  evenly  spread  throughout  the  year,  without  excessive  
heat,  especially  during    fruit   ripening. It is native to China and Japan. Altitude  is  
700-2400m,  mean annual  rainfall  is  650-1000  mm,  soil  type-  will  grow  on a  
great   variety   of soils, from sandy  to   heavy  clays.  The   best growth is   found in 
light, well-drained, deep, moist alluvial   soils. 
2.9.2.2. Description    
Eriobotrya  japonica is  an  evergreen  shrub  or  small  tree  6-8  m  high. Flowers  
fragrant,1.2  cm  broad,  fruits  borne  in clusters,  commonly  round,  oval  or  
pyriform, 2.5-8  cm  in length, pale  yellow  to  orange, skin about as thick as that of  
a peach  but  slightly  tougher, seeds 4-10  brownish, oblong,1-2cm  long.  Based  on  
origin,  2  groups  are  distinguished: the  Chinese  groups  with  large, pyriform, 
deep  orange  fruit, ripening  mid-season  to  late,  which  can  be  kept  for  1-2  
weeks,  and  the  Japanese  group  with  small  slender,  light-coloured  fruit,  
maturing  early  and  having  a  shorter  shelf  life. The  generic  name  is  derived  
from  the  Greek  words ―erion‖ (wool)  and  ―  botrys‖  (cluster),  from  the  woolly  
appearance  of  the  spiked  inflorescence,  the  specific  epithet  means  of  Japan. 
(Lin et al., 1999; Randhawa, 1970). 
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     a )     Whole Tree      b )      Fruits 
 
  
                            
 
 
 
 
 
 
 
b ) Fruits      c )  Seeds 
 
Fig   6:  Eriobotrya japonica whole tree, fruits and seeds 
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Leaves are somewhat crowded towards the end of the stout, wooly branchlets, large, 
alternate, subsessile, stiff, coriaceous, elliptic, lanceolate to obovate, lanceolate in 
outline, 21-23 cm in length, with remotely toothed to sharply dentate margins; dark, 
glossy, green above and rusty-recommended.  Manuring should be carried out every 
2 years at the rate of 40-50 kg/tree, or 12-40 t/ha. After planting out, the trees are 
pruned 60-75 m above the ground level to promote the growth of 3-5 branches.  They 
are also pruned immediately after harvesting to limit the number of fruits and even 
out production.  Grafted trees, when available, remain smaller but make stronger 
growth and produce fruit faster.  Where insolation is strong the fruit clusters are 
bagged to prevent sunburn.  On the other hand, the fruit is sour without sunshine, as 
occurs in northern Tanzania.  
2.9.2.3 Chemical Constituents 
 Seeds and young leaves of the plant are slightly toxic, containing small amounts of 
cyanogenic glycosides (including amygdalin) (Zhaung, 2002) which release cyanide 
when digested, though the low concentration and bitter taste normally prevents 
enough being eaten to cause harm. Volatile constituents of fresh loquat fruit contain 
78 compounds. Among them, 15 compounds significantly contribute to the aroma, 
and the most potent aroma compound in fresh loquat is phenylacetaldehyde. 
Additionally, other aroma compounds, hexanal, (E)-2—hexenal, hexanoic acid, ß-
ionone are also important (El-Hossary et al., 2000). 
The reported bioactive components of Eriobotrya japonica include flavonoids, 
triterpenic acids and carotenoids. The isomeric pentacyclic oleanolic acid (OA) and 
ursolic acid (UA) (Chun et al., 2011) are predominant triterpenoids found in E. 
japonica leavcs and fruits (Zhou et al., 2011) Based on pharmacological tests, both 
OA and UA have been proved to have bioactivities such as anti-inf1ammatory, 
diuretic, anti-tumor, hepatoprotective and anti HIV.Amygdalin, a cyanogenetic 
glycoside, was found to be present in loquat leaf and kernel in considerable amount. 
The loquat flower extract contains oleanic acid, ursolic acid and amygdalin. The fruit 
contains sugars: levulose and sucrose, citric acid, tartaric acid, succinic acid, 
cryptoxanthin, ß- carotene. neo-ß-carotene and polypherol oxidase (Selles-Merchant 
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et al., 2006). The seeds contain amygdalin and fatty oil. Other chemical constituents 
are mentioned in the table 12. 
Table 12: Chemical Constituents of Eriobotrya Japonica 
                            Chemical constituents    Part of the plant in which 
resent  
1-BETA HYDROXY-EUSCAPHIC-ACID LEAF  
2-ALPHA-3-ALPHA-19-ALPHA-TRIHYDROXY-URS-12-EN-28-OIC-ACID LEAF  
2-ALPHA-3-BETA-19-ALPHA-23-TETRAHYDROXY-URS-12-EN-28-OIC-
ACID 
LEAF  
23-CIS-P-COUMAROYL-TORMENTIC-ACID LEAF 
23-TRANS-P-COUMAROYL-TORMENTIC-ACID LEAF 
2 ALPHA-HYDROXYURSOLIC-ACID LEAF  
3,6,19-TRIHYDROXY-URS-12-EN-28-OIC-ACID LEAF  
3-BETA-6-ALPHA-19-ALPHA-TRIHYDROXY-URS-12-EN-28-OIC-ACID LEAF  
3-0-TRANS-CAFFEOYLTORMENTIC-ACID LEAF  
3-0-TRANS-P-COUMAROYL-ROTUNDIC-ACID LEAF  
3 BETA-6 BETA,19 ALPHA-TRIHYDROXY-URS-12-EN-28-OIC-ACID LEAF  
ALPHA-CAROTENE FRUIT  
AMYGDALIN LEAF, SEED 
ASCORBIC-ACID-OXIDASE LEAF  
AUCAPARIN PLANT 
AUCUPARIN BARK 
BENZALDEHYDE LEAF  
CAFFEIC-ACID PLANT  
CAMPESTEROL FRUIT  
CERYL-ALCOHOL SEED 
CERYL-PALMITATE  SEED 
CREATINE  SHOOT,STEM 
CRYPTOXANTHIN FRUIT  
CYANIDIN PLANT  
D-(+)- TARTARIC-ACID  FRUIT  
D-SORBITOL LEAF  
DEHYDRO-GIBBERELLIN-GA-25 SEED 
DEHYDRO-GIBBERELLIN-GA-35 SEED 
DL-LACTIC-ACID FRUIT 
EUSCAPHIC-ACID LEAF  
GAMMA-GUANIDINOBUTRAMIDE SHOOT; STEM 
GAMMA-GUANIDINOBUTYRIC-ACID SHOOT;STEM 
GAMMA-GUANIDINOPROPIONIC-ACID SHOOT; STEM 
GIBBERELLINS-A-15 SEED 
GIBBERELLINS-A-19 SEED 
GIBBERELLINS-A-20 SEED 
GIBBERELLINS-A-29 SEED 
GIBBERELLINS-A-35 SEED 
GIBBERELLINS-A-44 SEED 
GIBBERELLINS-A-61 SEED 
GIBBERELLINS-A-9 SEED 
GIBBERELLINS-A-50 SEED 
GIBBERELLINS-GA-15 SEED 
GIBBERELLINS-GA-24 SEED 
GIBBERELLINS-GA-35 SEED 
GIBBERELLINS-GA-50 SEED  
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GIBBERELLINS-GA-9 SEED 
GIBBERELLINS-METHYL-ESTER  SEED 
GUANIDINE SHOOT;STEM 
GUANIDINOACETIC-ACID SHOOT;STEM  
GUANIDINOSUCCINIC-ACID SHOOT;STEM 
HYPEROSIDE SHOOT 
KAEMPFEROL PLANT  
L-ARGININE SHOOT;STEM 
LEUCOPELARGONIDIN-3-0-ALPHA-L-RHAMNO-BETA-D-
GLUCOPYRENOSIDE 
PLANT  
LEVULOSE FRUIT 
LOQUATIFOLIN-A LEAF  
LOQUATOSIDE PERICARP 
MALIC-ACID LEAF  
MASLINIC-ACID LEAF  
MASLINIC-ACID-METHYL-ESTER LEAF  
METHYL-GUANIDINE SHOOT;STEM 
N-ALPHA-ACETYL-L-ARGININE SHOOT; STEM 
NEO-BETA-CAROTENE FRUIT  
NEO-BETA-CAROTENE-B FRUIT  
NEO-BETA-CAROTENE-U FRUIT  
L(1,2)-[ALPHA-L-(4-TRANS-FERULOYL)-RHAMNOPYRANOSYL(1,6) LEAF  
YL(1,2)- [ALPHA-L-RHAMNOPYRANOSYL(1,6) ] –BETA-D-GLUCOPYRA LEAF  
GLUCOPYRANOSIDE LEAF  
NEROLIDOL-3-0-[ALPHA-L-RHAMNOPYRANOSYL-(1,2)D-
GLUCOPYRANOSIDE] 
LEAF  
YL-(1,2)-BETA-D-GLUCOPYRANOSIDE] LEAF  
YL-(1,6)-BETA-D-GLUCOPYRANOSIDE] LEAF  
YL-(1,2)-[ALPHA-L-RHAMNOPYRANOSYL-(1,6)]- BETA-D-GLUCOP LEAF  
OLEANOLIC-ACID LEAF ,fFRUIT 
PENTOSANS SEED 
PHYTOSTEROLS FRUIT  
QUERCETIN PLANT  
ROSEOSIDE LEAF 
RUTIN LEAF  
SALICYLATES  FRUIT 
TORMENTIC-ACID LEAF 
URSOLIC-ACID LEAF,FRUIT 
VOMIFOLIOL-9-0-BETA-D-APIOFURANOSYL-(1,6)-BETA-D-
GLUCOPYRANOSIDE 
LEAF  
                              (Tierra M, 2006; Chun et al., 2011; Liang et al., 1990) 
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                               R1 R2                              R1 
Tormentic acid     OH OH   Maslinic acid OH  
Corosolic acid      OH    H                          
Triterpenes  
 
  
 
 
 
Ursane-type Triterpene Parent Nucleus     Oleanane -type triterpene Parent Nucleus 
Fig 7a:  Reported Phytoconstituents of Eriobotrya   japonica 
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Sesquiterpenes  
 
  
 
Open loop type sesquiterpenoid parent nucleus         Closed loop-type sesquiterpenoid parent nucleus  
 
Flavonoids  
 
 
 
                                        Flavonoid parent nucleus 
Fig  7b:  Reported Phytoconstituents of  Eriobotrya   japonica 
                            (Ho et al., 2008; Chen, 2008; Zhou et al., 2011) 
2.9.2.4 Traditional/Ayurvedic Uses 
 As  food-  The  fruit  has a  thick,  tough  peel  surrounding  the  firm  flesh,  with  a  
flavour  that of a peach. It  is  rich  in  pro-vitamin  A,  having  a  very  high  carotene  
content.( Godoy, 1995)  It  is  usually  eaten  fresh  but  may be  stewed,  served as a  
sauce, syrup  or  jam, or  made into  an  excellent  jelly.  The  fruits  are  a  good  
source  of  acid  and  pectin.  The  seeds, which  have  an  almond like  taste, are  
used  to  flavour  drinks  and  cakes.  
As  fodder-  Tender   branches  are  used  as  fodder  in  India  and   in  East  Africa. 
In apiculture:- Bees  are  easily  attracted  to  the  fragrant,  white  flowers. Honey  
is  amber  coloured  with an  agreeable   flavour. 
As   fuel- The wood has market value as firewood 
Alcohol- The fruit juice can be used to prepare an alcoholic drink. 
Repellent- The flowers are used as an insect repellent. 
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Medicine- The  fruits  are  considered  a  sedative and  are  used  in  allaying  
vomiting  and  thrist. The   leaves  are  astringent  and  antidiarrhoetic, and in China  
are  used  to  treat  wounds. The  flowers  are  used  as an  expectorant  and  extracted  
in  oil,  in cosmetics. 
2.9.2.5. Reported Pharmacological Activities   
i ) Antimutagenicity   
Ursolic acid is isolated from the ethanolic extract of the plant, decreased the numbers 
of Salmonella typhimurium TA 100 revertants per plate thus showing antimutagenic 
activity (Young et al., 1994) 
ii) Antioxidant activity   
The antioxidants in this plant possess free radical scavenging activity and oxidant 
reducing power, and the high positive correlation between antioxidant capacities and 
total phenolic content (Yokota et al., 2006). Loquat shows very high amount of 
antioxidant property.Seed extract also shows antioxidant activity (Kazunari et al., 
2007). Loquat contain significant amounts of secondary plant metabolites, including 
carotenoids, flavonols, anthocyanins, and procyanidins. These minor dietary 
compounds have been postulated to play a key role in humans as antioxidants, by 
preventing reactions produced by oxygen and nitrogen reactive species during the 
progression of different human pathologies (Espinosa et al., 2009; Hamada et al., 
2004; Huang et al., 2006). 
iii) Antiviral activity  
The phytochemicals found in the plant such as oleanolic acid, pomolic acid, and 
structurally related triterpenoids have also anti HIV activity and 3-O-acyl ursolic acid 
derivatives is effective against AIDS virus (Kashiwada et al., 1998) 
iv) Cytotoxic activity 
Three new flavonoid glycosides and  proanthocyanidin fraction in the water-soluble 
portion of the extract was characterized as a procyanidin oligomer mixture mainly 
composed of undecameric procyanidin. These polyphenols have also been assessed 
for cytotoxic activity against two human oral tumor (human squamous cell carcinoma 
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and human salivary gland tumor) cell lines. Selective cytotoxicity of the procyanidin 
oligomer between tumor and normal gingival fibroblast cells  have been  
reported.(Ito et  al., 2000; Banno et al., 2005) 
v) Hypolipidemic activity  
Leaf extracts have successfully shown anti oxidant and anti hypercholesterolemic 
properties (Said et al., 2009). Hypolipidemic properties were assessed in a double 
blinded- randomized clinical study carried out among 41 human volunteers with 
hyperlipidemia values.  Antiatherogenic and antioxidant activities have been reported 
from the extracts of leaves of the plant (Baljinder et al., 2010) 
vi) Liver function improvement  
The seed extract of Eriobotrya japonica,when evaluated for  liver function test 
against dimethyl nitrosamine-induced hepatopathy revealed that AST, ALT, and 
hydroxyproline levels and liver fibrosis rates were significantly lower, and retinoid 
levels were significantly higher in hepatopathic rats treated with 70% EtOH and 
MeOH extracts of the seed than in water-treated control rats. This suggests that the 
positive effect on liver function of the extracts varies depending on the extracting 
solvent used. 70% EtOH and MeOH extract of the seeds inhibited the development 
of liver fibrosis in hepatopathic rats, thus exhibiting potent improvement. The 
unsaturated linolenic and linoleic acids and the sterol b -sitosterol contained in these 
extracts may also contribute to the improvement of liver functio (Nishioka et al., 
2002). 
vii) Other activities 
The leaves extract of the plant also shows antispasmodic activity .They are 
prescribed in coryza, hyperemesis, especially vomiting in pregnancy, epistaxis and 
dyspepsia. Corosolic acid has significant effects on glucose transport across cell 
membranes. Proanthocynidin is hydrolysable tannin isolated from Loquat plant has 
anti Helicobactor pyroli activities. A decoction of the leaves has been known to be a 
cooling beverage preventing sunstroke and thirst, and has also been applied locally to 
wounds, ulcers and cancers. The triterpene isolated from loquat plant shows  
antitussive activity(Ju et al., 2003) The different parts of the loquat tree have been 
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used as anti-inf1ammatory (Shimizu et al., 1986) tumors, chronic bronchitis, 
nephropathy , NF kappaB  inhibitor (Know et al., 2000). Orally  administered  seed  
extract  decreases  allergic  contact  dermatitis  in rats (Guangchen et al., 2007; 
Baljinder et al., 2010). 
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3.1 GENERAL SCHEME (In Brief) 
3.2 DRUGS AND CHEMICALS USED 
3.3 EQUIPMENTS 
3.4 IDENTIFICATION, COLLECTION OF THE  
      SELECTED PLANTS AND PREPARATION OF  
      EXTRACTS 
3.5 PRELIMINARY PHYTOCHEMICAL SCREENING 
3.6 ANIMAL AND EXPOSURE CONDITIONS  
3.7 PHARMACOLOGICAL STUDIES 
3.7.1 Toxicity   studies 
3.7.1.1. Acute oral toxicity studies (72 hours)  
Portulaca oleracea (whole plant) 
Eriobotrya japonica fruits 
Eriobotrya japonica seeds  
3.7.1.2. Sub-acute toxicity study ( 14   days) 
Portulaca oleracea (whole plant) 
Eriobotrya japonica fruits    
3.7.2. Antidiabetic studies 
3.7.2.1. Alloxan induced diabetes (10 days) 
Portulaca oleracea (whole plant) 
Eriobotrya japonica fruits 
Eriobotrya japonica seeds   
3.7.2.2. Streptozotocin induced diabetes (15 days) 
Portulaca oleracea (whole plant) 
Eriobotrya japonica fruits 
Eriobotrya japonica seeds 
3.8 BIOCHEMICAL ESTIMATIONS DONE IN VARIOUS SETS OF EXPERIMENTS 
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3.1. GENERAL SCHEME (IN BRIEF) 
 
Pharmacological studies 
Selection of Plants for Screening 
Coarsely powdering of the plant materials 
Drying 
Literature Review 
Collection of  Selected  Plants 
Extraction (Cold maceration) with 50% ethanol 
Filtration of the extract (First Filtrate) 
               Addition of more 50%  ethanol to the left over plant material 
Combining the first and second Filtrate 
Recovery of the solvent (ethanol) under vacuum 
Drying  of the  extract  to  a  semi solid  mass 
Preliminary Phytochemical screening 
Identification of the plants 
Filtration of the extract (2nd Filtrate) 
Extract ready for various studies (stored in refrigerator for further use) 
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and Results 
Biochemical 
evaluation 
Histopathology of 
various organs 
Statistical 
Analysis 
CONCLUSION 
Pharmacological Studies 
a) Acute Oral Toxicity Study (72 hour 
study) 
b) Sub-acute Toxicity study(14-day 
Studies) 
 
Anti Diabetic Studies 
Biochemical 
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Various Organs 
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Induced 
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Induced 
Toxicity studies 
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and Results 
Observation and 
results 
 
Observation and 
results 
 
Statistical 
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3.2. DRUGS AND CHEMICALS 
The following drugs and chemicals were used in the present studies 
DRUGS AND CHEMICALS MANUFACTURER / SUPPLIER 
Acacia gum  Central  Drug  House ( P) Ltd Post  Box  No 7138, New  
Delhi 110002 
Acetic  anhydride Qualigen  fine  chemicals 
Albumin  Kit Crest  Biosystems  Goa  India 
Alkaline  Phosphatase  kit Crest  Biosystems  Goa  India 
Alloxan  Monohydrate Central  Drug  House ( Pvt) LtdNew  Delhi 
Bilirubin  Kit Transasia  Biomedicals Ltd, DamanIndia 
Chloroform  Central  Drug   House, Mumbai 
Citric  acid Central  Drug  House ( P) Ltd Post  Box  No 7138, New  
Delhi110002 
Concentrated   hydrochloric  acid  Central  Drug  House, Mumbai 
Concentrated   sulphuric  acid Merck  Laboratories 
Creatinine  Kit Accurex  Biomedical  Pvt  Ltd 
Diethyl  ether Merck  Ltd,Worli  Mumbai  400018 
Ehanol  (BP) Bengal  chemicals  & Pharmaceutical Ltd   Kolkata 
Ethanol Central  Drug  House, Mumbai 
Ferric  chloride Central  Drug  House, Mumbai 
Formaldehyde Central  Drug  House ( P) Ltd New  Delhi 
Glacial  acetic acid Central  Drug  House, Mumbai 
Glibenclamide  
Standard Antidiabetic drug 
Free  gift  sample  from  Sri  Krishna Drugs  Ltd, C-4, 
Industrial  Area Uppal, Hyderabad 500039 
Glucose   Kit Crest  Biosystems Goa  India 
Sterile Saline Punjab Formulations Ltd,Jalandhar 
HDL  Cholesterol  enzymatic  kit Accurex  Biomedical  Pvt  Ltd 
LDL  Cholesterol  Kit Accurex  Biomedical  Pvt   Ltd 
Magnesium s.d  fine  chemicals Pvt Ltd, Boisar 
Methanol  Central  Drug  House, Mumbai                     
Olive  oil Sisco  Research  Laboratories, Mumbai 
Rat  and  Mice   feed Ashirwad  Industries  Works, Tripari,  Tehsil  Kharar, 
Mohali, Punjab. 
SGOT  Kit Transasia  Biomedicals  Ltd, Daman, 
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India 
SGPT  Kit Transasia  Biomedicals Ltd, Daman,India 
Streptozotocin  extrapure 1948251 Sisco  Research  Laboratories  Pvt  Ltd 
Total   Cholesterol  Kit Accurex   Biomedical  Pvt  Ltd 
Total  Protein   Kit Accurex  Biomedical  Pvt  Ltd 
Triglyceride   Kit Accurex  Biomedical  Pvt  Ltd 
Tri-sodium  citrate Central  Drug  House ( P) LtdNew  Delhi 
Urea  Enzymatic  Kit Accurex  Biomedical  Pvt  Ltd G-54  MIDC, Tarapur,  
Boisar, Thane   401506 
Wagners  reagent Central  Drug  House, Mumbai 
Zinc s.d.fine  chemicals Pvt Ltd, Boisar 
Miscellaneous  
One-touch  ultra  glucostrips 
Johnson  &  Johnson  Ltd 
One- touch  ultra  blood  glucose 
Monitoring  system 
Johnson   &  Johnson  Ltd 
 
Chapter 3         Materials And Methods 
 
Ph.D Thesis                                                113                                          University of Kashmir 
 
3.3. EQUIPMENTS   USED 
S.No EQUIPMENT MANUFACTURER/SUPPLIER 
1.  Bottle  Aspirator BM Scientific Ltd 
2.  Centrifuge  tubes Borosil, India Ltd 
3.  Digital  balance Axis,India 
4.  Heating mantle Bells, India  Ltd 
5.  High precession digital balance Axis, India Ltd 
6.  Hot  air oven Bells, India 
7.  Incubator Remi Equipments,India 
8.  Laboratory  ultracentrifuge Remi Equipments, India 
9.  Micropipettes Gem,India 
10.  Oral feeding needles BIK Industries Ltd, India 
11.  Polypropylene rat and mice  
cages 
BIK Industries Ltd, India 
12.  Refrigerator LG,India 
13.  Test tubes/Collection tubes Borosil, India Ltd 
14.  UV spectrophotometer Labmed, India 
15.  Willey  mill Bells,India 
16.  Haemoglobinometer  The Laboratory Glassware Co,Ambala 
Cantt 
17.  Haemocytometer  (Naebeuer 
Chamber) 
The Laboratory Glassware Co,Ambala 
Cantt 
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3.4. IDENTIFICATION, COLLECTION OF THE SELECTED PLANTS AND 
PREPARATION OF EXTRACTS  
 Portulaca  oleracea whole plant (PO) 
  a)  Identification and collection: 
The  whole  plant  of   Portulaca  oleracea, (Family  Portulacaceae),  was  collected  
from  Nishat  side  of the  district, Srinagar. The  identification  was  done  on the  basis  
of the  characters  described  by Kirtikar  and  Basu, 1935 and   by  Plant  Taxonomist. 
A sample  of the plant  material was  deposited in the  herbarium  of the  Department of 
Taxonomy, University  of Kashmir  under voucher specimen numbers, Portulaca  
oleracea- 1011 (KASH)  for  future  reference.  The  plant  material  was collected and  
dried  in a  well  ventilated  room  with  outside  temperature  ranging  between  18 to  
32
0 
C . 
b) Preparation of 50% Ethanolic Extract:  
The  dried  plant  of  Portulaca   oleracea  PO was  coarsely  powdered  and  500 gm 
was  allowed  to  macerate  for  48 hrs  with  50%  ethanol, with  occasional  shaking. 
After 48 hrs, the ethanolic extract was filtered through Whatmans filter  paper. The  
plant  material  was  then  macerated  again  with  fresh  50%  ethanol  and   the  
combined  filtrate  obtained  from  the  first  and the  second  maceration  was  then   
distilled  under  vacuum, the  temperature of  distillation  being  in the  range  of  33-
44
o
C . After  the  distillation  of  alcohol,  the  extract  was  then  evaporated  to   
dryness. The process was   repeated   with 500 gms five times and with 250 gms once 
and the total yield was noted. 
 Eriobotrya japonica fruits  (EBJF) and  Eriobotrya  japonica seeds (EBJS) 
a) Identification  and   collection: 
The  whole  plant  of   Eriobotrya japonica, (Family  Rosaceae ) was  collected  from  
Shalimar  side  of the  district, Srinagar. The  identification  was  done  on the  basis  of 
the  characters  described  by Kirtikar  and  Basu, 1935 and   by Plant  Taxonomist. A  
sample of the  plant material was  deposited in the herbarium of the  Department of 
Taxonomy, University of  Kashmir under voucher specimen  number 1012(KASH) for   
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future   reference.The  fruits  were  dried  in a  well  ventilated  room  with  outside  
temperature  ranging  between  18 to 32
0 
C . The seeds were separated  from fruits  & 
kept separately  for  further  studies. 
b) Preparation of 50% Ethanolic  Extract  of  Eriobotrya  japonica  fruits: 
The  dried  fruits  of  Eriobotrya  japonica were  coarsely  powdered  and   500 gm was  
allowed  to  macerate  for  48 hrs  with  50%  ethanol, with  occasional  shaking. After  
48 hrs,  the  ethanolic  extract  was  filtered   through  Whatmans  filter  paper. The  
plant  material  was  then  macerated  again  with  fresh  50%  ethanol  and   the  
combined  filtrate  obtained  from  the  first  and the  second  maceration  was  then   
distilled  under  vacuum, the  temperature of  distillation  being  in the  range  of  33-
44
O
C. After  the  distillation  of  alcohol,  the  extract  was  then  evaporated  to   
dryness  and  the   yield  was   noted.    
c) Preparation of 50% Ethanolic Extract of Eriobotrya japonica seeds: 
The  dried  seeds  of  Eriobotrya  japonica  were  coarsely  powdered  and   500 gm 
were  allowed  to  macerate  for  48 hrs  with  50%  ethanol, with  occasional  shaking. 
After 48 hrs, the  ethanolic  extract  was  filtered   through  Whatmans  filter  paper. The  
plant  material  was  then  macerated  again  with  fresh  50%  ethanol  and   the  
combined  filtrate  obtained  from  the  first  and the  second  maceration  was  then   
distilled  under  vacuum, the  temperature of  distillation  being  in the  range  of  33-
44
O
C. After  the  distillation  of  alcohol,  the  extract  was  then  evaporated  to   
dryness. The process is   repeated   once again with 500 gms of the plant and the total 
yield was noted.  
 The 50% ethanolic extracts of Portulaca oleracea, whole plant (PO), Eriobotrya 
japonica   fruits (EBJF)   and   Eriobotrya  japonica  seeds (EBJS)  so prepared were 
stored  in the refrigerator for further  studies.   
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3.5 PRELIMINARY PHYTOCHEMICAL SCREENING 
The  powdered selected part  of   Portulaca  oleracea PO,  Eriobotrya  japonica fruits 
EBJF and Eriobotrya  japonica seeds EBJS, was subjected to preliminary 
phytochemical screening. The presence of various phytoconstituents was determined by 
the standard qualitative methods (Rafia et al., 2010; Kokate, 1994) 
Tannins: To 2 ml of aqueous extract 2 ml of 5% Fe CI 3 was added. Formation of 
yellow brown precipitate indicates that tannins are present (Jigna et al.,  2007).  
Alkaloids: To  2 ml methanolic filtrate, 1.5 ml of 1% HCI was added. After heating the 
solution in water bath, 6 drops of Mayors reagents/ Wagner‟s reagent / Dragendroff 
reagent was added. Formation of orange precipitate indicates the presence of alkaloids 
(Oguyemi, 1979). 
Saponins: Aqueous extract of 2 g powder was made and subjected to frothing test. 
Persistence of  the  froth  indicated presence of saponins. Latter the froth was mixed 
with few drops of olive oil. Formation of emulsion indicates presence of saponins  
(Sofowora, 1993).  
Glycosides: To 2 ml alcoholic filtrate, 1 ml glacial acetic acid and 1-2 drops of Fe CI3 
was added followed by 1 ml of concentrated H2SO4. Appearance of brown ring at the 
interface indicates presence of glycosides. A violet ring may also appear below the 
brown ring (Trease and Evans, 1989).  
Terpenes : To 2 ml of aqueous extract, 5 ml chloroform, 2 ml acetic anhydride and 
concentrated H2SO4 was added carefully to form layer. Reddish brown coloration of 
interface indicate terpenes (Harborne, 1973) 
Flavonoids: 2 g plant material was extracted in 10 ml alcohol of water. To 2 ml filtrate 
few drops of concentrated HCI followed by 0.5 g of zinc or magnesium turnings was 
added. After 3 minutes magenta red or pink colour indicated the presence of flavonoids 
(Jigna et al., 2007)   
Phenolics: To 2 ml of alcoholic or aqueous extract, 1 ml of 1% ferric choloride solution 
was added. Blue or green colour indicates phenols (Martinez, 2003)   
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Carbohydrates (Molischs  test): 200 mg of the powdered drug was exracted  in 10 ml 
of  water. To  5 ml of this  solution  were  added few  drops of  alcoholic ά napthol  and  
then  0.2 ml of  concentrated  H2 SO4  was  added slowly  along the ides of the test 
tube, any  purple colour  appereance at the  junction  confirms the presence of 
carbohydrates. (Rafia  et al.,  2010). 
Proteins ( Ninhydrin  test) : 20 mg of  powdered drug was boiled with 3 ml of 0.2% 
solution of  Ninhydrin ( Indane 1,2,3 trionehydrate). Appearance of violet colour 
indicates the presence of proteins (Rafia et al., 2010). 
Steroids: To 0.5 gms of ethanolic extract, 2 ml of acetic anhydride was added and then 
2 ml of H2SO4 were carefully added. Any colour change from violet to green indicates 
the presence of steroids (Rafia et al., 2010). 
3.6. ANIMAL AND EXPOSURE CONDITIONS 
The animals (rats and mice) were obtained from Indian Institute of Integrative Medium, 
Canal Road, Jammu. The animals were fed with rat feed (Ashirwad Industries Ltd, 
Chandigarh) and water ad libitum. They were housed in clean propylene cages, under 
identical conditions of food, water, temperature and degree of nursing care. Male and   
female animals were kept in separate cages. They were exposed to 12-hours, light-dark 
cycle and the relative humidity was in the range of 61-76% and temperature range was 
15-25
o
C. All procedures were performed according to CPCSEA guidelines after proper 
approval from the Institutional Animal and Ethics Committee at the Department of 
Pharmaceutical Sciences, University of Kashmir Reg No-F-IAEC (Pharm. Sc) 
APPROVAL/ 2008/4. All the chemicals used were of the analytical grade obtained 
from standard companies and distilled water was used during all the experiments. 
3.7. PHARMACOLOGICAL STUDIES 
50%  ethanolic extract of whole plant of  Portulaca oleracea (PO),  50%  ethanolic 
extract of Eriobotrya  japonica fruits  (EBJF) and 50%  ethanolic extract  of Eriobotrya  
japonica  seeds   (EBJS)  were   evaluated for  antidiabetic  activity in  rats. Acute oral 
toxicity studies for 72 hours and sub-acute   toxicity studies for 14 days were also 
conducted on the plant extracts using albino mice. Plant extracts were suspended in 2% 
gum acacia  and administered orally to rats and mice. In antidiabetic studies, alloxan 
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and streptozotocin were used to induce diabetes and were dissolved in normal saline. 
Glibenclamide  was used  as a standard antidiabetic drug and was given orally  to rats. 
In all the experiments, an oral feeding needle no 21 was used to administer the doses of 
extracts, glibenclamide and the vehicle. 
3.7.1. Toxicity Studies  
 Acute Toxicity Studies (72 hours)         (Babu et al., 2003) 
 Sub acute Toxicity Study (14 days)               (Babu et al., 2003) 
3.7.2. Antidiabetic Studies  
 These studies were conducted using two models 
 Alloxan (10 day study)                                 (Vivek et al., 2010) 
 Streptozotocin (15 day study)                      (Prasad et al., 2009) 
3.7.1.1  Acute Oral Toxicity Study (72 hours) 
The 50 %  ethanolic extract  of the  selected  plants  Portulaca oleracea (PO), 
Eriobotrya japonica fruits (EBJF) and Eriobotrya japonica seeds (EBJS) were 
evaluated  for its acute oral toxicity  in mice. The animals were divided into five groups 
of two mice each weighing about 20-25 g. The acute oral toxicity was conducted in 
three sets of experiments.  
In the first experiment, 50% ethanolic extracts of Portulaca oleracea (PO), in the 
second experiment (EBJF)  and  in the third  experiment (EBJS) respectively were 
studied for their acute oral toxicity effects  in mice. For this total thirty mice  were 
taken and in each set of experiment, ten  mice were divided into five groups of two 
mice each  and the  groups were as follows:- 
Group  I   -----       Normal Control. (2%  gum acacia) 
Group  II   -----      PO (500 mg / kg b.w) 
Group III   ----   PO (1000 mg / kg b.w) 
Group IV  ----   PO (1500 mg / kg b.w) 
Group V   ----   PO (2000 mg / kg b.w) 
The mice were acclimatized for a period of 7 days before the start of treatment. 
Ethanolic extract of PO in four dose  levels was given orally in single doses to mice of 
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Groups II, III, IV, V while Group  I received only the vehicle.( 2% gum acacia). The 
extracts were administered in 2% gum acacia. The animals were observed for  mortality 
and general behaviour  periodically, for 48 hr to 72 hr. The behaviour of the animals 
was observed daily for 1 hr in the forenoon (10 to 11.am) The animals were observed 
continuously for the initial 4 hr. and intermittently for the next six hr. and then again 
after   24, 48 and  72  hrs following  administration  of  different doses of PO extract. 
 The same procedure was followed for  carrying the acute oral toxicity study of  50%  
ethanolic extracts of Eriobotrya japonica  fruits (EBJF) in which again ten mice were 
 divided into  five groups  of  two mice  each. 
 Group  I   -----       Normal Control. (2%  gum acacia) 
Group  II   -----      EBJF (500 mg / kg b.w) 
Group III   ----   EBJF (1000 mg / kg b.w) 
Group IV  ----   EBJF (1500 mg / kg b.w) 
Group V   ----   EBJF (2000 mg / kg b.w) 
Eriobotrya  japonica  seeds  were also  administered  in the same  way  in which 
 again ten mice were  divided into  five groups  of  two mice  each. 
 
Group  I   -----       Normal Control. (2%  gum acacia) 
Group  II   -----      EBJS (500 mg / kg b.w) 
Group III   ----   EBJS (1000 mg / kg b.w) 
Group IV  ----   EBJS (1500 mg / kg b.w) 
Group V   ----   EBJS (2000 mg / kg b.w) 
 
Following  parameters were observed during acute oral toxicity study 
Grooming was considered in mice if the animal   cleared   the fur and skin of itself or 
another animal 
Hyperactive if there was any   abnormal or excessive activity and the animal was unable 
to relax 
Sedated if the animal was calm and composed without any stress 
Having  respiratory  arrest, if  there was raising of head 
Having convulsions if there was tremor in the tail  or  paddling  of  the  feet 
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Motor  activity, increased   or  decreased, 
Mortality, if  any. 
The   results  are  shown in the tables (14,15 and  16). 
3.7.1.2. Subacute Toxicity study (14  days)  
The  ethanolic extract of Portulaca oleracea whole plant (PO) and Eriobotrya japonica 
fruits (EBJF) were administered orally once daily to mice.  Before initiation of 
experiment, the mice were acclimatized for a period of seven days. To study subacute 
toxicity, animals of either sex (20-25 g body weight)  were divided into five groups of 
six mice each. The treatment was given as  per the following protocol.  
Group I-            Normal  Control ( 2% aqueous  gum acacia) 
Group II             PO      (200 mg/kg b.w)   
Group III           PO      (400 mg/kg b.w)   
Group  IV          EBJF  (250 mg/kg b.w)  
Group   V          EBJF  (500 mg/kg b.w) 
The treatment was continued for 14 days. During this period, mice of control group 
received only 2% gum acacia. After 14 days, animals were fasted overnight and blood 
was collected by cardiac puncture. The blood samples were taken for haemoglobin and 
white blood corpuscles estimation. The blood was allowed to clot for one hour and 
serum was separated by centrifuging and evaluated for different biochemical parameters  
The  results  obtained were subjected  to ANOVA  followed  by  students t  test,p > 0.05 
was considered as non significant, p< 0.05 – significant, p< 0.01- highly significant and 
p<0.001 as very highly  significant. 
After  taking the blood  samples, the animals were sacrificed. Liver kidney and   spleen  
were excised from the   animals, preserved in 10% formalin and sent  for  
histopathological studies. The following  biochemical   parameters were evaluated in 
the subacute  toxicity   studies.       
               a)  Serum Glucose Levels                     (Trinder et al., 1969) 
b)  Kidney Function Tests 
i. Serum Urea Levels                  (Varley, 1980) 
ii. Serum Creatinine Levels           (Zender, 1972) 
     c)   Liver Function Tests 
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i. Serum Bilirubin Levels           (Jendrassik et al., 1938) 
ii. Serum Glutamate Oxaloacetate  
Transaminase (SGOT)           (Reitman &Frankel, 1957) 
iii. Serum Glutamate Pyruvate  
Transaminase (SGPT)      (Reitman & Frankel, 1957) 
iv. Serum Total Proteins           (Lowry et al., 1951) 
v. Serum Albumin                     (Hallbach  et al., 1991) 
vi. Serum Alkaline Phosphatase    (Bowers et al., 1972) 
                d) Blood Function Tests 
i. Hemoglobin Value                         (Ghai, 2006) 
ii. WBC Count                                 (Ghai, 2006) 
  
3.7.2 ANTIDIABETIC   STUDY  
3.7.2.1. Study of  50% ethanolic extract of Portulaca oleracea  whole plant (PO), 
Eriobotrya japonica fruits (EBJF) and Eriobotrya japonica seeds(EBJS) against  
alloxan induced  diabetes ( 10 days  study) 
In this study, ethanolic extract of PO (100 and 200 mg/kg b.w) , EBJF (50,100 and 200 
mg/kg b.w)  and EBJS (100 and 200 mg/kg b.w)  were evaluated for antidiabetic 
activity against alloxan induced diabetes mellitus in rats. Rats were divided into 10 
groups consisting of  6 rats in each group. Initially  65 rats  were taken to account for 
any mortality. The rats were acclimatized for a period of 7 days before starting the 
experiment.  After   overnight fasting , hyperglycaemia was induced by administering a 
single dose of alloxan monohydrate supplied by  s.d Fine-Chemical Ltd. Mumbai, India  
(120 mg/kg b.w) (Vivek et  al., 2010)  prepared in sterile saline to all the  groups except  
group I which served as  normal control. During this period, the animals were given free 
access to water. After 5 days of alloxan administration, fasting blood glucose levels of 
rats were checked by glucostrips.  The animals having blood glucose levels > 250 mg/dl 
were separated and selected for further studies and then re-grouping of these 
hyperglycemic rats was done as per the following protocol, for studying the anti-
diabetic activity of different extracts.  
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Group I-  Normal Control ( 2%  of  gum  acacia.) 
Group II-  Diabetic Control (Alloxan monohydrate and 2%  gum acacia) 
Group III- Alloxan monohydrate +   Glibenclamide (10 mg/kg,) . 
Group  IV-  Alloxan   monohydrate  +   PO     (100 mg/kg b.w) 
Group  V    Alloxan   monohydrate +   PO     (200mg/kg  b.w) 
Group  VI   Alloxan   monohydrate  +  EBJF (50 mg/kg b.w) 
Group  VII  Alloxan   monohydrate  +  EBJF  (100 mg/kg b.w) 
Group  VIII Alloxan   monohydrate  + EBJF    (200 mg/kg b.w) 
Group  IX    Alloxan   monohydrate  + EBJS   (100 mg/kg b.w) 
Group  X    Alloxan   monohydrate  + EBJS    (200 mg/kg b.w) 
The treatment  was started from the same day except normal control and diabetic 
control groups for a period of 10 days orally. During this period, animals in all groups 
had free access to standard diet and water. Blood glucose levels were estimated on  1
st
 
,4
th
, 7
th
 and 10
th
 day of the treatment.  Besides this during this study the body weight of 
the rats were recorded on 1
st
 , 4
th
 7
th
  and 10
th
 day of the treatment. On the 11
th
 day, 
blood samples were collected from overnight fasted rats by cardiac puncture. The 
animals were anaethesized by mild ether anaesthesia before cardiac puncture.  Blood  
was collected  and allowed to stand for one hour,  serum  was  separated  by 
centrifuging  and  evaluated for  different   biochemical parameters. like  
a) Serum  Glucose  Levels                                   (Trinder et al., 1969) 
b) Lipid  Profile 
i. Serum   Total  Cholesterol  Levels       (Allain et al., 1974) 
ii. Serum     Triglycerides  Levels      (Bucolo, 1973) 
iii. Serum    HDL Cholesterol  Levels   (Izzo et al., 1981) 
iv. Serum   LDL  Cholesterol   Levels           (Friedewald et al., 1972) 
v. Serum   Total  Protein  Levels            (Lowry et al., 1951) 
c) Kidney  Function Tests 
i. Serum    Urea   Levels    (Varley,  1980) 
ii. Serum    Creatinine  Levels           (Zender, 1972) 
iii. Serum   Total  Protein  Levels            (Lowry et al., 1951) 
 
d) Body Weight. 
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 3.7.2.2. Study of  50% ethanolic extract of Portulaca oleracea whole  plant (PO), 
Eriobotrya japonica fruits (EBJF) and Eriobotrya japonica seeds (EBJS) against  
Streptozotocin (STZ)  induced  diabetes ( 15 days  study) 
In this study, ethanolic extract of  Portulaca  oleracea whole plant PO (50 and 100 
mg/kg b.w) ,  Eriobotrya  japonica  fruits EBJF (50 and 100  mg/kg b.w)  and 
Eriobotrya  japonica  seeds EBJS (50 and 100 mg/kg b.w)  were evaluated for 
antidiabetic activity against streptozotocin  induced diabetes mellitus in rats. Rats were 
divided into nine groups consisting of  six rats each. Initially  sixty rats  were taken to 
account for any mortality. The rats were acclimatized for a period of 7 days  before 
starting the experiment.  After  an overnight fasting, hyperglycaemia was induced by 
administering a single dose of streptozotocin.(50 mg/kg b.w) (Prasad et al, 2009) to all 
rats excepting group I which served as normal control. Streptozotocin  was freshly 
dissolved in 0.1 M citrate buffer ( pH=4.5)  and injected intraperitioneally within 15 
min of  dissolution in a vehicle volume of 0.4 mL with 1 mL of tuberculin syringe fitted 
with 24 gauge needle. Diabetes was confirmed by the determination of fasting glucose 
concentration on the third day post administration of streptozotocin. During this period, 
the animals were given free access to water. After 3
rd
   day of STZ administration, 
fasting blood glucose levels of rats were checked by glucostrips.  The animals having 
blood glucose levels > 250 mg/dl were separated and selected for further studies and 
then re-grouping of these hyperglycemic rats was done as per the  following protocol, 
for studying the anti-diabetic activity of different extracts.  
Rats were given the following treatment in this study. 
Group I  Normal Control ( 2%  of  gum  acacia). 
Group II  Diabetic Control. Received STZ (50 mg/kg b.w single dose i.p) 
Group III  STZ   + Glibenclamide (3 mg/kg,)  
Group IV  STZ +   PO (50 mg/kg b.w) 
Group V     STZ + PO (100mg/kg b.w) 
Group VI     STZ+ EBJF (50 mg/kg b.w) 
Group VII     STZ+ EBJF (100 mg/kg b.w) 
Group VIII    STZ + EBJS (50 mg/kg b.w) 
Group IX     STZ + EBJS (100 mg/kg b.w) 
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The treatment was started from the same day except normal control and diabetic control 
groups for a period of 15 days orally. During this period, animals in all groups had free 
access to standard diet and water. Blood glucose levels were estimated on 1
st
, 4
th
, 9
th
 
and 15
th
 day of the treatment.  Besides this during this study the body weight of the rats 
were recorded on  1
st
 , 4
th
 9
th
  and 15th day of the treatment. On day 16
th
, blood samples 
were collected from overnight fasted rats by cardiac puncture. The animals were 
anaethesized by mild ether anaesthesia before cardiac puncture.   Blood  was collected  
and allowed to stand for one hour,  serum  was  separated  by centrifuging  and  
evaluated for  different   biochemical parameters. The animals were  killed  and liver, 
kidney and pancreas were taken out.  Histopathology of these  organs   was  also done.  
A) Biochemical   parameters   evaluated   were:          
a)  Serum  Glucose Levels           (Trinder, 1969) 
b)  Liver Function Tests 
i. Serum Bilirubin Levels       (Jendrassik, 1938) 
ii. SGOT levels                    (Reitman & Frankel, 1957) 
iii. SGPT levels                         (Reitman& Frankel, 1957) 
iv. Serum Total Proteins            (Lowry et al., 1951) 
v. Serum Albumin                             (Hallbach  et al., 1991) 
vi. Serum Alkaline Phosphatase           (Bowers et al., 1966) 
c) Lipid  Profile 
i. Serum  Total  Cholesterol Levels  (Allain et al., 1974) 
ii. Serum   Triglycerides   Levels       (Bucolo, 1973) 
iii. Serum   HDL Cholesterol    Levels (Izzo et al., 1981) 
iv. Serum  LDL  Cholesterol  Levels  (Friedewald et al., 1972) 
d) Body Weight 
 STATISTICAL ANALYSIS 
The  data obtained  from  the  different  studies  and the biochemical estimations is 
expressed as Mean ±  SEM  for  each  group. After this, the  statistical  analysis was 
carried out using  one way  analysis of variance (ANOVA) followed by students  t-test. 
Values p> 0.05 were considered  non significant;  p< 0.05 as significant, p<0.01 as 
highly  significant and  p<0.001  as  very highly  significant respectively. 
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 B ) Histopathological studies 
Pancreas 
Kidney   
Liver  
The organs were taken out, preserved in 10% formalin and sent  for histopathological   
studies.  
3.8 BIOCHEMICAL ESTIMATIONS DONE IN VARIOUS 
EXPERIMENTS 
ESTIMATION OF GLUCOSE (Trinder, 1969)    
Principle:- 
Glucose is oxidized to gluconic acid and hydrogen peroxide in the presence of glucose 
oxidase. Hydrogen peroxide further reacts with phenol and 4-aminoantipyrine by the 
catalytic action of peroxidase to form a red coloured quinoneimine dye complex. 
Intensity of the colour formed is directly propotional to the amount of glucose present 
in the sample.  
                                                               Glucose Oxidase 
                             Glucose+O2+H2O              Gluconate+H2O2 
                                                             Peroxidase 
H2O2+4 Aminoantipyrine+Phenol   Red Quinoneimine dye+H2O 
Contents                                                 2x150 ml        3x150 ml          1000 ml 
L1: Glucose Reagent                             2x150 ml        3x150 ml          1000 ml 
S:  Glucose Standard (100 mg/dl)             5 ml                 5ml                5 ml 
Procedure 
Wavelength / filter                 :  505nm (Hg 546 nm)/ Green 
Temperature                           :  37
0
 C/R.T. 
Light path                               :  1 cm 
Pipette into clean dry test tubes labeled as Blank (B), Standard(S), and Test (T): 
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Addition 
Sequence 
                 B                     S                  T 
               (ml)                 (ml)              (ml) 
Glucose Reagent (L1) 
Distilled Water 
Glucose Standard(S) 
Sample 
                 1.0                  1.0                1.0 
                 0.01                   -                   - 
                 -                     0.01                 - 
                 -                       -                  0.01 
Mix well and incubate at 37
0
C for 10 min. or at R.T. (25
0
 C) for 30 min. Measure the 
absorbance of the Standard (Abs.S), and Test Sample (Abs.T) against the Blank, within 
60 Min. 
Calculations 
Total Glucose in mg/dl                               
   
ESTIMATION OF CHOLESTEROL (Allain et al., 1974; Wybenga et al., 1970)   
Principle 
Cholesterol esterase hydrolyses cholesterol esters into free cholesterol and fatty acids. 
In the second reaction cholesterol oxidase converts cholesterol to cholest 4-en-3-one 
and hydrogen peroxide. In presence of peroxidase, hydrogen peroxide oxidatively 
couples with 4–aminoantipyrine and phenol to produce red quinoneimine dye which has 
absorbance maximum at 510 nm. (500 – 530). The intensity of the red colour is 
proportional to the amount of total cholesterol in the specimen. 
Cholesterol esters __________CHE*_____________Cholesterol + Fatty acids 
Cholesterol +  O2   __________CHO*______________ H202 + Cholest-4-en-3-one 
2H2O2+4-aminoantipyrine _______POD*______Red Quinoneimine+Phenol Dye  
    + H2O 
*Abbreviations 
CHE              =           Cholesterol esterase 
CHO            =             Cholesterol oxidase 
POD             =            Peroxidase                     
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Components & concentration of working solution 
            Component                               Concentration 
Buffer, pH 6.8                       50      mmol/l 
Cholesterol oxidase                               >     100     IU/l 
Cholesterol esterase                           >     150     IU/l 
Peroxidase                                              ≥     500     IU/l 
4 – aminoantipyrine                               0.5     mmol/l 
Phenol                                                  >    10     mmol/l 
Stabilizers / Surfactants 
Specimen collection & preservation Blood is collected in a clean dry container. Fasting 
blood is preferred for cholesterol assay. Cholesterol in the serum is stable for 7 days 
when stored at 2-8
0
C and 60 days when stored at 20
0
C. 
Procedure 
Reaction type…………………………..End- Point 
Reaction  time............................5 mins. At 37
o
C/10 mins. At R.T.(25-30
0
C) 
Wavelength…………………………..510 nm.(500 – 530nm.) 
Zero setting with………………………..Reagent Blank 
Blank absorbance limit…………………..< 0.300 Abs. 
Sample volume………………………….0.01 ml(10 µl) 
Reagent Volume…………………………1.0 ml 
Standard concentration…………………..200 mg% 
Linearity…………………………………….1000 mg/dl 
Manual assay procedure 
Prewarm at room temperature the required amount of reagent before use. 
Perform the assay as given below. 
1.0ml Procedure 
                                    Serum          Standard                        Blank 
                                    0.01 ml         0.01 ml                                - 
Reagent                      1.0  ml          1.0 ml                              1.0 ml 
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Incubation 
Incubate the assay mixture for 5 minutes at 37
0
C or 10 minutes at room temperature (25 
– 300C). After incubation measure the absorbance of assay mixture against blank at 510 
nm. The final colour is stable for two hours if not exposed to direct light. 
Calculation: 
1. With Standard  
Conc. (mg %)      =      Absorbance of Sample      x 200 
                                    Absorbance of Standard 
2. With factor for wavelength range    : 500-510 nm. 
Conc. (mg %) =543 x Absorbance of sample 
ESTIMATION OF TRIGLYCERIDES ( Bucolo, 1973 )  
Principle 
Glycerol released from hydrolyses of triglycerides by lipoprotein lipase is converted by 
glycerol kinase into glycerol–3–phosphate which is oxidized by glycerol phosphate 
oxidase to dihydroxyacetone phosphate and hydrogen peroxide. In presence of 
peroxidase, hydrogen peroxidase, phenolic chromogen to a red coloured compound. 
Triglycerides_______              LPL*_________________                       _Fatty acids + Glycerol 
Glycerol + ATP _______GK*__________________                  Glycerol-3-phosphate + ADP 
Glycerol -3-phosphate____  GPO*____               Dihydroxyacetone phosphate     
              + O2              + H2O2 
H2O2 + Phenolic chromogen____            POD*_______                       _Red colour compound 
*Abbreviations 
LPL = Lipoprotein lipase                          GPO = Glycerol phosphate oxidase 
GK = Glycerol kinase                                POD = Peroxidase 
Components & concentration of working solution 
Component                                                               Concentration 
Buffer, pH 7.2                  50 mmol/l 
Lipase                                                      >     2000 IU/l 
Glycerol Kinase                                         >    300 IU/l 
Glycerol phosphate oxidase                        >   1000IU/l 
Peroxidase                                            >    500 IU/l 
ATP                                                  1 mmol/l 
 
Chapter 3         Materials And Methods 
 
Ph.D Thesis                                                129                                          University of Kashmir 
 
Chromogen                                               2 mmol/l 
Activators & stabilizers  
Specimen collection & preservation 
Blood is collected in a clean dry container.  
Triglycerides are stable for 4 days in neatly separated serum or plasma at 2-8
0 
C. 
Procedure 
Reaction type……………………..End point 
Reaction time……………………..10 mins.at 370C/20 mins. At R.T.(25-300C) 
Wavelength………………………..510 nm.(500 – 530 nm) 
Zero setting with…………………...Reagent Blank 
Blank absorbance limit……………< 0.300 Abs. 
Sample volume………………… ….0..01 ml (10 µ1) 
Reagent volume……………...........1.0 ml 
Standard concentration…………..200 mg% 
Linearity…………………………..800 mg/dl 
 
Manual assay procedure 
Prewarm at room temperature (25-30
0
C) the required amount of reagent before use. 
Perform the assay as given below: 
1.0 ml procedure 
                                         Serum / plasma           Standard                 Blank 
                                             0.01 ml                     0.01 ml                      - 
Reagent                               1.0 ml                      1.0 ml                    1.0 ml 
Incubation 
Incubate the assay mixture for 10 minutes at 37 
0
C or 20 minutes at R.T.(25 -30
0
C). 
After incubation, measure the absorbance against blank at 510 nm. (500-530 nm). Final 
colour is stable for 30 minutes if not exposed to direct light. 
Calculation: 
1. With standard 
Conc. (mg %) = Absorbance of Sample       x   200 
                                       Absorbance of Standard 
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2. With factor for wavelength range: 500-510 nm. 
      Conc. (mg %) = 745 x Absorbance of sample 
ESTIMATION OF HDL – CHOLESTEROL (Izzo et al., 1981) 
Principle 
In the first step, LDL, VLDL & Chylomicrons are eliminated under specific conditions. 
In the second step, special reagents break up HDL and make HDL-Cholesterol available 
for measurement. 
Reagent storage, stability & handling 
The reagents R1 & R2 are ready- to- use. 
The reagent kit is stored at 2-8
0
C and is stable till the expiry date indicated on the label. 
Components & concentration of working solution 
         Component                                                Concentration 
R1 
Chromogen 
Cholesterol oxidase                                       1.0U/ml 
Buffer 
R2 
4-aminoantipyrine                                        <1 mol/l 
Buffer 
Specimen collection & preservation 
Blood is collected in a clean and dry container.. 
Procedure 
Reaction type…………………………………. End point (2-step) 
Reaction time…………………………………. 5 + 5 mins 
Wavelength……………………………………. 578 nm. 
Flow cell temperature…………………………. 370C 
Zero setting with……………………………….. Distilled water 
Sample volume………………………………… 0.01 ml (10µl) 
Reagent volume……………………………….. 0.750 ml + 0.250 ml 
Linearity……………………………………….. 150 mg/dl 
 
 
 
Chapter 3         Materials And Methods 
 
Ph.D Thesis                                                131                                          University of Kashmir 
 
Manual assay procedure 
Perform the assay as given below : 
                                             Calibrator                                       Sample 
                                             0.01 ml                                        0.01ml 
R1                                        0.750 ml                                    0.750 ml 
Mix and incubate for 5 minutes at 37
o
C. 
Measure the absorbance A1 at 578 nm. 
R2                                     0.250ml                                           0.250 ml 
Mix and incubate for 5 minutes at 37
0
C. 
Measure the absorbance A2 at 578 nm. 
Calculation: 
HDL-Cholesterol in mg%    = (A2-A1) sample           x       Conc. Of Calibrator 
                                              (A2 – A1) calibrator 
ESTIMATION OF LDL – CHOLESTEROL (Friedewald  et al., 1972) 
Principle 
In the first step, HDL, VLDL & Chylomicrons are eliminated under specific conditions. 
In the second step, special reagents break up LDL and make LDL-Cholesterol available 
for measurement. 
Reagent storage, stability & handling 
The reagents R1 & R2 are ready- to- use. 
The reagent kit is stored at 2-8
0
C and is stable till the expiry date indicated on the label. 
Components & concentration of working solution 
       Component                                                                     Concentration 
R1 
Chromogen 
Cholesterol oxidase                                         <1.5U/ml 
Cholesterol esterase                                         <1.5U/ml 
Buffer 
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R2 
4-aminoantipyrine                                          <1 mol/l 
Buffer 
Specimen collection & preservation 
Blood is collected in a clean and dry container. 
Procedure 
Reaction type…………………………………. End point (2-step) 
Reaction time…………………………………. 5 + 5 mins 
Wavelength…………………………………… 546 nm. 
Flow cell temperature……………………….. 370C 
Zero setting with……………………………… Distilled water 
Sample volume……………………………….. 0.01 ml (10µl) 
Reagent volume………………………………. 0.750 ml + 0.250 ml 
Linearity………………………………………. 450 mg/dl 
Manual assay procedure 
Perform the assay as given below: 
                                             Calibrator                                       Sample 
                                             0.01 ml                                        0.01ml 
R1                                        0.750 ml                                    0.750 ml 
Mix and incubate for 5 minutes at 37
0
C. 
Measure the absorbance A1 at 546 nm. 
R2                                     0.250ml                                           0.250 ml 
Mix and incubate for 5 minutes at 37
0
C. 
Measure the absorbance A2 at 546 nm. 
Calculation: 
LDL-Cholesterol in mg%    = (A2-A1) sample          x Conc. Of Calibrator 
                                               (A2 – A1) calibrator 
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ESIMATION OF UREA (Varley, 1980) 
Principle: 
Urease splits urea into ammonia and carbon dioxide. Ammonia released in this reaction 
reacts with hypochlorite and phenolic chromogen to produce green colour. The 
absorbance of this green colour at 578 nm. (570-620) is directly propotional to the 
concentration of urea in specimen. 
NH2-CO-NH2                  Urease    2NH3+CO2 
NH3+Hypochlorite + phenolic chromogen          Green colour. 
Preparation of  enzyme solution 
Reconstitute enzyme & diluent as per instructions indicated  to prepare enzyme 
solution. Mix gently by inversion. The chromogen solution is ready to use. 
Components & concentration of assay mixture 
The following components are present: 
        Component                                                   Concentration 
Phosphate buffer; pH 7.0                       35mmol /l 
Urease                                                      15 KU /l 
Phenolic Chromogen                                  2mmol /l 
Hypochlorite                                              4mmol /l 
Activators and preservative 
Specimen collection & preservation 
Blood is collected in a clean and dry container Following anticoagulants may be used of 
plasma separation: 
Urea in the specimen is stable for a week when stored at 2
0
-8
0
 C and for a month when 
stored at -10
0
 C. 
Procedure 
Reaction Type………………………………… ………  End Point 
Reaction Time………………………………………… 3+5 mins. 
Wavelength…………………………………………… 578nm (570-620 nm). 
Zero Setting With…………………………………….. Reagent Blank. 
Blank absorbance limit……………………………… <0.200Abs. 
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Sample Volume……………………………….. ………   0.01ml (10 µ l). 
Reagent Volume………………………………. ………   1.0 ml.+1.0ml. 
Standard Concentraction……………………………. 40mg% 
Linearity……………………………………….. ………   350mg/dl. 
Manual assay procedure 
Prewarm at room temperature (25
0
C – 300C) the required amount of enzyme solution 
and Chromogen before use. 
Perform the assay as given below: 
2.0 ml procedure 
                                                       Serum/Plasma             Standard                         Blank 
                                                      0.01 ml                0.01 ml     
Enzyme Solution                                1.0 ml                      1.0 ml                              1.0ml 
Mix and incubate for three minutes at 37 
o
C. 
Chromogen Solution                          1.0ml                       1.0 ml                              1.0 ml 
Incubation Mix and incubate the assay mixture at 37 
o
C for 5 minutes. After 
completion of incubation  measure the absorbance of assay  mixture against blank at  
578 nm (570-620 nm). The final colour is stable for 2 hours if not exposed to direct 
light. 
Calculation 
Urea in mg%   =        Absorbance of sample          x      40 
                                Absorbance of standard 
ESTIMATION OF CREATININE ( Zender,1972) 
Principle 
Creatinine in alkaline medium reacts with picrate to produce orange colour. This colour 
absorbs light at 492 nm.(490-510 nm). The rate of increase in absorbance is directly 
propotional to the concentration of creatinine in specimen. 
Creatinine + Picrate     Alkaline medium    Orange colour 
Preparation   of   working  solution 
Prepare working solution by mixing equal volume of Picrate Reagent and Diluent 
Reagent. 
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 Components & concentration of working solution 
  Component                              Concentration 
Sodium Picrate                            7.7 mmol/l 
Sodium Hydroxide                     500 mmol/l 
Specimen  collection & preservation 
Blood is collected in a clean dry container. Creatinine in serum and plasma is stable for 
2 days when stored at 2-8
0
C. 
Procedure 
Reaction Type……………………………………. Initial rate 
Reaction direction………………………………… Up 
Wavelength……………………………………….  492 nm.(490-510 nm). 
Flowcell temperature…………………………….. 300C /370C 
Zero setting with…………………………………. Distilled water 
Delay time……………………………………........ 30 seconds 
No. of readings…………………………………… 2 
Interval……………………………………………. 60 seconds 
Sample volume……………………………..…….. 0.05 ml (50 µl) 
Reagent volume………………………… ………. 1.0 ml 
Standard concentration…………………………. 2 mg% 
Factor……………………………………….……. 2÷ Abs. of   standard               
Linearity…………………………………………. 30 mg/dl  
 
Manual assay procedure 
 
Prewarm the required amount of working solution to 30
o
C/37
o
C before use. 
 
1.0 ml procedure 
Standard / sample……………………………… ………. 0.05 ml (50 µl) 
Working solution…………………………………………1.0 ml 
Mix and start stopwatch simultaneously. Record absorbance assay mixture at exactly 30 
seconds after Standard/ Specimen addition and then again at 90 seconds. 
Note : It is recommended to run a creatinine standard with each batch of assay. 
Calculation: 
Calculate the average change in absorbance per minute (Abs.) of standard & specimen. 
 Abs.=Abs. at 90 sec.--- Abs. at 30 sec. 
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Serum Creatinine (mg %)   =   Abs. of Specimen          x 2 
                                                 Abs. of Standard  
ESTIMATION OF BILIRUBIN ( Jendrassik, 1938) 
Principle 
Bilirubin reacts with diazotized sulphanilic acid in acidic medium to form pink colored 
azobilirubin with absorbance directly proportional to bilirubin concentration. Direct 
Bilirubin, being water soluble directly reacts in acidic medium. However indirect or 
unconjugated Billirubin is solubilised using a surfactant and then it reacts similar to 
direct Bilirubin 
Reagent composition 
Reagent 1: Total Bilirubin Reagent 
Surfactant 1.00% 
HCI 100 mmol/L 
Sulphanilic Acid 5 mmol/L 
 
Reagent 2: Direct Bilirubin Reagent 
Sulphanilic Acid 10mmol/L 
HCI 100 mmol/L 
Reagent 3: Sodium Nitrite Reagent 
Sodium Nitrite 144 mmol/L 
Reagent preparation 
Test Volume of Working 
Reagent 
                                          Add 
Reagent 1 Reagent 2 Reagent 3 
 
Bilirubin 
Total 
10 ml 10 ml - 0.2 ml 
25 ml 25 ml - 0.5 ml 
50 ml 50 ml - 1.0 ml 
100 ml 100 ml - 2.0 ml 
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Bilirubin 
Direct 
10 ml - 10 ml 0.1 ml 
25 ml - 25 ml 0.25 ml 
50 ml - 50 ml 0.5 ml 
100 ml - 100 ml 1.0 ml 
Sample 
Unhaemolysed serum or Plasma.  Samples should be protected from bright light as 
bilirubin is photolabile. Samples may be stored refrigerated for 3 days or frozen for 1 
month. 
Assay parameters 
Parameter Bilirubin Total  Bilirubin Direct 
Mode End Point End point 
^(nm)1/2 EC5+V2/Chem5 546/630 546/630 
^(nm)1/2 Chem. 7 546/670 546/670 
Sample Volume (µl) 25/50 25/50 
Reagent Volume(µl) 500/1000 500/1000 
Incubation time (mins) 5 5 
Incubation temperature(
o
C) 37 37 
Normal Low 0.1 0 
Normal High 1.2 0.3 
Linearity Low 0 0 
Linearity High(mg/dl) 20 20 
Factor 546/630 23 17 
Factor 546/670 21 12 
Blank with Reagent Reagent 
Absorbance Limit(max) 0.2 0.2 
Units mg/dl mg/dl 
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Assay procedure 
Total bilirubin/ direct bilirubin 
Pipette into test tubes 
 Marked 
 Blank   Standard Test 
Working Reagent 500 µl 500 µl 500µl 
Distilled Water 25 µl - - 
*Standard / calibrator - 25 µl - 
Test - - 25 µl 
Mix well, incubate for 5 minutes at 37
o
C for Total Bilirubin and direct Bilirubin. Read 
Absorbance at 546/630 nm against reagent blank. 
Calculation with calibrator / standard 
Total Bilirubin (mg/dl)   =   Abs. of Test            x   Concentration of  
                                             Abs. of Standard        Standard (mg/dl) 
Direct Bilirubin (mg/dl)  =  Abs. of Test            x    Concentration of          
                                            Abs. of Standard         tandard (mg/dl) 
In the biochemical estimation, only total bilirubin was taken. 
 
ESTIMATION OF SGPT (Reitman & Frankel, 1957) 
Principle 
L-Alanine + 2-Oxoglutarate   ALT   Pyruvate + L- Glutamate 
Pyruvate + NADH        LDH   L-Lactate + NAD 
 
ALT:     Alanine aminotransferase 
LDH:     Lactate Dehydrogenase. 
Reagent composition (When reconstituted as directed)  
Reagent 1: SGPT reagent 
L-Alanine 500 mmol/L 
NADH (Yeast) 0.18 mmol/L 
LDH >1820 IU/L 
2 – Oxoglutarate 12 mmol/L 
Tris Buffer (ph 7.5±0.1 at 25
o
C) 80 mmol/L 
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Reagent reconstitution 
Allow the reagent bottle and Aqua-4 (supplied in the kit) to attain room temperature. 
Add the amount of Aqua -4 indicated on the label to contents of each vial. Swirl to 
dissolve, do not shake vigorously. 
Storage and stability 
Prior to Reconstitution 
Unopened reagent vial is stable till the expiry date stated on the label when stored at  2-
8
0
C. 
After Reconstitution 
The reagent is stable for 30 days at 2-8
0
C.  
Sample: Serum  
ALT is stable for 3 days at 2-8
o
C. 
Assay parameters 
Mode Kinetic 
Wavelength(nm) 340 
Sample Volume(µl) 50/100 
Reagent Volume(µl) 500/1000 
Lag time (sec.) 60 
Kinetic Interval(sec.) 60 
No.of readings 3 
Kinetic factor 1768 
Reaction Temperature(
0
C) 37 
Reaction Direction Decreasing 
Normal Low 0 
Normal High 40 
Linearity Low 0 
Linearity High 450 
Absorbance Limit(Min) 0.8 
Blank with Water 
Units IU/L 
Assay procedure 
 
Pipette Volumes 
Working Reagent 1000 µL 
Test 100 µL 
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Calculation 
Determine the mean absorbance change/min (A/min) for every reading, find the mean 
value. 
The general formula for converting absorbance change into international Units (IU) of  
activity is:   
IU/L                 =     ( A/min.) x T.V. x 10
3
 
                                          S.V. x Absorptivity x p 
Where :                             
T.V.                           =    Total reaction volume in µL 
S.V.                           =     Sample volume in µL 
Absorptivity               =    millimolar absorptivity of  
                                          NADH at 340 nm 
                                    =    6.22 
P                                =    cuvette lightpath = 1 cm 
Activity of ALT 
At 37
0
C (IU/L)            =   (A/min) x Factor (1768) 
ESTIMATION OF SGOT (Reitman & Frankel, 1957) 
Principle 
SGOT converts L-Aspartate and x Ketogutarate to Oxaloacetate and Gultamate. The 
Oxaloacetate formed reacts with 2,4 Dinitrophenyl hydrazine to produce a hydrazone 
derivative, which in an alkaline medium produces a brown coloured complex whose 
intensity is measured. The reaction does not obey Beer‟s law and hence a calibration 
curve is plotted using a pyruvate standard. The activity of SGOT  is read off this 
calibration curve. 
    L – Aspartate          SGOT                         Oxaloacetate 
               +                                                                             + 
   Ketoglutarate            PH 7.4                           L – Glutamate 
   
Oxaloacetate                   Alkaline                     2,4,   Dinitrophenyl      Hydrazone 
            + 
    2,4, DNPH                   Medium                      (Brown coloured complex) 
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Contents                                                                    40 assays 
L1: Substrate Reagent                                                   25 ml 
L2: DNPH Reagent                                               2 x 12.5 ml 
L3: NaOH Reagent (4N)                                                25 ml 
 S:  Pyruvate Standard (2mM)                                        5 ml 
Storage / Stability 
Contents are stable at 2-8
0
C. Sodium Hydroxide can be stored at R.T.  
Reagent Preparation 
All reagents can be used except NaOH Reagent (4N) which has to be diluted 1:10 with 
distilled/deionised water. 
Working Na0H Reagent 
Dilute the sodium Hydroxide to 250ml or for every 1.0 ml of Na0H Reagent (4N) add 
9.0 ml distilled water. The Working Sodium Hydroxide reagent is stable at R.T  in a 
plastic bottle. 
Sample Material 
Serum. Free from hemolysis. SGOT  is reported to be stable in serum for 3 days at 2-
8
0
C. 
Procedure 
Wavelength / filter            :                505 nm (Hg 546 nm) / Green 
Temperature                      :                37
0
 C & R.T. 
Light Path                          :               1 cm 
Plotting of the Calibration curve: 
 Pipette into five clean dry test tubes labeled as 1, 2, 3, 4, & 5: 
Addition Sequence 1        2         3         4           5 
Enzyme Activity (U/ml) 0 ml  24ml  61ml  114ml  190ml 
Substrate Reagent (L1) 0.50   0.45   0.40    0.35     0.30 
Pyruvate Standard (S)           0.05    0.10   0.15     0.20 
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Distilled Water 0.10   0.10   0.10    0.10     0.10 
DNPH Reagent (L2) 0.50   0.50   0.50    0.50     0.50 
                      Mix well and allow to stand at R.T. for 20 minutes. 
Working Na0H Reagent (L3) 5.00   5.00   5.00    5.00      5.00 
Mix well and allow to stand at R.T. for 10min. Measure the absorbances of the tubes 2 
– 5 against tube 1 (Blank). Plot a graph of the absorbances of tubes 2 – 5 on the „Y‟ axis 
versus the corresponding Enzyme activity on the „X‟ axis. 
Assay: 
Pipette into clean dry test tubes labeled as Blank (B) & Test (T): 
 Addition  
Sequence 
    ( B )                    ( T ) 
   (ml)                      (ml) 
Substrate Reagent (L1)     0.50                     0.50 
Incubate at 37
0
C for 3 minutes  
Sample      -                        0.10 
Mix well and incubate at 37
0
C for 60 minutes  
DNPH Reagent ( L2)     0.50                   0.50 
Mix well and allow to stand at R.T. for 20 minutes  
Distilled Water      0.10                   - 
Working NaOH Reagent (L3)     5.00                   5.00 
Mix well and allow to stand at R.T for 10 min. Measure the absorbance of the test (T) 
against Blank (Blank) and read the activity of the test from the calibration curve plotted 
earlier. One sample blank is sufficient for each assay series. If Enzyme activity exceeds 
190 U/ml dilute the sample with  distilled water and repeat the assay. Multiply the value 
with the proper dilution factor. 
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System   parameters 
 Reaction End  Point 
Wavelenth 505 nm 
Zero Setting Reagent Blank 
Incub. Temp 37
O
 C 
Incub Temp 80 min 
Delay Time ……. 
Read Time …….. 
No of read ……… 
Interval ……… 
Sample Vol 0.10 ml 
Reagent  Vol 6.00 ml 
Standard  Factor Calib Curve 
React  Slope Increasing 
Linearity 190 U/ml 
Units U/ml 
 
ESTIMATION OF TOTAL PROTEINS: ( Lowry et  al., 1951) 
Principle 
Proteins, in an alkaline medium, bind with the cupric ions present in the biuret reagent 
to form a blue-violet coloured complex. The intensity of the colour formed is directly 
propotional to the amount of proteins present in the sample. 
               Proteins + Cu++    Blue Violet Coloured Complex 
Contents                                        150 ml             2 x 150 ml 
Carton 1 
L1: Biuret Reagent                        150 ml              2 x 150 ml 
Carton 2 
S: Protein Standard (8 g/dl)               5 ml                  5 ml 
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Sample Material 
Serum or plasma. Proteins are  stable in the sample for 6 days at 2 – 8oC. 
Procedure 
Wavelength / Filter   :  550 nm (Hg 546 nm) / Yellow – Green 
Temperature             :  R. T. / 37
o
C  
Light path                 :   1 cm 
Pipette into clean dry test tubes labeled as Blank (B), Standard (S), and Test (T): 
Addition 
Sequence 
              B                    S                        T 
            (ml)               (ml)                    (ml) 
Biuret reagent (L1) 
Distilled Water 
Protein Standard  (S) 
Sample 
              1.0                 1.0                      1.0 
              0.02                -                          - 
                 -                  0.02                    - 
                  -                    -                       0.02 
Mix well and incubate at 37oC for 10 min. or at R.T. for 30 min. Measure the 
absorbance of the Standard (Abs. S), and Test Sample (Abs. T) against the Blank within 
60 Min. 
Calculations 
Total Proteins in g / dl          =    Abs.T             x     8 
                                                   Abs. S 
ESTIMATION OF ALBUMIN (Hallbach et al., 1991) 
Principle 
Albumin binds with the dye Bromocresol green in a buffered medium to form a green 
coloured complex. The intensity of the colour formed is directly propotional to the 
amount of albumin present in the sample. 
Albumin + Bromocresol Green ___________  Green Albumin BCG Complex 
Contents                                   150 ml                             2 x 150 ml 
Carton 1                                       - 
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L1 : BCG Reagent                     150 ml                             2 x 150 ml 
Carton 2 
S : Albumin Standard ( 4 g/dl)         5  ml                                5 ml 
Storage / Stability 
Carton 1 : BCG Reagent is stable at R.T.  
Carton 2 : Albumin Standard is stable at 2-8
0
C . 
Reagent Preparation 
Reagents are ready to use. Protect from bright light. 
Sample material 
Serum, EDTA plasma.. Albumin is  stable in the sample for 6 days at 2-80C. 
Procedure 
Wavelength / filter      :    630 nm (Hg 623 nm) / Red 
Temperature                :   R.T. 
Light path                    : 1 cm 
Pipette into clean dry test tubes labeled as Blank ( B ), Standard (S), and Test (T): 
Addition 
Sequence 
       B                            S                   T 
   (ml)                        (ml)                 (ml) 
BCG reagent ( L1) 
 Distilled water 
Albumin Standard (S) 
  Sample 
     1.0                         1.0                  1.0 
    0.01                         -                      - 
      -                           0.01                 - 
     -                           -                      0.01 
Mix well and incubate at R.T. for 5 min. Measure absorbance of the Standard (Abs. S), 
and Test Sample (Abs. T) against the Blank. 
Calculation 
Albumin in g/dl                    =       Absorbance of Test       x 4      
                                                   Absorbance of Standard 
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ESTIMATION OF ALKALINE PHOSPHATASE (Bowers, 1966) 
Principle 
ALP at an alkaline pH hydrolyses p-Nitrophenylphosphate to form p-Nitrophenol and 
phosphate. The rate of formation of p-Nitrophenol is measured as an increase in 
absorbance which is propotional to the ALP activity in the sample. 
P-Nitrophenylphosphate                               ALP                          p-Nitrophenol + phosphate 
 
Contents                               10 x 3 ml                  5 x 15 ml         20 x 15 ml 
L1: Buffer Reagent               35 ml                        80 ml               2 x 150 ml 
T1  Substrate Reagent          10 Nos.                     10 Nos.           2 x 10 Nos.. 
 
Reagent Preparation 
Working Reagent: Dissolve 1 substrate tablet in 3.2 ml ( 10 x 3 ml pack ) or 15 ml ( 5 x 
15 ml / 20 x 15 ml pack ) of buffer reagent. 
This working reagent is stable for at least 15 days when stored at 2-8
0
C. The substrate is 
light and temperature sensitive. Adequate care is  taken especially after reconstitution. 
Sample  
Serum Free from hemolysis. ALP is  stable in serum for 3 days at 2-8
0
C. 
Procedure 
Wavelength / filter          : 405 nm 
Temperature                    : 37
0
C / 30
0
C /25
0
C 
Light path                         :  1 cm 
Pipette into a clean dry test labeled as Test (T) : 
Addition 
Sequence 
     ( T ) 
     (ml) 
Working Reagent      1.0 
Incubate at the assay temperature for 1 minute and add 
Sample     0.02 
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Mix well and read the initial absorbance A0 after 1 minute & repeat the absorbance 
reading after every 1, 2 & 3 minutes. Calculate the mean absorbance change per minute 
( A / min.) 
Calculation 
ALP Activity in U/L                        =   A / min. x 2754 
HEMOGLOBIN ESTIMATION (Ghai, 2006) 
1. Fill the graduated measuring tube up to the bottom graduation line (mark 2) with 
N/10 Hydrochloric Acid. 
2. Take a drop of blood.. 
3. Suck 20μl blood into the capillary pipette precisely up to the mark, wipe the 
pipette point and blow the blood into the measuring tube. A good mixture of the 
liquid is obtained by repeated suction and blowing. The mixture will be dark 
brown and clear after about one minute. 
4. Add water by means of the water pipette and mix with the glass stirrer until the 
colour of the solution matches the colour of the test rods. 
5. Read the result by diffused day-light exactly three minutes after adding the 
blood to the Hydrochloric Acid.   
The Haemometer is equipped with two non-fading glass colour standards.  
WBC COUNT ( Ghai, 2006) 
Principle:  
The blood is diluted with a suitable diluting fluid which destroys the red blood 
corpuscles and stains the nuclei of the white blood cells. The leucocytes are then 
counted in a haemocytometer and their number in undiluted blood calculated  
Apparatus and Reagents 
1. Haemocytometer (counting chamber) 
2. WBC pipette 
3. Turk's fluid 
Procedure.  Place a\counting chamber with its “centred” cover slip near the microscope. 
Draw blood upto\the mark 0.5, followed by Turk‟s fluid to the mark 11. Mix the 
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contents of the bulb for 2 minutes.  Discard the first 2-3 drops of the diluted blood and 
charge the counting chamber, taking the necessary precautions. Place the 'charged' 
haemocytometer on the stage of the microscope and allow the cells to settle for two 
minutes.  Focus the lines and the cells to get a general impression of the distribution of 
cells. Switch to high power and count the cells in the four groups of 16 squares each.  . 
Dilution obtained: The volume of the bulb is 10 (11-1=10). From the tip of the pipette to 
the mark 1 .0, the stem contains only Turk's fluid which does not take part in the 
dilution of blood. Thus 10 volumes of the diluted blood (in the bulb) contain 0.5 volume 
of blood and 9.5 volumes of Turk's fluid, giving a dilution of half in ten or one in 
twenty i.e., 1: 20. The blood is thus diluted 20 times. 
Calculations. The volume of one small square is 1/160 c mm (side= 1/4 mm, area =1/4 x 
1/4= 1/16 sq mm, depth =l/10 mm, volume= l/4 x ¼ x 1/10= 160 cubic millimeters. 
Suppose, number of cells in 64 squares= 192 
Number of cells in one square= 192/64=3 
Volume of one square =1/160c mm (mm3)  
Thus, there are 3 cells in 1/160 c mm of diluted blood. 
The number of ce1ls in 1c mm blood will be 160 x 3 = 480 
As the dilution employed is 1: 20, the number of cells in 1 cubic mm of undiluted 
 Blood is = 480 x 20=9600/ c mm of blood. 
 Result is expressed as: TLC=9600/ cubic mm (mm
3
). 
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4.1 PHYSICAL CHARACTERISTICS AND PERCENTAGE YEILD OF    
      DIFFERENT EXTRACTS 
4.2 RESULTS OF PRELIMINARY PHYTOCHEMICAL SCREENING 
4.3 PHARMACOLOGICAL   STUDIES 
 4.3.1 TOXICITY STUDIES 
4.3.1.1. Results   of Acute oral toxicity studies (72 hours) using: 
a) Portulaca oleracea whole plant 
b) Eriobotrya japonica fruits 
c) Eriobotrya japonica seeds        
4.3.1.2 Results of   Sub-acute toxicity study (14   days) on:  
i) Biochemical estimations  
ii) Histopathology  of  various   organs  using  
a) Portulaca oleracea whole plant 
b) Eriobotrya japonica fruits  
4.3.2 ANTIDIABETIC STUDIES  
4.3.2.1. Results of Alloxan induced diabetes on 
                       Biochemical Estimations using 
a) Portulaca   oleracea whole plant 
b) Eriobotrya  japonica  fruits 
c) Eriobotrya   japonica   seeds 
4.3.2.2. Results of Streptozotocin -induced diabetes on 
i) Biochemical  estimations    
ii) Histopathology  of  various  organs using 
a) Portulaca oleracea whole plant 
b) Eriobotrya japonica fruits 
c) Eriobotrya japonica seeds 
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4.1. PHYSICAL CHARACTERISTICS AND   PERCENTAGE YEILD OF 
DIFFERENT EXTRACTS 
a)Ethanolic   extract   of   Portulaca  oleracea (  whole  plant) 
Weight of the   dried whole plant taken   = 2750  gms 
Weight of the extract obtained                     = 385 gms 
% yield =               Weight of the extract obtained               x        100 
      Weight of the dried whole plant taken  
% age yield of the ethanolic extract        = 14 % 
Extract Colour Odour % Extractive value 
 50% Ethanolic Dark Brown Characteristic 14% 
b)Ethanolic   extract   of   Eriobotrya  japonica  fruits 
Weight of the   dried fruits taken              = 500   gms 
Weight of the extract obtained                    = 150  gms 
% yield =              Weight of the extract obtained                      x           100 
          Weight of the dried fruit taken  
% age yield of the ethanolic extract        =  30 % 
Extract Colour Odour % Extractive value 
 50% Ethanolic Dark Brown Characteristic 30% 
c)Ethanolic  extract  of  Eriobotrya  japonica  seeds 
Weight of the   dried  seeds  taken              = 1000   gms 
Weight of the extract obtained                     =110   gms 
% yield =                Weight of the extract obtained                x               100 
         Weight of the dried Seeds taken  
%  age  yield  of the  ethanolic  extract         =  11% 
Extract Colour Odour % Extractive value 
 50% Ethanolic Dark Brown Characteristic 11 % 
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4.2. RESULTS  OF PRELIMINARY PHYTOCHEMICAL  SCREENING ON 
THE  ETHANOLIC  EXTRACT  OF  PORTULACA  OLERACEA (PO) 
ERIOBOTRYA  JAPONICA  FRUITS (EBJF)  AND  ERIOBOTRYA  
JAPONICA  SEEDS (EBJS)   
Phytochemical  screening  of the  three plant  extracts  showed the  following  results. 
Portulaca  oleracea  showed  the  presence  of tannins, alkaloids, saponins, 
glycosides, terpenes, phenolics, flavonoids, carbohydrates, proteins and  steroids. 
Eriobotrya  japonica  fruits  showed  the presence of alkaloids, glycosides, 
flavonoids and carbohydrates. 
 Eriobotrya  japonica  seeds showed the presence  of  alkaloids, glycosides and  
flavonoids ( Table 13) 
TABLE:13 
                                PRELIMINARY PHYTOCHEMICAL    RESULTS 
S.No Phytoconstituents PO EBJF EBJS 
1 Tannins + _ _ 
2 Alkaloids + + + 
3 Saponins + _ _ 
4 Glycosides + + + 
5 Terpenes + _ _ 
6 Phenolics + _ _ 
7 Flavonoids + + + 
8 Carbohydrates + + _ 
9 Proteins + _ _ 
10 Steroids + _ _ 
4.3. PHARMACOLOGICAL  STUDIES 
50%  ethanolic extract of whole plant of  Portulaca oleracea (PO),   50%  ethanolic 
extract of Eriobotrya japonica fruits  (EBJF) and 50%  ethanolic extract  of 
Eriobotrya  japonica  seeds   (EBJS) evaluated for  acute oral toxicity studies for 72 
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hours and sub-acute   toxicity studies  for 14 days antidiabetic  activity,showed the 
following results    
4.3.1.Toxicity Studies      
4.3.1.1.  Acute  Oral  Toxicity  Tests ( 72 hour  study) 
The 50 %  ethanolic extract  of the  selected  plants  Portulaca oleracea (PO), 
Eriobotrya japonica fruits (EBJF) and Eriobotrya japonica seeds (EBJS) were 
evaluated  for their acute oral toxicity in swiss albino mice. 
In the first experiment, 50% ethanolic extracts of Portulaca oleracea (PO), in the 
second experiment (EBJF)  and  in the third  experiment (EBJS) were studied for its 
acute oral toxicity effects  in swiss albino mice. 
a. Portulaca  oleracea administered  at four dose levels (500, 1000, 1500 and 
2000 mg/kg  b.w)  revealed the following effects during the acute toxicity 
studies conducted in mice for 72  hours. Control  mice which had received  
2% of gum acacia showed normal behaviour (Table 14) 
i) Grooming: After, 48 and 72 hours, no grooming was observed at all the four 
dose levels. 
ii) Hyperactivity: PO extract at the administered dose levels had no effect on the 
activity of mice which remained normal. 
iii) Sedation: After 48 hours, sedation was seen in 50 % of animals at the dose of 
500 mg/kg b.w  while 100 %  of animals  in the dose range of  1000,1500 and  
2000 mg/kg b.w showed sedation ,as the animals remained calm  and 
composed  without  any stress. 
iv) Respiratory arrest: After 48 hours, 50 % of animals in the dose range of   500 
mg/kg b.w and 100% animals in the dose range of 1000, 1500 and 2000 
mg/kg b.w   showed respiratory arrest indicated by raising of head in both 
animals of these groups. 
v) Convulsions : After  48 and 72 hours  50 %  of animals  in the dose range of  
500 mg/kg b.w and 100% animals in the dose range of 1000,1500 and  2000 
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mg/kg b.w showed convulsions as  tremor in the tail and the paddling of the 
feet. 
vi) Motor  Activity: After 48 hours, 50 % of animals  at the dose of 500 mg/kg 
b.w  and. 100 %  of animals  in the dose range of  1000,1500 and  2000 mg/kg 
b.w showed decreased  motor  activity. 
vii) Mortality: 50 %  of animals died at the dose of  500 mg/kg  b.w  after  72  
hours while 100 % of animals  in the dose range  of 1000,1500 and  2000 
mg/kg b.w  died after 24 hours .  
b. Eriobotrya japonica fruits administered at four dose levels (500, 1000, 1500 
and 2000 mg/kg b.w) to mice revealed the following effects during acute 
toxicity studies. (Table 15)  
i) Grooming:  After 48 hours, there was less grooming in the dose level of 
1500 and 2000 mg/kg b.w. 
ii) Hyperactivity: There was no effect   on hyperactivity at all the dose levels. 
iii) Sedation: After 48 hours, 100 %  of animals  in the dose range of  500 and 
1000  mg/kg b.w  did  not  show sedation while 100 % of animals  in the dose 
range  of 1500 and  2000 mg/kg b.w showed sedation as the animals remained 
calm  and composed  without  any stress. After 72 hours, 50% animals  in the 
dose of 1000mg/kg b.w and  100% animals  in the  dose of 1500 and 50% 
animals in the  dose range  of  2000 mg/kg b.w  showed sedation 
iv) Respiratory arrest: After 48 hours, 50 %  of animals  in the dose range of  
2000 mg/kg b.w and  after 72 hours 50% at the dose  of  1000  mg/kg b.w    
showed respiratory arrest while 100 % of animals  in the dose range  of 1500 
and  2000 mg/kg b.w showed respiratory arrest. After 72 hours, 50% animals  
in the dose of 1000mg/kg b.w and  100% animals  in the  dose of 1500 and  
50 % animals  in the  dose  of   2000 mg/kg b.w  showed respiratory  arrest. 
v)  Convulsions: After 48 hours, 50 % of animals in the dose range of 2000 
mg/kg b.w and after 72 hours 50% in the dose range of 1000 mg/kg b.w    
showed convulsions while 100 % of animals in the dose range of 1500 and 
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2000 mg/kg b.w showed convulsions. After 72 hours, 50% animals  in the 
dose of 1000mg/kg b.w and  100% animals  in the  dose of 1500 and 50 % 
animals  in the  dose of  2000 mg/kg b.w  showed  convulsions 
vi) Motor Activity: After 48 hours, 50 %  of animals  in the dose range of  2000 
mg/kg b.w and  after 72 hours 50% in the dose range of  1000  mg/kg b.w    
showed decreased  motor  activity while 100 % of animals  in the dose range  
of 1500 and  2000 mg/kg b.w showed decreased  motor  activity. After 72 
hours, 50% animals  in the dose of 1000mg/kg b.w and  100% animals  in the  
dose of 1500 and  and  50% animals in the  dose of 2000 mg/kg b.w  showed 
decreased  motor  activity. 
vii) Mortality: After 48  hours, 50 % of animals  in the dose range  of 2000 
mg/kg b.w  died  while 50 %  of animals  in the dose range of  1000mg/kg 
b.w  and 100% animals  died  in the  dose range  of  1500 and  2000 mg/kg 
b.w   after 72  hours. 
c. Eriobotrya japonica  seeds  administered  at four dose levels (500,1000,1500 
and 2000 mg/kg  b.w)  to  mice revealed the following effects (Table 16)  
i) Grooming:  Grooming was observed after   48, 72   hours at all the dose 
levels.  
ii) Hyperactivity: No hyperactivity was seen in mice after 48, 72   hours that 
had received different doses.  
iii) Sedation: .There was no effect    on sedation. 
iv) Respiratory arrest: There was no effect   on respiratory arrest. 
v) Convulsions: There was no effect   on convulsions. 
vi) Motor  Activity: After 48  hours, there was increased activity  at all the dose 
levels 
vii) Mortality:  None of the animals died after 72 hours. 
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Table 14: Results of different doses of 50% ethanolic extract of Portulaca oleracea (PO) on different parameters recorded in 
acute oral toxicity studies 
No of 
Mice 
          Treatment  Grooming    
(Hours) 
Hyperactivity 
(Hours)  
Sedation (Hours) Respiratory 
arrest(Hours) 
Convulsions 
(Hours)  
Increased motor 
activity 
(Hours)  
Decreased 
motor activity 
(Hours)  
Death  
48 72 48 72 48 72 48 72 48 72 48 72 48 72 48 72 
1 0.2 ml of 2% aqueous 
gum acacia 
+ + - - - - - - - - - - - - - - 
2 + + - - - - - - - - - - - - - - 
1 PO (500 mg/kg b.w) - - -  - - - - - - - - - - - Dead  
2 - -   + + + + + + - - + + - Dead  
1 PO(1000 mg/kg b.w)     + + + + + + - - + + Dead  Dead  
2     + + + + + + - - + + Dead  Dead  
1 PO(1500mg /kg b.w)     + + + + + + - - + + Dead  Dead  
2     + + + + + + - - + + Dead  Dead  
1 PO(2000 mg/kg b.w)     + + + + + + - - + + Dead  Dead  
2     + + + + 
 
+ + - - + + Dead  Dead  
 
                                              All extracts were given in 2%   gum acacia 
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Table 15: Results of different doses of 50% ethanolic extract of Eriobotrya japonica fruits (EBJF) on different parameters 
recorded in acute oral toxicity studies 
 
No of 
Mice 
Treatment Grooming    
(Hours) 
Hyperactivity 
(Hours)  
Sedation 
(Hours) 
Respiratory 
arrest(Hours) 
Convulsions 
(Hours)  
Increased motor 
activity 
(Hours)  
Decreased 
motor activity 
(Hours)  
Death  
48 72 48 72 48 72 48 72 48 72 48 72 48 72 48 72 
1 0.2 ml of 2% aqueous gum acacia + + - - - - - - - - - - - - - - 
2 + + - - - - - - - - - - - - - - 
1 EBJF (500 mg/kg b.w) + + - - - - - - - - - - - - - - 
2 + + - - - - - - - - - - - - - - 
1 EBJF (1000 mg/kg b.w) + - - - - - - - - - - - - - - - 
2 + - - - - + - + - + - - - + - Dead 
1 EBJF( 1500 mg /kg b.w) - - - - + + - + - + - - - + - Dead 
2 - - - - + + - + - + - - - + - Dead 
1 EBJF (2000 mg/kg b.w) - - - - + + - + - + - - - + - Dead 
2 - - - - + - + - + - - - + - Dead Dead 
 
                                              All extracts were given in 2%   gum acacia 
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Table 16:  Results of different doses of 50% ethanolic extract of Eriobotrya japonica seeds (EBJS) on different parameters 
recorded in acute oral toxicity studies 
       
No of 
Mice 
                  Treatment  Grooming    
(Hours) 
Hyperactivity 
(Hours)  
Sedation 
(Hours) 
Respiratory 
arrest(Hours) 
Convulsions 
(Hours)  
Increased motor 
activity 
(Hours)  
Decreased 
motor activity 
(Hours)  
Death  
48 72 48 72 48 72 48 72 48 72 48 72 48 72 48 72 
1 0.2 ml of 2% aqueous gum acacia + + - - - - - - - - - - - - - - 
2 + + - - - - - - - - - - - - - - 
1 EBJS (500 mg/kg b.w) + + - - - - - - - - + + - - - - 
2 + + - - - - - - - - + + - - - - 
1 EBJS (1000 mg/kg b.w) + + - - - - - - - - + + - - - - 
2 + + - - - - - - - - + + - - - - 
1 EBJS (1500 mg /kg b.w) + + - - - - - - - - + + - - - - 
2 + + - - - - - - - - + + - - - - 
1 EBJS( 2000 mg/kg b.w) + + - - - - - - - - + + - - - - 
2 + + - - - - - - - - + + - - - - 
                                              All extracts were given in 2%   gum acacia 
 
 
 
Chapter 4         Observation And Results 
 
Ph.D Thesis                                  158                                          University of Kashmir 
 
4.3.1.2. Subacute Toxicity Study (14 days) 
50% ethanolic extract of the whole plant of Portulaca oleracea whole plant 
(PO) and Eriobotrya japonica fruits (EBJF) were evaluated for toxicity evaluation in 
swiss albino mice. No subacute toxicity study was done in case of Eriobotrya 
japonica seeds as 8000mg of the seeds have been reported to be non toxic. Mice 
were divided in five groups with six mice in each group. Group I served as Normal 
Control  and received 2 % of  aqueous gum acacia The extracts were administered 
orally at the dose levels of 200mg/kg b.w. (PO) to Group II  and 400 mg/kg b.w (PO)  
administered  to Group III and  250  mg/kg b.w  of  EBJF  administered  to  Group  
IV and  500 mg/kg b.w of EBJF  administered  to  Group V daily for 14 days. All the 
experimental work was carried out in the temperature range of 15-19
o
C and humidity 
range of 70-75%. During this 14 days study, none of the mice died. Mice were fasted 
overnight and biochemical estimations and histopathology was done on 15
th
 day. The 
removed organs were preserved in 10% formalin and sent for histopathological 
studies.  
Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole  plant and  
fruits of  Eriobotrya  japonica (EBJF) on swiss albino mice during subacute 14- 
day toxicity study 
A) Biochemical parameters. In the subacute toxicity, the following parameters   
were estimated. 
i. Serum  Glucose Levels 
ii. Kidney Function Tests 
Serum Urea Levels 
Serum Creatinine Levels 
iii. Liver Function Tests 
Serum Bilirubin Levels 
SGOT Levels 
SGPT Levels 
Serum Total Proteins 
Serum Albumin 
Serum Alkaline Phosphatase 
iv. Blood Function Tests 
Hemoglobin Value 
WBC Count  
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        B )    Histopathology          
I. Liver 
II. Kidney 
III. Spleen 
Serum Glucose Levels Portulaca  oleracea whole plant (PO)  when administered to 
mice of Group II (200mg/kg b.w)  showed a significant reduction (p<0.05) in serum 
glucose levels (60.3±3.99 mg/dl) compared to mice of Group I (91.58±2.76mg/dl) 
which received only vehicle (2% gum acacia). PO when administered to mice of 
Group III (400mg/kg b.w) showed a highly significant decrease (p<0.01) in the 
serum glucose levels (47.18±2.36mg/dl) as compared to mice of group I. 
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV (250mg/kg b.w) 
showed a significant decrease (p<0.05) in serum glucose levels (48.28±1.43 mg/dl) 
compared to mice of group I (91.58±2.76mg/dl). EBJF when administered to mice of 
Group V (500mg/kg b.w) showed a highly significant decrease (p<0.01) in the serum 
glucose levels (25.66±2.08 mg/dl) as compared to mice of group I (Table 17; Fig 8).  
Serum Urea Levels: Portulaca  oleracea whole plant (PO)  when given to mice  of 
Group II (200mg/kg b.w) in 2% gum acacia showed a significant increase (p<0.05) in 
urea levels (21.17±1.02mg/dl) compared to mice of group I (16.74±1.28mg/dl). Mice 
of Group III received 400mg/kg of the ethanolic extract (PO) showed a significant 
rise (p<0.01) in urea levels (22.64±1.44mg/dl) as compared to mice of group I.  
Eriobotrya japonica fruits (EBJF), when administered to mice of Group IV  
(250mg/kg b.w) in 2% gum acacia showed a non significant decrease (p>0.05) in 
urea levels (15.78±1.03mg/dl) compared to mice of group I (16.74±1.28mg/dl). Mice 
of Group V which received 500mg/kg of the ethanolic extract (EBJF) also revealed a 
non-significant increase (p>0.05) in urea levels (16.02±0.76 mg/dl) as compared to 
mice of group I (Table 18; Fig 9).  
 
Serum Creatinine Levels: Portulaca  oleracea whole plant (PO)  when administered to 
mice  of Group II (200mg/kg b.w)  in 2% gum acacia showed a  non significant 
decrease (p>0.05) in creatinine levels (0.52+0.05mg/dl) compared to mice of group I 
(0.83+0.25mg/dl). Mice of Group III which received 400mg/kg of the ethanolic 
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extract (PO) revealed a non significant reduction (p>0.05) in creatinine levels 
(0.65+0.08 mg/dl) as compared to mice of group I.  
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV  (250mg/kg b.w)  
in 2% gum acacia revealed a  highly significant rise (p<0.01) in creatinine levels 
(1.04+0.18mg/dl) compared to mice of  group I (0.83+0.25mg/dl). Mice of Group V 
received 500mg/kg of the ethanolic extract (EBJF) showed a non significant decrease 
(p>0.05) in creatinine levels (0.79+0.17mg/dl) as compared to mice of group I 
(Table 19; Fig 10).  
Serum Bilirubin Levels: Portulaca  oleracea whole plant (PO)  when administered to 
mice of Group II (200mg/kg b.w) in 2% gum acacia showed a non-significant 
(p>0.05) decrease in bilirubin levels (0.52+0.04mg/dl) compared to mice of group I 
(0.58+0.14mg/dl). Mice of Group III which received 400mg/kg of the ethanolic 
extract (PO) revealed a non-significant decrease (p>0.05) in bilirubin levels 
(0.42+0.06mg/dl) as compared to mice of group I.  
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV  (250mg/kg b.w) 
in 2% gum acacia revealed a non-significant (p>0.05) levels in bilirubin levels 
(0.58+0.05mg/dl) compared to mice of group I (0.58+0.14mg/dl). Mice of Group V 
received 500mg/kg of the ethanolic extract (EBJF) showed a non-significant decrease 
(p>0.05) in bilirubin levels (0.36+0.03mg/dl) as compared to mice of group I. (Table 
20; Fig 11). 
SGOT Levels : Portulaca  oleracea whole plant (PO)  when administered to mice  of 
Group II (200mg/kg b.w) in 2% gum acacia showed a non-significant reduction in 
SGOT levels (p>0.05) (57.88+2.60 IU/L) compared to mice  of group I (60.03±1.43 
IU/L). Mice of Group III which received 400mg/kg of the ethanolic extract (PO) 
revealed a significant decrease (p<0.05) in SGOT levels (52.67±2.15 IU/L) as 
compared to mice of group I.  
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV  (250mg/kg b.w) 
in 2% gum acacia showed a  non significant levels in SGOT levels (p>0.05) 
(60.91+3.17 IU/L) compared to mice of group I (60.03±1.43 IU/L). Mice of Group V 
received 500mg/kg of the ethanolic extract (EBJF) revealed a significant reduction 
(p<0.05) in SGOT levels (52.67±2.15 IU/L) as compared to mice of group I (Table 
21; Fig 12). 
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SGPT Levels: Portulaca  oleracea whole plant (PO)  when administered to mice  of 
Group II (200mg/kg b.w) in 2% gum acacia  showed a  significant decrease 
(30.78+2.16 IU/L) (p<0.05) compared to mice of group I (46.24+5.03 IU/L). Mice of  
Group III which received 400mg/kg (PO) showed a   highly significant decrease 
(20.47+1.69 IU/L) (p<0.01) as compared to mice of group I.   
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV  (250mg/kg b.w) 
in 2% gum acacia showed a non significant decrease (45.38 ±3.82 IU/L) (p>0.05) 
compared to mice of group I (46.24+5.03 IU/L). Mice of Group V received 
500mg/kg (EBJF) revealed a significant decrease (26.54±2.11 IU/L) (p<0.05) as 
compared to mice of group I. (Table 22; Fig 13). 
Serum Total Proteins: Portulaca  oleracea whole plant (PO)  when administered to 
mice  of Group II (200mg/kg b.w) in 2% gum acacia showed a non-significant 
change (6.49+0.45 g/dl) (p>0.05) as compared to mice of  group I (6.81+0.08 g/dl). 
Mice of Group III which were treated with 400mg/kg (PO) showed a non-significant 
increase (6.93+0.31 g/dl) (p>0.05) as compared to mice of group I.  
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV   (250mg/kg  
b.w) in 2%  gum acacia showed a non-significant change (6.85+0.18 g/dl) (p>0.05) 
as compared to mice of group I (6.81+0.08). Mice of Group V which were treated 
with 500mg/kg (EBJF) showed a non-significant change (6.97+0.22 g/dl) (p>0.05) as 
compared to mice of group I (Table 23; Fig 14). 
Serum Albumin Levels: Portulaca  oleracea whole plant (PO)  when administered to 
mice of Group II (200mg/kg b.w) in  2% gum  acacia showed a non-significant 
change (3.64+0.34 g/dl) (p>0.05) as compared to mice of group I ( 3.45±0.26 g/dl). 
Mice of Group III which were treated with 400mg/kg (PO) also showed a non-
significant rise (4.00+0.27 g/dl) (p>0.05) as compared to mice of group I.  
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV (250mg/kg b.w) 
in 2% gum acacia revealed a non-significant change (3.61+0.33 g/dl) (p>0.05) as 
compared to mice of group I. Mice of Group V which were treated with 500mg/kg 
(EBJF)also showed a non-significant rise (3.74+0.21 g/dl) (p>0.05) as compared to 
mice of group I. (Table 24; Fig 15). 
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Serum Alkaline Phosphatase: Portulaca  oleracea whole plant (PO)  when administered 
to mice of Group II (200mg/kg b.w)in 2% gum acacia showed a non-significant 
decrease (70.38+5.48 U/L) (p>0.05) as compared to  mice of group I (72.16±4.53 
U/L). Mice of Group III treated with 400mg/kg (PO) also revealed a highly 
significant reduction (60.47±8.37 U/L)(p<0.01).  
 Eriobotrya japonica fruits (EBJF), when given to mice of Group IV  (250mg/kg 
b.w) in 2% gum acacia showed a significant change (82.86±7.40 U/L) (p<0.05) as 
compared to  mice of group I (72.16±4.53). Mice of Group V treated with 500mg/kg 
(EBJF) also showed a highly significant reduction (60.47±8.37 U/L) (p<0.01) as 
compared to mice of group I (Table 25; Fig 16).  
Hemoglobin Value: Portulaca  oleracea whole plant (PO)  when administered to mice   of 
Group II (200mg/kg b.w) in 2% gum acacia revealed a non-significant change in 
hemoglobin value (7.36+0.23 g/dl) (p>0.05) as compared to mice of group I 
(7.40+0.21 g/dl). Mice of Group III which received 400mg/kg (PO) also showed a 
non-significant change (7.53+0.32 g/dl) as compared to mice of group I.    
Eriobotrya japonica fruits (EBJF), when given to mice of Group IV  (250mg/kg b.w)  
in 2% gum acacia showed a non-significant rise in hemoglobin value (8.03+0.32 
g/dl) (p>0.05) as compared to mice of  group I (7.40+0.21 g/dl). Mice of Group V 
received 500mg/kg (EBJF) also revealed a non-significant change (8.16+0.22 g/dl as 
compared  to mice of group I. (Table 26; Fig 17).  
WBC Count: Portulaca  oleracea whole plant (PO)  when administered to mice  of Group 
II (200mg/kg b.w) in 2% gum acacia showed a significant decrease in WBC count 
(1866.66+251.21/cubic mm) (p<0.05) as compared to mice of group I 
(1900+355.9/cubic mm). Mice of Group III which received 400mg/kg (PO) also 
showed a highly significant decrease (1500+61.72/cubic mm) (p<0.01) as compared 
to mice of group I.  Eriobotrya japonica fruits (EBJF), when given to mice of Group 
IV  (250mg/kg b.w)in 2%  gum acacia showed a significant decrease in WBC count 
(1700±85.63) /cubic mm)  (p<0.05) as compared to mice of group I 
(1900+355.9/cubic mm). Mice of Group V which received 500mg/kg (EBJF) also 
revealed a highly significant decrease (1566.66±140.63/cubic mm) as compared to 
mice of group I (Table 27; Fig 18). 
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Table 17: Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant and Eriobotrya japonica                                                        
fruit (EBJF) on Serum Glucose Levels (mg/dl) in swiss albino mice (Subacute toxicity  study 14 
days)   
Serum Glucose    Levels ( mg/dl) 
Mice 
Group I 
Normal control 
(0.2 ml of 2%   
gum  acacia) 
Group II 
PO 
(200mg /kg ) 
Group III 
PO 
(400mg/kg) 
Group IV 
EBJF 
(250mg/kg) 
Group V 
EBJF 
(500mg/kg) 
1 89.13 66.05 44.62 54.23 22.14 
2 99.42 50.45 52.06 45.27 18.52 
3 98.45 45.32 56.45 50.61 24.05 
4 85.24 67.63 43.52 47.45 27.01 
5 83.67 67.06 45.06 47.01 32.14 
6 95.21 65.32 41.42 45.16 30.15 
Mean 91.58 60.3* 47.18** 48.28* 25.66** 
SD 6.78 9.78 5.78 3.51 5.09 
SEM 2.76 3.99 2.36 1.43 2.08 
P-Value  p < 0.05 p < 0.01 p < 0.05 p < 0.01 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs  I 
PO = 50% ethanolic extract of Portulaca oleracea whole plant  
EBJF= 50% ethanolic extract of Eriobotrya   japonica fruits.  
All extracts were administered orally in 2% gum acacia, daily for 14 days. 
 n=6 (Number of animals in each group) 
   ** p< 0.01   Highly significant  ,*p<0.05 Significant  
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 8: Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant   and  
Eriobotrya japonica fruit (EBJF) on Serum Glucose Levels (mg/dl) in swiss 
albino mice. 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 18: Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant and Eriobotrya japonica 
fruit (EBJF) on Serum Urea Levels (mg/dl)  in swiss albino mice  (Subacute toxicity  study 14 
days)  
Serum  Urea   Levels   (mg/dl) 
Mice 
Group I 
Normal 
control (0.2 ml 
of 2%    gum  
acacia 
Group II 
PO 
(200mg /kg) 
Group III 
PO 
(400mg/kg) 
Group IV 
EBJF 
(250mg/kg) 
Group V 
18.42 
1 12.06 21.06 18.42 15.05 18.42 
2 16.34 23.54 23.09 17.23 15.32 
3 17.53 18.73 27.34 19.56 16.51 
4 19.34 17.72 19.63 16.34 13.21 
5 20.64 22.23 26.07 14.31 17.56 
6 14.53 23.74 21.34 12.23 15.14 
Mean 16.74 21.17* 22.64** 15.78 16.02 
SD 3.14 2.49 3.53 2.59 1.87 
SEM 1.28 1.02 1.44 1.03 0.76 
P-Value  p < 0.05 p < 0.01 p > 0.05 p > 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs  I 
PO =  50% ethanolic  extract  of Portulaca oleracea whole plant  
EBJF=50% ethanolic extract of Eriobotrya   japonica  fruits.  
All extracts were  administered orally in 2% gum acacia, daily for  14  days. 
 n=6 ( Number  of   animals  in each  group) 
  *p<0.05 Significant; **p< 0.01 highly  significant; ; p>0.05 non significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 9:  Effect of 50% ethanolic extract of  Portulaca oleracea  (PO) whole plant  and  
Eriobotrya japonica fruit (EBJF) on Serum Urea Levels (mg/dl)  in swiss albino 
mice. 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 19: Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant and  Eriobotrya japonica 
fruit ( EBJF) on Serum Creatinine Levels (mg/dl)  in swiss albino mice  (Subacute toxicity  
study14 days) 
Serum  Creatinine   Levels  (mg/dl) 
Mice 
Group I 
Normal 
control (0.2 
ml of 2%    
gum  acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 1.91 0.67 0.81 1.12 0.84 
2 0.31 0.53 0.35 0.61 0.53 
3 0.52 0.43 0.44 1.12 0.32 
4 0.33 0.49 0.76 1.36 0.81 
5 0.71 0.32 0.84 0.42 1.55 
6 1.23 0.68 0.72 1.64 0.73 
Mean 0.83 0.52 0.65 1.04** 0.79 
SD 0.62 0.13 0.2 0.45 0.41 
SEM 0.25 0.05 0.08 0.18 0.17 
P-Value  p > 0.05 p > 0.05 p < 0.01 p > 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs  I 
 
PO = 50% ethanolic extract of Portulaca oleracea whole plant  
EBJF= 50% ethanolic extract of Eriobotrya   japonica fruits.  
All extracts were administered orally in 2% gum acacia, daily for 14  days.  
n=6 (Number of animals in each group) 
   **p< 0.01 highly significant;  p>0.05 non-significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 10: Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant and  Eriobotrya 
japonica fruit(EBJF) on Serum Creatinine Levels (mg/dl)  in swiss albino mice. 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 20: Effect of 50% ethanolic extract of  Portulaca oleracea( PO) whole plant  and  
Eriobotrya japonica fruit on Serum Bilirubin Levels (mg/dl)  in swiss albino mice 
(Subacute  toxicity  study 14 days) 
Serum  Bilirubin  Levels (mg/dl) 
Mice 
Group I 
Normal 
control (0.2 
ml of 2%  )  
gum  acacia 
Group II 
PO 
(200mg /kg ) 
Group III 
PO 
(400mg/kg ) 
Group IV 
EBJF 
(250mg/kg) 
Group V 
EBJF 
(500mg/kg) 
1 0.93 0.64 0.37 0.72 0.47 
2 0.27 0.51 0.26 0.56 0.28 
3 0.31 0.49 0.25 0.73 0.36 
4 0.23 0.45 0.49 0.39 0.24 
5 0.79 0.36 0.51 0.52 0.37 
6 0.95 0.64 0.67 0.61 0.46 
Mean 0.58 0.52 0.42 0.58 0.36* 
SD 0.34 0.11 0.16 0.12 0.09 
SEM 0.14 0.04 0.06 0.05 0.03 
P-Value  p > 0.05 p > 0.05 p > 0.05 p < 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs  I 
PO =  50% ethanolic  extract  of Portulaca oleracea  whole plant 
EBJF= 50% ethanolic extract of Eriobotrya   japonica  fruits. 
 All extracts were  administered orally in 2% gum acacia, daily for  14  days.  
n=6 (Number  of  animals  in each  group) 
  *p<0.05 Significant;  p>0.05 non significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 11:  Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant and  Eriobotrya 
japonica (EBJF)fruit on Serum Bilirubin Levels (mg/dl)  in swiss albino mice. 
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 21: Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant  and  
Eriobotrya japonica fruit( EBJF) on SGOT  levels  (IU/L)  in swiss albino mice 
(Subacute toxicity  study 14 days) 
SGOT  levels (IU/L) 
Mice 
Group I 
Normal 
control (0.2 ml 
of 2%  
aqueous  gum  
acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 62.32 51.07 45.08 64.03 45.08 
2 56.05 54.84 55.78 56.34 55.78 
3 65.32 52.45 60.45 48.56 60.45 
4 58.46 67.42 53.32 69.05 53.32 
5 61.06 63.07 49.38 59.43 49.38 
6 57.02 58.45 52.05 68.07 52.05 
Mean 60.03 57.88 52.67* 60.91 52.67* 
SD 3.51 6.37 5.28 7.78 5.28 
SEM 1.43 2.6 2.15 3.17 2.15 
P-Value  p > 0.05 p < 0.05 p > 0.05 p < 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs I 
PO =  50% ethanolic  extract  of Portulaca oleracea whole plant  
EBJF= 50% ethanolic extract of Eriobotrya   japonica  fruits. 
 All extracts were  administered orally in 2% gum acacia, daily for  14  days.  
n=6 Number  of  animals  in each  group) 
  *p<0.05 Significant;  p>0.05 non significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 12:  Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant  and  
Eriobotrya japonica fruit (EBJF) on SGOT  Levels  (IU/L)  in swiss albino mice  
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 22: Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant and  Eriobotrya 
japonica fruit(EBJF) on SGPT  levels (IU/L) in swiss albino mice  (Subacute  toxicity  
study 14 days) 
SGPT  Levels IU/L 
Mice 
Group I 
Normal 
control (0.2 ml 
of 2%  
aqueous  gum  
acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 57.45 22.06 17.06 47.08 33.45 
2 47.07 28.45 16.56 33.09 25.67 
3 44.32 36.56 16.45 57.56 31.35 
4 49.21 34.35 24.32 44.06 24.32 
5 23.34 29.23 23.67 53.46 19.05 
6 56.05 34.06 24.76 37.07 25.42 
Mean 46.24 30.78* 20.47** 45.38 26.54* 
SD 12.32 5.3 4.16 9.36 5.17 
SEM 5.03 2.16 1.69 3.82 2.11 
P-Value  p < 0.05 p < 0.01 p > 0.05 p < 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs I 
PO = 50% ethanolic extract of Portulaca oleracea (Whole plant . 
EBJF= 50% ethanolic extract of Eriobotrya   japonica fruits.  
All extracts were administered orally in 2% gum acacia, daily for 14 days.  
n=6 (Number of animals in each group) 
  *p<0.05 Significant; **p< 0.01 highly significant; ; p>0.05 non-significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 13:  Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant and 
Eriobotrya japonica fruit (EBJF) on SGPT  Levels (IU/L) in swiss albino mice. 
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 23: Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant and  Eriobotrya 
japonica fruit (EBJF)  on Serum Total Proteins  levels  (g/dl) in swiss albino mice  
(Subacute toxicity  study 14 days) 
Serum  total Proteins levels 
Mice 
Group I 
Normal 
control (0.2 
ml of 2%  
aqueous  gum  
acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 6.73 6.48 8.16 6.45 6.82 
2 6.61 7.45 7.67 7.48 6.42 
3 6.73 7.13 6.52 6.92 6.28 
4 7.06 5.92 6.38 6.44 7.24 
5 7.12 4.56 6.35 6.53 7.62 
6 6.64 7.42 6.51 7.32 7.44 
Mean 6.81 6.49 6.93 6.85 6.97 
SD 0.21 1.11 0.78 0.45 0.55 
SEM 0.08 0.45 0.31 0.18 0.22 
P-Value  p > 0.05 p > 0.05 p > 0.05 p > 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs  I V Vs I 
PO = 50% ethanolic extract of Portulaca oleracea whole plant  
EBJF= 50% ethanolic extract of Eriobotrya   japonica fruits.  
All extracts were administered orally in 2% gum acacia, daily for  14  days. 
 n=6 ( N umber  of   animals  in each  group) 
   p>0.05 non significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 14:  Effect of 50% ethanolic extract of different doses of Portulaca oleracea (PO) whole 
plant  and  Eriobotrya japonica fruit on Serum Total Proteins  levels  (g/dl) in swiss 
albino mice. 
(200mg/kg, b.w, in 2% gum 
acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 24: Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant and  Eriobotrya 
japonica fruit (EBJF) on Serum Albumin Levels (g/dl)  in swiss albino mice  (Subacute 
toxicity  study  14 days) 
Serum Albumin Level (g/dl) 
Mice 
Group I 
Normal 
control (0.2 
ml of 2%  
aqueous  gum  
acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group VI 
EBJF 
500mg/kg 
1 3.52 2.56 3.15 3.43 3.92 
2 3.23 4.32 3.87 3.04 2.83 
3 3.07 4.68 4.63 4.32 3.62 
4 2.54 3.36 4.92 2.63 4.25 
5 4.03 2.91 3.43 3.45 3.64 
6 4.34 4.05 4.05 4.83 4.23 
Mean 3.45 3.64 4.00 3.61 3.74 
SD 0.65 0.83 0.67 0.81 0.52 
SEM 0.26 0.34 0.27 0.33 0.21 
P-Value  p > 0.05 p > 0.05 p > 0.05 p > 0.05 
Statistically  
Compared 
Groups 
 II Vs I III  Vs I IV Vs I V Vs  I 
PO =  50% ethanolic  extract  of Portulaca oleracea whole plant  
EBJF= 50% ethanolic extract of Eriobotrya   japonica  fruits.  
All extracts were  administered orally in 2% gum acacia, daily for  14  days. 
 n=6 (  Number   of   animals  in each  group) 
   p>0.05 non significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 15:  Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant  and  Eriobotrya 
japonica fruit (EBJF) on Serum Albumin Levels (g/dl)  in swiss albino mice. 
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 25:  Effect of 50% ethanolic extract  of Portulaca oleracea  (PO) whole plant  and  Eriobotrya 
japonica fruit (EBJF) on Serum Alkaline Phosphatase Levels (U/L)  in swiss albino mice  
(Subacute  toxicity  study 14 days) 
Serum Alkaline Phosphatase  Levels U/l 
Mice 
Group I 
Normal 
control (0.2 
ml of 2%  
aqueous  gum  
acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 78.56 54.07 30.45 86.34 30.45 
2 67.32 86.34 45.05 98.23 45.05 
3 78.37 73.62 55.02 87.62 55.02 
4 65.06 65.78 72.23 78.03 72.23 
5 87.07 84.42 84.07 97.72 84.07 
6 56.62 58.06 76.04 49.23 76.04 
Mean 72.16 70.38 60.47** 82.86* 60.47** 
SD 11.11 13.42 20.52 18.14 20.52 
SEM 4.53 5.48 8.37 7.4 8.37 
P-Value  p > 0.05 p < 0.01 p < 0.05 p < 0.01 
Statistically  
Compared 
Groups 
 II  Vs I III Vs I IV Vs  I V Vs  I 
PO =   50% ethanolic  extract  of Portulaca oleracea  whole plant. 
EBJF=  50% ethanolic extract of Eriobotrya   japonica  fruits. 
 All extracts were administered orally in 2% gum acacia, daily for  14  days. 
 n=6 (Number   of  animals  in each  group) 
  *p<0.05 Significant; **p< 0.01 highly significant;  p>0.05 non-significant 
 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 16: Effect of 50% ethanolic extract of  Portulaca oleracea  (PO) whole plant  and  Eriobotrya 
japonica fruit (EBJF) on Serum Alkaline Phosphatase Levels (U/L)  in swiss albino mice.  
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table 26: Effect of 50% ethanolic extract of Portulaca oleracea (PO) whole plant   and Eriobotrya 
japonica fruit (EBJF) on Hemoglobin Value Levels (g/dl) in swiss albino mice  
(Subacute toxicity  study 14 days  ) 
Hemoglobin value (g/dl) 
Mice 
Group I 
Normal control 
(0.2 ml of 2%  
aqueous  gum  
acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 6.8 7.5 8.4 8.6 7.8 
2 7.3 7.2 7.4 7.5 8.9 
3 8.1 6.9 6.5 6.8 7.8 
4 7.9 7.4 8.5 7.9 8.4 
5 7.4 8.4 7.5 8.9 8.6 
6 6.9 6.8 6.9 8.5 7.5 
Mean 7.40 7.36 7.53 8.03 8.16 
SD 0.52 0.57 0.79 0.78 0.54 
SEM 0.21 0.23 0.32 0.32 0.22 
P-Value  p > 0.05 p > 0.05 p >0.05 p > 0.05 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs  I V Vs I 
PO = 50% ethanolic extract of Portulaca Oleracea  whole plant 
EBJF= 50% ethanolic extract of Eriobotrya   japonica fruits. 
 All extracts were administered orally in 2% gum acacia, daily for 14 days. 
 n=6 (Number of   animals in each group) 
   p>0.05 non significant 
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 17: Effect of 50% ethanolic extract of  Portulaca oleracea (P.O) whole plant  and  Eriobotrya 
japonica fruit (EBJF) on Hemoglobin Value  Levels ( g/dl) in swiss albino mice. 
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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Table27: Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant and  Eriobotrya 
japonica fruit (EBJF) on Total WBC Count /cubic mm  in swiss albino mice  (Subacute 
toxicity  study 14 days) 
WBC Count (thousand / Cubic mm) 
Mice 
Group I 
Normal control (0.2 
ml of 2%  aqueous  
gum  acacia) 
Group II 
PO 
200mg /kg 
Group III 
PO 
400mg/kg 
Group IV 
EBJF 
250mg/kg 
Group V 
EBJF 
500mg/kg 
1 3000 2000 1400 1700 1300 
2 1000 3000 1700 1900 1500 
3 1500 1200 1600 1300 1300 
4 3000 1600 1500 1800 1400 
5 1400 1800 1200 1800 2200 
6 1500 1600 1600 1700 1700 
Mean 1900 1866.66* 1500** 1700* 1566.66** 
SD 871.77 615.35 163.29 209.76 344.48 
SEM 355.9 251.21 61.72 85.63 140.63 
P-Value  p < 0.05 p < 0.01 p < 0.05 p < 0.01 
Statistically  
Compared 
Groups 
 II Vs I III Vs I IV Vs I V Vs  I 
PO = 50% ethanolic  extract  of Portulaca oleracea whole plant  
EBJF= 50% ethanolic extract of Eriobotrya   japonica fruits. 
 All extracts were administered orally in 2% gum acacia, daily for 14 days.  
n=6 (Number of animals in each group) 
  *p<0.05 Significant; **p< 0.01 highly significant  
Results of Sub-acute Toxicity Study (14 days) 
 
All extracts were administrated orally in 2% gum acacia daily for 14 days 
Fig 18: Effect of 50% ethanolic extract of  Portulaca oleracea (PO) whole plant  and  
Eriobotrya japonica fruit (EBJF) on Total WBC Count /cubic mm  in swiss 
albino mice. 
(200mg/kg, b.w, in 2% gum acacia) 
Group I- Control (2% gum acacia) 
Group II- PO (200mg/kg, b.w,) 
Group III- PO (400mg/kg, b.w,) 
Group IV- EBJF (250mg/kg, b.w,) 
Group V- EBJF (500mg/kg, b.w,) 
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B. Histopathology  
Effect of 50 % Ethanolic extract of Portulaca oleracea (PO) whole plant, 
Eriobotrya japonica fruits (EBJF) on histopathology of different organs in 
subacute toxicity studies  (14 days) are: 
Liver:  Histopathological examination of the liver slides of mice of Group I (Normal 
control) showed the portal triad area with no abnormality (Fig 19). 
Portulaca oleracea (PO)  whole plant  when  administered  at two  dose levels (200 
& 400mg/kg)  to  mice of  Group II & Group III respectively  showed   normal portal 
triad  with no abnormality in  liver  ( Fig 20a & Fig 20b). Eriobotrya Japonica fruit 
when  given  at two  dose levels (250 & 500mg/kg)  to mice of Group IV & Group  V  
respectively revealed  the portal area with no abnormality  (Fig  21a & Fig  21b). 
Spleen: Spleen  of  mice of Group I (Normal control) showed the normal  spleen  
with red and white pulp areas in the splenic parenchyma (Fig 22). 
Portulaca oleracea  (PO) whole plant  when  given  at two  dose levels (200 & 
400mg/kg b.w)  to  mice of  Group II & Group III respectively showed the normal 
red and white pulp areas in the splenic parenchyma (Fig   23a & Fig  23b). Extract of 
Eriobotrya Japonica fruit when given at two dose levels (250 & 500mg/kg b.w) to 
mice of Group IV & Group V respectively also revealed the normal spleen (Fig 24a 
& Fig 24b). 
Kidney: Histopathological examination of the kidney in mice of Group 1 (Normal 
control) showed the glomerulus is of normal size and cellularity and the tubules are 
within normal limits (Fig 25). Portulaca oleracea  whole plant  (PO) when  given  at 
two  dose levels (200 & 400mg/kg b.w)  to  mice of  Group II & Group III 
respectively showed that the glomerulus is of normal size and cellularity and tubules 
are within normal limits (Fig  26a &  Fig  26b). 
Eriobotrya Japonica fruit when  given  at two  dose levels (250 & 500mg/kg b.w)  to 
mice of Group IV & Group  V respectively also revealed that the  kidneys  do not 
show any abnormality (Fig  27a &  Fig  27b). 
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HISTOPATHOLOGY OF LIVER IN MICE 
SUBACUTE TOXICITY STUDY  
(14- DAYS) 
 
 
 
 
 
 
 
 
 
 
                             Fig 19: Group –I –Normal Control  
                                           Liver of mice showing normal portal triad area. No abnormality seen.   
                                                                      ( H & E x 40X) 
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HISTOPATHOLOGY OF LIVER IN MICE 
SUBACUTE TOXICITY STUDY  
(14- DAYS) 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 20a: Group II: Portulaca oleracea whole plant (200mg/kg b.w) 
Liver of mice showing normal portal area (H&E x 40X).                                   
 PV= Portal Vein, BD = Bile Duct 
                                  
 
Fig 20b:  Group III :Portulica oleracea  whole plant (400 mg/kg) b.w) 
Liver of mice showing the  normal portal area. (H&E x 40X)  
PV = Portal Vein, BD= Bile Duct. 
                                      
 
Fig 21a: Group IV –Eriobotrya japonica fruit (250mg/kg b.w)  
Liver of mice showing the portal area. No. abnormality 
seen. (H&E x 40X) 
HA = Hepatic Artery, BD= Bile Duct. 
 
Fig 21b: Group V : Eriobotrya japonica fruit  (500 mg/ kg b.w)  
Liver  of mice showing a large bile duct from portal area. 
No. abnormality seen (H&E x 40X) 
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HISTOPATHOLOGY OF SPLEEN IN MICE 
SUBACUTE TOXICITY STUDY  
(14- DAYS) 
 
 
 
 
 
 
 
 
 
Fig 22: Group I –Normal Control  
Spleen of mice showing normal red and white pulp areas in the 
splenic parenchyma. (H&E x 40X) 
WP= White Pulp, RP= Red Pulp.              
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HISTOPATHOLOGY OF SPLEEN IN MICE 
SUBACUTE TOXICITY STUDY  
(14- DAYS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
  
 
 
 
 
 
 
Fig 23a8:Group –II Portulaca oleracea whole plant (200 mg/ kg b.w) 
Spleen of mice showing the normal red and white pulp areas in 
the splenic parenchyma. (H&E x 40X) 
WP=White Pulp, RP=Red Pulp. 
                                  
  
 
Fig  23b:Group –III –Portulaca oleracea  whole plant (400mg/kg b.w) 
Spleen of mice showing the normal red and white pulp areas  in 
the splenic parenchyma. (H&E x 40X)  
WP= White Pulp, RP= Red Pulp 
                                   
 
 
Fig 24a: Group IV Eriobotrya japonica fruit (250 mg/kg b.w) 
Spleen of mice showing the normal red and white pulp areas in 
the splenic parenchyma. (H&E x 40X) 
WP=White Pulp, RP = Red Pulp 
                        
 
 
Fig 24b: Group V Eriobotrya japonica fruit (500mg/kg b.w) 
Spleen of mice showing the normal red and white pulp areas in 
the splenic parenchyma(H&E x 40X) 
WP=White Pulp RP=Red Pulp 
                            
.    
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HISTOPATHOLOGY OF KIDNEY  IN MICE 
SUBACUTE TOXICITY STUDY  
(14- DAYS) 
 
 
 
 
 
 
 
 
 
 
 
Fig  25: Group I- Normal Control  
Kidney of mice showing renal parenchyma.  Glomerulus of normal 
size and cellularity. Tubules  are within normal limits (H&E x 40X)  
G = Glomerulus, T= Tubules 
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HISTOPATHOLOGY OF KIDNEY IN MICE 
SUBACUTE TOXICITY STUDY  
(14- DAYS) 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig 26a:Group II  Portulaca oleracea whole plant (200mg/kg ) 
Kidney  of mice showing  renal parenchyma. The 
Glomerulus is of normal size and cellularity. Tubules  are 
within normal limits. (H&E x 40X)    
G = Glomerulus    T= Tubules 
                                      
 
 
Fig 26b:Group III Portulaca oleracea wholeplant(400mg/kg.w) 
Kidney  of mice showing  renal parenchyma. Glomerulus  
of normal size and cellularity. Tubules within normal 
limits. (H&E x 40X)  
G = Glomerulus    T= Tubules 
                                     
 
Fig 27a:Group IV Eriobotrya japonica fruit (250 mg/kg b.w) 
Kidney of mice showing renal parenchyma.  Glomerulus 
of normal size and cellularity. Tubules within normal 
limits. (H&E x 40X) 
G = Glomerulus    T= Tubules 
                            
Fig 27b:Group V  Eriobotrya japonica fruit (500mg/kg b.w) 
Kidney of mice showing renal parenchyma. Glomerulus 
of normal size and cellularity. Tubules within normal 
limits. (H&E x 40X)  
G = Glomerulus    T= Tubules 
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4.3.2   ANTIDIABETIC   STUDIES 
Antidiabetic studies using alloxan and streptozotocin as diabetic models 
revealed the following results 
4.3.2.1.  Alloxan (10  days  study) Effect of different doses of 50% ethanolic extract 
of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya   japonica seeds (EBJS),  against alloxan induced diabetes mellitus in rats   
was  studied  on the  following  parameters :- 
i. Serum Glucose Levels (Recorded on day 1,day 4,day 7 and day10)  
ii. Lipid  Profile 
a. Serum Total  Cholesterol  Levels        
b. Serum Triglycerides  Levels             
c. Serum HDL Cholesterol  Levels           
d. Serum LDL  Cholesterol   Levels        
iii.  Kidney  Function Tests 
a. Serum Urea   Levels           
b. Serum Creatinine  Levels                  
c. Serum Total  Protein  Levels              
   iv        Body  Weight  (Recorded on day 1,day 4,day 7 and day10).          
                 STATISTICAL ANALYSIS 
The data obtained from the different   biochemical estimations is expressed as Mean 
± SEM for each group. After this, the statistical analysis was carried out using one 
way analysis of variance (ANOVA) followed by student’s t-test. Values p> 0.05 
were considered non-significant; p< 0.05 as significant, p<0.01 highly significant and 
p<0.001 very highly significant respectively. 
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Serum Glucose Levels (mg/dl) 
There  was   very highly significant (p<0.001)  rise in serum glucose levels in rats  in 
the  diabetic  group (Group II) (271.02±8.18) as  compared to  levels in normal 
control group  (Group I) (84.71± 6.11 mg/dl). Portulaca oleracea extract (100 and 
200 mg/kg b.w) showed a decrease in the serum glucose levels. At the dose of 
100mg/kg, administered to Group IV, the decrease was highly significant (p<0.01)  
(142.82±2.76 mg/dl) while the  dose of 200mg/kg administered  to Group V showed 
a  very highly significant decrease(p<0.001) (111.58±2.69 mg/dl) in the serum 
glucose levels. 
.Eriobotrya japonica fruits at the dose  of 50 mg/kg administered to rats of Group VI 
showed a  highly significant decrease (p<0.01) (157.04±3.09 mg/dl), while 100 
mg/kg administered to Group VII showed a very highly significant decrease 
(p<0.001)  (128.64±1.61 mg/dl) and at 200 mg/kg b.w  administered to rats of Group 
VIII  also showed a very highly significant   decrease (p<0.001) in serum glucose 
levels in a dose dependent   manner (82.82±5.53 mg/dl) as compared  to the group II  
that had received only alloxan monohydrate (271.02±8.18mg/dl )(p<0.001).  The 
levels of serum glucose levels in case of rats administered EBJF at the dose of 
200mg/kg b.w were found to be similar to the levels of normal control rats.  
The seeds of Eriobotrya japonica at the dose of 100 mg/kg administered to rats of 
Group IX showed a highly significant decrease (p<0.01) of (155.54±2.54 mg/dl) 
while the dose of 200 mg/kg b.w administered to rats of Group X also showed a very 
highly significant   decrease (p<0.001) (120.74±6.13 mg/dl) in serum glucose   
levels. The standard anti-diabetic drug, glibenclamide administered to rats of Group 
III also revealed a very highly significant decrease (p<0.001) in the serum glucose   
levels (114.84±3.20 mg/dl) (Table 28; Fig 28)  
Serum Total Cholesterol levels (mg/ dl) 
As  compared  to  group I (85.25±8.51 mg/dl) the  levels  in the  group II   rats which  
had received  only  alloxan  monohydrate, there was very  highly  significant  
increase (p<0.001) in the total cholesterol levels (218.15±23.79 mg/dl). 50% 
ethanolic  extract of Portulaca  oleracea (100 mg/kg b.w)    administered  to rats of 
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Group IV    showed   a  highly  significant  decrease (p<0.01)  (196.80±25.95 mg/dl) 
while  dose  of  200 mg/kg b.w administered to rats of Group  V  revealed  a   very 
highly  significant  decrease  (p<0.001) in the  total cholesterol levels (101.85±19.17 
mg/dl). 
Eriobotrya japonica fruits at the dose  of 50mg/kg administered to rats of Group  VI  
showed a  highly significant decrease (p< 0.01) of (159.40± 13.65 mg/dl), a dose of 
100mg/kg administered to rats of Group  VII  showed a  very highly significant 
decrease(p<0.001) (133.17±19.41 mg/dl) while a dose of 200 mg/kg administered to 
rats of Group  VIII  also showed a  very highly significant decrease(p<0.001) 
(98.15±4.78 mg/dl)  in total cholesterol levels in a dose dependent   manner, as 
compared  to the group II  that had received only alloxan monohydrate.  The levels of 
EBJF at the dose of   100 mg/kg and 200mg/kg b.w were found   to be very highly 
significant.  
The seeds of Eriobotrya  japonica  at the dose  of 100mg/kg b.w administered to rats 
of Group  IX  showed a  highly significant decrease (p<0.01) (170.55±9.03 mg/dl) 
while  200 mg/kg b.w administered to rats of Group  X    also showed  a very highly 
significant   decrease (p<0.001)  in total  cholesterol   levels (121.68± 14.57 mg/dl). 
The standard drug, glibenclamide administered to rats of Group III also showed  a  
non significant   decrease p>0.05  in the  total  cholesterol    levels (206.35±6.11 
mg/dl ) (Table 30; Fig 29) 
Serum Triglyceride Levels (mg/ dl) 
The   rats of Group I revealed serum triglyceride levels of (80.71±9.38 mg/dl). Rats 
of  groups  receiving 100  mg/kg b.w  of the extract administered to rats of Group  IV      
and  200 mg/kg b.w administered to rats of Group  V   of  50%  ethanolic  extract of  
Portulaca  oleracea showed a dose  dependent   highly significant (p<0.01) reduction 
in  serum  triglycerides(140.58±18.62 mg/dl)  and (p<0.001) (97.32±12.15mg/dl)   
indicating    a very highly significant   reduction in lipid  profile. Group  II  rats  
which  received   only  alloxan  monohydrate  showed a  very highly significant   
increase   in serum    triglycerides.(194.56±14.99 mg/dl )(p<0.001)  
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The  dose of   50 , 100 and  200 mg/kg  b.w  of   fruits  of Eriobotrya  japonica   
when administered to rats showed an extremely significant  decrease when  compared 
to the levels of triglycerides in  diabetic  control rats of Group II.  Rats which 
received 50 mg/kg administered to rats of Group VI   b.w showed  a highly 
significant (p<0.01)  level of (158.53±13.66 mg/dl) and rats receiving 100 mg/kg b.w 
administered to rats of Group  VII    showed a  very highly significant level(p<0.001)   
(111.21±12.52 mg/dl) while rats which received 200 mg/kg b.w administered to rats 
of Group  VIII    showed a very highly significant level (p<0.001) ( 86.13±11.49 
mg/dl ) 
Moreover, the  Groups treated with  100 mg /kg b.w of seeds of Eriobotrya  japonica  
given to rats of Group  IX  (127.49±12.66) mg/dl showed a highly significant 
decrease (p<0.01)  and  200 mg/kg b.w administered to rats of Group  X    showed a 
very highly significant (p<0.001)  level of (124.29±10.67) of  triglycerides. The 
standard drug glibenclamide administered to rats of Group III showed a non-
significant (p>0.05) level of (184.30±9.68 mg/dl) of  serum triglycerides. (Table 31; 
Fig 30) 
Serum HDL Cholesterol Levels (mg/ dl)                                                                                                                                                    
There  was  non significant)(p.>0.05)  decrease in  serum HDL Cholesterol levels in 
rats  in the  diabetic  group (Group II) (21.11±1.45 mg/ dl)as  compared to  normal 
control  (Group I)  (24.54±6.49 mg/dl)  . Portulaca  oleracea  at the dose  of  100 
mg/kg b.w administered to rats of Group IV showed a level of (26.63±5.39 mg/dl) 
(p>0.05) and 200 mg/kg  b.w administered to rats of Group V showed a  non 
significant increase (p>0.05) in the serum HDL cholesterol levels(29.04±7.67 mg/dl ) 
Eriobotrya japonica fruits at the dose  of 50  mg/kg b.w administered to rats of 
Group VI showed a  non significant   increase(p>0.05)   (29.94±4.92 mg/dl) ,while 
the dose of 100 mg/kg b.w administered to rats of Group VII showed a  significant 
level (p<0.05) of  (30.54±3.23 mg/dl) and the dose of 200 mg/kg b.w administered to 
rats of Group VIII showed a significant rise (p<0.05)  (32.73±4.04 mg/dl) in  serum  
HDL cholesterol   levels in a dose dependent   manner, as compared  to the group II  
that had received only alloxan monohydrate.   
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The seeds of Eriobotrya  japonica seeds at the dose   of 100mg/kg b.w  given to rats 
of Group IX  showed  a  non significant   increase (p>0.05)    in serum  HDL 
cholesterol   levels.(25.04±3.21 mg/dl) and  a dose of 200 mg/kg b.w showed 
administered to rats of Group X a significant increase (p<0.05) of (31.29±6.12 mg/dl) 
of  HDL Cholesterol  was seen. The standard drug, glibenclamide administered to 
rats of Group III also showed a non-significant   increase (p>0.05) in the  serum HDL 
cholesterol  levels.(29.03±3.16 mg/dl) (Table 32; Fig 31) 
Serum LDL Cholesterol Levels (mg/ dl)                                                                                                                                         
As  compared  to  group I (52.03±3.21 mg/dl), the  levels  in the  group II   rats which  
had received  only  alloxan  monohydrate, there was   highly  significant  increase 
(p<0.01)  in the  serum LDL cholesterol   levels ( 89.59±13.82 mg/dl). When  50% 
ethanolic  extract  of  Portulaca  oleracea (100 mg/kg b.w)   was  administered 
administered to rats of Group IV it   showed   a   very highly significant  increase 
(p<0.001) (143.14±19.38 mg/dl )  but  dose  of  200 mg/kg  b.w administered to rats 
of Group V showed a significant  decrease  ( p<0.05).  in the   serum LDL cholesterol   
levels (60.06±12.46 mg/dl). 
Eriobotrya japonica fruits in the dose levels of 50mg/kg b.w administered to rats of 
Group VI showed a  non significant level(p>0.05),  of (103.21±10.67 mg/dl), a dose 
of 100 mg/kg b.w administered to rats of Group VII  showed a non significant level 
(p>0.05) of  (60.54±4.99 mg/dl) and   a dose of 200 mg/kg b.w administered to rats 
of Group VIII showed a  non significant   decrease (p>0.05)  in  LDL cholesterol 
levels (60.78±6.68) mg/dl in a dose dependent   manner, as compared  to the group II  
that had received only alloxan monohydrate.   
The seeds of Eriobotrya  japonica   at the dose levels  of 100 mg/kg administered to 
rats of Group IX (68.91±13.34) mg/dl showed a non significant decrease (p>0.05)   
and   at dose of 200 mg/kg bw administered to rats of Group X  also showed  a   
significant   decrease (p<0.05) (50.47±2.63 mg/dl )in serum LDL  cholesterol   
levels. The standard drug, glibenclamide administered to rats of Group III also 
showed  a  non-significant   decrease( p>0.05). in the  serum LDL cholesterol levels 
(85.39±7.24 mg/dl ) (Table 33; Fig 32) 
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Serum Urea Levels (mg/ dl) 
The rats of Group I showed a level of serum urea level of (22.32±3.75 mg/dl). Group  
II  rats  which  received   only  alloxan  monohydrate  showed a  non significant   
increase (p>0.05)  in serum  urea levels (23.06±0.69 mg/dl)  
The  rats of group IV receiving  100 mg/kg b.w  of 50%  ethanolic  extract of  
Portulaca  oleracea showed a  non significant level (p>0.05)of (26.47±2.95 mg/dl) 
increase  in  serum  urea  levels. Rats of group V which received 200mg/kg b.w of 
ethanolic extract showed a non-significant level (p>0.05) of (25.95±2.88 mg/dl).  
The  dose of   50,100 and  200 mg/kg  b.w  of   fruits  of Eriobotrya  japonica   when 
administered   showed non  significant  changes  when  compared  to  the activity of  
diabetic  control rats of Group II rats. A dose of 50 mg/kg b.w administered to rats of 
Group VI showed a  non significant level(p>0.05),  of (26.46±3.84 mg/dl) a dose of 
100 mg/kg b.w administered to rats of Group VII also showed a non significant  level 
(p>0.05), of  (24.31±2.65 mg/dl) . A dose of 200 mg/kg b.w administered to rats of 
Group VIII also showed a  non significant level(p>0.05) of (17.92±2.44 mg/dl) .  
Moreover, the  Groups treated with  100 mg and  200 mg of seeds of Eriobotrya  
japonica  seeds also showed  a   non significant changes  in  serum  urea levels. Rats 
of group IX which received 100 mg/kg b.w showed a  nonsignificant level (p>0.05), 
of (26.11±2.25 mg/dl)  and  rats of  Group X which  received 200 mg/kg b.w of  
ethanolic extract  showed a non significant level (p>0.05),  of (29.06± 2.10 mg/dl) . 
The levels in the standard drug, glibenclamide administered to rats of Group III 
showed a non-significant level (p>0.05) of   (20.82± 1.32 mg/dl). (Table 34; Fig 33) 
Serum Creatinine   Levels (mg/ dl)                                                                                                                                                  
There  was  non significant  rise (p>0.05), in serum  creatinine  levels in rats  in the  
diabetic  group ( Group II) (1.14±0.12  mg/dl)  as  compared to  normal control 
(GroupI)  (0.85±0.07) . Portulaca oleracea in the dose levels of 100 and 200 mg/kg 
b.w showed a  non-significant decrease   in the serum creatinine  levels. A dose of 
100 mg/kg b.w administered to rats of Group IV showed a non-significant level 
(p>0.05), of (1.65 ±0.24 mg/dl)   and a dose of 200 mg/kg b.w administered to rats of 
Group V also showed a  non significant level (p>0.05), of (1.38±0.14 mg/dl ). 
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 Eriobotrya japonica fruits in the dose levels of 50, 100, and 200 mg/kg b.w showed 
a  non-significant   changes(p>0.05),   in serum creatinine levels, as compared  to the 
group II  that had received only alloxan monohydrate.   The dose of 50 mg/kg b.w 
administered to rats of Group VI showed a non-significant level (p>0.05), of 
(1.19±0.87 mg/dl), a dose of 100 mg/kg b.w administered to rats of Group VII 
showed a level (p>0.05), of (1.06±0.64 mg/dl) and a dose of 200 mg/kg b.w 
administered to rats of Group VIII showed a non-significant level (p>0.05), of (0.89 
±0.65 mg/dl).  
 The seeds of Eriobotrya  japonica  at the dose   of 100 mg/kg b.w administered to 
rats of Group IX showed a non significant level(p>0.05),  of  (0.84±0.16 mg/dl ) and  
200 mg/kg bw administered to rats of Group X (1.02±0.12 mg/dl)    also showed  a  
non significant   changes (p>0.05),   in serum creatinine   levels. The standard drug, 
glibenclamide   also showed a non-significant levels (p>0.05), in the serum creatinine 
levels (0.76±0.08 mg/dl). (Table 35; Fig 34) 
Serum Total Proteins   Levels (g/ dl)                                                                                                                                                    
As  compared  to  group I (4.95±0.61), the  levels  in the  group II   rats which  had 
received  only  alloxan  monohydrate, there was non  significant  change ( p>0.05).  
in the   serum  total protein   levels(3.18±0.26 g/ dl). When  50% ethanolic  extract  
of  Portulaca  oleracea ( 100 mg/kg b.w)   was  administered  to rats of Group IV it   
showed   a  non  significant ( p>0.05).  Increase (4.66±0.77 g/ dl) while a dose of 200 
mg/kg b.w administered to rats of Group V showed a significant increase (p<0.05).   
In the serum total proteins levels (5.20±0.66 g/ dl)  
 Eriobotrya japonica fruits at the dose levels of 50, 100, and 200 mg/kg b.w showed 
a non-significant   decrease in serum total proteins levels as compared to the group II 
that had received only alloxan monohydrate. A dose of 50 mg/kg b.w administered to 
rats of Group VI showed a nonsignificant level (p>0.05), of  (4.29±1.01 g/dl)  and   a 
dose of 100 mg/kg b.w administered to rats of Group VII showed a  non significant 
level(p>0.05) of (4.62±0.99 g/ dl) and a dose of 200 mg/kg b.w administered to rats 
of Group VIII showed a non significant  level  (p>0.05)  (4.90 ±0.39 g/ dl) . 
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The seeds of Eriobotrya  japonica  at the dose levels  of 100 mg/kg b.w administered 
to rats of Group IX showed a  non significant level(p>0.05)  of (3.01±0.70 g/ dl) and  
200 mg/kg b.w  administered to rats of Group X also showed  a  non significant   
change(p>0.05).  in  serum total  proteins   levels.(3.36±0.58) g/ dl The  standard  
drug, glibenclamide administered to rats of Group III also showed  a   non significant   
decrease (p>0.05)  in the  serum total  proteins    levels (4.14±0.88 g/ dl). 
(Besides recording the effect on biochemical parameters, effect on body weight of 
rats revealed the following results. (Table 36; Fig 35) 
Average Body Weight (g) 
The rats of Group I showed a body weight of (222.05±4.74 g) in grams and the rats 
of Group II showed a very highly significant decrease (p<0.001). In average body 
weight (124.76± 2.35 g) in grams. The rats receiving 50%  ethanolic  extract of  
Portulaca  oleracea showed a dose  dependent   increase in  average body  weight  
indicating   significant  reduction in  average  body weight. A dose of 100 mg/kg b.w 
administered to rats of Group IV showed a significant increase (p<0.05) of 
(145.50±8.35 g) and a dose of 200 mg/kg b.w administered to rats of Group V 
showed a highly significant increase (p<0.01).of (150.61 ±3.62 g) . 
 The dose of   50.100 and 200 mg/kg b.w of fruits of Eriobotrya japonica when 
administered to rats   showed an extremely significant increase when compared to the 
activity of diabetic control rats of Group II rats. A dose of 50 mg/kg b.w 
administered to rats of Group VI showed a  highly significant average body weight 
(p<0.01), of (171.47 ±2.74g) and a dose of 100 mg/kg b.w administered to rats of 
Group VII  showed a  very highly significant average body weight (p<0.001)  of 
(172.62 ±4.05g) and a dose of 200 mg/kg b.w administered to rats of Group VIII 
showed a  very highly significant average body weight (p<0.001)  of (176.41 ±3.52 
g)  
Moreover, the  Groups treated with  100 mg/kg b.w administered to rats of Group IX 
of seeds of Eriobotrya  japonica showed a highly significant increase(p<0.01)  of  
(162.37±3.08 g) and  200 mg/kg b.w when  administered to rats of Group X ( 167.20 
±3.58g)  seeds also showed  a   very highly significant increase (p<0.001)   in  
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average body weight. The standard drug, glibenclamide administered to rats of Group 
III showed a non significant average body weight (p>0.05) of (137.50±3.90g) as 
compared to rats of group II. (Table 37; Fig 36) 
During the course of these studies, blood glucose levels and average body weight 
were observed on day 1, day 4, day, 7 and day 10. (Table 29; 38) 
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Table 28:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica seeds (EBJS), on Serum Glucose Levels  (mg/dl) against alloxan induced diabetes mellitus in rats (10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group VIII Group-IX Group-X 
Rats Normal 
control 
 ( 0.2ml of 
2% Gum 
acacia) 
Diabetic 
control 
( Alloxan 
monohydrate) 
Alloxan
a
 + Std 
Anti diabetic 
drug 
Glibenclamide 
(10mg/kg.) 
Alloxan
a
 + 
PO  
(100mg /kg)  
Alloxan
a
  +  
PO 
(200mg / kg) 
 
Alloxan
a
 + 
EBJF 
(50mg/kg)  
 
Alloxan
a
 + 
EBJF 
(100mg /kg)  
 
Alloxan
a
 +  
EBJF 
(200mg /kg)  
 
Alloxan
a
 + 
EBJS 
(100mg /kg)  
Alloxan
a
 +  
EBJS 
(200mg /kg)  
1 86.09 307.87 112.12 150.78 118.78 156.67 127.56 99.45 152.65 144.32 
2 74.11 250.56 122.45 144.76 120.04 160.45 133.32 66.32 144.07 124.05 
3 88.07 274.05 101.64 149.71 112.43 155.07 128.45 78.06 158.43 129.31 
4 99.23 260.43 115.23 138.43 105.32 144.34 130.32 70.56 160.21 105.54 
5 61.06 272.56 114.54 133.64 105.85 158.32 123.56 86.06 158.46 105.65 
6 99.67 260.67 123.07 139.61 107.05 167.39  96.45 159.42 115.54 
Mean 84.71 271.02*** 114.84*** 142.82** 111.58*** 157.04** 128.64*** 82.82*** 155.54** 120.74*** 
SD 14.96 20.03 7.84 6.76 6.58 7.56 3.59 13.56 6.22 15.01 
SEM 6.11 8.18 3.2 2.76 2.69 3.09 1.61 5.53 2.54 6.13 
P Value  p< 0.001 p< 0.001 p< 0.01 p< 0.001 p <0.01 p <0.001 p <0.001 p < 0.01 p < 0.001 
Statistically  
Compared 
groups 
 II Vs  I III  Vs II IV  Vs II V  Vs  II VI  Vs  II VII  Vs  II VIII Vs  II IX  Vs  II X  Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard 
drug, Glibenclamide & three plants given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
  n=6 (No of animals in each group) except  in group  VII  where  n=5 ; 
 Group II compared with Group I & all other   groups compared with Group II      
 ***p< 0.001 Very highly significant; ** P< 0.01; highly significant;  
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 28: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum Glucose Levels (mg/ dl) against alloxan induced diabetes mellitus in rats. 
I    II      III       IV         V           VI             VII            VIII   IX              X  
Groups 
(                             )      
(                             )      
(                          )      
(                             )      
(                             )      
(                             )      
(                             )      
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Table 29: Effect   of   50% ethanolic  extract of   Portulaca  oleracea (whole plant) PO, Eriobotrya   japonica  fruits ( EBJF)  and   
Eriobotrya  japonica  seeds( EBJS)  on  Blood Glucose   Levels  ( mg/dl) against  alloxan  induced  diabetes mellitus  in  
rats  ( 10  days  study) 
Groups Treatment              Blood                                   Glucose    Levels                   ( mg/dl) 
DAY  1 DAY 4 DAY 7 DAY 10 
I Normal  control 
0.2ml of 2%  gum acacia 
85.07± 4.35 
 
86.16±4.43 84.82±5.96(NS) 84.71±6.11(NS) 
II Diabetic control 
 Alloxan monohydrate 
261.47±8.37 264.28±8.29 268.03±8.48(NS) 271.33± 8.18(NS) 
III  Alloxan monohydrate + Std  
drug  -Glibenclamide 
(10 mg/kg b.w) 
200.37± 5.25 141.18± 2.43 124.52± 2.00** 114.84±3.20*** 
IV  Alloxan monohydrate  
+ PO(100 mg/kg b.w) 
203.38±4.04 147.87± 2.30 144.56± 2.56** 142.82± 2.76*** 
V  Alloxan monohydrate 
+ PO(200 mg/kg b.w) 
201.24± 4.90 146.29± 2.06 130.44± 1.87** 111.57± 2.67*** 
VI  Alloxan monohydrate 
+ EBJF(50 mg/kg b.w) 
201.17±4.85 159.48±2.68 158.76±2.81** 157.04±3.09*** 
VII  Alloxan monohydrate 
+ EBJF(100 mg/kg b.w) 
201.17±4.85 146.43±2.46 135.44±2.72** 128.64±1.61*** 
VIII  Alloxan monohydrate 
+EBJF(200 mg/kg b.w) 
204.27±4.25 144.65±1.53 118.35±3.42** 82.82±5.53*** 
IX  Alloxan monohydrate 
+EBJS(100 mg/kg b.w) 
204.27±4.25 156.99±2.48 156.21±2.85** 155.54±2.54*** 
X  Alloxan monohydrate 
+ EBJS(200 mg/kg b.w) 
202.95±4.95 144.67±1.56 128.22±5.55** 120.74±6.13*** 
 Alloxan monohydrate (120 mg/kg) was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard 
drug, Glibenclamide & three plants given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
  n=6  ( No of animals in each group) except  in group  VII  where  n=5 ; 
 DAY 10 compared with DAY 1;    ***p< 0.001 very highly significant; p < 0.01 Highly Significant; p> 0.05 non-significant (NS)  
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Table  30:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum Total  Cholesterol  Levels (mg/ dl) against alloxan induced diabetic rats  ( 10  days  study)                                   
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group  VIII Group-IX Group-X 
Rats Normal 
control 
(0.2ml of 
2%  gum 
acacia) 
Diabetic 
control  
(Alloxan 
monohydrate) 
Alloxan  a+ Std  
Antidiabetic 
drug 
Glibenclamide 
(10mg/kg) 
Alloxan a +   
 PO  
100mg/kg  
Alloxan  a+ 
 PO 
 200mg / kg,  
Alloxan  a+  
 EBJF 
 50mg/kg 
Alloxan a +  
 EBJF 
 100mg / kg  
Alloxan a +  
 EBJF 
 200mg / kg  
Alloxan  a+  
EBJS 
100mg/kg 
 
Alloxan a +   
EBJS 
200mg / kg  
1 80.05 207.04 212.96 215.34 69.23 122.06 107.45 106.23 160.07 72.03 
2 99.21 267.43 190.56 144.07 109.67 167.56 110.56 92.54 133.45 164.56 
3 68.04 139.07 187.07 180.43 63.73 152.32 89.23 77.05 176.61 123.17 
4 104.05 299.23 215.87 300.53 187.05 175.68 170.06 105.67 199.72 148.56 
5 55.07 178.06 230.67 122.01 112.38 175.72 188.56 100.45 176.03 87.34 
6 105.06 218.06 200.98 218.45 69.04 215.02  107.23 177.45 134.45 
Mean  85.25 218.15*** 206.35 196.80** 101.85*** 159.4** 133.17*** 98.15*** 170.55** 121.68*** 
SD 20.85 58.28 14.97 63.58 46.95 36.13 43.39 11.71 22.14 35.69 
SEM 8.51 23.79 6.11 25.95 19.17 13.65 19.41 4.78 9.03 14.57 
P Value  p < 0.001 p >0.05 p < 0.01 p < 0.001 p < 0.01 p < 0.001 p < 0.001 p < 0.01 p <0.001 
Statistically  
Compared 
groups 
 
II Vs I III Vs II IV  Vs  II V  Vs  II VI Vs II VII  Vs II VIII  Vs II IX  Vs  II X Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
 n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I & all other   groups compared with  Group II                                    
 ***p< 0.001 very highly significant; ** p< 0.01; Highly significant; p>0.05; Non-significant 
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 29:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum Total  Cholesterol  Levels (mg/ dl) against alloxan induced diabetes  mellitus  in   rats. 
Se
ru
m
 C
h
o
le
st
e
ro
l L
e
ve
ls
 (
m
g/
d
l)
 
 
Chapter 4          Observation And Results 
 
Ph.D Thesis                                   195                      University of Kashmir 
 
Table 31: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum Triglyceride Levels (mg/ dl) against alloxan induced diabetes  mellitus  in  rats ( 10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group VIII Group-IX Group-X 
Rats Normal 
control 
(0.2ml of 
2%  gum 
acacia) 
Diabetic control  
(Alloxan 
monohydrate) 
Alloxan a + Std 
Antidiabetic 
drug 
Glibenclamide 
(10mg/kg.) 
Alloxan a  
+  
 PO  
(100mg/kg) 
 
Alloxan a 
 + 
 PO 
(200mg/kg) 
Alloxan a +  
 EBJF 
 (50mg/kg)  
Alloxan  a +  
 EBJF 
(100mg/ kg) 
Alloxan  a +  
 EBJF 
 (200mg / 
kg)  
Alloxan  a  
+   
EBJS 
(100mg/kg)  
Alloxan   a 
+  
 EBJS 
(200mg / kg) 
1 65.05 215.04 190.98 177.23 50.34 116.07 69.24 99.34 124.05 123.43 
2 106.21 201.34 185.67 123.08 104.23 200.04 123.56 38.12 101.34 152.45 
3 50.23 155.23 184.97 160.56 74.64 144.34 103.12 66.06 128.67 106.12 
4 101.07 254.12 124.78 167.23 129.23 132.32 115.09 98.01 122.52 154.43 
5 66.67 165.23 218.78 55.34 122.03 166.37 145.05 105.04 102.18 122.23 
6 95.05 176.41 200.67 160.06 103.45 192.09  110.23 186.23 87.08 
Mean  80.71 194.56*** 184.30 140.58** 97.32*** 158.53** 111.21*** 86.13*** 127.49** 124.29*** 
SD 22.98 36.74 23.72 45.61 29.78 33.47 28.01 28.14 31.02 26.15 
SEM 9.38 14.99 9.68 18.62 12.15 13.66 12.52 11.49 12.66 10.67 
P Value  p < 0.001 p >0.05 p < 0.01 p < 0.001 p < 0.01 p <0.001 p <0.001 p < 0.01 p < 0.001 
Statistically  
Compared 
groups 
 
II Vs  I III Vs II IV Vs  II V  Vs  II V I Vs  II VII Vs  II VIII Vs II IX  Vs  II X   Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard 
drug, Glibenclamide & three plants given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
 n=6 (No of animals in each group) except in group VII where n=5  
 Group II compared with Group I  & all other   groups compared with  Group II                                    
***p< 0.001 very highly significant; ** P< 0.01; Highly significant; p>0.05 Non-significant 
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 30:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum Triglyceride Levels (mg/ dl) against alloxan induced diabetes mellitus in rats. 
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Table 32:  Effect of different doses of 50% ethanolic extract of Portulaca Oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum  HDL  Cholesterol   Levels (mg/ dl) against alloxan induced diabetes mellitus in  rats. ( 10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group  VIII Group-IX Group-X 
Rats Normal 
control (0.2ml 
of 2%  gum 
acacia) 
Diabetic 
control 
(Alloxan 
monohydrate) 
Alloxan a + Std 
Antidiabetic 
drug 
Glibenclamide 
(10mg/kg.) 
Alloxan  a+ 
PO 
(100mg/kg) 
Alloxan a + 
PO 
(200mg / kg) 
Alloxan  a + 
EBJF 
(50mg/kg) 
Alloxan  a + 
EBJF 
(100mg / kg) 
Alloxan  a+ 
EBJF  
(200mg / kg) 
Alloxan  a+  
EBJS 
(100mg/kg) 
Alloxan  a+  
EBJS 
(200mg / 
kg) 
1 16.45 19.06 24.12 15.42 12.05 19.67 21.34 
34.01 
12.34 50.05 
2 16.23 25.45 37.03 29.05 16.34 34.42 25.07 
15.45 
30.56 29.23 
3 23.56 19.12 23.23 19.13 44.13 18.34 32.23 
33.23 
22.03 40.56 
4 15.45 23.71 35.45 50.56 32.04 23.05 35.03 
36.12 
34.23 14.07 
5 19.12 16.06 35.23 16.41 57.34 34.12 
39.02 23.05 
29.02 40.12 
6 56.43 23.23 19.12 29.23 12.32 50.03  
48.23 
22.06 13.73 
Mean 24.54 21.11 29.03 26.63 29.04 29.94 30.54* 32.73* 25.04 31.29* 
SD 15.91 3.57 7.74 13.21 18.79 12.07 7.23 10.68 7.84 14.99 
SEM 6.49 1.45 3.16 5.39 7.67 4.92 3.23 4.04 3.21 6.12 
P Value  p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p < 0.05 p < 0.05 p>0.05 p < 0.05 
Statistically  
Compared 
groups 
 
II Vs  I III Vs  II IV  Vs  II V  Vs  II VI Vs II VII  Vs II VI II Vs  II IX  Vs  II X  Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard 
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
 n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I  & all other   groups compared with  Group II                                    
 *p<0.05 significant; p> 0.05 ( Non-significant) 
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 31: Effect of different doses of 50% ethanolic extract of Portulaca  oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum HDL Cholesterol  Levels (mg/ dl) against alloxan induced diabetes mellitus in rats. 
(                             )      
(                             )      
(                           )      
(                             )      
(                             )      
(                             )      
(                             )      
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Table 33: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum LDL  Cholesterol  Levels (mg/ dl) against alloxan induced diabetes mellitus  in  rats  ( 10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group  VIII Group-IX Group-X 
Rats Normal 
control 
(0.2ml of 
2%  gum 
acacia) 
Diabetic control 
(Alloxan 
monohydrate) 
Alloxan a + Std 
Antidiabetic drug 
Glibenclamide 
(10mg/kg.) 
Alloxan a  + 
PO 
(100mg/kg) 
Alloxan  a+ 
PO 
(200mg / kg) 
Alloxan  a + 
EBJF 
(50mg/kg) 
Alloxan  a+ 
EBJF 
(100mg / kg) 
Alloxan  a+ 
EBJF 
(200mg / kg) 
Alloxan a +  
EBJS 
(100mg/kg) 
Alloxan a+   
EBJS 
(200mg / 
kg) 
1 48.04 80.23 86.08 165.12 35.45 60.67 67.08 68.45 33.04 45.06 
2 49.23 131.34 78.76 91.56 85.04 93.32 69.12 64.04 100.23 52.34 
3 39.56 75.03 78.56 132.23 75.23 106.67 44.05 31.12 80.56 46.21 
4 60.51 80.34 89.58 217.43 100.45 126.52 68.45 79.56 81.06 43.56 
5 56.78 43.07 90.34 95.23 31.12 98.35 54.02 56.34 23.21 58.23 
6 58.02 127.56 89.05 157.32 33.06 133.72  65.21 95.34 57.42 
Mean 52.03 89.59** 85.39 143.14*** 60.06* 103.21* 60.54* 60.78* 68.91* 50.47** 
SD 7.86 33.86 17.74 47.49 30.52 26.14 11.11 16.38 32.67 6.43 
SEM 3.21 13.82 7.24 19.38 12.46 10.67 4.99 6.68 13.34 2.63 
P Value  p < 0.01 p > 0.05 p < 0.001 p < 0.05 p <0.05 p <0.05 p<0.05 p<0.05 p < 0.01 
Statistically  
Compared 
groups 
 
II Vs I III Vs  II IV  Vs  II V  Vs  II VI  Vs  II VII  Vs  II VIII Vs  II IX  Vs  II X Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
  n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I  & all other   groups compared with  Group II                   
 ***p< 0.001 very highly significant; ** p< 0.01 Highly  significant; *p<0.05 Significant;p>0.05 
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 32: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum LDL Cholesterol  Levels (mg/ dl) against alloxan induced diabetes  mellitus in rats. 
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Table 34: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum Urea Levels (mg/ dl) against alloxan induced diabetes  mellitus in rats. (  10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group 
VI 
Group 
VII 
Group 
VIII 
Group-IX Group-X 
Rats 
 
Nor mal 
control 
 (0.2ml of 
2% Gum 
acacia) 
Diabetic control  
(Alloxan 
monohydrate) 
Alloxana+Std 
Antidiabetic  
drug 
Glibenclamide                    
(10mg/kg.) 
Alloxana  +  
 PO 
  
(100mg/kg)  
 
Alloxana +  
   PO 
(200mg / 
kg ) 
Alloxana  +   
EBJF  
(50mg/kg)  
 
Alloxana  +   
 EBJF  
(100mg / kg) 
 
Alloxana  +  
EBJF 
 (200mg / kg) 
Alloxana  +  
EBJS 
 (100mg/kg) 
Alloxana  +  
 EBJS  
(200mg / kg) 
1 34.74 24.56 21.76 18.56 21.37 21.74 21.62 12.07 33.07 33.24 
2 16.21 24.74 15.35 24.81 15.19 36.11 16.12 9.07 19.45 32.23 
3 18.65 22.05 19.06 19.73 29.05 34.07 28.43 20.56 25.65 31.03 
4 14.54 20.43 23.74 34.06 32.46 17.14 31.32 19.54 32.04 29.43 
5 33.35 24.05 23.95 25.57 24.09 34.32 24.05 22.06 25.13 19.01 
6 16.45 22.51 21.05 36.07 33.51 15.43  24.23 21.35 29.45 
Mean  22.32 23.06  20.82 26.47 25.95 26.46 24.31 17.92 26.11 29.06 
SD 9.18 1.69 3.2 7.22 7.06 9.41 8.31 5.98 5.51 5.15 
SEM 3.75 0.69 1.32 2.95 2.88 3.84 2.65 2.44 2.25 2.1 
P Value  p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 
Statistical
ly  
Compare
d groups 
 
II Vs I III Vs  II IV  Vs  II V  Vs  II VI  Vs II VII  Vs  II VIII Vs II IX  Vs II X Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia.. 
  n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I & all other   groups compared with Group II          
p> 0.05;  Non  significant 
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 33:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum Urea Levels (mg/ dl) against alloxan induced diabetes mellitus rats. 
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 Table 35: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum Creatinine Levels (mg/dl) against alloxan induced diabetes mellitus in rats ( 10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group VIII Group-IX Group-X 
Rats Normal 
control 
(0.2ml 
of 2%  
gum 
acacia) 
Diabetic 
control  
(Alloxan 
monohydr
ate) 
Alloxana  + 
Std 
Antidiabetic 
drug 
Glibenclami
de 
(10mg/kg.) 
Alloxan a +   
 PO 
(100mg/kg) 
Alloxan a   +  
        PO 
 (200mg / kg) 
Alloxan a  +   
 EBJF 
 (50mg/kg) 
Alloxan a  +  
 EBJF 
 (100mg / kg) 
 
Alloxan a  +  
 EBJF 
 (200mg / kg) 
Alloxan a  +   
EBJS 
(100mg/kg)  
Alloxan a  +  
EBJS  
(200mg / kg)  
1 1.06 1.21 1.02 1.07 1.35 1.68 1.17 0.54 1.61 0.71 
2 0.77 1.02 1.03 1.76 1.76 1.76 1.23 0.66 0.71 1.02 
3 1.05 1.32 0.75 0.97 1.67 0.56 1.09 0.96 0.75 1.21 
4 0.81 1.61 0.55 2.23 1.43 0.02 0.93 1.23 0.71 0.65 
5 0.82 1.01 0.55 1.45 1.37 1.45 1.38 0.75 0.75 1.12 
6 0.61 0.71 0.66 2.45 0.74 1.66  1.24 0.51 1.41 
Mean  0.85 1.14  0.76 1.65 1.38 1.19 1.06 0.89 0.84 1.02 
SD 0.17 0.307 0.218 0.604 0.358 0.72 0.29 0.18 0.38 0.29 
SEM 0.07 0.12 0.089 0.24 0.146 0.8766 0.6475 0.65 0.16 0.12 
P Value  p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 
Statistica
lly  
Compare
d groups 
 
II Vs I III Vs  II IV  Vs  II V  Vs  II VI  Vs II VII  Vs  II VIII Vs II IX  Vs  II X  Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia.. 
   n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I  & all other   groups compared with  Group II                                    
 p> 0.05  Non  significant;    
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 34:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum Creatinine Levels (mg/ dl) against alloxan induced diabetes mellitus in rats. 
(                             )      
(                             )      
(                          )      
(                             )      
(                             )      
(                             )      
(                             )      
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Table 36: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on   Serum Total Proteins Levels (g/ dl) against alloxan induced diabetes mellitus  in  rats.  (  10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group VIII Group-IX Group-X 
Rats Normal 
control 
(0.2ml of 
2% gum 
acacia) 
Diabetic 
control  
(Alloxan 
monohyd
rate) 
Alloxana  + Std 
Antidiabetic 
drug 
Glibenclamide 
(10mg/kg ) 
Alloxan a +  
 P.O.  
(100mg/kg)   
 
Alloxan a +  
 P.O 
(200mg / kg)  
Alloxan a +  
EBJF 
 (50mg/kg)  
Alloxan a +  
EBJF 
 (100mg / kg)  
Alloxan a +  
EBJF  
(200mg / kg)  
Alloxan a +  
EBJS 
(100mg/kg)  
Alloxan a + 
EBJS 
(200mg / kg)  
1 4.31 2.31 6.62 7.09 7.72 2.14 3.33 3.93 6.41 4.43 
2 2.52 3.42 6.31 2.11 4.32 8.09 7.45 4.25 2.13 1.85 
3 7.07 4.12 4.13 4.42 4.41 2.33 3.71 4.76 2.52 2.14 
4 5.05 3.33 2.32 6.62 6.42 3.36 2.15 5.32 1.62 4.12 
5 5.04 3.31 1.08 3.31 3.22 6.62 6.46 4.52 2.52 5.32 
6 5.71 2.62 4.41 4.41 5.12 3.24  6.62 2.82 2.32 
Mean  4.95 3.18 4.14 4.66 5.20* 4.29 4.62 4.90 3.01 3.36 
SD 1.51 0.64 2.17 1.9 1.62 2.46 2.23 0.96 1.71 1.44 
SEM 0.61 0.26 0.88 0.77 0.66 1.01 0.99 0.39 0.7 0.58 
P Value  p>0.05 p > 0.05 p > 0.05 p < 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 
Statisti
cally  
Compa
red 
groups 
 
II Vs I III Vs  II IV  Vs  II V Vs II VI  Vs II VII  Vs II VIII Vs II IX  Vs II X Vs II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I  & all other   groups compared with  Group II                                    
 *p< 0.05 Significant;  p> 0.05;  Non  significant;  
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 35:  Effect of different doses of 50% ethanolic extract of Portulaca Oleracea whole plant (P.O), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Serum Total Proteins Levels (gms/ dl) against alloxan induced diabetes mellitus in rats. 
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Table 37: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Average Body Weight  ( g) against alloxan induced diabetes mellitus in rats.  (10  days  study) 
S.No. Group-I Group-II Group –III Group-IV Group-V Group-VI Group-VII Group  VIII Group-IX Group-X 
Rats Normal 
control 
(0.2ml of 2%  
gum acacia) 
Diabetic control 
(Alloxan 
monohydrate) 
Alloxan  a+ Std  
Antidiabetic drug 
Glibenclamide 
(10mg/kg.) 
Alloxan  a + 
P.O. 
(100mg/kg) 
Alloxan  a+ 
P.O. 
(200mg / kg) 
Alloxan  a + 
EBJF 
(50mg/kg) 
 
Alloxan a + 
EBJF 
(100mg / kg) 
Alloxan a + 
EBJF 
(200mg / kg) 
Alloxan  a +  
EBJS 
(100mg/kg) 
Alloxan  a+  
EBJS 
(200mg / kg) 
1 220.7 125.7 140 160.2 160.7 170.3 175.8 190.7 170.7 170.7 
2 210.3 130.5 120 160.4 160.2 160.7 180.4 170.4 160.3 160.4 
3 240.2 125.4 140 150.7 140.8 170.8 160.8 165.7 170.8 180.7 
4 230.4 130.6 150 105.5 140.5 180.9 180.7 180.5 150.7 155.8 
5 220.2 115.8 145 150.8 150.7 175.7 165.4 175.4 160.9 165.2 
6 210.5 120.6 130 145.4 150.8 170.4  175.8 160.8 170.4 
Mean 222.05 124.76*** 137.50 145.50* 150.61** 171.47** 172.62*** 176.41*** 162.37** 167.20*** 
SD 11.62 5.76 8.72 20.46 8.86 6.72 9.05 8.64 7.55 8.77 
SEM 4.74 2.35 3.9 8.35 3.62 2.74 4.05 3.52 3.08 3.58 
P Value  p < 0.001 p >0.05 p < 0.05 p < 0.01 p < 0.01 p < 0.001 p < 0.001 p < 0.01 p < 0.001 
Statistically  
Compared 
groups 
 
II Vs  I III Vs  II IV Vs  II V  Vs   II VI Vs II VII  Vs  II VI II  Vs  II IX Vs  II X   Vs  II 
a   
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia.. 
 n=6 ( No of animals in each group)  except  in group  VII  where  n=5  
 Group II compared with Group I  & all other   groups compared with  Group II                                    
 ***p< 0.001 Very highly  significant;  ** P< 0.01;  Highly  significant; *p<0.05 significant;p>0.05 Non significant. 
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Anti-diabetic Study using alloxan monohydrate in Rats (10 day study) 
 
All extracts were administrated orally in 2% gum acacia daily for 10 days 
Fig 36:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya 
japonica  seeds (EBJS), on Average Body Weight  (g) against alloxan induced diabetes mellitus in rats. 
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Table 38: Effect   of   50% ethanolic  extract of   Portulaca  oleracea (whole plant), Eriobotrya   japonica  fruits  and  Eriobotrya  
japonica  seeds  on  Average Body Weight ( g) against  alloxan  induced  diabetes  mellitus  in  rats  ( 10  days  study) 
 Groups Treatment Average       Body       Weight       ( g) 
DAY  1 DAY 4 DAY 7 DAY 10 
I Normal  control 
0.2ml of 2%  gum acacia 
228.85 229.88 233.00(NS) 222.05(NS) 
II Diabetic control 
 Alloxan monohydrate 
180.58 163.86 152.21*** 124.76*** 
III  Alloxan monohydrate + Std  
drug  -Glibenclamide 
(10 mg/kg b.w) 
183.83 173.85 152.98(NS) 137.50** 
IV  Alloxan monohydrate  
+ PO(100 mg/kg b.w) 
167.20 167.00 163.12(NS) 145.50* 
V  Alloxan monohydrate 
+ PO(200 mg/kg b.w) 
156.37 153.98 148.15(NS) 150.61(NS) 
VI  Alloxan monohydrate 
+ EBJF(50 mg/kg b.w) 
180.53 177.23 171.36* 171.47* 
VII  Alloxan monohydrate 
+ EBJF(100 mg/kg b.w) 
188.58 185.48 179.58(NS) 172.62* 
VIII  Alloxan monohydrate 
+EBJF(200 mg/kg b.w) 
193.88 184.54 176.42(NS) 176.41** 
IX  Alloxan monohydrate 
+EBJS(100 mg/kg b.w) 
183.87 174.7 165.52** 162.37*** 
X  Alloxan monohydrate 
+ EBJS(200 mg/kg b.w) 
185.56 178.11 171.43* 167.20** 
Alloxan monohydrate (120 mg/kg), was administered i.p, in sterile saline, single dose, 5 days before the administration of different ethanolic extracts.  Standard  
drug, Glibenclamide & three plants  given as 50% ethanolic extracts in  2%  gum  acacia were  administered orally for 10 days, in a single dose daily five days after 
confirmation of hyperglycaemia..  
  n=6  ( No of animals in each group) except  in group  VII  where  n=5 ; 
DAY 10 compared with DAY 1 *p< 0.05  significant; **p<0.01  highly  significant; ***p< 0.001 very highly  significant; p> 0.05 non significant ( NS)  
 
Chapter 4         Observation And Results 
 
Ph.D Thesis                                 210                                          University of Kashmir 
 
4.3.2.2. Streptozotocin (15 day study) 
Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant 
(PO), Eriobotrya japonica fruits (EBJF) and Eriobotrya japonica  seeds (EBJS),  
against streptozotocin ( STZ) induced diabetes mellitus  in rats  was  studied   on the 
following parameters:-        
i. Serum  glucose levels (Recorded on day 1,day 4,day 9 and day 15)             
ii. Lipid  Profile 
a) Serum  Total  Cholesterol Levels               
b) Serum   Triglycerides   Levels                        
c) Serum   HDL Cholesterol    Levels              
d) Serum  LDL  Cholesterol  Levels                     
iii)  Liver function tests 
a) Serum bilirubin levels                    
b) Serum SGOT                                              
c) Serum SGPT levels                                          
d) Serum total proteins                               
e) Serum albumin                                                  
f) Serum alkaline phosphatase                            
iv) Body   Weight    (Recorded on day 1,day 4,day 9 and day 15)                         
  STATISTICAL ANALYSIS 
The  data obtained  from  the  different  studies  and the biochemical estimations is 
expressed as Mean ±  SEM  for  each  group. After this, the statistical analysis was 
carried out using one way analysis of variance (ANOVA) followed by student’s t-
test. Values p> 0.05 were considered non-significant, p< 0.05 significant, p<0.01 
highly significant and p<0.001 very highly significant respectively. 
B) Histopathological studies 
a) Pancreas, 
b) Kidney  
c) Liver.  
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The organs were taken out, preserved in 10% formalin and sent for histopathological 
studies.   
Serum   Glucose Levels (mg/dl) 
There  was  very highly significant  rise(p<0.001) in serum  glucose levels in rats  in 
the  diabetic  group ( Group II) (207.50±2.97 mg/dl) as  compared to  normal control 
(Group I) (77.62±4.95 mg/dl). Portulaca  oleracea  at the dose levels of  50  and 100 
mg/kg  b.w  showed a significant decrease   in the serum   glucose levels. A dose of 
50 mg/kg administered to rats of Group IV showed a highly significant decrease 
(p<0.01)  of  (166.99±3.29 mg/dl) and a dose of 100 mg/kg administered to rats of 
Group V showed a  very highly significant level (p<0.001)  of  (145.96±1.94 mg/dl).  
Eriobotrya japonica fruits at the dose levels of 50 and 100 mg/kg b.w  showed a very 
highly significant   decrease in serum glucose levels in a dose dependent   manner, as 
compared  to the group II  that had received only STZ.  A dose of  50 mg/kg b.w 
administered to rats of Group VI showed a  significant level (p<0.01)   of   
(152.06±4.35 mg/dl) and a dose of 100 mg/kg b.w administered to rats of Group VII 
showed a  very highly significant level (p<0.001) of (136.65±2.37 mg/dl). The  
levels of  EBJF  at the dose  of  100mg/kg b.w were found  to be  highly  
significant.  
The seeds of Eriobotrya japonica at the dose levels of 50 and 100 mg/kg bw   also 
revealed a significant   decrease   in serum   glucose   levels. A dose of 50 mg/kg b.w 
administered to rats of Group VIII showed a highly significant level (p<0.01) of 
(181.75±4.03) while a dose of 100 mg/kg b.w administered to rats of Group IX 
showed a very highly significant level (p<0.001) of (150.22±5.34mg/dl). The 
standard drug, glibenclamide administered to rats of Group III also showed a very 
highly significant   decrease (p<0.001). in the  serum   glucose   levels (129.56±12.97 
mg/dl) (Table 39; Fig 37) 
Serum Total Cholesterol Levels ( mg/dl)  
As  compared  to  group I (88.22 ±2.01 mg/dl)  the  levels  in the  group II   rats 
which  had received  only  STZ, there was very  highly  significant  increase 
(p<0.001)  in the  total cholesterol   levels (195.18±3.54 mg/dl). When  50% 
ethanolic  extract  of  Portulaca  oleracea (50 mg/kg b.w)   was   administered to rats 
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of Group IV,  it   showed   a    significant  decrease ( p<0.05)  (180.56±1.56 mg/dl) 
but  dose  of  100 mg/kg b.w administered to rats of Group V showed  a  highly  
significant  decrease (p<0.01)   in the  total   cholesterol   levels (171.09±1.20 mg/dl). 
 Eriobotrya japonica fruits at the dose levels of 50 and 100 mg/kg b.w  showed a 
very highly significant   decrease in total cholesterol levels in a dose dependent   
manner, as compared  to the group II  that had received only STZ.    A dose of  50 
mg/kg b.w administered to rats of Group VI showed a  highly significant level 
(p<0.01)  of (161.46±2.66 mg/dl) and   a dose  of   100 mg/kg administered to rats of 
Group VII  showed a very highly significant level (p<0.001) of (132.92±4.63 mg/dl). 
The levels of EBJF at the dose of 100mg/kg b.w were found   to be very highly 
significant.  
The seeds of Eriobotrya japonica at the dose levels of 50 and 100 mg/kg bw   also 
showed a significant   decrease   in total cholesterol   levels. A dose  of 50 mg/kg b.w 
administered to rats of Group VIII showed a highly significant  level (p< 0.01)   of  
(182.54±1.97 mg/dl) while a dose  of   100 mg/kg b.w administered to rats of Group 
IX showed a very highly significant level (p< 0.001) of  (130.35± 3.30 mg/dl). The 
standard drug, glibenclamide administered to rats of Group III also showed a non-
significant   decrease (p>0.05) in the  total  cholesterol  levels (193.34±5.69 mg/dl). 
(Table 41; Fig 38) 
 Serum Triglycerides Levels (mg/dl) 
 The  rats of group I  showed  a level of  (76.71±3.45 mg/dl), while the rats of group 
II   which  received  only   STZ  showed a  very highly significant level(p<0.001)   of   
(193.01±4.84 mg/dl). The   rats  of the  groups  receiving 50%  ethanolic  extract of  
Portulaca  oleracea showed a dose  dependent   reduction in  serum  triglycerides  
indicating   significant  reduction in lipid  profile.  A dose  of 50 mg/kg b.w 
administered to rats of Group IV revealed a  significant level (p<0.01)  of 
(162.44±4.44 mg/dl) and a dose of 100 mg/kg b.w administered to rats of Group V 
showed a very highly significant level(p<0.001) of  (149.09± 2.38 mg/dl). 
 The  dose of   50 and 100 mg/kg  b.w  of   fruits  of Eriobotrya  japonica   when 
administered to rats    showed an extremely significant  decrease when  compared to 
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the levels of  diabetic   control rats of Group II rats. A dose  of 50 mg/kg b.w 
administered to rats of Group VI showed a highly significant  level (p<0.01) of 
(159.90±5.68 mg/dl) while  a dose of   100 mg/kg b.w administered to rats of Group 
VII  showed a very highly significant level (p<0.001) of  (124.95 ±5.68 mg/dl).   
Moreover, the Groups treated with 50 mg and 100 mg of seeds of Eriobotrya 
japonica seeds also showed a significant decrease in triglycerides. A dose of 50 
mg/kg administered to rats of Group VIII showed a highly significant level (p<0.01) 
of (152.34±3.60 mg/dl) while   a dose   of   100mg/kg b.w administered to rats of 
Group IX showed a very highly significant level (p<0.001)  of  (134.69±3.30 mg/dl). 
The standard drug, glibenclamide administered to rats of Group III   also showed a  
non-significant decrease (p>0.05). In the serum triglycerides levels (186.96±4.31 
mg/dl) (Table 42; Fig 39) 
Serum HDL Cholesterol Levels (mg/dl) 
There  was  very highly significant  decrease (p<0.001) in  serum HDL cholesterol 
levels in rats  in the  diabetic  group ( Group II) (18.88±2.62 mg/dl)   as  compared to  
normal control (Group I) (33.07±2.15 mg/dl). Portulaca  oleracea  at the dose levels 
of  50  and 100 mg/kg  b.w  showed a significant  increase   in the  serum HDL 
cholesterol levels. A dose of 50 mg/kg administered to rats of Group IV showed a 
non-significant increase (p>0.05)  of (25.91±4.64 mg/dl) while a dose of 100 mg/kg  
given to rats of Group V showed a  highly significant  increase (p<0.01) of 
(29.59±2.86 mg/dl) . 
Eriobotrya japonica fruits in the dose levels of 50 and 100 mg/kg b.w showed a very 
highly significant   decrease in  serum HDL cholesterol  levels in a dose dependent   
manner, as compared  to the group II  that had received only STZ.  A dose of 50 
mg/kg b.w administered to rats of Group VI showed a significant increase p<0.05) of  
(22.65± 0.77 mg/dl) and  a dose of 100 mg/kg b.w administered to rats of Group VII 
showed a  highly  significant  level (p<0.01) of   (30.37±3.95 mg/dl). The levels of 
EBJF at the dose of 100mg/kg b.w were found to be highly significant.  
The seeds of Eriobotrya japonica at the dose levels of 50 and 100 mg/kg bw   also 
showed a significant increase in serum HDL cholesterol levels. A dose of 50 mg/kg  
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b.w administered to rats of Group VIII showed a level of significant  level(p<0.05)  
of (26.11± 3.73 mg/dl) while a dose of  100 mg/kg b.w administered to rats of Group 
IX showed a highly significant  level (p<0.01) of (26.48±1.86 mg/dl). The standard 
drug, glibenclamide administered to rats of Group III also revealed a non-significant   
increase (p>0.05). in the  serum HDL cholesterol    levels (19.75±1.95 mg/dl) (Table 
43; Fig 40). 
Serum LDL Cholesterol Levels (mg/dl) 
As  compared  to  group I (42.51±2.35 mg/dl ) the  levels  in the  group II   rats which  
had received  only  STZ  there was very  highly  significant  increase (p<0.001) in the  
serum LDL cholesterol   levels (87.02±3.07 mg/dl).  When  50% ethanolic  extract  
of  Portulaca  oleracea (50 mg/kg b.w)   was  administered  to rats of Group IV it   
showed   a     non significant  decrease (p>0.05)  (82.36±3.91 mg/dl) while a  dose  of  
100 mg/kg b.w administered to rats of Group V showed  a  significant  decrease 
(p<0.05)  in the  serum LDL   cholesterol   levels (74.04±3.76 mg/dl ).  
Eriobotrya japonica fruits in the dose levels of 50, 100 mg/kg b.w  showed a  
significant   decrease in serum LDL cholesterol levels in a dose dependent   manner, 
as compared  to the group II  that had received only STZ.   A dose of  50 mg/kg b.w 
administered to rats of Group VI showed a  non significant level (p>0.05) of  
(92.56±2.52  mg/dl)  while   a dose  of   100 mg/kg administered to rats of Group VII  
showed a  significant  level (p<0.05) of  (75.01±2.58 mg/dl).  
The seeds of Eriobotrya  japonica  at the dose levels  of 50 and  100 mg/kg b.w   
also showed  a significant   decrease   in serum LDL  cholesterol   levels. A dose  of 
50 mg/kg b.w administered to rats of Group VIII showed a  non  significant  level 
(p>0.05) of  (72.26±2.67 mg/dl) while a dose  of   100 mg/kg b.w administered to 
rats of Group IX showed a  significant  level (p<0.05) of   (63.21±3.62 mg/dl). The  
standard  drug, glibenclamide administered to rats of Group III  also showed  a   non 
significant   decrease (p>0.05) in the  serum  LDL  cholesterol    levels  (86.26 ±3.02) 
mg/dl (Table 44; Fig 41). 
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Serum   Bilirubin  Levels ( mg/dl) 
 The  rats of group I  showed  a level of  (0.55±0.05 mg/dl),   while the rats of group 
II   which  received  only   STZ  showed a highly significant level (p<0.001)   of 
(3.11±0.23 mg/dl). The   rats  of the  groups  receiving 50%  ethanolic  extract of  
Portulaca  oleracea showed a dose  dependent   reduction in  serum  bilirubin levels. 
A dose of 50 mg/kg b.w administered to rats of Group IV showed a significant  level 
(p<0.05)  of (1.61±0.17 mg/dl) while  a dose of 100mg/kg b.w administered to rats of 
Group V showed a highly significant reduction (p<0.01) of (0.75± 0.11 mg/dl).  
The dose of   50 and 100 mg/kg b.w of fruits of Eriobotrya  japonica   when 
administered to rats    showed an extremely significant  decrease when  compared to 
the levels of  diabetic   control rats of Group II. A dose of 50 mg/kg b.w administered 
to rats of Group VI showed a significant level (p<0.05) of (1.65±0.12 mg/dl) while a 
dose of   100 mg/kg b.w administered to rats of Group VII showed  a significant 
value (p<0.01) of (0.64±0.12 mg/dl). 
 Moreover, the Groups treated with 50 mg and 100 mg of seeds of Eriobotrya 
japonica seeds also showed a significant decrease in serum bilirubin levels. A dose 
of 50 mg/kg b.w administered to rats of Group VIII showed a significant level 
(p<0.05)   of (2.83±0.11 mg/dl) while   a dose   of   100mg/kg b.w administered to 
rats of Group IX showed   a highly significant level (p<0.01) of (1.55±0.10 mg/dl). 
The standard drug, glibenclamide administered to rats of Group III also showed a   
non-significant   level (p>0.05).  In the serum bilirubin levels (2.54±0.15 mg/dl) 
(Table 45; Fig 42) 
Serum SGOT Levels (IU/L) 
There  was  a highly significant  rise (p<0.01) in serum SGOT levels in rats  in the  
diabetic  group,  Group II (32.12±4.23 IU/L))  as  compared to  normal control 
(Group I) (21.61±1.31 IU/L). Portulaca  oleracea  at the dose levels of  50  and 100 
mg/kg  b.w  showed a significant decrease   in the serum SGOT  levels. A dose of  50 
mg/kg administered to rats of Group IV showed  a  non significant decrease (p>0.05)    
of  (28.58±1.60 IU/L) and a dose of 100 mg/kg administered to rats of Group V 
showed a significant  decrease of  (18.17±1.02 IU/L) (p<0.05).               
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Eriobotrya japonica fruits at the dose levels of 50 and 100 mg/kg b.w  showed a 
significant   decrease in  serum SGOT levels in a dose dependent   manner, as 
compared  to the group II  that had received only STZ.  A dose of 50 mg/kg b.w 
administered to rats of Group VI showed a non-significant level (p>0.05)   of  
(25.98±1.85 IU/L), a dose of 100 mg/kg b.w administered to rats of Group VII 
showed a significant  level (p<0.05).of (17.95±2.27 IU/L ). 
The seeds of Eriobotrya japonica at the dose levels of 50 and 100 mg/kg b.w   also 
showed a significant   decrease   in serum SGOT   levels. A dose of 50 mg/kg  b.w 
administered to rats of Group VIII showed a  non significant level (p>0.05)  of  
(28.39±1.26 IU/L) and a dose of  100 mg/kg b.w administered to rats of Group IX 
showed a  significant level (p<0.05).  of (21.90±1.51 IU/L). The  standard  drug, 
glibenclamide administered to rats of Group III   also showed  a  non significant   
decrease (p>0.05).   in the  serum SGOT   levels (31.77±1.46 IU/L) (Table 46; Fig 
43) 
Serum SGPT   Levels (IU/L) 
As  compared  to  group I (26.06 ±1.78 IU/L) the  levels  in the  group II   rats which  
had received  only  STZ, there was   highly  significant  increase (p<0.01)  in the  
serum SGPT   levels (40.72±2.28 IU/L). When  50% ethanolic  extract  of  Portulaca  
oleracea (50 mg/kg b.w) administered to rats of Group IV    it   showed   a    non 
significant   decrease (p>0.05)  of   (29.69±2.27 IU/L) while a  dose  of  100 mg/kg 
b.w administered to rats of Group V showed  a    significant  decrease   in the  serum 
SGPT   levels (23.03±1.76 IU/L)(p<0.05). 
Eriobotrya japonica fruits at the dose levels of 50 and 100 mg/kg b.w  showed a  
highly significant   decrease in  serum SGPT  levels, as compared  to the group II  
that had received only STZ.    A dose of  50 mg/kg b.w administered to rats of Group 
VI showed a non significant   level (p>0.05) of  (26.06±1.63 IU/L)   and   a dose  of   
100 mg/kg administered to rats of Group VII showed a  highly significant level 
(p<0.01)   of  (18.92±0.73 IU/L).  
The seeds of Eriobotrya  japonica  at the dose levels  of 50 and  100 mg/kg bw   also 
showed  a significant   decrease   in serum SGPT   levels. A dose  of 50 mg/kg b.w 
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administered to rats of Group VIII showed a non significant  level (p>0.05) of  
(28.13±1.02 IU/L),   and a dose  of   100 mg/kg b.w administered to rats of Group IX 
revealed a highly significant level(p<0.01) of (23.45±0.99 IU/L). The  standard  drug, 
glibenclamide administered to rats of Group III  also revealed  a   non significant   
decrease (p>0.05). in the  serum SGPT  levels (38.13±1.97 IU/L) (Table 47; Fig 44) 
Serum Total Proteins Levels (g/dl) 
 The  rats of group I  showed  a level of  (7.13±0.31 g/dl)  while the rats of group II   
which  received  only   STZ  showed a  significant decrease (p<0.05)  of (4.79±0.33 
g/dl). The   rats  of the  groups    receiving 50%  ethanolic  extract of  Portulaca  
oleracea showed a  non significant increase in  serum  total proteins. A dose of 50 
mg/kg b.w administered to rats of Group IV showed a non significant  level (p>0.05) 
of  (4.55±0.34 g/dl) and a dose of 100 mg/kg b.w administered to rats of Group V 
showed a  non significant level (p>0.05) of  (5.99±0.17 g/dl).    
The  dose of   50 and 100 mg/kg  b.w  of   fruits  of Eriobotrya  japonica   when 
administered to rats    showed a  significant  increase when  compared to the levels of  
diabetic   control rats of Group II rats. A dose  of 50 mg/kg b.w administered to rats 
of Group VI showed a  non significant  level (p>0.05) of (4.67±0.27 g/dl)  while  a 
dose of   100 mg/kg b.w administered to rats of Group VII showed a  significant level 
( p<0.05)  of  (6.28±0.21 g/dl).  
 Moreover, the Groups treated with  50 mg and  100 mg of seeds of Eriobotrya  
japonica  seeds also revealed  a   non significant increase in  serum total proteins. A 
dose of 50 mg/kg administered to rats of Group VIII showed a non significant value 
of (p>0.05) of (4.92±0.18 g/dl) while   a dose   of   100mg/kg b.w administered to 
rats of Group IX  showed   a  non significant level of  (p>0.05) (5.93±0.31 g/dl).                                     
The  standard  drug, glibenclamide administered to rats of Group III  also showed  a   
non significant   level (p>0.05)   in the  serum total proteins   levels (5.41±0.26 g/dl). 
(Table 48; Fig 45) 
Serum Albumin Levels (g/dl) 
There  was significant  decrease  in serum  albumin  levels in rats  in the  diabetic  
group (Group II) (1.16±0.19 g/dl) (p<0.05)  as  compared to  normal control (Group 
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I) (2.65±0.09 g/dl).   Portulaca  oleracea  at the dose levels of  50 and 100 mg/kg  
b.w  showed a  non significant levels    in the serum albumin  levels. A dose of  50 
mg/kg administered to rats of Group IV showed  a non significant  level (p>0.05)   of 
(1.34±0.07 g/dl) while a dose of 100 mg/kg  administered to rats of Group V showed 
a non significant level (p>0.05)  of (2.08±0.21 g/dl) .          
      Eriobotrya japonica fruits at the dose levels of 50 and  100 mg/kg b.w  showed a  
non significant   increase in  serum albumin levels, as compared  to the group II  that 
had received only STZ.  A dose of  50 mg/kg b.w administered to rats of Group VI 
showed a non significant level of (p>0.05)  (1.40±0.10 g/dl), a dose of 100 mg/kg 
administered to rats of Group VII b.w showed a  non significant level (p>0.05)  of 
(2.08±0.21g/dl) . 
 The seeds of Eriobotrya  japonica  at the dose levels  of 50 and  100 mg/kg b.w   
also showed  a  non significant   levels (p>0.05)   in serum albumin   levels. A dose 
of 50 mg/kg  b.w administered to rats of Group VIII showed a level (p>0.05)  of  
(1.46±0.18 g/dl)  and a dose of  100 mg/kg b.w  administered to rats of Group IX 
showed a  non significant  level (p>0.05) of  (1.68±0.03 g/dl).  The standard  drug, 
glibenclamide administered to rats of Group III   also showed  a   non significant   
levels (p>0.05)    in the  serum albumin   levels (1.57±0.13g/dl) (Table 49; Fig 46)  
Serum Alkaline  Phosphatase  Levels (U/L) 
 As  compared  to  group I (78.20±4.60 U/L),  the  levels  in the  group II   rats which  
had received  only  STZ, there was   highly  significant  increase in the  serum 
alkaline phosphatase   levels (92.88±2.58 U/L) (p<0.01). When  50% ethanolic  
extract  of  Portulaca  oleracea (50 mg/kg b.w)   was  administered  to rats of Group 
IV it   showed   a    non significant  levels (p>0.05)  of (92.28±2.06 U/L)   but  dose  
of  100 mg/kg b.w administered to rats of Group V showed  a    significant  decrease 
(p<0.05) in the   serum alkaline phosphatase levels ( 81.39±6.85 U/L)   
  Eriobotrya japonica fruits at the dose levels of 50 and 100 mg/kg b.w  showed a 
non significant   levels  of serum alkaline phosphatase  levels, as compared  to the 
group II  that had received only STZ.  A dose of  50 mg/kg b.w administered to rats 
of Group VI showed a nonsignificant  level(p>0.05)  of (92.34±3.09 U/L) and   a 
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dose  of   100 mg/kg administered to rats of Group VII  showed a non significant  
level (p>0.05)  of  (91.53±1.68 U/L).    
The seeds of Eriobotrya  japonica  at the dose levels  of 50 and  100 mg/kg bw   also 
showed  a  non significant   levels of  serum alkaline phosphatase   levels. A dose  of  
50 mg/kg b.w administered to rats of Group VIII showed a  non significant level 
(p>0.05)  of  (91.31±3.84 U/L)   and a dose  of   100 mg/kg b.w administered to rats 
of Group IX showed a  non significant  level of (p>0.05) (87.87±5.04 U/L).   The  
standard  drug, glibenclamide administered to rats of Group III  also showed  a   non 
significant   level (p>0.05)  of serum alkaline phosphatase  levels (86.92±1.59 U/L) 
(Table 50; Fig 47) 
 Besides recording the effect on biochemical parameters effect on body weight of rats 
revealed the following results.  
Average Body Weight   (g) 
The  rats of group I  showed  an average weight  of (267.23±13.09 g) while the rats 
of group II   which  received  only   STZ  showed a  very highly significant decrease  
of  (158.80±7.51  g) (p<0.001) in average body weight. The   rats  of the  groups  
receiving 50%  ethanolic  extract of  Portulaca  oleracea showed a dose  dependent   
increase  in   average body weight.  A dose of 50 mg/kg b.w administered to rats of 
Group IV showed a  significant level (p<0.05)  of (207.18±11.12 g) and a dose of 
100 mg/kg b.w administered to rats of Group V showed a highly significant level 
(p<0.01)  of (238.78 ±10.12  g)  
The  dose of   50  and  100 mg/kg  b.w  of   fruits  of Eriobotrya  japonica   when 
administered to rats    showed an extremely significant  increase when  compared to 
the levels of  diabetic   control rats of Group II . A dose  of 50 mg/kg b.w 
administered to rats of Group VI showed a  significant average body weight (p<0.05)  
of   (222.12 ±13.83  g) while  a dose of   100 mg/kg b.w administered to rats of 
Group VII showed a  highly significant average body weight ( p<0.01)  of 
(245.50±4.28  g).  
 Moreover, the  groups treated with  50 mg and  100 mg of seeds of Eriobotrya  
japonica  seeds also showed  a  significant increase in average body weight. A dose 
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of  50 mg/kg administered to rats of Group VIII  showed a  significant average body 
weight (p<0.05) of  (220.45±6.27  g) while   a dose   of   100mg/kg b.w administered 
to rats of Group IX  showed   a  highly significant average body weight (p<0.01). of 
(240.57±7.68  g). The standard drug, glibenclamide administered to rats of Group III 
also showed a   non-significant increase (p>0.05) in the average body weight 
(160.00±8.69 g) (Table 51; Fig 48) 
During the course of these studies blood glucose level and average body weight were 
recorded on day 1, day 4, day 9 and day 15 (Table 40; 52)  
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Table  39:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS) on  Serum  Glucose Levels (mg/dl) against Streptozotocin ( STZ) induced diabetes mellitus  in rats (15 
day study)                                                                                                                                   
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control 
(0.2 ml of 
2% gum  
acacia) 
Diabetic 
control 
( STZ) 
STZ + Std  
Antidiabetic 
drug 
Glibenclamide 
(3mg/kg) 
STZ + 
PO 
 (50mg/kg) 
STZ+ 
PO 
 (100mg/kg) 
STZ + 
EBJF 
(50mg/kg) 
STZ + 
EBJF  
(100mg/kg) 
STZ+ 
EBJS 
(50mg/kg) 
STZ+ 
EBJS 
(100mg/kg) 
1 72.05 200.45 120.34 170.23 145.34 155.73 130.41 189.71 160.03 
2 92.23 220.31 190.51 165.06 143.12 153.14 145.16 184.64 153.46 
3 90.63 210.32 110.05 175.05 154.31 164.63 138.41 169.14 157.03 
4 68.42 205.36 100.42 155.45 145.32 138.23 135.21 187.56 163.06 
5 80.05 207.32 130.72 160.62 147.45 140.32 130.42 190.12 135.45 
6 62.34 201.24 125.32 175.56 140.23 160.31 140.34 169.36 132.32 
Mean 77.62 207.5*** 129.56*** 166.99** 145.96*** 152.06** 136.65*** 181.75** 150.22*** 
SD 12.14 7.28 31.77 8.07 4.76 10.67 5.81 9.87 13.08 
SEM 4.95 2.97 12.97 3.29 1.94 4.35 2.37 4.03 5.34 
P Value  p < 0.001 p < 0.001 p < 0.01 p < 0.001 p < 0.01 p < 0.001 p < 0.01 p < 0.001 
Statistically 
Compound 
Groups 
 
II Vs I III Vs  II IV  Vs  II V  Vs II VI  Vs II VII  Vs  II VIII  Vs II IX Vs II 
STZ Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected  i.p. single dose  Diabetes confirmed on third day post administration of 
streptozotocin.   Standard  drug  Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily 
after  confirmation of hyperglycaemia.   
n  =  6  (Number   of  animals   in each   group)  
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II  
*** p < 0.001 Very  highly  significant;  ** p< 0.01; Highly  significant;                                                                                                                                                                              
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Anti-diabetic Study  using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 37:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Glucose Levels ( mg/dl) against streptozotocin induced diabetes  mellitus in rats. 
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Table 40:  Effect   of   50% ethanolic  extract of   Portulaca  oleracea(PO) whole plant, Eriobotrya   japonica  fruits(EBJF)  and  Eriobotrya  japonica  
seeds (EBJS)  on  Blood   Glucose   Levels  ( mg/dl) against  Streptozotocin  induced  diabetes  mellitus in  rats . 
Groups Treatment Blood    Glucose   Levels( mg/dl) 
  DAY  1 DAY 4 DAY 9 DAY15 
I Normal  control 
0.2 ml of 2%  gum  acacia 
80.83±3.63 79.58±3.37 80.26±3.96(NS) 77.62±4.96(NS) 
II Diabetic control 
0.2 ml of 2%  gum  acacia 
200.48±2.89 200.24±3.67 206.76±3.23(NS) 207.50±2.97(NS) 
III STZ+ Std  drug Glibenclamide (3mg/kg. 
b.w) 
220.85±2.37 201.98±6.58 158.71±4.04** 129.56±12.97** 
IV STZ + P.O (50 mg/kg b.w) 210.52±2.29 186.10±2.44 176.99±1.73** 166.99±3.29*** 
V STZ + P.O1(00 mg/kg b.w) 220.84±1.70 193.01±3.47 167.87±3.67** 145.96±1.95*** 
VI STZ + EBJF (50 mg/kg b.w) 215.50±2.09 184.83±1.91 167.98±3.06** 152.06±4.36*** 
VII STZ + EBJF (100 mg/kg b.w) 225.27±1.98 202.59±4.19 176.92±3.82** 136.65±2.37*** 
VIII STZ + EBJS (50 mg/kg b.w) 210.36±1.90 208.49±2.09 185.23±3.67** 181.76±4.03*** 
IX STZ + EBJS (100 mg/kg b.w) 220.99±1.96 205.59±3.70 177.52±5.35** 150.23±5.34*** 
STZ Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected  i.p. single dose  Diabetes confirmed on third day post administration of 
streptozotocin.   Standard  drug  Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily 
after  confirmation of hyperglycaemia.   
n  =  6  (Number   of  animals   in each   group)  
DAY 1 compared with  DAY 15 
 **p<0.01  highly  significant; ***p< 0.001 very highly  significant; p> 0.05 non significant ( NS) 
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Table  41 : Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on   Serum  Cholesterol Levels ( mg/dl) against Streptozotocin  ( STZ) induced diabetes  mellitus in  
rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII GroupVIII Group IX 
Rats 
 
 
Normal 
Control 
(0.2 ml of 2%  
gum  acacia) 
Diabetic 
control 
STZ + Std  
Antidiabetic  drug  
Glibenclamide 
(3mg/kg) 
STZ+ 
 PO 
 (50mg/kg)  
STZ+ 
 PO  
(100mg/kg)  
STZ+ 
 EBJF 
(50mg/kg)  
STZ + 
EBJF 
(100mg/kg)  
STZ+ 
EBJS 
(50mg/kg)  
STZ+ 
EBJS 
(100mg/kg)  
1 92.06 190.31 215.98 180.53 173.65 165.96 132.32 
183.87 138.23 
2 81.65 187.42 187.54 174.08 168.43 169.54 147.65 
176.34 134.32 
3 82.73 192.43 224.67 180.41 174.32 153.34 124.32 
184.32 129.31 
4 90.23 190.05 190.65 183.56 169.67 164.32 145.53 179.56 131.15 
5 89.12 210.34 160.56 179.62 173.07 154.19 127.67 
190.42 134.07 
6 93.56 200.53 180.67 185.21 167.43 161.45 120.05 
180.74 115.05 
Mean 88.22 195.18*** 193.34 180.56* 171.09** 161.46** 132.92*** 182.54** 130.35*** 
SD 4.92 8.67 13.94 3.83 2.94 6.51 11.34 4.84 8.09 
SEM 2.01 3.54 5.69 1.56 1.2 2.66 4.63 
1.97 3.3 
P Value  p < 0.001 p >0.05 p < 0.05 p < 0.01 p < 0.01 p < 0.001 p < 0.01 p < 0.001 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI  Vs II VII Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose.  Diabetes confirmed on third day post administration  of 
streptozotocin.   Standard  drug  Glibenclamide&  three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily 
after  confirmation of hyperglycaemia  
n  =  6  (Number   of  animals   in each   group)   
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II                                                                                                                                                                             
 *** p < 0..001 Very  highly  significant;  ** P< 0.01; Highly  significant;  *p< 0.05 significant      
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Anti-diabetic Study using Streptozotocin (STZ) in Rats (15-day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 38: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Cholesterol Levels ( mg/dl) against streptozotocin induced diabetes mellitus in rats.  
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Table  42: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on   Serum Triglycerides Levels ( mg/dl) against  Streptozotocin (STZ)  induced diabetes  mellitus in  
rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2%  
gum  acacia) 
Diabetic 
control  
STZ + Std  
Antidiabetic 
drug 
Glibenclamide 
(3mg/kg) 
STZ + 
 P.O. 
(50mg/kg)  
STZ+ 
 P.O 
(100mg/kg)  
STZ+ 
 EBJF 
(50mg/kg)  
STZ+  
EBJF 
(100mg/kg)  
STZ+ 
 EBJS 
(50mg/kg)  
STZ+  
EBJS 
(100mg/kg)  
1 84.05 190.67 213.89 163.53 143.42 165.07 120.37 153.96 132.64 
2 78.56 184.32 175.53 157.06 151.74 154..96 134.21 160.23 142.07 
3 66.32 195.96 214.56 180.64 147.17 174.45 141.56 156.63 125.34 
4 80.53 200.45 190.56 147.32 152.84 15734 110.63 159.56 126.63 
5 66.04 176.63 150.64 164.34 142.04 162.62 112.85 137.74 136.13 
6 84.73 210.07 176.59 161.76 157.05 140.06 130.08 145.95 145.38 
Mean 76.71 193.01*** 186.96 162.44** 149.09*** 159.90** 124.95*** 152.34** 134.69*** 
SD 8.46 11.86 10.57 10.9 5.85 12.7 12.33 8.82 8.09 
SEM 3.45 4.84 4.31 4.44 2.38 5.68 5.68 3.6 3.3 
P Value  p < 0.001 p >0.05 p < 0.01 p < 0.001 p < 0.01 p < 0.001 p < 0.01 p < 0.001 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V  Vs II VI Vs II VII Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose.  Diabetes confirmed on third day post administration  of 
streptozotocin.   Standard  drug  Glibenclamide &  three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily 
after  confirmation of hyperglycaemia. 
n  =  6  (  Number   of  animals   in each   group) 
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II      
*** p < 0.001 Very  highly  significant;  ** p< 0.01; Highly  significant; p>0.05 Non significant       
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Anti-diabetic Study using Streptozotocin (STZ) in Rats (15- day study)  
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 39:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Triglycerides Levels ( mg/dl) against  streptozotocin  induced diabetes mellitus in  rats.  
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Table  43: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS) on   HDL Cholesterol Levels ( mg/dl)   against  Streptozotocin (STZ) induced diabetes mellitus in  rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI  Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2% ) 
gum  acacia 
Diabetic 
control  
STZ + Std  
Antidiabetic drug 
Glibenclamide 
(3mg/kg.) 
STZ+ 
 PO 
 (50mg/kg)  
STZ+  
PO  
(100mg/kg)  
STZ+ 
 EBJF 
(50mg/kg)  
 
 
 
STZ+  
EBJF 
(100mg/kg)  
STZ+  
EBJS 
(50mg/kg)  
STZ+  
EBJS 
(100mg/kg)  
1 33.97 16.41 18.97 26.08 26.32 25.07  26.53 23.86 27.45 
2 30.45 14.07 19.76 45.34 21.34 20.45  32.39 35.06 31.75 
3 29.64 12.46 20.45 31.64 32.04 23.74  45.74 32.45 24.78 
4 26.34 21.08 19.74 21.34 38.52 20.67  21.08 21.43 22.31 
5 37.73 30.34 21.98 16.53 23.28 23.95  35.95 32.78 21.06 
6 40.34 18.96 17.64 14.56 36.07 22.07  20.56 11.05 31.56 
Mean 33.07 18.88*** 19.75 25.91 29.59** 22.65*  30.37** 26.11* 26.48** 
SD 5.27 6.42 4.79 11.38 7.01 1.88  9.68 9.14 4.56 
SEM 2.15 2.62 1.95 4.64 2.86 0.77  3.95 3.73 1.86 
P Value  p < 0.001 p >0.05 p > 0.05 p < 0.01 p < 0.05  p < 0.01 p < 0.05 p < 0.01 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI Vs II  VII Vs II VIII Vs II IX Vs II 
           
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p. single dose  Diabetes confirmed on third day post administration  of streptozotocin.   
Standard  drug  Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of 
hyperglycaemia. 
 n  =  6  (  Number   of  animals   in each   group)  
 Group  II  is compared   with   Group   I  and   all other   groups are   compared   with  Group  
*** p < 0.001 Very  highly  significant;  ** P< 0.01; Highly  significant; *p<0.05 significant; p>0.05  Non significant     
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Anti-diabetic Study  using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 40:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on HDL Cholesterol Levels ( mg/dl)   against  streptozotocin induced diabetes mellitus in rats.  
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Table 44 : Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on    LDL Cholesterol Levels ( mg/dl) against Streptozotocin  (STZ) induced diabetes  mellitus  in 
rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII GroupVIII Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2%  
gum  acacia) 
Diabetic 
control  
STZ + Std 
 Antidiabetic drug 
Glibenclamide 
(3mg/kg) 
STZ+ 
 PO 
 (50mg/kg)  
STZ+ 
 PO  
(100mg/kg)  
STZ+ 
 EBJF 
(50mg/kg)  
STZ+ 
 EBJF 
(100mg/kg)  
STZ+ 
EBJS. 
(50mg/kg)  
STZ+ 
 EBJS 
(100mg/kg)  
1 43.07 90.56 89.07 89.74 76.42 98.65 75.43 70.75 65.73 
2 36.43 86.54 90.45 83.72 69.63 95.32 74.56 75.83 67.62 
3 42.67 74.42 76.12 79.64 78.62 84.73 65.51 63.23 48.82 
4 38.73 90.56 94.45 86.06 64.86 90.07 8513 67.52 73.05 
5 41.03 83.67 87.96 90.45 89.03 99.54 76.73 81.74 56.45 
6 53.12 96.42 79.56 64.56 65.72 87.05 73.08 74.52 67.62 
Mean 42.51 87.02*** 86.26 82.36 74.04* 92.56 75.01* 72.26 63.21*  
SD 5.76 7.53 7.41 9.58 9.21 6.18 6.31 6.54 8.88 
SEM 2.35 3.07 3.02 3.91 3.76 2.52 2.58 2.67 3.62 
P Value  p < 0.001 p >0.05 p > 0.05 p < 0.05 p > 0.05 p < 0.05 p > 0.05 p < 0.05 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI Vs II VII  Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose. Diabetes confirmed on third day post administration  of streptozotocin.   Standard  drug  
Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia.  
n  =  6  (  Number   of  animals   in each   group)  
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II   
***p<0.001 Very  highly  significant;  ** P< 0.01; Highly  significant; *p<0.05 significant; p>0.05  Non significant      
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Anti-diabetic Study using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 41:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on LDL Cholesterol Levels ( mg/dl) against streptozotocin  induced diabetes mellitus in rats. 
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Table  45:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on     Serum  Bilirubin  Levels  (mg/dl)  against  streptozotocin (STZ) induced diabetes mellitus in 
rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2%  
gum  acacia) 
Diabetic 
control  
STZ+ Std  
Antidiabetic drug  
Glibenclamide 
(3mg/kg.) 
STZ+ 
 PO 
(50mg/kg)  
STZ+ 
 PO  
(100mg/kg)  
STZ+ 
 EBJF 
(50mg/kg)  
STZ+ 
 EBJF 
(100mg/kg)  
 STZ+ 
EBJS 
(50mg/kg)  
STZ+ 
 EBJS 
(100mg/kg)  
1 0.64 2.45 2.97 1.45 0.83 1.67 0.19 2.45 1.43 
2 0.72 3.21 3.01 1.61 0.76 1.74 0.95 2.67 1.54 
3 0.52 2.95 2.45 1.45 1.12 2.18 0.56 3.17 1.94 
4 0.48 3.67 1.98 0.97 0.95 1.56 0.73 2.78 1.45 
5 0.57 2.56 2.43 2.15 0.32 1.45 0.43 3.12 1.78 
6 0.37 3.85 2.42 2.03 0.56 1.34 0.98 2.84 1.21 
Mean 0.55 3.11*** 2.54 1.61* 0.75** 1.65* 0.64** 2.83* 1.55** 
SD 0.12 0.57 0.38 0.43 0.28 0.29 0.3 0.27 0.26 
SEM 0.05 0.23 0.15 0.17 0.11 0.12 0.12 0.11 0.1 
P Value  p < 0.001 p >0.05 p < 0.05 p <0.01 p< 0.05 p<0.01 p < 0.05 p < 0.01 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V  Vs II VI Vs II VII  Vs II VIII  Vs II IX  Vs  II 
STZ issolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose. Diabetes confirmed on third day post administration  of streptozotocin Standard  drug  Glibenclamide &  
three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia 
. n  =  6  (Number   of  animals   in each   group) 
 Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II      
  *** p < 0.001 Very  highly  significant;  ** P< 0.01; Highly  significant; *p<0.05 significant; p>0.05 Non significant                                                                                                 
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Anti-diabetic Study using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 42: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Bilirubin Levels (mg/dl) against streptozotocin induced diabetes mellitus in rats. 
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Table 46 : Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on    SGOT ( IU/L) against Streptozotocin ( STZ) induced diabetes mellitus in rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control 
(0.2 ml of 
2%  gum  
acacia) 
Diabetic 
control 
STZ + Std 
Antidiabetic 
drug 
Glibenclamide 
(3mg/kg) 
STZ+ 
PO 
(50mg/kg) 
STZ+ 
PO 
(100mg/kg) 
STZ+ 
EBJF 
(50mg/kg) 
STZ+ 
EBJF 
 (100mg/kg) 
STZ+ 
EBJS 
(50mg/kg) 
STZ+ 
EBJS 
(100mg/kg) 
1 19.75 21.53 29.98 26.05 15.91 20.96 18.63 28.75 25.56 
2 22.32 32.09 32.67 28.91 17.56 27.45 15.03 26.45 27.07 
3 21.72 41.53 31.89 31.56 19.07 24.62 12.64 23.43 21.46 
4 27.21 38.73 28.67 27.07 21.45 32.86 27.96 30.56 19.06 
5 21.04 41.23 34.98 23.53 20.13 28.57 19.43 32.13 17.47 
6 17.63 34.14 32.45 34.38 14.95 21.45 14.05 29.05 20.81 
Mean 21.61 32.12** 31.77 28.58 18.17* 25.98 17.95* 28.39 21.9* 
SD 3.2 10.36 3.58 3.91 2.5 4.55 5.56 3.08 3.72 
SEM 1.31 4.23 1.46 1.6 1.02 1.85 2.27 1.26 1.51 
P Value  p < 0.01 p > 0.05 p > 0.05 p < 0.05 p > 0.05 p < 0.05 p > 0.05 p < 0.05 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V  Vs II VI Vs II VII Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose.  Diabetes confirmed on third day post administration  of streptozotocin.   Standard  drug  
Glibenclamide &  three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia. 
n  =  6  ( Number   of  animals   in each   group)  
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II                                                              
** P< 0.01; Highly  significant; *p<0.05 significant ;p>0.05 Non significant                                                                                                  
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Anti-diabetic Study  using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 43: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on SGOT Levels ( IU/L) against streptozotocin induced diabetes mellitus in rats. 
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Table 47 : Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on     SGPT ( IU/L)  against Streptozotocin  ( STZ) induced diabetes  mellitus in  rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control 
(0.2 ml 
of 2%  
gum  
acacia) 
Diabetic 
control  
STZ +Std  
Antidiabetic 
drug 
Glibenclamide 
(3mg/kg.) 
STZ+ 
 P.O. 
(50mg/kg)  
STZ+ 
 P.O  
(100mg/kg)  
STZ+ 
 EBJF 
(50mg/kg)  
STZ+ 
 EBJF 
(100mg/kg)  
 STZ+ 
EBJS 
 (50mg/kg)  
STZ+ 
 EBJS 
(100mg/kg)  
1 21.94 34.04 41.98 32.04 24.42 26.07 17.75 27.86 26.53 
2 26.39 45.56 34.67 27.75 21.54 25.45 19.03 23.43 21.62 
3 28.06 41.82 40.34 38.65 21.63 27.62 21.57 29.56 20.73 
4 32.56 38.43 32.54 24.52 19.03 18.63 18.02 30.52 25.57 
5 27.03 36.05 39.51 31.48 20.46 28.46 20.46 27.95 24.67 
6 20.43 48.45 39.78 23.74 31.07 30.14 16.74 29.46 21.61 
Mean 26.06 40.72** 38.13 29.69 23.02* 26.06 18.92** 28.13 23.45* 
SD 4.38 5.58 4.84 5.56 4.32 4.01 1.8 2.51 2.43 
SEM 1.78 2.28 1.97 2.27 1.76 1.63 0.73 1.02 0.99 
P Value  p < 0.01 p > 0.05 p > 0.05 p < 0.05 p > 0.05 p< 0.01 p > 0.05 p < 0.01 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI Vs II VII Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p. single dose.  Diabetes confirmed on third day post administration  of streptozotocin.   Standard  drug  
Glibenclamide &  three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia. 
n  =  6  (  Number   of  animals   in each   group) significant     
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II   
** P< 0.01; Highly  significant ; *p< 0.05  significant ; p> 0.05  Non significant                                                                                               
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Anti-diabetic Study using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 44: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on SGPT Levels (IU/L) against streptozotocin induced diabetes mellitus in rats. 
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Table  48: Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on     Serum Total Proteins Levels  (gm/dl)  against Streptozotocin induced diabetes mellitus in rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2%  
gum  acacia) 
Diabetic 
control  
STZ +Std  
Antidiabetic 
drug 
Glibenclamide 
(3mg/kg.) 
STZ+ 
 PO 
 (50mg/kg)  
 STZ+ 
PO 
 (100mg/kg)  
STZ+  
EBJF 
 (50mg/kg)  
 STZ+ 
EBJF 
(100mg/kg)  
 STZ+ 
EBJS  
(50mg/kg)  
STZ+ 
 EBJS 
(100mg/kg)  
1 7.37 5.15 4.54 5.28 6.45 5.17 6.65 4.97 5.25 
2 6.93 5.47 5.18 5.42 5.68 4.93 6.36 4.53 6.83 
3 7.86 4.92 5.62 4.91 5.42 3.63 5.92 4.82 6.42 
4 5.92 4.75 5.34 4.63 6.47 5.16 5.42 5.81 5.95 
5 6.71 5.28 6.49 3.71 6.04 4.04 6.63 4.73 4.82 
6 8.02 3.19 5.32 3.36 5.92 5.12 6.72 4.67 6.31 
Mean 7.13 4.79* 5.41 4.55 5.99 4.67 6.28* 4.92 5.93 
SD 0.78 0.82 0.63 0.84 0.41 0.66 0.51 0.45 0.76 
SEM 0.31 0.33 0.26 0.34 0.17 0.27 0.21 0.18 0.31 
P Value  p < 0.05 p >0.05 p > 0.05 p > 0.05 p > 0.05 p < 0.05 p > 0.05 p > 0.05 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI Vs II VII  Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose.  Diabetes confirmed on third day post administration  of 
streptozotocin.   Standard  drug  Glibenclamide &  three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily 
after  confirmation of hyperglycaemia.  
n  =  6  (  Number   of  animals   in each   group)   
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II                                                                                                                                                     
 * P< 0.05   significant;  p>0.05 Non significant      
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Anti-diabetic Study using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 45:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Total Proteins (g/dl) against streptozotocin induced diabetes mellitus in rats. 
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Table  49:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on Serum Albumin Levels ( gm/dl) against  streptozotocin induced diabetes mellitus in  rats.       
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control 
(0.2 ml 
of 2%  
gum  
acacia)  
Diabetic 
control  
STZ +Std  
Antudiabetic 
drug 
Glibenclamide 
(3mg/kg) 
STZ+ P.O. 
(50mg/kg)  
 STZ+P.O 
(100mg/kg)  
STZ+ 
EBJF 
(50mg/kg)  
STZ+ 
EBJF 
(100mg/kg)  
STZ+ EBJS 
(50mg/kg)  
STZ+ 
EBJS 
(100mg/kg)  
1 2.91 1.38 1.47 1.58 1.82 1.47 1.83 1.63 1.95 
2 2.75 1.46 1.24 1.32 1.63 1.39 2.87 1.54 1.57 
3 2.43 1.09 1.82 1.13 1.74 1.54 1.93 1.72 1.63 
4 2.87 1.15 1.16 1.28 2.84 1.35 2.12 1.38 1.72 
5 2.34 1.62 1.83 1.23 1.78 1.72 1.85 1.46 1.34 
6 2.62 0.28 1.92 1.55 2.67 0.93 1.93 1.05 1.92 
Mean 2.65 1.16* 1.57 1.34 2.08 1.40 2.08* 1.46 1.68 
SD 0.23 0.47 0.32 0.17 0.52 0.26 0.39 0.23 0.22 
SEM 0.09 0.19 0.13 0.07 0.21 0.10 0.21 0.1841 0.0329 
P Value  p < 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05            p > 0.05 p > 0.05 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V  Vs II VI Vs II VII  Vs II VIII Vs II IX  Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose.  Diabetes confirmed on third day post administration  of streptozotocin.   Standard  drug  
Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia. 
 n  =  6  (  Number   of  animals   in each   group) 
 Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II          
 * P< 0..05   significant;; p>0.05  Non significant       
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Anti-diabetic Study  using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 46:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Albumin Levels (g/dl) against streptozotocin induced diabetes mellitus in rats 
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Table  50:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on   Serum Alkaline Phosphatase  Levels (U/l) against Streptozotocin induced diabetes  mellitus in 
rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI Group VII Group VIII Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2%  
gum  acacia) 
Diabetic 
control  
STZ +Std 
 Antidiabetic drug 
Glibenclamide 
(3mg/kg.) 
STZ+ 
 P.O. 
(50mg/kg)  
 STZ+ 
P.O  
(100mg/kg)  
 STZ+ 
 EBJF 
(50mg/kg)  
STZ+  
EBJF 
(100mg/kg)  
 STZ+ 
EBJS 
 (50mg/kg)  
STZ+ 
 EBJS 
(100mg/kg)  
1 68.09 94.76 79.62 87.64 76.52 97.07 95.64 80.08 89.64 
2 78.45 98.43 89.94 90.95 98.53 78.64 86.96 98.64 94.08 
3 92.42 80.97 87.42 96.85 67.75 90.96 95.06 78.57 96.03 
4 66.56 91.03 87.64 90.74 97.06 99.85 90.88 98.43 67.94 
5 72.62 96.65 90.52 87.56 57.53 90.96 96.86 97.83 90.02 
6 91.07 95.45 86.42 99.95 90.96 96.56 89.12 94.32 89.53 
Mean 78.2 92.88** 86.92 92.28 81.39* 92.34 91.53 91.31 87.87 
SD 11.28 6.33 3.9 5.05 16.79 7.59 3.75 9.42 11.28 
SEM 4.6 2.58 1.59 2.06 6.85 3.09 1.68 3.84 5.04 
P Value  p < 0.01 p > 0.05 p > 0.05 p < 0.05 p > 0.05  p > 0.05 p > 0.05 p > 0.05 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI Vs II VII  Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p single dose.  Diabetes confirmed on third day post administration  of streptozotocin.   Standard  drug  
Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia. 
 n  =  6  (  Number   of  animals   in each   group)  
 Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II                                                                                                                                                                             
  ** P< 0.01; Highly  significant;  * p<0.05  significant   p>0.05  Non  significant     
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Anti-diabetic Study  using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 47:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Serum Alkaline Phosphatase Levels  ( U/L) against streptozotocin induced diabetes mellitus in rats. 
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Table 51:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica  seeds (EBJS), on Average  Body  Weight ( gms) against  Streptozotocin ( STZ)  induced diabetes mellitus in rats.                                                                                                                                                  
S.No. Group I Group II Group III Group IV Group V Group VI  Group VII Group VIII  Group IX 
Rats 
 
 
Normal 
Control (0.2 
ml of 2%  
gum  acacia 
Diabetic 
control  
STZ +Std  
Antidiabetic drug 
Glibenclamide 
(3mg/kg.) 
STZ+ 
 P.O. 
(50mg/kg)  
STZ+ 
 P.O  
(100mg/kg)  
 STZ+ 
EBJF 
(50mg/kg)  
 
 
 
STZ+ 
 EBJF 
(100mg/kg)  
STZ+ 
 EBJS 
(50mg/kg) 
 
 
 
 STZ+ 
EBJS 
(100mg/kg)  
1 230.6 150.2 160 210.3 250.1 170.2  230.4 210.6  230.5 
2 240.2 130.7 150 180.7 270.5 230.6  250.7 240.1  240.6 
3 260.8 170.2 150 170.6 220.7 190.3  250.5 230.6  210.9 
4 260.7 180.7 160 210.4 240.7 250.4  240.8 200.4  260.3 
5 300.4 150.2 175 230.9 250.3 250.9  260.3 230.3  240.6 
6 310.7 170.8 165 240.2 200.4 240.3  240.3 210.7  260.5 
Mean 267..23 158 . 80*** 160 207. 18* 238.78** 222..12*  245..50** 220. 45*  240..57** 
SD 32.08 18.39 21.29 27.24 24.78 33.87  10.47 15.36  18.81 
SEM 13.09 7.51 8.69 11.12 10.12 13.83  4.28 6.27  7.68 
P Value  p < 0.001 p >0.05 p < 0.05 p < 0.01 p < 0.05  p < 0.01 p < 0.05  p < 0.01 
Statistically 
compound 
groups  
II Vs I III Vs II IV Vs II V Vs II VI Vs II VII Vs II VIII Vs II IX Vs II 
STZ       Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected i.p.single dose.  Diabetes confirmed on third day post administration  of streptozotocin.   Standard  drug  
Glibenclamide &  three  plants given as 505 ethanolic  extracts were administered  orally for 15  days, in a  single dose daily after  confirmation of hyperglycaemia. 
 n  =  6  (  Number   of  animals   in each   group)   
Group  II  is compared   with   Group   I  and   all other   groups are   compared   with   group II  
*** p < 0.001 Very  highly  significant;  ** p< 0.01; Highly  significant; *p <  0.05  significant  p>0.05 Non significant        
                                                                                                                                                                        
 
Chapter 4                                                                                                   Observation And Results 
Ph.D Thesis                                                                                   245                                                                          University of Kashmir 
 
                                                                       Anti-diabetic Study  using Streptozotocin (STZ) in Rats (15- day study) 
 
All extracts were administrated orally in 2% gum acacia once daily for 15 days 
Fig 48:  Effect of different doses of 50% ethanolic extract of Portulaca oleracea whole plant (PO), Eriobotrya japonica fruits (EBJF) and 
Eriobotrya japonica seeds (EBJS), on Average Body Weight (g) against streptozotocin induced diabetes mellitus in rats. 
B
o
d
y 
W
e
ig
h
t 
(g
) 
 
Chapter 4                                                                                                   Observation And Results 
Ph.D Thesis                                                                                   246                                                                          University of Kashmir 
 
Table 52:  Effect   of   50% ethanolic  extract of   Portulaca  oleracea(PO) whole plant, Eriobotrya   japonica  fruits(EBJF)  and  Eriobotrya  japonica  
seeds(EBJS)  on  Average Body Weight ( gms) against  Streptozotocin  induced  diabetes  mellitus in  rats . 
Groups Treatment                             Average Body  weight  ( in gms) 
  DAY  1 DAY 4 DAY 9 DAY 15 
I Normal  control 
0.2 ml of 2% gum  acacia 
250.58±8.14 253.90±9.93 262.12±10.47(NS) 267.23±13.09(NS) 
II Diabetic control 
0.2 ml of 2% gum  acacia 
205.83±7.64 202.16±6.61 175.56±6.77** 158.8±7.51** 
III STZ + Std drug Glibenclamide 
(3mg/kg. b.w) 
203.17±4.91 200.67±4.94 180.92±7.63* 160.00±8.69** 
IV STZ + P.O (50 mg/kg b.w) 220.82±9.49 222.17±10.75 212.30±10.82* 207.18±11.12** 
V STZ + P.O (100 mg/kg b.w) 210.17±12.18 223.98±12.03 232.20±11.14* 238.78±10.12** 
VI STZ + EBJF (50 mg/kg b.w) 240.13±9.15 237.13±9.17 228.80±12.58* 222.12±13.83** 
VII STZ + EBJF (100 mg/kg b.w) 223.87±6.71 230.42±5.76 238.80±4.76* 245.50±4.27** 
VIII STZ + EBJS (50 mg/kg b.w) 248.98±3.06 242.23±4.80 232.10±4.74* 220.45±6.27** 
IX STZ + EBJS (100 mg/kg b.w) 213.73±7.14 223.86±7.11 233.88±7.53* 240.57±7.67** 
  
STZ Dissolved in 0.1M citrate buffer at a. dose of 50mg/kg  b..w and injected  i.p. single dose  Diabetes confirmed on third day post administration of 
streptozotocin.   Standard  drug  Glibenclamide &  three  plants given as 50% ethanolic  extracts were administered  orally for 15  days, in a  single dose daily 
after  confirmation of hyperglycaemia.   
n  =  6  (Number   of  animals   in each   group)  
 
 DAY 1 compared with  DAY 15 
*p< 0.05  significant; **p<0.01  highly  significant; ***p< 0.001 very highly  significant; p> 0.05 non-significant ( NS) 
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HISTOPATHOLOGY    RESULTS 
Effect of 50% Ethanolic extract of Portulaca oleracea (PO) whole plant, 
Eriobotrya japonica fruits (EBJF) and Eriobotrya japonica seeds on 
histopathology of different organs against streptozotocin induced diabetes 
mellitus. (15 days study) 
Liver 
Histopathological examination of the liver slides of rats of Group I (Normal control) 
showed the portal triad area with no abnormality (Fig 49) 
Livers of the rats of diabetic group II also showed sinusoidal dilatation and 
necrosis with inflammatory cell infiltration and haemorrhage (Fig 50 a, b). 
 Glibenclamide  ( Standard  antidiabetic  drug) when  administered  at the  
dose level of   3 mg/kg b.w  to  rats of  Group III  showed the portal triad area with no 
abnormality  (Fig 51). 
Portulaca  oleracea whole  plant when  administered  at the  dose level of   50 
mg/kg b.w  to  rats of  Group IV  showed the portal triad area with no abnormality   
(Fig 52a). 
  Portulaca  oleracea whole  plant when  administered  at the  dose level of   
100 mg/kg b.w  to  rats of  Group V  showed the portal triad area with no abnormality  
(Fig 52b). 
 Eriobotrya japonica fruits when administered at the dose level of   50 mg/kg 
b.w to rats of Group VI showed the portal triad area with no abnormality   (Fig 53a). 
 Eriobotrya japonica fruits when administered at the dose level of   100 mg/kg 
b.w to rats of Group VII showed the portal triad area with no abnormality   (Fig 53b). 
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Eriobotrya  japonica seeds  when  administered  at the  dose level of   50 
mg/kg b.w  to  rats of  Group VIII  showed the portal triad area with no abnormality  
(Fig 54a). 
  Eriobotrya japonica seeds when administered at the dose level of   100 
mg/kg b.w to rats of Group IX showed the portal triad area with no abnormality   (Fig 
54b). 
Kidney 
Histopathological studies of the kidney of the slides of rats of Group I 
(Normal control) showed glomerulus is of normal size and cellularity, no increase in 
mesangium or thickening of the glomerulus basement membrane. Tubules were 
within the normal limits (Fig 55). 
The kidneys from the slides of diabetic control group II shows the glomerulus 
shows increase in mesangial matrix and thickening of glomerulus basement 
membrane. Tubules were within the normal limits (Fig 56). 
Glibenclamide ( Standard  antidiabetic  drug)  when  administered  at the  dose 
level of   3 mg/kg b.w  to  rats of  Group III  showed  the glomerulus is of normal size 
and cellularity, no increase in mesangium or thickening of glomerular basement 
membrane is seen. Tubules were within the normal limits (Fig 57). 
 Portulaca  oleracea whole  plant when  administered  at the  dose level of   50 
mg/kg b.w  to  rats of  Group IV  showed   that the glomerulus  is  of normal size and 
cellularity,a mild  increase in mesangium is seen. There is no thickening of 
glomerular basement membranes. Tubules were within the normal limits  (Fig  58a). 
 Portulaca  oleracea whole  plant when  administered  at the  dose level of   
100 mg/kg b.w  to  rats of  Group V  showed  that the glomerulus  is  of normal size 
and cellularity,a mild  increase in mesangium is seen. There is no thickening of 
glomerular basement membranes. Tubules were within the normal limits (Fig 58b). 
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Eriobotrya japonica fruits when  administered  at the  dose level of   50 mg/kg 
b.w  to  rats of  Group VI  showed   that the glomerulus  is  of normal size and 
cellularity,a mild  increase in mesangium is seen. There is also mild thickening of 
glomerular basement membranes. Tubules were within the normal limits (Fig 59a). 
Eriobotrya japonica fruits when  administered  at the  dose level of   100 
mg/kg b.w  to  rats of  Group VII  showed   that the glomerulus  is  of normal size and 
cellularity,a moderate  increase in mesangium is seen. There is no thickening of 
glomerular basement membranes. Tubules were within the normal limits (Fig 59b) 
 Eriobotrya japonica seeds when  administered  at the  dose level of   50 
mg/kg b.w  to  rats of  Group VIII  showed   that the glomerulus  is  of normal size 
and cellularity,a moderate  increase in mesangium is seen. There is also mild 
thickening of glomerular basement membranes. Tubules were within the normal 
limits (Fig 60a) 
Eriobotrya japonica seeds when  administered  at the  dose level of   100 
mg/kg b.w  to  rats of  Group IX  showed   that the glomerulus  is  of normal size and 
cellularity,a moderate  increase in mesangium is seen. There is no thickening of 
glomerular basement membranes. Tubules were within the normal limits (Fig 60b). 
Pancreas 
Histopathological studies of the Pancreas of the slides of rats of Group I 
(Normal control) shows a large islet structure surrounded by exocrine gland tissue. No 
inflammatory cells are seen in the islet (Fig 61). 
Pancreas from the slides of diabetic control group II shows the islet structure 
surrounded by exocrine gland tissue. There is also vacuolation of the islet cells and 
lymphocytic infiltration into the islet (Fig 62 a, b). 
Glibenclamide ( Standard  antidiabetic  drug)  when  administered  at the  dose 
level of   3 mg/kg b.w  to  rats of  Group III  showing a large islet structure 
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surrounded by exocrine gland tissue. No inflammatory cells are seen in the islet (Fig 
63).  
Portulaca  oleracea whole  plant when  administered  at the  dose level of   50 
mg/kg b.w  to  rats of  Group IV    showing a large islet structure surrounded by 
exocrine gland tissue seen at the  upper  edge. Few inflammatory cells are seen in 
the islet (Fig 64a). 
 Portulaca  oleracea whole  plant when  administered  at the  dose level of   
100 mg/kg b.w  to  rats of  Group V  showed   a large islet structure with exocrine 
gland tissue seen at the upper edge. No inflammatory cells are seen in the islet  (Fig 
64b). 
Eriobotrya japonica fruits when administered at the dose level of   50 mg/kg 
b.w to rats of Group VI showed an islet structure surrounded by exocrine gland tissue. 
Few inflammatory cells are seen at the margins of the islet (Fig 65a). 
Eriobotrya japonica fruits when administered at the dose level of   100 mg/kg 
b.w to rats of Group VII showed a comparatively smaller islet structure with exocrine 
gland tissue seen at the lower and left edges. No inflammatory cells are seen in the 
islet  (Fig 65b). 
 Eriobotrya japonica seeds when administered at the dose level of   50 mg/kg 
b.w  to  rats of  Group VIII  showed   an islet structure with exocrine gland tissue seen 
at the upper edge. Several inflammatory cells are seen in the islet and there is also 
vacuolation of islet cells present (Fig 66a). 
Eriobotrya japonica seeds when administered at the dose level of   100 mg/kg b.w  to  
rats of  Group IX  showed   an islet structure surrounded by exocrine gland tissue. 
Few inflammatory cells are seen at the margins of the islet (Fig 66b). 
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HISTOPATHOLOGY OF LIVER IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 49: Group –I Normal Control  
Liver of rats showing the portal triad area. No. 
abnormality seen. (H&E x 40X) 
BD= Bile Duct, PV= Portal Vein 
 
Fig:50 (a)Group II- Diabetic Control   
Streptozotocin (STZ) (50mg/kg) b.w. 
Liver of diabetic rats showing the 
sinusoidal dilatation and necrosis with 
inflammatory cell infiltration & 
haemorrhage (H&E x 40X) 
Fig:50 (b):Group II- Diabetic Control   
Streptozotocin (STZ) (50mg/kg) b.w. 
Liver of diabetic rats showing inflammatory 
cell infiltration and haemorrhage around a bile 
duct. (H&E x 40X) 
  
(H&E x 40X) 
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HISTOPATHOLOGY OF LIVER IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 51: Group III- STZ*+Standard Antidiabetic 
Glibenclamide (3 mg/kg b.w)  
Liver of diabetic rats showing the portal area. 
No. abnormality seen. (H&E x 40X) 
BD= Bile Duct, HA=  Hepatic Artery.  
Fig 52a:Group IV- STZ*+Portulaca oleracea (50 mg/ kg .w)   
Liver of diabetic rats showing the portal area. No 
abnormality seen. (H&E x 40X) 
BD- Bile Duct, PV = Portal Vein. 
 
 
Fig 52b:Group V – STZ*+Portulaca  oleracea  (100 mg/kg b.w)  
Liver of diabetic rats showing the portal area. No 
abnormality seen. (H&E x 40X) 
BD- Bile Duct, PV= Portal Vein.  
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HISTOPATHOLOGY OF LIVER IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig  53a: Group VI – STZ*+Eriobotrya japonica fruit  (50mg/kg b.w) 
Liver of diabetic rats showing the portal area. No abnormality 
seen. (H&E x 40X) 
BD= Bile Duct, PV = Portal Vein  
Fig 53b: Group VII- STZ*+Eriobotrya japonica fruit (100mg/kgb.w) 
Liver of diabetic rats showing the portal area. No 
abnormality seen. (H&E x 40X) 
BD= Bile Duct, PV = Portal Vein 
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HISTOPATHOLOGY OF LIVER IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 54a: Group-VIII- STZ*+Eriobotrya japonica seeds (50  mg/kg b.w) 
Liver of diabetic rats showing the portal area. No abnormality 
seen.  (H&E x 40X) 
BD = Bile Duct, PV = Portal Vein.  
Fig 54b:Group IX- STZ*+Eriobotrya japonica seeds (100mg/kg b.w) 
Liver of diabetic rats showing the portal area. No. abnormality  
seen.  (H&E x 40X) 
BD = Bile Duct, PV = Portal Vein.  
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HISTOPATHOLOGY OF KIDNEY IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 57:Group –III – STZ*+Standard antidiabetic drug Glibenclamide (3 mg/kg b.w)   
Renal parenchyma from diabetic rats. The Glomerulus  is of normal size ad 
cellularity, no increase in mesangium or thickening of glomerular basement 
membranes is seen. Tubules  are within normal limits. (H&E x 40X) 
G = Glomerulus T= Tubules 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 55:Group- I – Normal Control 
Renal   parenchyma of   rats. The Glomerulus is of 
normal size and cellularity, no increase in mesangium 
or thickening of glomerular basement membranes is 
seen. Tubules  are within normal limits. (H&E x 40X) 
G = Glomerulus T= Tubules 
 
Fig 56:   Group II- Diabetic control. 
Streptozotocin (STZ) (50mg/kg) b.w. 
Renal parenchyma from diabetic rats. The Glomerulus 
shows increase in size and cellularity, and a mild increase in 
mesangium is seen. There is also mild thickening of 
glomerular basement membranes. Tubules are within 
normal limits. (H&E x 40X) 
G = Glomerulus T= Tubules 
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HISTOPATHOLOGY OF KIDNEY IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 58a:Group IV-STZ*+Portulaca oleracea (50mg /kg b.w) 
Renal parenchyma from diabetic rats. The Glomerulus 
is of normal size and cellularity, a mild increase in 
mesangium is seen. There is no thickening of 
glomerular basement membranes. Tubules are within 
normal limits. (H&E x 40X) 
G = Glomerulus T= Tubules 
Fig 58b:Group V STZ*+Portulaca oleracea (100 mg / kg.) 
Renal parenchyma from diabetic rats. The Glomerulus is 
of normal size and cellularity, a mild increase in 
mesangium is seen There is no thickening of glomerular 
basement membranes. Tubules are within normal limits. 
(H&E x 40X) 
G = Glomerulus T= Tubules 
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HISTOPATHOLOGY OF KIDNEY IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 59a:Group VI- STZ*+Eriobotrya japonica fruit  (50mg/kg b.w) 
Renal parenchyma from diabetic rats. The Glomerulus) 
shows increase in size and cellularity, and a mild increase in 
mesangium is seen. There is also mild thickening of 
glomerular basement membranes. Tubules  are within 
normal limits. (H&E x 40X) 
G = Glomerulus T= Tubules 
  
 
Fig 59b:Group-VII-STZ*+Eriobotrya japonica fruit (100 mg/kg b.w)     
Renal parenchyma from diabetic rats. The Glomerulus shows 
increase in mesangial matrix and thickening of glomerular 
basement membranes. Tubules are within normal limits 
(H&E x 40X) 
G = Glomerulus T= Tubules 
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HISTOPATHOLOGY OF KIDNEY IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY)  
 
(H&E x 40 X)   
 
 
 
 
 
Fig 60a:Group VIII –STZ*+Eriobotrya japonica seeds (50 mg/kg b.w) 
Renal parenchyma from diabetic rats. The Glomerulus is of normal size and 
cellularity and a moderate increase in mesangium is seen. There is also mild 
thickening of glomerular basement membranes. Tubules  are within normal 
limits. (H&E x 40X) 
G = Glomerulus T= Tubules 
 
 
     
 
 
 
 
 
Fig 60b:Group IX- STZ*+Eriobotrya japonica seeds (100 mg/kg b.w) 
Renal parenchyma from diabetic rats. The Glomerulus (G) is of normal size 
and cellularity and a mild increase in mesangium is seen. There is no 
thickening of glomerular basement membranes. Tubules (T) are within 
normal limits (H&E x 40X) 
G = Glomerulus T= Tubules 
 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
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HISTOPATHOLOGY OF PANCREAS IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 61:Group –I  Normal Control 
Pancreas  of  rats showing a large islet structure 
surrounded by exocrine gland tissue. No inflammatory 
cells are seen in the islet (H&E x 40X) 
Fig 62 (a):Group-II – Diabetic Control   
Pancreas from diabetic rats showing a islet 
structure surrounded by exocrine gland tissue. 
There is vacuolation of the islet cells and 
lymphocytic infiltration into the islet. (H&E x 40X) 
Fig  62 (b): Group-II – Diabetic Control   
Pancreas from diabetic rats showing a islet structure 
surrounded by exocrine gland tissue. There is 
vacuolation of the islet cells and lymphocytic 
infiltration into the islet. (H&E x 40X) 
 
Fig 63: Group III–STZ*+Standard anti diabetic drug Glibenclamide (3 
mg/kg b.w)  
Pancreas from diabetic rats showing a large islet structure 
surrounded by exocrine gland tissue with no vacuolation. No 
inflammatory cells are seen in the islet (H&E x 40X) 
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HISTOPATHOLOGY OF PANCREAS IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 64b:Group V- STZ*+ Portulaca oleracea (100 mg / kg b.w) 
Pancreas from diabetic  rats showing a large islet structure 
with exocrine gland tissue seen at upper edge. No 
inflammatory cells are seen in the islet. (H&E x 40X) 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
 
Fig 64a ::Group IV- STZ*+Portulaca oleracea (50mg/ kg b. w) 
Pancreas from diabetic  rats showing a large islet structure 
with exocrine gland tissue seen at upper edge. Few 
inflammatory cells are seen in the islet. (H&E x 40X) 
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HISTOPATHOLOGY OF PANCREAS IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
*Streptozotocin (STZ) (50mg/kg) b.w. given once  i.p 
Fig 65a:Group VI  STZ*+ Eriobotrya japonica fruit 50mg/kgb.w) 
Pancreas from diabetic  rats showing an islet structure 
surrounded by exocrine gland tissue. Few inflammatory cells 
are seen at the margins of the islet. (H&E x 40X) 
Fig 65b:Group VII STZ*+ Eriobotrya japonica fruit (100 mg/kg b.w) 
Pancreas from diabetic rats showing a comparatively smaller islet 
structure with exocrine gland tissue seen at the lower and left edges. 
No inflammatory cells are seen in the islet.  (H&E x 40X) 
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 HISTOPATHOLOGY OF PANCREAS IN RATS 
DIABETES INDUCED BY STREPTOZOTOCIN (STZ) 
(15- DAYS STUDY) 
 
 
 
 
 
 
 
 
Fig 66a:Group VIII STZ*+ Eriobotrya japonica seeds (50 mg/ kg b.w) 
Pancreas from diabetic  rats showing an islet structure with exocrine 
gland tissue seen at the upper edge. Several inflammatory cells are seen 
in the islet and there is also vacuolation of islet cells.    (H&E x 40X) 
 
 
p 
 
 
 
 
 
 
 
 
 
Fig 66b:Group IX  STZ*+ Eriobotrya japonica seeds (100mg/ kg b.w)   
 Pancreas from diabetic rats showing an islet structure surrounded by 
exocrine gland tissue. Few inflammatory cells are seen around the islet  
(H&E x 40X). 
 
 
*Streptozotocin (STZ) (50mg/kg) b.w. given once i.p 
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DISCUSSION 
Diabetes mellitus is a metabolic disorder characterized by resistance in the action of 
insulin, insufficient insulin secretion or both. It is becoming one of the most common 
diseases of the world.  Type II diabetes in young has increased 30 fold over the last 
20 years concomitant with increase in obesity. Studies have revealed that all 
incidences of diabetes in this young age group is 2.5% and alarmingly 25% of their 
young adults have abnormalities of blood glucose (Barbara & Jeffrey, 2000).  
In Diabetes mellitus, besides hyperglycemia, cardiovascular disease (CVD) is a 
major cause of death in the world and is mainly due to atherosclerosis (hardening of 
the arteries). Abnormal blood lipids are risk factors for CVD (Chandila et al., 1988). 
So the prevention of cardiovascular disease in diabetic patients is necessary. It has 
also been seen that the liver function tests which include serum aminotransferases   
i.e  ALT, AST, Alkaline phosphatases (AP) and Bilirubin  are raised in diabetes. 
(Elizebath et al., 2005).  Prevention of liver injury in type-II diabetes due to insulin 
resistance is necessary (Lebovitz et al., 2002; Marshall, 2004). 
The treatment for diabetes mellitus would be a drug that not only controls the 
glycemic level but also prevents the development of atherosclerosis and other 
complications of diabetics.  New drugs and new drug delivery systems for insulin 
have also  been introduced (Tripathi, 2010). 
The Indian indigenous drugs have great importance both from professional and 
economic point of view. A large number of plants have been  reported to possess 
anti-diabetic activity e.g., Aconitum napeilus, Aloe vera, Carum carvi, Cichorium 
intybus, Allium cepa, Aralia cachemirica, Allium sativum, Momordia charantia,etc  
(Chopra et al., 1966).  
In the present study two plants, Portulaca oleracea whole plant and Eriobotrya 
japonica fruits and Eriobotrya japonica seeds were evaluated  for their toxicity 
studies and for antidiabetic activity as they have been reported to have 
hypoglycaemic activity in the traditional system of medicine. 
 Chapter 5  Discussion  
 
Ph.D Thesis   264                                                  University of Kashmir 
 
Different model systems like alloxan, streptozotocin (Lenzen, 1988)  viruses, insulin 
antibodies, hormones like dexamethasone, adrenaline and dithizone are available to 
screen the anti-diabetic activity of a given substance In the present  study chemicals 
like alloxan and streptozotocin were used to produce marked diabetic effects in 
animals. Alloxan diabetic model resembles type I diabetes (IDDM) without 
significant insulin resistance whereas streptozotocin induced diabetic animals inhibit 
reduced response to insulin in hepatic and peripheral tissues. Further rats treated with 
streptozotocin display many of the features seen in human with uncontrolled diabetes 
mellitus (Szkudelski, 2001). In the present study, alloxan was given at the dose of 
120 mg/kg b.w, i.p, while streptozotocin was administered (i.p) at the dose of 50 
mg/kg, b.w, for inducing diabetes. 
Albino rats  (Wistar strain) of both  sexes, weighing 125-250g and swiss albino mice  
weighing  20-25g, were procured from IIIM Jammu and kept in clean polypropylene 
cages under uniform conditions of food, water, temperature and degree of nursing  
care. It was ensured that the  animals were in good health  and free from any  
infectious diseases. Male and  female  animals were  kept  in separate cages so that 
there was no interference in evaluation of biochemical parameters during the period 
of study. The temperature and the humidity of the  room in which the animals were 
housed were in the range of 15-25
o
C  and 70-75 % respectively.  
In the  present  study, preliminary  phytochemical screening, acute oral toxicity study 
(72  hours), subacute  toxicity  study (14  days), and antidiabetic  studies using 
alloxan (10 days ) and  streptozotocin ( 15 days)    for inducing diabetes, were carried 
out. 
 Studies have reported that Portulaca  oleracea whole plant (PO) contains alkaloids  
(Mirajkar et al., 1984)  coumarins, tannins, flavonoids,  glycosides, carbohydrates 
(Bagepalli  et al., 2008) fixed oil, saponins (Kamil et al., 1998) proteins and  amino  
acids  and  steroids (Zijuan et al., 2009) and omega-3-fatty acids (Simopoulous, 
1992). Our studies have revealed the presence of alkaloids, saponins, glycosides, 
terpenes, phenolics ,flavonoids, carbohydrates, proteins and  steroids (Table  13) in 
Portulaca oleracea. 
 Chapter 5  Discussion  
 
Ph.D Thesis   265                                                  University of Kashmir 
 
 Reports  reveal that  Eriobotrya  japonica fruits (EBJF) contains  alkaloids, 
glycosides  (Zhaung  et al., 2002) flavonoids (Zhou et al., 2011). The fruit contains 
sugars (Selles-Merchant et al., 2006).  Our studies have  also revealed the presence 
of alkaloids, glycosides, flavonoids, carbohydrates in  Eriobotrya japonica fruits.  
(Table  13). 
 Eriobotrya  japonica seeds (EBJS) are reported to contain  glycosides, amygdalin, 
fatty oil and flavonoids ( Zhaung  et al., 2002). Our studies also revealed the 
presence of alkaloids, glycosides and  flavonoids in the seeds of  Eriobotrya  
japonica  seeds (Table  13). 
The evaluation of the toxic action of the plant extracts is important in order to 
consider a treatment safe. It enables the meaning of the  toxicity of the plant and the 
effects of acute overdose. The  acute toxicity test aims at establishing the  therapeutic 
index, i.e. the  ratio between the pharmacologically effective dose and  the lethal dose 
on the same strain and  species (LD50/ED50). The greater the index the safer the 
compound and  vice versa. However, the term acute oral toxicity is most often used 
in connection to lethality and LD determinations (Ghosh, 2005).  
In the  present study, 50% ethanolic  extract of Portulaca  oleracea, whole plant  
(PO), Eriobotrya  japonica fruits  (EBJF), Eriobotrya  japonica seeds  (EBJS), at 
the  four  dose  levels (500,1000,1500 and 2000 mg/kg b.w) were evaluated  for acute 
oral toxicity  effects and its effect on  behavioural  parameters like grooming, 
hyperactivity, sedation, respiratory arrest, convulsions, motor activity  and  mortality 
were  also  observed in order to ascertain the LD 50 of the extracts and any abnormal 
effects on different parameters. 
Portulaca  oleracea whole plant (PO) administered  at four dose levels (500, 1000, 
1500 and 2000 mg/kg b.w) revealed  no grooming   at all the  four dose  levels after 
48 and 72 hours.  No abnormal effect on the activity of mice was seen. After 48 
hours, 50% animals  showed sedation  at the dose of 500  mg/kg, b.w  and 100%  
animals showed sedation at the dose  of 1000,1500 and 2000mg/kg b.w. Respiratory 
arrest, indicated by raising of head, was seen in 50% of animals at the dose of 
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500mg/kg b.w and  in 100% animals with doses of 1000, 1500 and 2000 mg/kg b.w. 
500mg/kg of PO showed convulsions, indicated by tremor in the tail and the paddling 
of the feet, after  48 and 72 hours in 50 %  of animals  while convulsions were seen 
in 100% animals in the dose range of 1000,1500 and  2000 mg/kg . Decreased motor 
activity was observed in 50 % of animals  at the dose of 500 mg/kg,and in all animals 
at doses of 1000, 1500 and 2000 mg/kg, b.w. 50% mortality was observed at the dose 
of 500 mg/kg, b.w after 72 hours and 100% mortality  with doses of 1000, 1500 and 
2000mg/kg, b.w after 48 hours  indicating  that LD50 of this plant is 500mg and  
doses above it will be toxic, while doses below this  are safe for  oral  administration, 
so the antidiabetic  studies  were carried at the  dose levels of  50,100 and 200   
mg/kg b.w/day  of the 50% ethanolic  extract  of this  plant (Table 14).    
Eriobotrya japonica  fruits (EBJF) administered  at four dose levels (500,1000,1500 
and 2000 mg/kg  b.w)  showed  less grooming  with the dose  of  1500 and  2000 
mg/kg b.w. No  abnormal  activity was observed with all the  dose  levels . No 
sedation was seen with 500 and 1000  mg/kg b.w  after 48 hours of administration 
while the dose of 1500 & 2000 mg/kg b.w produced sedation in all animals as they 
were calm and composed without any stress. 50% animals showed respiratory arrest. 
Convulsions were observed with 1500 & 2000 mg/kg b.w dose in all the animals. 50 
% mortality was observed with 1000 mg/kg b.w after 48 hours and 100% mortality 
with 1500 & 2000 mg/kg b.w respectively after 72 hours  indicating that LD50 of the  
Eriobotrya japonica  fruits  is  1000 mg/kg b.w. So the  present  antidiabetic  
studies  were carried at lower dose levels of  50,100 and 200  mg/kg b.w/day of 
50% ethanolic extract  of the  fruits of Eriobotrya japonica (Table 15).   
Eriobotrya japonica  seeds (EBJS) when  administered  at four dose levels 
(500,1000,1500 and 2000 mg/kg  b.w)  to  mice revealed no effects on grooming  
after  48 and 72   hours at all the  dose  levels. No  hyperactivity was seen in mice 
after  48, 72   hours. There was no effect  on sedation, on respiration and  on 
convulsions. After 48  hours, there was increased motor activity observed at all the 
dose levels. No mortality occurred during  72 hours (Table 16) in the dose  range  of   
500, 1000, 1500 and  2000 mg/kg b.w   after  72 hours  so  LD50 of the  plant is    
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2000mg/kg b.w  meaning  that  doses   above  2000 mg/kg b.w  are safe for  oral  
administration. The  present  antidiabetic  studies  were carried at lower dose 
levels of  50,100 and 200  mg/kg b.w/day of 50% ethanolic extract  of the  seeds 
of Eriobotrya japonica  One  study  reports  that  8000 mg/kg b.w  are  safe  for  
oral  administration (Kazunari  et al., 2007) confirming our observation that upto 
2000mg /kg  b.w of Eriobotrya japonica seeds  can be safely administered.  
After acute oral toxicity study, subacute (14 days) toxicity study was carried to find 
out the effect on various biochemical parameters  and  also on the histopathology of 
various organs (Babu et al., 2003).  
The biochemical  parameters  evaluated  were  serum glucose levels, urea, 
creatinine, bilirubin, total protein, albumin, SGPT,SGOT, alkaline phosphatase, 
hemoglobin and WBC  count and  histopathology of  liver, spleen and kidney 
was examined.  
50%  ethanolic extract of  Portulaca oleracea  whole plant (PO)  in    subacute  
toxicity  studies,  was administered for 14 days  at the  dose  levels of  200 and  400 
mg/kg b.w. The dose of 400 mg/kg b.w showed significant changes. It showed 
significant decrease in  serum glucose levels (p<0.01), (Table 17; Fig 8)  showing  
that  Portulaca oleracea  has  significant  hypoglycemic  effect. Kidney  function 
tests like serum  urea  levels (Table 18; Fig 9) showed a significant increase while 
serum creatinine (Table 19; Fig 10) showed a non-significant decrease. Liver 
enzymes  like bilirubin  (Table 20; Fig 11) total proteins (Table 23; Fig 14) albumin 
levels (Table 24; Fig 15) showed  non-significant increase indicating less effect on 
these while SGOT, (Table 21; Fig 12) SGPT, (Table 22; Fig 13) alkaline 
phosphatase   levels (Table 25; Fig 16)   showed a significant  decrease, thereby  
indicating that  Portulaca oleracea  can have some useful role in treating 
hepatotoxicity.  Blood   function  tests , haemoglobin  value  (Table 26; Fig 17) 
showed  a  non-significant  increase  while  WBC  count  (Table 27; Fig 18) showed  
a significant   decrease.     
Eriobotrya japonica  fruits (EBJF) in   subacute  toxicity  studies was administered 
for 14 days  at the  dose  levels of  250 and  500 mg/kg b.w. The dose of 500 mg/kg 
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b.w showed significant changes. It showed significant decrease in  serum glucose 
levels (Table 17; Fig 8) revealing  significant hypoglycemic activity.  Kidney  
function tests like serum  urea  (Table 18; Fig 9) and   serum creatinine levels  
(Table 19; Fig 10) did  not  show   much  increase, thereby  indicating  that  
Eriobotrya japonica  does not have  toxic effect  on kidneys. Liver enzymes  like 
bilirubin  (Table 20; Fig 11) total protein  (Table 23; Fig 14) albumin levels (Table 
24; Fig 15) showed  non-significant increase  while SGOT, (Table 21; Fig 12) 
SGPT, (Table 22; Fig 13) and alkaline phosphatase   levels (Table 25; Fig 16) also  
revealed a significant  decrease. Blood   function  tests, haemoglobin  value  (Table 
26; Fig 17) showed  a  non-significant  increase  while  WBC  count (Table 27; Fig 
18)   showed  a significant   decrease  thereby  indicating   it  can  have  effect on 
haematological parameters also and can reduce the immunity.   
These  biochemical parameters  were  supported  by  histopathological  studies. 
The histopathology  was done to see the toxic effects of these extracts  on various 
organs i.e  hepatotoxic  effect  on liver, renal toxicity on  kidneys and its toxicity 
on spleen (haemopoietic effect) .  
Portulaca oleracea  whole plant (PO)  when  administered  at the  dose  of  200 (Fig 
20a) & 400mg/kg (Fig 20b) to  mice  showed   normal  liver,   normal red and white 
pulp areas in the splenic parenchyma (Fig 23a;Fig 23b) and in kidneys the 
glomerulus is of normal size and cellularity and tubules are within normal limits (Fig 
26a;Fig 26b).  
Eriobotrya Japonica fruit (EBJF) when  given  at two dose levels of 250 (Fig 21a) 
& 500mg/kg  (Fig 21b) to mice  also revealed  no abnormality in livers, spleen (Fig 
24a;   Fig 24b)   and showed that the  kidneys  do not have any abnormality (Fig 
27a;Fig 27b). 
This  indicates that  these two plant extracts  Portulaca oleracea whole plant and 
Eriobotrya japonica fruits do not have any  toxic effect on liver, spleen and 
kidneys. 
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No   subacute  studies  were carried  for the seeds  of  Eriobotrya japonica   as   8000 
mg/kg b.w   of the  seeds  have been reported to be  non toxic (Kazunari  et al., 
2007).  
There are contradictory reports about the antidiabetic activity of Portulaca oleracea.  
One study reports that aqueous extract of Portulaca  oleracea (PO) (200mg/kg b.w) 
did not  show any activity against streptozotocin induced diabetic rats (Rafi-ullah 
etal., 2006). Another study showed that aqueous extract of leaves of Portulaca  
oleracea (PO)  after 2  hours  of administration  produce hypoglycaemic effect 
(Medhabati et al., 2011).  
There is no report from India regarding the antidiabetic activity of  Eriobotrya 
japonica. Only one report regarding the antidiabetic  activity of fruit of 
Eriobotrya japonica is available (Baljinder et al., 2010). One study from Italy 
reports that the sesquiterpene glycosides and polyhydroxylated triterpenoids of 
Eriobotrya  japonica leaves have  shown hypoglycaemic effect (Tommasi et al., 
1991; Chen et al., 2008).  In  another study from Japan, Eriobotrya  japonica  seed 
extract is reported to have hypoglycaemic activity  in type-2 diabetic  Otsuka Long 
Evans Tokushima Fatty  (OLETF ) rats  and   KK- A
Y
mice (Kazunari  et al., 
2007).However there has been no report on Eriobotrya japonica fruits. So in the 
present study 50% ethanolic extract of Portulaca oleracea, Eriobotrya japonica 
fruits and Eriobotrya  japonica seeds were studied for their  antidiabetic  activity. 
Apart from  antidiabetic  studies, additional  biochemical estimations  related to 
lipid profile, liver function tests and  kidney  function  tests  were also  studied. 
The effect on  body weight was also studied. 
Portulaca  oleracea whole plant (PO) in alloxan induced diabetic model  was given 
in two dose levels, (100 and  200  mg/kg b.w). At  the dose level of  200 mg/kg b.w  
serum glucose level showed a significant decrease (p<0.001) (Table 28; Fig 28).  
During the course of 10 study alloxan induced diabetes mellitus, blood glucose levels 
were estimated on day 1, day 4, day 7 and day 10. Day 1 was compared with day 10. 
In diabetes control group, the changes were non-significant. In group treated with 
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standard antidiabetic drug, Glibenclamide, the decrease in blood glucose was 
significant on day 4, day 7, and on day 10. Rats  treated with 100 and 200mg/kg b.w. 
of Portulaca oleracea showed significant decrease after day 7 and day 10.The dose 
of 200 mg/kg b.w showed  more significant effect. 
 Dyslipidemia is the major risk factor for cardiovascular disease in diabetes mellitus 
which includes increased concentration of total cholesterol, plasma triglyceride,  low 
HDL cholesterol concentration  and  increased concentration of LDL and VLDL. 
In our study, the dose of 200 mg/kg b.w showed significant changes.  Serum total 
cholesterol (p<0.001) (Table 30;Fig 29) serum triglycericles levels(p<0.001), (Table 
31; Fig 30) serum LDL levels (p<0.05) (Table 33; Fig 32) showed  a significant 
decrease whereas  total proteins  (p<0.05)  (Table 36; Fig 35)  showed significant 
increase. Parameters like  HDL, (Table 32; Fig 31) urea, (Table 34; Fig 33) 
creatinine, (Table 35; Fig 34) showed  non-significant changes. This shows that 
Portulaca oleracea  has a  significant antidiabetic and hypolipidemic effect. 
Decrease in body  weight  seen in diabetes  can also be reversed  by the  plant to 
some  extent (Table 37; Fig 36) 
During the course of 10 days alloxan induced diabetes mellitus average body weight 
was recorded on day 1, day 4, day 7 and day 10. Day 1 was compared with day 10. 
Diabetic control rats showed significant decrease in body weight from day 1 to day 
10. Glibenclamide (standard antidiabetic drug) produced significant decrease in body 
weight on day 10. Portulaca oleracea at the dose of 100  & 200 mg/kg b.w showed 
significant increase in body weight (Table 38). 
Eriobotrya  japonica  fruits (EBJF) in alloxan induced diabetic model  given  in  
three dose levels of  50,100 and 200 mg/kg b.w.  showed the  following  changes  in  
biochemical parameters. The dose of 200 mg/kg b.w showed significant 
changes.At the dose level of 200 mg/kg b.w, serum glucose levels (p<0.001), 
decreased significantly (Table 28; Fig 28). During this 10 day study, blood glucose 
levels were recorded on day 1, day 4, day 7 and day 10. Day 1 was compared with 
day 10. The groups treated with 50, 100, 200mg/kg b.w of Eriobotrya japonica fruits 
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showed significant decrease in blood glucose levels after day 7 and day 10.(Table 
29). The dose of 200 mg/kg b.w also showed significant changes in lipid profile 
parameters. Serum total cholesterol levels (p<0.001), (Table 30; Fig 29) serum 
triglycericles levels  (p<0.001), (Table 31; Fig 30) serum LDL cholesterol levels 
(p<0.05) (Table 33; Fig 32) showed a significant decrease whereas   serum HDL 
cholesterol levels (p<0.05) (Table 32; Fig 31) showed significant increase. 
Biochemical parameters like urea, (Table 34; Fig 33) creatinine, (Table 35; Fig 34) 
total proteins, (Table 36; Fig 35)  showed  non-significant changes. This shows that 
Eriobotrya  japonica  fruits  have a  significant antidiabetic and hypolipidemic effect. 
There is also increase in body weight (Table 37; Fig 36). During the course of 10 
days study alloxan induced diabetes mellitus average body weight was recorded on 
day 1, day 4, day 7 and day 10. Diabetic control rats showed significant decrease in 
body weight from day 1 to day 10. Eriobotrya japonica fruits at the dose of 100  & 
200 mg/kg b.w showed significant increase in body weight  on day 10 (Table 38). 
Eriobotrya  japonica  seeds (EBJS)  in alloxan induced diabetic model  was given at 
two doses(100 and  200 mg/kg b.w). At the  dose level of 200 mg/kg b.w serum 
glucose levels(p<0.001) showed significant decrease (Table 28; Fig 28). During this 
10 day study, blood glucose levels were recorded on day 1,day 4,day 7 and day 10.  
The groups treated with 100 and 200 mg/kg b.w of Eriobotrya japonica seeds also 
showed a significant decrease after day 7 and day 10 (Table 29) indicating  
antidiabetic effect of Eriobotrya  japonica  seeds. The dose of 200 mg/kg b.w also 
showed significant changes in lipid profile parameters. Serum total cholesterol 
(p<0.001), (Table 30; Fig 29) serum triglycerides levels (p<0.001), (Table 31; Fig 
30) serum LDL cholesterol levels (p<0.05)  (Table 33; Fig 32) showed a significant 
decrease whereas serum HDL cholesterol levels (p<0.05) (Table 32; Fig 31)  showed 
significant increase. Biochemical parameters like urea, (Table 34; Fig 33) creatinine, 
(Table 35; Fig 34)  total proteins, (Table 36; Fig 35) showed  non-significant 
changes. This shows that Eriobotrya  japonica  seeds  have a  significant antidiabetic 
and hypolipidemic effect.There is also increase in body weight (Table 37; Fig 36). 
During the course of 10 days alloxan induced diabetes mellitus average body weight 
was recorded on day 1, day 4, day 7 and day 10. Diabetic control rats showed 
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significant decrease in body weight from day 1 to day 10. Eriobotrya japonica seeds 
at the dose of 100  & 200 mg/kg b.w showed significant increase in body weight on 
day 10 (Table 38). 
In this study the  diabetic control group showed   significant  rise  in  blood  glucose  
levels  and  other biochemical   parameters  as compared  to the normal control group 
(p<0.001). Glibenclamide, used as standard  antidiabetic  drug was  found to be 
effective in  significantly (p<0.001)  reducing the  blood  glucose  levels  with  non  
significant  effect  on  other  parameters.   
So in alloxan induced diabetic model, all the three extracts showed significant 
antidiabetic potential and also hypolipidemic action. Among these three extracts, 
the dose of 200 mg/kg b.w of Eriobotrya japonica fruits was found to be more 
potent as it decreased the  blood glucose levels to almost that of levels in normal 
control rats.All the three plant extracts also showed significant increase in body 
weight as there is loss of body weight in diabetes mellitus. 
Portulaca  oleracea  whole plant (PO) in streptozotocin  induced diabetic model  
given at  the dose levels of 50 and 100 mg/kg b.w  showed the  following  effects  in  
biochemical parameters. At the  dose level of 100 mg/kg b.w , serum glucose level 
(p<0.001)  showed a significant decrease (Table 39; Fig 37).  
During the course of 15 days streptozotocin induced diabetes mellitus, blood glucose 
levels were estimated on day 1, day 4, day 9, day 15. Day 1 was compared with day 
15. There was non-significant decrease in blood glucose level in normal control 
group while diabetic control group revealed non significant rise in blood glucose 
levels on day 15.  Glibenclamide, revealed significant reduction  of blood glucose 
levels after 9
th
 day and on day 15. Rats treated with Portulaca oleracea, (50 and 
100mg/kg b.w) revealed significant decrease in blood glucose levels on day 9 and on 
day 15 (Table 40) at dose of 100mg/kg b.w. This shows that  Portulaca  oleracea 
has a significant antidiabetic activity.   
The dose of 100 mg/kg b.w also showed significant changes in lipid profile. 
Serum total cholesterol level (p<0.01), (Table 41; Fig 38) serum  triglycericles level 
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(p<0.001), (Table 42; Fig 39) serum LDL cholesterol (p<0.05),  (Table 44; Fig 41) 
showed a significant decrease whereas serum HDL cholesterol level (p<0.001) 
(Table 43; Fig 40) showed significant increase. Increase in HDL cholesterol levels is 
very beneficial effect as it can prevent cardiovascular disease related to diabetes 
mellitus.  
Chronic mild elevation of transaminases (Elizebath et al.,2005) are found in type II 
diabetic patients, due to insulin resistance. All elevated transaminases contribute to 
direct hepatocyte injury. Serum Bilirubin (p<0.05), (Table 45 Fig 42) SGOT  
(p<0.05), (Table 46; Fig 43) SGPT level (p<0.05) (Table 47; Fig 44) serum alkaline 
phosphatase (p<0.05) (Table 50; Fig 47) showed a significant decrease. Biochemical 
parameters like  total proteins (Table 48; Fig 45) and albumin (Table 49 Fig 46)  
showed  non-significant changes. Decrease in  liver enzymes  which are increased  in 
diabetes  show that  it has  a hepatoprotective action also. Increase  in  body weight 
(Table 51;Fig 48) shows  that it has a protective  action. 
During the course of 15 days streptozotocin induced diabetes mellitus, average body 
weight was recorded on day 1, day 4, day 9, day 15.Day 1 was compared with day 
15.  Rats in diabetic group showed significant decrease in body weight on day 9 but 
more significant decrease was seen on day 15. Rats treated with standard antidiabetic 
drug, glibenclamide, there was significant decrease on day 15. Portulaca oleracea 
when administered at the dose of 50 and 100mg/kg b.w showed  significant increase 
on day 15 (Table 52).  
Eriobotrya  japonica  fruits ( EBJF) were given at the dose of 50 and 100 mg/kg 
b.w in streptozotocin induced diabetic model. EBJF administered at the dose of 100 
mg/kg b.w produced highly significant decrease in serum glucose levels (p<0.001) 
compared to the animals that had received only streptozotocin indicating the 
antidiabetic potential of the fruits of Eriobotrya japonica fruits (Table 39; Fig 37). 
During the course of 15 days streptozotocin induced diabetes mellitus, blood glucose 
levels were estimated on day 1, day 4, day 9, day 15. Rats treated with Eriobotrya 
japonica fruits, (50 and 100mg/kg b.w) revealed significant decrease in blood 
glucose levels on day 9 and on day 15 (Table 40). The dose of 100 mg/kg b.w  
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showed  very  highly significant decrease  in serum total cholesterol level 
(p<0.001),(Table 41; Fig 38) serum triglycericles level (p<0.001), (Table 42; Fig 
39) serum LDL level (p<0.05) (Table 44; Fig 41)   while serum HDL level (p<0.01) 
(Table 43; Fig 40) showed significant increase.Serum bilirubin level (p<0.01), 
(Table 45; Fig 42) SGOT level (p<0.05), (Table 46; Fig 43) SGPT level (p<0.01) 
(Table 47; Fig 44) showed significant decrease  whereas  serum total  proteins level 
(p<0.05) (Table 48; Fig 45) alkaline phosphatase  (Table 50; Fig 47) and  serum 
albumin  (Table 49; Fig 46) showed  non-significant changes in the group that had 
received 100 mg/kg b.w  of the extract. Reducing the  level  of  serum glucose  levels 
shows  that  it  has a  significant  antidiabetic  effect  and decreasing  the  level of  
liver enzymes  shows that it has  a hepatoprotective  action. The dose of 100 mg/kg 
b.w was found to be more potent (Table 51;Fig 48). During the course of 15 days 
streptozotocin induced diabetes mellitus, average body weight was recorded on day 
1, day 4, day 9, day 15.  Eriobotrya japonica fruits,  when administered at the dose of 
50 and 100mg/kg b.w showed  significant increase on day 15 (Table 52).  
Eriobotrya  japonica  seeds (EBJS) in streptozotocin induced diabetic model  given 
at  the dose level of  50 and  100 mg/kg b.w.  showed the  following  effects  in  
biochemical parameters. During the course of 15 days streptozotocin induced 
diabetes mellitus, blood glucose levels were estimated on day 1, day 4, day 9, day 15. 
Rats treated with Eriobotrya  japonica  seeds, (50 and 100mg/kg b.w) revealed 
significant decrease in blood glucose levels on day 9 and on day 15 (Table 40). This 
shows that  Eriobotrya  japonica  seeds has a significant antidiabetic activity.   
 At the dose level of 100 mg/kg b.w  serum glucose levels (p<0.001) decreased 
significantly  (Table 39; Fig 37).  Serum total cholesterol level (p<0.001), (Table 
41; Fig 38) serum triglycerides level (p<0.001), (Table 42; Fig 39) serum LDL 
cholesterol level (p<0.05), (Table 44; Fig 41) serum bilirubin level (p<0.01), (Table 
45; Fig 42) SGOT level (p<0.05), (Table 46; Fig 43) SGPT level (p<0.01) (Table 
47; Fig 44) showed  significant decrease while serum HDL cholesterol level (p<0.01) 
(Table 43; Fig 40)   showed   significant increase whereas biochemical parameters 
like serum total proteins level, (Table 48; Fig 45) serum albumin level (Table 49; 
 Chapter 5  Discussion  
 
Ph.D Thesis   275                                                  University of Kashmir 
 
Fig 46) and serum alkaline phosphatase level (Table 50;Fig 47) were non-
significant. The dose of 100 mg/kg b.w was found to be more potent.This shows 
that Eriobotrya  japonica  seeds  have a significant antidiabetic activity. Decrease in  
liver enzymes  which  are increased  in diabetes   show that  it has  a 
hepatoprotective action also. Increase  in serum HDL cholesterol level  shows that it 
can prevent cardiovascular disease related to diabetes.Increase in  body weight 
shows  that it has a protective  action.  
During the course of 15 days study streptozotocin induced diabetes mellitus, average 
body weight was recorded on day 1, day 4, day 9, day 15. Eriobotrya  japonica  
seeds when administered at the dose of 50 and 100mg/kg b.w showed  significant 
increase on day 15 (Table 52).  
Diabetic control group showed   significant  rise  in  blood  sugar  levels  and  other 
biochemical   parameters  as compared  to the normal control group (p<0.001) while 
the antidiabetic  drug, glibenclamide  showed  significant  changes  as  compared  to 
the  diabetic  control animals (p<0.001) in reducing  blood  glucose levels.  
Histopathology   was also done to see the effect of these three extracts  on  various 
organs  like  pancreas, liver and  kidneys.The effect on  pancreas was to see their 
antidiabetic  potential, hepatoprotective effect on liver and renoprotective  effect on 
kidneys.  
Histopathological studies of the Pancreas of  rats of normal control showed no 
inflammatory cells  in the islets (Fig 61) while rats of diabetic control group showed 
vacuolation  and lymphocytic infiltration into the islet (Fig 62 a, b).Glibenclamide, 
standard  antidiabetic  drug (3 mg/kg b.w) showed no inflammatory cells in the islets 
(Fig 63).  
Portulaca  oleracea whole plant (50 mg/kg b.w)  showed few inflammatory cells  
(Fig 64a) while  at the  dose level of  100 mg/kg b.w   no inflammatory cells were 
seen (Fig 64b). 
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Eriobotrya japonica fruits (50 mg/kg b.w)  also showed  few inflammatory cells.  
(Fig 65a) while at  dose  of   100 mg/kg b.w doses showed  no inflammatory cells 
were seen in the islet  (Fig 65b). 
Eriobotrya japonica seeds  (50 mg/kg b.w)   showed   an islet structure with several 
inflammatory cells.There was also vacuolation of islet cells   (Fig 66a).The  dose 
level of   100 mg/kg b.w   showed   an islet structure with few inflammatory cells 
(Fig 66b). 
  Histopathological examination of the liver  of rats of normal control showed  no 
abnormality in livers (Fig 49). Livers of the rats of diabetic group showed  sinusoidal 
dilatation and necrosis  with inflammatory cell infiltration and  haemorrhage  (Fig 50 
a, b). 
Portulaca  oleracea whole  plant at the  dose of  (50  and 100 mg/kg b.w)  showed 
the portal triad area with no abnormality (Fig 52 a,b). 
Eriobotrya  japonica fruits  (50  and 100 mg/kg b.w )  showed  the normal liver   (Fig 
53 a,b). 
Eriobotrya  japonica seeds (50 and  100 mg/kg b.w)  also showed the portal triad 
area with no abnormality  (Fig  54 a,b) 
Histopathological studies of the kidney  of rats  of normal control showed glomerulus  
of normal size and cellularity, no increase in mesangium or thickening of the 
glomerulus basement membrane. Tubules were within the normal limits (Fig 55).The 
kidneys  of diabetic control rats showed the glomerulus with increased mesangial 
matrix and thickening of glomerulus basement membrane (Fig 56). 
Portulaca  oleracea whole  plant (50  and 100 mg/kg b.w)  to  rats showed   a mild  
increase in mesangium of rats (Fig 58 a,b). 
Eriobotrya japonica fruits when  administered  at the  dose level of   50 mg/kg b.w  
to  rats showed a mild  increase in mesangium . There is also mild  thickening of 
glomerular basement membranes (Fig 59a) while  at the  dose level of   100 mg/kg 
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b.w   showed   that the glomerulus  is  of normal size and cellularity and there is  
moderate  increase in mesangium. There is no thickening of glomerular basement 
membranes. (Fig 59b) 
Eriobotrya japonica seeds  at the  dose level of   50 mg/kg b.w  to  rats showed   that 
there is a moderate  increase in mesangium. There is also mild thickening of 
glomerular basement membranes. (Fig 60a) while at the  dose level of   100 mg/kg 
b.w   showed   that the glomerulus  is  of normal size and cellularity and there is 
moderate  increase in mesangium. There is no thickening of glomerular basement 
membranes (Fig 60b). 
Histopathological studies show that these three plant extracts have antidiabetic 
potential, hepatoprotective  and  renoprotective effects. 
The results of our studies indicate that Portulaca  oleracea (PO), Eriobotrya  
japonica  fruits (EBJF) and  Eriobotrya  japonica seeds (EBJS)  can play a vital role 
in   diabetes  which may be  due to the phytoconstituents  present in these plant 
extracts.  
 Besides  antidiabetic studies, there  was  significant  decrease in lipid  profile   
thereby, showing that these plants may have hypolipidemic effect also. Some  
significant changes in the  liver  function   tests  may  also contribute   to their  liver 
protective function.  
Studies have reported the hepatoprotective  (Prabhakaran et al., 2010) and the 
antihyperlipidemic activity of leaves of Portulaca oleracea Linn. (Pragda et al., 
2012) and hypolipidemic (Said et al., 2009) and hepatoprotective effect (Bae et al., 
2012) of extracts of Eriobotrya japonica. The same effects were also observed in our 
studies.  
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PERCENTAGE YEILD 
The percentage yield of 50% ethanolic extract of 
  Whole plant of Portulaca oleracea was 14%. 
  Eriobotrya japonica fruits was 30%. 
  Eriobotrya japonica seeds was 11%. 
PRELIMINARY PHYTOCHEMICAL SCREENING   
 Portulaca oleracea whole plant contains alkaloids, saponins, glycosides, 
terpenes, phenolics, flavonoids, carbohydrates, proteins and steroids.  
 Eriobotrya japonica fruits contain alkaloids, glycosides, flavonoids and 
carbohydrates. . 
 Eriobotrya japonica seeds contain alkaloids, glycosides and flavonoids. 
TOXICITY STUDIES 
a)     Acute Oral Toxicity Studies (72 Hours) 
  LD50 of 50% ethanolic extract of   
 Portulaca  oleracea whole plant was found to be 500mg/kg b.w.  
 Eriobotrya japonica fruit was found to be 1000mg/kg b.w. 
 Eriobotrya japonica seeds was found to be more than 2000mg/kg b.w. 
b)    Subacute   toxicity study (14 days)  
50% ethanolic extract of Portulaca oleracea whole plant showed 
 Hypoglycemic activity.  
 Increase in urea levels. 
 Serum creatinine levels showed a non-significant decrease.  
 Non significant increase in liver enzymes like bilirubin levels, total protein 
levels, albumin levels. 
 Significant decrease in SGOT, SGPT, alkaline phosphatase   levels. 
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 Non-significant increase in haemoglobin value.   
 Significant decrease in W BC count.  
50% ethanolic extract of Eriobotrya japonica fruits   showed 
 Significant hypoglycemic effect.  
 Non-significant increase in serum  urea, creatinine levels   and hemoglobin  
value.  
 Non significant increase in liver enzymes like bilirubin levels, total protein 
levels and albumin levels.   
 Significant decrease in SGOT, SGPT, alkaline phosphatase levels and WBC 
count.  
Histopathological studies of Portulaca oleracea whole plant and Eriobotrya   
japonica fruit in mice: 
Portulaca oleracea whole plant revealed  
 Normal liver, spleen and kidney.  
Eriobotrya Japonica fruit also revealed 
 No abnormality in liver, normal spleen and kidneys. 
ANTIDIABETIC STUDIES 
Alloxan (120 mg/kg b.w) and   streptozotocin (50 mg/kg b.w)  were  found to induce  
diabetes in rats as evidenced by  the  increased  blood  glucose  levels. 
a) Alloxan induced Diabetes mellitus (10 day study) 
50 % ethanolic extract of Portulaca oleracea whole plant (PO)  
 Revealed a dose dependent antidiabetic potential in rats with doses of 100 
and 200 mg/kg b.w. The dose of 200 mg/kg b.w /day was found to be having 
maximum activity,and the effect  was seen equal to  the levels of blood 
glucose with standard  antidiabetic  drug, glibenclamide. 
 Exhibited significantly hypolipidemic effect in rats.  
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 Non-significant increase in kidney function tests, i.e., serum urea levels, 
serum creatinine levels and serum total protein levels. 
 Significantly reversed the decrease in body weight seen in diabetes.  
50% ethanolic extract of  Eriobotrya  japonica  fruits (EBJF) 
 Revealed a dose dependent antidiabetic potential in rats with doses of 
50,100 and 200 mg/kg b.w. The dose of 200 mg/kg b.w /day was found to 
more effective as it decreased the blood glucose levels even below the 
standard antidiabetic drug, glibenclamide and the values were nearly equal to 
normal control levels. 
 Exhibited significant hypolipidemic effect in rats in a dose dependent 
manner.  
 Non significant  increase  in  kidney function tests, i.e  serum  urea levels, 
serum creatinine  levels  and  serum total protein levels. 
 Significantly reversed the decrease in body weight seen in diabetes.  
50 % ethanolic extract of Eriobotrya japonica seeds (EBJS) 
 Revealed a dose dependent antidiabetic potential in rats with doses of 100 
and 200 mg/kg b.w.  
 Exhibited significantly hypolipidemic effect in rats. 
 Showed  non significant  increase  in  kidney function tests, i.e  serum  urea 
levels, serum creatinine  levels  and  serum total protein levels. 
 Significantly reversed the decrease in body weight seen in diabetic rats.  
 Glibenclamide, used as standard  antidiabetic  drug was  found to be  more 
effective as it   significantly  reduced the  blood  glucose  levels  while it had  
non  significant  effect  on  other  parameters.  
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 b) Streptozotocin induced Diabetes mellitus (15 day study)  
50 % ethanolic extract of Portulaca oleracea  whole plant (PO)  
 Revealed a dose dependent antidiabetic potential in rats with doses of 50 and 
100mg/kg b.w. The dose of 100 mg/kg b.w /day was found to be more active. 
 Exhibited significant hypolipidemic effect in rats.  
 Exhibited significant hepatoprotective   effect in rats. 
 Significantly reversed the decrease in body weight seen in diabetes.  
Histopathological studies of Portulaca olereacea  
 Portulaca oleracea   whole plant when administered (50 and 100 mg/kg b.w) 
to  rats showed  few inflammatory cells in the islets of pancreas at the dose 
of 50 mg/kg b.w while  at 100 mg/kg b.w showed no inflammatory cells, 
thereby  indicating  its  antidiabetic  potential.   
 No abnormality  in livers  
 No abnormality in kidneys. 
50 % ethanolic extract of Eriobotrya japonica fruits (EBJF) 
 Revealed a dose dependent antidiabetic potential in rats with the dose of 50 
and 100 mg/kg b.w.  
 Exhibited significant hypolipidemic effect in rats.  
 Exhibited significant hepatoprotective effect in rats.  
 Significantly reversed the decrease in body weight seen in diabetes.  
Histopathological studies of Eriobotrya japonica fruits 
 Eriobotrya japonica  fruits when administered (50 and 100 mg/kg b.w)  to  
rats   showed  an islet structure  with few inflammatory cells at the dose of 50 
mg/kg b.w while at the dose level of 100mg/kg b.w showed few 
inflammatory cells in the islet  of the  pancreas.  
 No abnormality   in livers  
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 No abnormality in kidneys.   
50% ethanolic extract of Eriobotrya japonica seeds (EBJS) 
 Revealed a dose dependent antidiabetic potential in rats with doses of 50 
and 100 mg/kg b.w.  
 Exhibited significant hypolipidemic effect in rats.  
 Exhibited significant hepatoprotective   effect in rats.  
 Significantly reversed the decrease in body weight seen in diabetes in a  dose 
dependent  manner  
Histopathological studies of Eriobotrya japonica seeds  
 Eriobotrya  japonica seeds  when  administered  at the  dose level of   50 and  
100 mg/kg b.w  to  rats  showed   an islet structure with several inflammatory 
cells at the dose of 50 mg/kg b.w with  vacuolation of islet cells while the  
dose of 100 mg/kg b.w to rats showed an islet structure with few 
inflammatory cells.  
 No abnormality  in liver 
 No abnormality in kidney 
 Glibenclamide , used as standard  antidiabetic  drug was  found to be effective 
in  significantly  reducing the  blood  glucose  levels  with  non  significant  
effect  on  other  parameters.  
It can be concluded that 50%  ethanolic  extract  of Portulaca  oleracea whole plant, 
Eriobotrya  japonica  fruits  and  Eriobotrya japonica  seeds  have  a significant 
antidiabetic potential. Besides they are found to have hypolipidemic and   
hepatoprotective effects as evident from the studies.  
Out of these three extracts used, extract of Eriobotrya japonica fruits was found to 
be most effective in reducing the blood glucose levels. However, further work needs 
to be done for isolating the main constituents responsible for this activity and for 
elucidating the mechanism of action of the antidiabetic activity of these three plant 
extracts.  
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